<html lang="en"><head>
	<!-- Required meta tags -->
	<meta charset="utf-8">
	<meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
	<!-- Check Browser, as well as Hostname and set JS, CSS, Favicon path based on that-->

	<!-- Favicon -->
	<!-- cpcommit -->
	<!-- <link rel="shortcut icon" type="image/x-icon" href="https://www.sec.gov/favicon.ico"> -->

	<script>
		(function () {
			var hostName = window.location.hostname;

			var browserAccepted = function () {

				var ua = window.navigator.userAgent;
				var trident = ua.indexOf('Trident/'); //IE 11;
				var msie = ua.indexOf('MSIE '); // IE 10 or older
				if (msie > 0) {
					return false;
				}
				return true;
			}();

			var pathToLibs = './js';
			var pathToError = './';
			// uncomment following lines only when running ix symlink to ix.xhtml on *.sec.gov
			/* commented out for running ix redirector script
			if (hostName === 'www-test.sec.gov' || hostName === 'www.sec.gov') {
				pathToLibs = './ixviewer/js';
				pathToError = '/ixviewer/';
			}
			*/
			if (browserAccepted) {

				// css
				document
					.write('<link rel="stylesheet" href=' + pathToLibs + '/css/custom-bootstrap.css>');
				document
					.write('<link rel="stylesheet" href=' + pathToLibs + '/lib/fontawesome/css/all.min.css>');
				document
					.write('<link rel="stylesheet" href=' + pathToLibs + '/css/app.css>');

				// js
				document
					.write('<script type="text/javascript" src="' + pathToLibs + '/lib/jquery-3.7.1.slim.min.js"><\/script>');
				document
					.write('<script type="text/javascript" src="' + pathToLibs + '/lib/popper.min.js"><\/script>');
				document
					.write('<script type="text/javascript" src="' + pathToLibs + '/lib/bootstrap.min.js"><\/script>');
				document
					.write('<script type="text/javascript" src="' + pathToLibs + '/lib/moment.js"><\/script>');
				document
					.write('<script type="text/javascript" src="' + pathToLibs + '/lib/vanilla-picker.min.js"><\/script>');
				document
					.write('<script type="text/javascript" src="' + pathToLibs + '/lib/he.js"><\/script>');

				var date = new Date();
				var todaysDate = date.getDate() + '-' + (date.getMonth() + 1) + '-'
					+ date.getFullYear();
				document.write('<script type = "text/javascript" defer=true src="'
					+ pathToLibs + '/production.min.js?d=' + todaysDate
					+ '"><\/script>');
			} else {
				// user us on a browser that we do not support
				var currentUrl = window.location.href.split('?')[0];
				var browserError = currentUrl.substring(0, currentUrl
					.lastIndexOf('/'));
				browserError += pathToError + 'browser-error.html?url='
					+ encodeURIComponent(window.location.href);
				window.location.href = browserError;
			}
		})();
	</script><link rel="stylesheet" href="./js/css/custom-bootstrap.css"><link rel="stylesheet" href="./js/lib/fontawesome/css/all.min.css"><link rel="stylesheet" href="./js/css/app.css"><script type="text/javascript" src="./js/lib/jquery-3.7.1.slim.min.js"></script><script type="text/javascript" src="./js/lib/popper.min.js"></script><script type="text/javascript" src="./js/lib/bootstrap.min.js"></script><script type="text/javascript" src="./js/lib/moment.js"></script><script type="text/javascript" src="./js/lib/vanilla-picker.min.js"></script><style>.picker_wrapper.no_alpha .picker_alpha{display:none}.picker_wrapper.no_editor .picker_editor{position:absolute;z-index:-1;opacity:0}.picker_wrapper.no_cancel .picker_cancel{display:none}.layout_default.picker_wrapper{display:-webkit-box;display:flex;-webkit-box-orient:horizontal;-webkit-box-direction:normal;flex-flow:row wrap;-webkit-box-pack:justify;justify-content:space-between;-webkit-box-align:stretch;align-items:stretch;font-size:10px;width:25em;padding:.5em}.layout_default.picker_wrapper input,.layout_default.picker_wrapper button{font-size:1rem}.layout_default.picker_wrapper>*{margin:.5em}.layout_default.picker_wrapper::before{content:'';display:block;width:100%;height:0;-webkit-box-ordinal-group:2;order:1}.layout_default .picker_slider,.layout_default .picker_selector{padding:1em}.layout_default .picker_hue{width:100%}.layout_default .picker_sl{-webkit-box-flex:1;flex:1 1 auto}.layout_default .picker_sl::before{content:'';display:block;padding-bottom:100%}.layout_default .picker_editor{-webkit-box-ordinal-group:2;order:1;width:6.5rem}.layout_default .picker_editor input{width:100%;height:100%}.layout_default .picker_sample{-webkit-box-ordinal-group:2;order:1;-webkit-box-flex:1;flex:1 1 auto}.layout_default .picker_done,.layout_default .picker_cancel{-webkit-box-ordinal-group:2;order:1}.picker_wrapper{box-sizing:border-box;background:#f2f2f2;box-shadow:0 0 0 1px silver;cursor:default;font-family:sans-serif;color:#444;pointer-events:auto}.picker_wrapper:focus{outline:none}.picker_wrapper button,.picker_wrapper input{box-sizing:border-box;border:none;box-shadow:0 0 0 1px silver;outline:none}.picker_wrapper button:focus,.picker_wrapper button:active,.picker_wrapper input:focus,.picker_wrapper input:active{box-shadow:0 0 2px 1px dodgerblue}.picker_wrapper button{padding:.4em .6em;cursor:pointer;background-color:whitesmoke;background-image:-webkit-gradient(linear, left bottom, left top, from(gainsboro), to(transparent));background-image:-webkit-linear-gradient(bottom, gainsboro, transparent);background-image:linear-gradient(0deg, gainsboro, transparent)}.picker_wrapper button:active{background-image:-webkit-gradient(linear, left bottom, left top, from(transparent), to(gainsboro));background-image:-webkit-linear-gradient(bottom, transparent, gainsboro);background-image:linear-gradient(0deg, transparent, gainsboro)}.picker_wrapper button:hover{background-color:white}.picker_selector{position:absolute;z-index:1;display:block;-webkit-transform:translate(-50%, -50%);transform:translate(-50%, -50%);border:2px solid white;border-radius:100%;box-shadow:0 0 3px 1px #67b9ff;background:currentColor;cursor:pointer}.picker_slider .picker_selector{border-radius:2px}.picker_hue{position:relative;background-image:-webkit-gradient(linear, left top, right top, from(red), color-stop(yellow), color-stop(lime), color-stop(cyan), color-stop(blue), color-stop(magenta), to(red));background-image:-webkit-linear-gradient(left, red, yellow, lime, cyan, blue, magenta, red);background-image:linear-gradient(90deg, red, yellow, lime, cyan, blue, magenta, red);box-shadow:0 0 0 1px silver}.picker_sl{position:relative;box-shadow:0 0 0 1px silver;background-image:-webkit-gradient(linear, left top, left bottom, from(white), color-stop(50%, rgba(255,255,255,0))),-webkit-gradient(linear, left bottom, left top, from(black), color-stop(50%, rgba(0,0,0,0))),-webkit-gradient(linear, left top, right top, from(gray), to(rgba(128,128,128,0)));background-image:-webkit-linear-gradient(top, white, rgba(255,255,255,0) 50%),-webkit-linear-gradient(bottom, black, rgba(0,0,0,0) 50%),-webkit-linear-gradient(left, gray, rgba(128,128,128,0));background-image:linear-gradient(180deg, white, rgba(255,255,255,0) 50%),linear-gradient(0deg, black, rgba(0,0,0,0) 50%),linear-gradient(90deg, gray, rgba(128,128,128,0))}.picker_alpha,.picker_sample{position:relative;background:url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='2' height='2'%3E%3Cpath d='M1,0H0V1H2V2H1' fill='lightgrey'/%3E%3C/svg%3E") left top/contain white;box-shadow:0 0 0 1px silver}.picker_alpha .picker_selector,.picker_sample .picker_selector{background:none}.picker_editor input{font-family:monospace;padding:.2em .4em}.picker_sample::before{content:'';position:absolute;display:block;width:100%;height:100%;background:currentColor}.picker_arrow{position:absolute;z-index:-1}.picker_wrapper.popup{position:absolute;z-index:2;margin:1.5em}.picker_wrapper.popup,.picker_wrapper.popup .picker_arrow::before,.picker_wrapper.popup .picker_arrow::after{background:#f2f2f2;box-shadow:0 0 10px 1px rgba(0,0,0,0.4)}.picker_wrapper.popup .picker_arrow{width:3em;height:3em;margin:0}.picker_wrapper.popup .picker_arrow::before,.picker_wrapper.popup .picker_arrow::after{content:"";display:block;position:absolute;top:0;left:0;z-index:-99}.picker_wrapper.popup .picker_arrow::before{width:100%;height:100%;-webkit-transform:skew(45deg);transform:skew(45deg);-webkit-transform-origin:0 100%;transform-origin:0 100%}.picker_wrapper.popup .picker_arrow::after{width:150%;height:150%;box-shadow:none}.popup.popup_top{bottom:100%;left:0}.popup.popup_top .picker_arrow{bottom:0;left:0;-webkit-transform:rotate(-90deg);transform:rotate(-90deg)}.popup.popup_bottom{top:100%;left:0}.popup.popup_bottom .picker_arrow{top:0;left:0;-webkit-transform:rotate(90deg) scale(1, -1);transform:rotate(90deg) scale(1, -1)}.popup.popup_left{top:0;right:100%}.popup.popup_left .picker_arrow{top:0;right:0;-webkit-transform:scale(-1, 1);transform:scale(-1, 1)}.popup.popup_right{top:0;left:100%}.popup.popup_right .picker_arrow{top:0;left:0}</style><script type="text/javascript" src="./js/lib/he.js"></script><script type="text/javascript" defer="true" src="./js/production.min.js?d=22-4-2024"></script>
	<title>Inline XBRL Viewer</title>
<style type="text/css" id="customized-styles"> #dynamic-xbrl-form [enabled-taxonomy="true"][continued-taxonomy="false"]{border-top:2px solid #FF6600;border-bottom:2px solid #FF6600;display:inline;} #dynamic-xbrl-form [enabled-taxonomy="true"][continued-main-taxonomy="true"]{box-shadow:-2px 0px 0px 0px #FF6600, 2px 0px 0px 0px #FF6600;} #dynamic-xbrl-form [enabled-taxonomy="true"][text-block-taxonomy="true"]{box-shadow:-2px 0px 0px 0px #FF6600, 2px 0px 0px 0px #FF6600;border-top:none;border-bottom:none;} #dynamic-xbrl-form [highlight-taxonomy="true"]{background-color:#FFD700 !important;} #dynamic-xbrl-form [highlight-taxonomy="true"] > *{background-color:#FFD700 !important;} #dynamic-xbrl-form [selected-taxonomy="true"][continued-main-taxonomy="true"]{box-shadow:-2px 0px 0px 0px #003768, 2px 0px 0px 0px #003768;} #dynamic-xbrl-form [selected-taxonomy="true"][text-block-taxonomy="true"]{box-shadow:-2px 0px 0px 0px #003768, 2px 0px 0px 0px #003768;} #dynamic-xbrl-form [selected-taxonomy="true"][continued-taxonomy="false"]{border:3px solid #003768 !important;display:inline;} #dynamic-xbrl-form [hover-taxonomy="true"]{background-color:rgba(255,0,0,0.3);} #dynamic-xbrl-form .text-block-indicator-left{border-left:.75rem solid ##003768;} #dynamic-xbrl-form .text-block-indicator-right{border-right:.75rem solid ##003768;} .tagged-data-example-1{border-top:2px solid #FF6600;border-bottom:2px solid #FF6600;} .search-results-example-1{background-color:#FFD700;} .tag-shading-exmple-1:hover{background-color:rgba(255,0,0,0.3);} .selected-fact-example-1{border:3px solid #003768 !important;}</style></head>

<body>
	<noscript>This application relies heavily on JavaScript, you
		will need to allow JavaScript to use this application.</noscript>
	<nav class="reboot navbar navbar-expand-md navbar-dark navbar-height bg-sec fixed-top w-100 pl-0">
		<button class="reboot navbar-toggler ml-1" type="button" data-test="" data-toggle="collapse" data-target="#main-navbar" aria-controls="main-navbar" aria-expanded="false" aria-label="Toggle navigation">Inline Viewer</button>
		<div class="reboot navbar-height collapse navbar-collapse bg-sec w-100" data-test="main-navbar" id="main-navbar">
			<ul class="reboot navbar-nav mr-auto bg-inherit">
				<li class="reboot nav-item dropdown my-auto ml-1">
					<a id="menu-dropdown-link" data-test="menu-dropdown-link" class="reboot nav-link dropdown-toggle click disabled" role="button" data-toggle="dropdown" aria-haspopup="true" aria-expanded="false" tabindex="1" accesskey="1">
						<i class="reboot nav-loading fas fa-bars" title="Menu"></i>
						<span class="reboot d-md-none d-lg-inline">Menu</span>
						<span class="reboot sr-only sr-only-focusable">Menu</span>
					</a>
					<div class="reboot dropdown-menu">
						<a id="menu-dropdown-information" data-test="menu-dropdown-information" class="reboot dropdown-item click text-body" tabindex="1">Information</a>
						<a id="form-information-instance" data-test="form-information-instance" class="reboot dropdown-item click text-body" target="_blank" tabindex="1">Save XBRL
							Instance</a>
						<a id="form-information-zip" data-test="form-information-zip" class="reboot dropdown-item click text-body" target="_blank" tabindex="1">Save XBRL Zip
							File</a>
						<a id="form-information-html" data-test="form-information-html" class="reboot dropdown-item click text-body" target="_blank" tabindex="1">Open as HTML</a>
						<a id="menu-dropdown-settings" data-test="menu-dropdown-settings" class="reboot dropdown-item click text-body" tabindex="1">Settings</a>
						<a id="form-information-help" data-test="form-information-help" class="reboot dropdown-item click text-body" tabindex="1">Help</a>
						<span id="form-information-version" class="reboot dropdown-item-text text-body" tabindex="1"></span>
					</div>
				</li>
				<li class="reboot nav-item my-auto ml-1">
					<a id="sections-dropdown-link" data-test="sections-dropdown-link" class="reboot nav-link click disabled meta-required" tabindex="2" accesskey="2">
						<i class="reboot fas fa-layer-group" title="Sections"></i>
						<span class="reboot d-md-none d-lg-inline">Sections</span>
						<span class="reboot sr-only sr-only-focusable">Sections</span>
					</a>
				</li>
				<li class="reboot nav-item my-auto ml-1 mr-1">
					<form id="global-search-form" data-test="global-search-form" class="reboot my-2 my-lg-0 input-group disabled" novalidate="">
						<div class="reboot input-group-prepend">
							<button data-name="global-search-options" class="reboot dropdown btn btn-outline-light disabled" type="button" data-toggle="dropdown" tabindex="3">
								<i class="reboot nav-loading fas fa-cog" title="Additional Search Options">
									<span class="reboot sr-only sr-only-focusable">Additional
										Search Options</span>
								</i>
							</button>
							<div class="reboot dropdown-menu px-2">
								<div class="reboot form-check">
									<input disabled="" class="reboot form-check-input meta-required" type="checkbox" name="search-options" value="1" checked="" tabindex="3">
									<label class="reboot form-check-label mb-0">
										<span class="reboot">Include Fact Name</span>
									</label>
								</div>
								<div class="reboot form-check">
									<input disabled="" class="reboot form-check-input meta-required" type="checkbox" name="search-options" value="2" checked="" tabindex="3">
									<label class="reboot form-check-label mb-0">
										<span class="reboot">Include Fact Content</span>
									</label>
								</div>
								<div class="reboot form-check">
									<input disabled="" class="reboot form-check-input meta-required" type="checkbox" name="search-options" value="3" checked="" tabindex="3">
									<label class="reboot form-check-label mb-0">
										<span class="reboot">Include Labels</span>
									</label>
								</div>
								<div class="reboot form-check">
									<input disabled="" class="reboot form-check-input meta-required" type="checkbox" name="search-options" value="4" tabindex="3">
									<label class="reboot form-check-label mb-0">
										<span class="reboot">Include Definitions</span>
									</label>
								</div>
								<div class="reboot form-check">
									<input disabled="" class="reboot form-check-input meta-required" type="checkbox" name="search-options" value="5" tabindex="3">
									<label class="reboot form-check-label mb-0">
										<span class="reboot">Include Dimensions</span>
									</label>
								</div>
								<div class="reboot bg-light border p-1">
									<span class="reboot dropdown-item-text">Reference
										Options</span>
									<div class="reboot form-check">
										<input disabled="" class="reboot form-check-input meta-required" type="checkbox" name="search-options" value="6" tabindex="3">
										<label class="reboot form-check-label mb-0">
											<span class="reboot">Include Topic</span>
										</label>
									</div>
									<div class="reboot form-check">
										<input disabled="" class="reboot form-check-input meta-required" type="checkbox" name="search-options" value="7" tabindex="3">
										<label class="reboot form-check-label mb-0">
											<span class="reboot">Include Sub-Topic</span>
										</label>
									</div>
									<div class="reboot form-check">
										<input disabled="" class="reboot form-check-input meta-required" type="checkbox" name="search-options" value="8" tabindex="3">
										<label class="reboot form-check-label mb-0">
											<span class="reboot">Include Paragraph</span>
										</label>
									</div>
									<div class="reboot form-check">
										<input disabled="" class="reboot form-check-input meta-required" type="checkbox" name="search-options" value="9" tabindex="3">
										<label class="reboot form-check-label mb-0">
											<span class="reboot">Include Publisher</span>
										</label>
									</div>
									<div class="reboot form-check">
										<input disabled="" class="reboot form-check-input meta-required" type="checkbox" name="search-options" value="10" tabindex="3">
										<label class="reboot form-check-label mb-0">
											<span class="disabled">Include Section</span>
										</label>
									</div>
								</div>
								<div class="reboot form-check">
									<input class="reboot form-check-input" type="checkbox" name="search-options" value="11" tabindex="3">
									<label class="reboot form-check-label mb-0">
										<span class="reboot">Match Case</span>
									</label>
								</div>
							</div>
						</div>
						<input type="text" class="reboot form-control disabled" id="global-search" data-test="global-search" placeholder="Search Facts" disabled="" aria-label="Search all Facts and highlight them accordingly." tabindex="4">
						<div class="reboot input-group-append">
							<button id="search-btn-clear" data-name="global-search-clear" class="reboot btn btn-outline-light disabled" type="button" tabindex="5">
								<i class="reboot nav-loading fas fa-times-circle" title="Clear Search"></i>
								<span class="reboot sr-only sr-only-focusable">Clear
									Search</span>
							</button>
							<button class="reboot btn btn-outline-light disabled" type="submit" tabindex="6">
								<i class="reboot nav-loading fas fa-search" title="Submit Search"></i>
								<span class="reboot sr-only sr-only-focusable">Submit
									Search</span>
							</button>
						</div>
					</form>
				</li>
				<li class="reboot nav-item dropdown my-auto ml-1">
					<a href="#" id="nav-filter-data" data-test="nav-filter-data" class="reboot nav-link dropdown-toggle disabled click" role="button" data-toggle="dropdown" aria-haspopup="true" aria-expanded="false" tabindex="7" accesskey="3">
						<i class="reboot nav-loading fas fa-list-alt" title="Data"></i>
						<span class="reboot d-md-none d-lg-inline">Data</span>
						<span class="reboot sr-only sr-only-focusable">Data</span>
					</a>
					<div class="reboot dropdown-menu">
						<form id="nav-filter-dropdown" data-name="data-dropdown" class="reboot px-2">
							<div class="reboot form-check">
								<input class="reboot form-check-input" type="radio" name="data-radios" value="0" checked="" tabindex="7">
								<label class="reboot form-check-label mb-0">All</label>
							</div>
							<div class="reboot form-check">
								<input class="reboot form-check-input" type="radio" name="data-radios" value="1" tabindex="7">
								<label class="reboot form-check-label mb-0">
									<i title="The first time choosing this will take a few moments." class="reboot far fa-clock d-none performance-concern"></i>
									<span class="reboot">Amounts Only</span>
								</label>
							</div>
							<div class="reboot form-check">
								<input class="reboot form-check-input" type="radio" name="data-radios" value="2" tabindex="7">
								<label class="reboot form-check-label mb-0">
									<i title="The first time choosing this will take a few moments." class="reboot far fa-clock d-none performance-concern"></i>
									<span class="reboot">Text Only</span>
								</label>
							</div>
							<div class="reboot form-check">
								<input class="reboot form-check-input meta-required" type="radio" name="data-radios" value="3" disabled="" tabindex="7">
								<label class="reboot form-check-label mb-0">
									<i title="The first time choosing this will take a few moments." class="reboot far fa-clock d-none performance-concern"></i>
									<span class="reboot">Calculations Only</span>
								</label>
							</div>
							<div class="reboot form-check">
								<input class="reboot form-check-input" type="radio" name="data-radios" value="4" tabindex="7">
								<label class="reboot form-check-label mb-0">
									<i title="The first time choosing this will take a few moments." class="reboot far fa-clock d-none performance-concern"></i>
									<span class="reboot">Negatives Only</span>
								</label>
							</div>
							<div class="reboot form-check">
								<input class="reboot form-check-input" type="radio" name="data-radios" value="5" tabindex="7">
								<label class="reboot form-check-label mb-0">
									<i title="The first time choosing this will take a few moments." class="reboot far fa-clock d-none performance-concern"></i>
									<span class="reboot">Additional Items Only</span>
								</label>
							</div>
						</form>
					</div>
				</li>
				<li class="reboot nav-item dropdown my-auto ml-1">
					<a href="#" id="nav-filter-tags" data-test="nav-filter-tags" class="reboot nav-link dropdown-toggle disabled click" role="button" data-toggle="dropdown" aria-haspopup="true" aria-expanded="false" tabindex="8" accesskey="4">
						<i class="reboot nav-loading fas fa-tags" title="Tags"></i>
						<span class="reboot d-md-none d-lg-inline">Tags</span>
						<span class="reboot sr-only sr-only-focusable">Tags</span>
					</a>
					<div class="reboot dropdown-menu">
						<form id="nav-filter-tags-dropdown" data-name="tags-dropdown" class="reboot px-2">
							<div class="reboot form-check">
								<input class="reboot form-check-input" type="radio" name="tags-radios" value="0" aria-label="Radio Button for All Tag Types" checked="" tabindex="8">
								<label class="reboot form-check-label mb-0">All</label>
							</div>
							<div class="reboot form-check">
								<input class="reboot form-check-input" type="radio" name="tags-radios" value="1" aria-label="Radio Button for Standard Only Tag Types" tabindex="8">
								<label class="reboot form-check-label mb-0">
									<i title="The first time choosing this will take a few moments." class="reboot far fa-clock d-none performance-concern"></i>
									<span>Standard Only</span>
								</label>
							</div>
							<div class="reboot form-check">
								<input class="reboot form-check-input meta-required" type="radio" name="tags-radios" value="2" disabled="" aria-label="Radio Button for Custom Only Tag Types" tabindex="8">
								<label class="reboot form-check-label mb-0">
									<i title="Facts whose tags are outside the realm of DEI, US-GAAP, etc." class="reboot far fa-question-circle"></i>
									<i title="The first time choosing this will take a few moments." class="reboot far fa-clock d-none performance-concern"></i>
									<span class="reboot">Custom Only</span>
								</label>
							</div>
						</form>
					</div>
				</li>
				<li class="reboot nav-item dropdown my-auto ml-1">
					<a href="#" id="nav-filter-more" data-test="nav-filter-more" class="reboot nav-link dropdown-toggle disabled click" role="button" data-toggle="dropdown" aria-haspopup="true" aria-expanded="false" tabindex="9" accesskey="5">
						<i id="loading-more-filters" class="reboot nav-loading fas fa-filter" title="More Filters"></i>
						<span class="reboot d-md-none d-lg-inline">More Filters</span>
						<span class="reboot sr-only sr-only-focusable">More Filters</span>
						<span title="Total active filters." class="reboot badge badge-warning"></span>
					</a>
					<div class="reboot dropdown-menu dropdown-menu-width">
						<label class="reboot dropdown-item-text d-none performance-concern">
							Selecting any of the below will take a few moments.</label>
						<div class="reboot accordion" id="more-filters-accordion">
							<form class="reboot" data-test="more-filters-form">
								<div class="reboot mx-1">
									<div class="reboot px-0 py-0">
										<a href="#" data-test="Period" data-target="#user-filters-periods" data-toggle="collapse" class="reboot d-flex justify-content-between align-items-center w-100 click text-primary" tabindex="9">
											<span class="reboot">Periods</span>
											<span data-test="Period-count" id="filters-periods-count" class="reboot badge badge-secondary">
												<i class="reboot fas fa-spinner fa-spin"></i>
											</span>
										</a>
									</div>
									<div id="user-filters-periods" class="reboot collapse height-200 overflow-y-auto" data-parent="#more-filters-accordion">
										<!-- Below is populated dynamically VIA JS -->
										<div class="reboot list-group list-group-flush"></div>
									</div>
								</div>
							</form>
							<form>
								<div class="reboot mx-1">
									<div class="reboot px-0 py-0">
										<a href="#" data-test="Measures" data-target="#user-filters-measures" data-toggle="collapse" class="reboot d-flex justify-content-between align-items-center w-100 click text-primary" tabindex="9">
											<span class="reboot">Measures</span>
											<span data-test="Measures-count" id="filters-measures-count" class="reboot badge badge-secondary">
												<i class="reboot fas fa-spinner fa-spin"></i>
											</span>
										</a>
									</div>
									<div id="user-filters-measures" class="reboot collapse height-200 overflow-y-auto" data-parent="#more-filters-accordion">
										<!-- Below is populated dynamically VIA JS -->
										<div class="reboot list-group list-group-flush"></div>
									</div>
								</div>
							</form>
							<form>
								<div class="reboot mx-1">
									<div class="reboot  px-0 py-0">
										<a href="#" data-test="Axis" data-target="#user-filters-axis" data-toggle="collapse" class="reboot d-flex justify-content-between align-items-center w-100 click text-primary" tabindex="9">
											<span class="reboot">Axis</span>
											<span data-test="Axis-count" id="filters-axis-count" class="reboot badge badge-secondary">
												<i class="fas fa-spinner fa-spin"></i>
											</span>
										</a>
									</div>
									<div id="user-filters-axis" class="reboot collapse height-200 overflow-y-auto" data-parent="#more-filters-accordion">
										<div class="reboot list-group list-group-flush d-none">
											<div class="reboot d-flex justify-content-between align-items-center w-100 px-1">
												<div class="reboot form-check">
													<input id="axes-all-0" title="Select/Deselect all options below." class="reboot form-check-input" type="checkbox" tabindex="9">
													<label class="reboot form-check-label mb-0">
														<a class="reboot" href="#axes-filters-accordion-0" data-toggle="collapse" tabindex="9">Explicit</a>
													</label>
												</div>
												<span class="reboot badge badge-secondary" id="axis-explicit-count"></span>
											</div>
										</div>
										<!-- Below is populated dynamically VIA JS -->
										<div class="reboot list-group list-group-flush d-none">
											<div class="reboot d-flex justify-content-between align-items-center w-100 px-1">
												<div class="reboot form-check">
													<input id="axes-all-1" title="Select/Deselect all options below." class="reboot form-check-input" type="checkbox" tabindex="9">
													<label class="reboot form-check-label mb-0">
														<a class="reboot" href="#axes-filters-accordion-1" data-toggle="collapse" tabindex="9">Typed</a>
													</label>
												</div>
												<span class="reboot badge badge-secondary" id="axis-typed-count"></span>
											</div>
										</div>
									</div>
								</div>
							</form>
							<form>
								<div class="reboot mx-1">
									<div class="reboot px-0 py-0">
										<a href="#" data-test="Members" data-target="#user-filters-members" data-toggle="collapse" class="reboot d-flex justify-content-between align-items-center w-100 click text-primary" tabindex="9">
											<span class="reboot">Members</span>
											<span data-test="Members-count" id="filters-members-count" class="reboot badge badge-secondary">
												<i class="reboot fas fa-spinner fa-spin"></i>
											</span>
										</a>
									</div>
									<div id="user-filters-members" class="reboot collapse height-200 overflow-y-auto" data-parent="#more-filters-accordion">
										<div class="reboot list-group list-group-flush d-none">
											<div class="reboot d-flex justify-content-between align-items-center w-100 px-1">
												<div class="reboot form-check">
													<input id="members-all-0" title="Select/Deselect all options below." class="reboot form-check-input" type="checkbox" tabindex="9">
													<label class="reboot form-check-label mb-0">
														<a class="reboot" href="#members-filters-accordion-0" data-toggle="collapse" tabindex="9">Explicit</a>
													</label>
												</div>
												<span class="reboot badge badge-secondary" id="members-explicit-count"></span>
											</div>
										</div>
										<!-- Below is populated dynamically VIA JS -->
										<div class="reboot list-group list-group-flush d-none">
											<div class="reboot d-flex justify-content-between align-items-center w-100 px-1">
												<div class="reboot form-check">
													<input id="members-all-1" title="Select/Deselect all options below." class="reboot form-check-input" type="checkbox" tabindex="9">
													<label class="reboot form-check-label mb-0">
														<a class="reboot" href="#members-filters-accordion-1" data-toggle="collapse" tabindex="9">Typed</a>
													</label>
												</div>
												<span class="reboot badge badge-secondary" id="members-typed-count"></span>
											</div>
										</div>
									</div>
								</div>
							</form>
							<form>
								<div class="reboot mx-1">
									<div class="reboot px-0 py-0">
										<a href="#" data-test="Scale" data-target="#user-filters-scales" data-toggle="collapse" class="reboot d-flex justify-content-between align-items-center w-100 click text-primary" tabindex="9">
											<span class="reboot">Scale</span>
											<span data-test="Scale-count" id="filters-scales-count" class="reboot badge badge-secondary">
												<i class="reboot fas fa-spinner fa-spin"></i>
											</span>
										</a>
									</div>
									<div id="user-filters-scales" class="reboot collapse height-200 overflow-y-auto" data-parent="#more-filters-accordion">
										<!-- Below is populated dynamically VIA JS -->
										<div class="reboot list-group list-group-flush"></div>
									</div>
								</div>
							</form>
							<form>
								<div class="reboot mx-1">
									<div class="reboot px-0 py-0">
										<a href="#" data-test="Balance" data-target="#user-filters-balances" data-toggle="collapse" class="reboot d-flex justify-content-between align-items-center w-100 click text-primary" tabindex="9">
											<span class="reboot">Balance</span>
											<span data-test="Balance-count" id="filters-balances-count" class="reboot badge badge-secondary">2</span>
										</a>
									</div>
									<div id="user-filters-balances" class="reboot collapse height-200 overflow-y-auto" data-parent="#more-filters-accordion">
										<div class="reboot d-flex justify-content-between align-items-center w-100 px-2">
											<div class="reboot form-check">
												<input id="user-filters-balances-debit" title="Select/Deselect this option." class="reboot form-check-input" type="checkbox" tabindex="9">
												<label class="reboot form-check-label mb-0">Debit</label>
											</div>
										</div>
										<div class="reboot d-flex justify-content-between align-items-center w-100 px-2">
											<div class="reboot form-check">
												<input id="user-filters-balances-credit" title="Select/Deselect this option." class="reboot form-check-input" type="checkbox" tabindex="9">
												<label class="reboot form-check-label mb-0">Credit</label>
											</div>
										</div>
									</div>
								</div>
							</form>
						</div>
					</div>
				</li>
				<li id="current-filters-reset" data-test="current-filters-reset" class="reboot nav-item d-none my-auto ml-1">
					<a href="#" id="current-filters-reset-all" data-name="current-filters-reset" class="reboot nav-link dropdown-toggle text-danger disabled click" tabindex="11" accesskey="7">
						<i class="reboot nav-loading fas fa-redo"></i>
						<span class="reboot d-md-none d-lg-inline">Reset All
							Filters</span>
					</a>
				</li>
				<li id="links-dropdown" data-test="links-dropdown" class="reboot nav-item dropdown d-none my-auto ml-1">
					<a href="#" id="additional-links-dropdown" class="reboot nav-link dropdown-toggle disabled click" role="button" data-toggle="dropdown" aria-haspopup="true" aria-expanded="false" tabindex="12" accesskey="8">
						<i class="reboot nav-loading fas fa-link"></i>
						<span class="reboot d-md-none d-lg-inline">Links</span>
					</a>
					<div id="links-dropdown-content" class="reboot dropdown-menu dropdown-menu-width w-auto"></div>
				</li>
			</ul>
			<ul class="reboot navbar-nav pull-right bg-inherit">
				<li class="reboot nav-item my-auto ml-1">
					<a id="facts-menu" data-test="facts-menu" class="reboot nav-link click" tabindex="13" accesskey="9">
						Facts
						<span class="reboot taxonomy-total-count badge badge-light"><i class="fas fa-spinner fa-spin"></i></span>
					</a>
				</li>
			</ul>
		</div>
	</nav>
	<div class="reboot main-container">
		<div id="error-container" data-test="error-container" class="reboot px-0"></div>
		<div id="xbrl-form-loading" data-test="xbrl-form-loading" class="reboot jumbotron h-100 d-none">
			<h2 class="reboot display-4 text-center">
				<i class="reboot fas fa-spinner fa-spin"></i>
				Loading Inline Form.
			</h2>
		</div>
		<div id="sections-menu" data-test="sections-menu" class="reboot left-sidenav col-sm-3 bg-light overflow-x-auto invisible">
			<div class="reboot mb-2">
				<span class="reboot lead">Tagged Sections</span>
				<a id="sections-menu-toggle" class="reboot float-right click color-inherit" tabindex="2">
					<i class="reboot fas fa-times-circle mt-2 text-dark"></i>
				</a>
			</div>
			<form id="sections-menu-search-submit" data-name="sections-menu-search" class="reboot my-2 my-lg-0 input-group" novalidate="">
				<div id="sections-search-additional" class="reboot input-group-prepend d-none">
					<button class="reboot dropdown btn btn-sec" type="button" data-toggle="dropdown" tabindex="2">
						<i class="reboot nav-loading fas fa-cog"></i>
					</button>
					<div class="reboot dropdown-menu px-2">
						<div class="reboot form-check">
							<input class="reboot form-check-input" type="radio" name="sections-search-options" value="1" checked="" tabindex="2">
							<label class="reboot form-check-label">Search in All.</label>
						</div>
						<div class="reboot form-check">
							<input class="reboot form-check-input" type="radio" name="sections-search-options" value="2" tabindex="2">
							<label class="reboot form-check-label">Search in Internal
								Sections Only.</label>
						</div>
						<div class="reboot form-check">
							<input class="reboot form-check-input" type="radio" name="sections-search-options" value="3" tabindex="2">
							<label class="reboot form-check-label">Search in External
								Sections Only.</label>
						</div>
					</div>
				</div>
				<input type="text" class="reboot form-control" id="sections-search" data-test="sections-search" placeholder="Search Sections" aria-label="Search all Sections by their associated label." name="search-sections" tabindex="2" required="">
				<div class="reboot input-group-append">
					<button id="section-menu-search-btn-clear" data-name="sections-menu-search-clear" class="reboot btn btn-sec" type="button" tabindex="2">
						<i class="nav-loading fas fa-times-circle" title="Clear Sections Search"></i>
						<span class="reboot sr-only sr-only-focusable">Clear
							Sections Search</span>
					</button>
					<button class="reboot btn btn-sec" type="submit" tabindex="2">
						<i class="reboot nav-loading fas fa-search" title="Submit Sections Search"></i>
						<span class="reboot sr-only sr-only-focusable">Submit
							Sections Search</span>
					</button>
				</div>
			</form>
			<hr>

			<div class="reboot accordion" id="tagged-sections">
				<!-- Below is populated dynamically VIA JS -->
			</div>
		</div>



		<div id="help-menu" data-test="help-menu" class="reboot left-sidenav col-sm-3 bg-light overflow-x-auto invisible">

			<div class="reboot mb-2">
				<span class="reboot lead">Help</span> <a id="help-menu-close" data-test="help-menu-close" class="reboot float-right click"> <i class="reboot fas fa-times-circle mt-2"></i>
				</a>
			</div>
			<div class="reboot accordion" id="help-sections">
				<div class="reboot card">
					<div class="reboot card-header px-0 py-0">
						<h5 class="reboot mb-0">
							<button class="reboot btn btn-link d-flex justify-content-between align-items-center w-100" type="button" data-toggle="collapse" data-target="#help-getting-started">
								<span class="reboot font-size-1 ">Getting Started</span>
							</button>
						</h5>
					</div>
					<div id="help-getting-started" class="reboot collapse" data-parent="#help-sections">
						<p class="reboot m-2">The Inline XBRL viewer allows a user
							to quickly and easily review details of the tagged information in
							an Inline document by automatically placing a top and bottom
							highlight border around each tagged numeric fact and left and
							right border for each block tagged fact. Hovering over a tagged
							fact will highlight (shade) all content related to the tagged
							fact, and clicking on a tagged fact will reveal its tagging
							details in the Fact Review Window. Navigation, search and filter
							options are also provided to easily refine and identify specific
							types of tagged information.</p>
					</div>
				</div>
				<div class="reboot card">
					<div class="reboot card-header px-0 py-0">
						<h5 class="reboot mb-0">
							<button class="reboot btn btn-link d-flex justify-content-between align-items-center w-100" type="button" data-toggle="collapse" data-target="#help-fact-review-window">
								<span class="reboot font-size-1">Fact Review Window</span>
							</button>
						</h5>
					</div>
					<div id="help-fact-review-window" class="reboot collapse" data-parent="#help-sections">
						<p class="reboot m-2">The Fact Review Window shows the tagging
							details for the currently selected fact, which is highlighted
							with a solid blue border. There are four categories of fact detail
							which can be viewed; an "N/A" value indicates there is no
							available information for the item within the given category:</p>
						<ul class="reboot">
							<li class="reboot">Attributes - All primary information (as
								applicable) describing the tagged fact including period, sign,
								decimals, dimensional detail (axes and members), scale, measure
								and data type.</li>
							<li class="reboot">Labels - Detailed documentation
								(definition) for the tag used, and other labels.</li>
							<li class="reboot">References - Authoritative reference
								information (as applicable) for the selected tag.</li>
							<li class="reboot">Calculation - Balance and calculation
								hierarchy details (numeric non-dimensioned items only).</li>
						</ul>
					</div>
				</div>
				<div class="reboot card">
					<div class="reboot card-header px-0 py-0">
						<h5 class="reboot mb-0">
							<button class="reboot btn btn-link d-flex justify-content-between align-items-center w-100" type="button" data-toggle="collapse" data-target="#help-search">
								<span class="reboot font-size-1">Searching</span>
							</button>
						</h5>
					</div>
					<div id="help-search" class="reboot collapse" data-parent="#help-sections">
						<p class="reboot m-2">There are two ways to search the
							document: FACTS AND SECTIONS. To search information, enter a
							keyword in a search box and select the magnifying glass icon to
							return matching results. Search operators "and" (via "AND" or
							"&amp;") and "or" (via "OR" or "|") are available to further refine a
							search.</p>
						<p class="reboot m-2">
							<strong>FACTS</strong>
						</p>
						<p class="reboot m-2">The Search Facts box can be used to find
							tagged facts matching entered keywords. By default, tag name, tag
							labels, and tagged content are included in Search. Tagged facts
							matching the search criteria are shown with a yellow-colored
							(default) shading on the page and appear in the Facts List.
							Select the "X" button to the left of the magnifying glass icon to
							clear the search.</p>
						<p class="reboot m-2">The content included in Search can be increased to
							included tag definitions, dimensions, and authoritative
							references by selecting the cog / wheel icon to the left of the
							search box. See Settings for more information.</p>

						<p class="reboot m-2">
							<strong>SECTIONS</strong>
						</p>
						<p class="reboot m-2">The Search Sections box can be used to
							filter the tagged sections of the financial statements.</p>
					</div>
				</div>
				<div class="reboot card">
					<div class="reboot card-header px-0 py-0">
						<h5 class="reboot mb-0">
							<button class="reboot btn btn-link d-flex justify-content-between align-items-center w-100" type="button" data-toggle="collapse" data-target="#help-filter">
								<span class="reboot font-size-1">Filters</span>
							</button>
						</h5>
					</div>
					<div id="help-filter" class="reboot collapse" data-parent="#help-sections">
						<p class="reboot m-2">Filters change the number of highlighted
							facts and items in the fact list by providing several ways to
							review and pinpoint certain tagged information. Multiple filters
							can be used at once.</p>
						<p class="reboot m-2">
							<strong>DATA FILTERS</strong>
						</p>
						<p class="reboot m-2">These filter options allow the user to
							refine the highlighted tagged facts by data type:</p>
						<ul class="reboot">
							<li class="reboot">All - Displays all tagged data (default)</li>
							<li class="reboot">Amounts Only - Numeric facts only</li>
							<li class="reboot">Text Only - Textual facts only</li>
							<li class="reboot">Calculations Only - Numeric facts
								participating in a calculation only</li>
							<li class="reboot">Negatives Only - Negative Numeric amounts
								only</li>
							<li class="reboot">Additional Items Only - Tagged facts
								without a corresponding HTML presentation (i.e., hidden facts)
								only</li>
						</ul>
						<p class="reboot m-2">
							<strong>TAGS FILTER</strong>
						</p>
						<p class="reboot m-2">These filters allow the user to refine
							the highlighted facts by tag type:</p>
						<ul class="reboot">
							<li class="reboot">All - Displays all tagged data (default)</li>
							<li class="reboot">Standard Only- Facts with standard tags
								from a common taxonomy (e.g., US_GAAP, IFRS, DEI).</li>
							<li class="reboot">Custom Only - Facts with extension
								"custom" tags unique to the entity's document.</li>
						</ul>
						<p class="reboot m-2">
							<strong>MORE FILTERS</strong>
						</p>
						<p class="reboot m-2">Additional filters that allow user to
							further refine the highlighted facts:</p>
						<ul class="reboot">
							<li class="reboot">Periods - List of all used context years
								and reporting periods</li>
							<li class="reboot">Measures - List of all used units of
								measure (e.g., US Dollars); as applicable</li>
							<li class="reboot">Axis - List of all used axis
								(dimensions); as applicable (dimensions); as applicable</li>
							<li class="reboot">Scale - List of all used scaled options
								(e.g., thousands, millions); as applicable</li>
							<li class="reboot">Balance - Debit, credit; as applicable</li>
						</ul>
						<p class="reboot m-2">Multiple filters work in conjunction
							with each other. For example, selecting the "Amounts Only" Data
							filter and "Custom Only" Tags filter will highlight only numeric
							tagged facts using custom tags and list them in the fact list.
							Active filters are displayed in the Filter toolbar as they are
							selected. Active filters can be removed individually by
							unchecking or selecting ALL option for each filter, or all at
							once via the "Reset All Filters" option.</p>
					</div>
				</div>
				<div class="reboot card">
					<div class="reboot card-header px-0 py-0">
						<h5 class="reboot mb-0">
							<button class="reboot btn btn-link d-flex justify-content-between align-items-center w-100" type="button" data-toggle="collapse" data-target="#help-facts-results-list">
								<span class="reboot font-size-1">Facts List (Results)</span>
							</button>
						</h5>
					</div>
					<div id="help-facts-results-list" class="reboot collapse" data-parent="#help-sections">
						<p class="reboot m-2">On the toolbar, select the "count" to
							the right of the word Facts (e.g., Facts 234) to reveal the Facts
							List results - a navigable listing of all currently highlighted
							tagged facts. The count represents the current number of facts.</p>
						<p class="reboot m-2">By default, all tagged facts are
							displayed in the Fact List Results. The list content and count
							reflects the currently highlighted facts (i.e., both Filters and
							Search criteria refine the list to match the highlighted tagged
							facts). Navigation controls are available to move through the
							list as well as move the current view to the corresponding
							highlighted fact location automatically. When a fact in the Facts
							Results List is selected, it will reveal the Fact Review Window.</p>
						<p class="reboot m-2">Certain letters may appear to the right
							of an item in the Fact Result list to indicate a certain
							property. If the letter "A" appears for a fact, it indicates the
							fact is additional data (i.e., hidden with potentially no
							corresponding HTML presentation). If the letter "C" appears, the
							fact is tagged with a custom tag. If the letter "D" appears, the
							fact is tagged with dimensional information.</p>
					</div>
				</div>
				<div class="reboot card">
					<div class="reboot card-header px-0 py-0">
						<h5 class="reboot mb-0">
							<button class="reboot btn btn-link d-flex justify-content-between align-items-center w-100" type="button" data-toggle="collapse" data-target="#help-tagged-sections">
								<span class="reboot font-size-1">Sections</span>
							</button>
						</h5>
					</div>
					<div id="help-tagged-sections" class="reboot collapse" data-parent="#help-sections">
						<p class="reboot m-2">The SECTIONS toolbar item provides a
							listing of the tagged sections of the Inline document. Sections
							are divided into three groups:</p>
						<ul class="reboot">
							<li class="reboot">Document &amp; Entity Information</li>
							<li class="reboot">Financial Statements</li>
							<li class="reboot">Notes to the Financial Statements</li>
						</ul>
						<p class="reboot m-2">By expanding a group and selecting a
							section item in the listing, Inline XBRL viewer will navigate to that section.
							When the Tagged Sections feature is open, the Search Sections box
							will additionally filter the list of sections to only those
							sections that match the entered criteria.</p>
					</div>
				</div>

				<div class="reboot card">
					<div class="reboot card-header px-0 py-0">
						<h5 class="reboot mb-0">
							<button class="reboot btn btn-link d-flex justify-content-between align-items-center w-100" type="button" data-toggle="collapse" data-target="#help-tagged-menu">
								<span class="reboot font-size-1">Menu</span>
							</button>
						</h5>
					</div>
					<div id="help-tagged-menu" class="reboot collapse" data-parent="#help-sections">
						<p class="reboot m-2">
							<strong>Information</strong>
						</p>
						<p class="reboot m-2">The Information menu item provides
							additional detail about the current Inline document and
							customizable viewer settings.</p>
						<ul class="reboot">
							<li class="reboot">Company and Document - Basic company and document
								information</li>
							<li class="reboot">Tags - Fact and tag (standard and custom)
								information</li>
							<li class="reboot">Files - Files used</li>
							<li class="reboot">Additional Items - Additional hidden data
								that's been tagged but potentially does not have a corresponding
								location in the HTML</li>
						</ul>
						<p class="reboot m-2">
							<strong>Save XBRL Instance</strong>
						</p>
						<p class="reboot m-2">The Save XBRL Instance menu item allows
							an XBRL instance document (*.xml) that is extracted from the
							Inline document to be saved locally for use by software
							supporting the XBRL format.</p>
						<p class="reboot m-2">
							<strong>Save XBRL Zip</strong>
						</p>
						<p class="reboot m-2">The Save XBRL Zip menu item allows a zip
							file (*.zip) that contains the as-provided XBRL instance document
							and related custom taxonomy files to be saved locally.</p>
						<p class="reboot m-2">
							<strong>Settings</strong>
						</p>
						<p class="reboot m-2">The Settings menu item provides the
							ability to customize Viewer features.</p>
						<p class="reboot m-2">
							<strong>Tagged Fact Hover</strong>
						</p>
						<ul class="reboot">
							<li class="reboot">On - Displays the hover fact review
								window for any tagged fact*</li>
							<li class="reboot">Off - Hides the hover fact review window
								for any tagged fact (default)</li>
						</ul>
						<p class="reboot m-2">* May impact performance with certain
							web browsers.</p>
						<p class="reboot m-2">
							<strong>Auto Scrolling Position </strong>(This setting will have
							no effect on IE 10 or Safari)
						</p>
						<ul class="reboot">
							<li class="reboot">Top - Selecting a fact from the Sections
								Menu or the Fact Menu will automatically scroll that element to
								the Top of the Inline XBRL viewer window (default)</li>
							<li class="reboot">Center - Selecting a fact from the
								Sections Menu or the Fact Menu will automatically scroll that
								element to the middle of the Inline XBRL viewer window</li>
						</ul>
						<p class="reboot m-2">
							<strong>Highlight Colors</strong> (Use the save and reset buttons
							to save the selected setting or reset to default)
						</p>
						<ul class="reboot">
							<li class="reboot">Tagged Data - Change the highlight color
								of the tagged fact border</li>
							<li class="reboot">Search Results - Change the background
								color of tagged items matching the Search results</li>
							<li class="reboot">Selected Fact - Change the color of
								highlight border used to identify the currently selected fact</li>
							<li class="reboot">Tag Shading (hover) - Change the color of
								the shading applied to tagged data on hover</li>
						</ul>
						<p class="reboot m-2">
							<strong>Search Options</strong>
						</p>
						<ul class="reboot">
							<li class="reboot">Match Case - Matches the specific case of
								the entered Search keyword</li>
							<li class="reboot">Include Labels - Extends Search to
								include tag labels</li>
							<li class="reboot">Include Definitions - Extends Search to
								include tag definitions</li>
							<li class="reboot">Include Dimensions - Extends Search to
								include dimensional detail</li>
							<li class="reboot">Include References - Extends Search to
								include authoritative reference information. Optionally specify
								the reference parts to include in the search (e.g., topic,
								subtopic, section)</li>
						</ul>
						<p class="reboot m-2">
							<strong>Help</strong>(this content)
						</p>
						<p class="reboot m-2">
							<strong>Version</strong>
						</p>
						<p class="reboot m-2">Indicates the current build of the Inline XBRL viewer
							application.</p>
					</div>
				</div>

			</div>
		</div>



		<div data-test="taxonomies-menu" id="taxonomies-menu" class="reboot right-sidenav col-sm-3 bg-light invisible">
			<div class="reboot d-flex flex-column flex-fill h-100">
				<div class="reboot mb-2">
					<span class="reboot lead">Facts</span>
					<a id="taxonomy-menu-secondary-toggle" data-test="taxonomy-secondary-toggle" class="reboot float-right click">
						<i class="reboot fas fa-times-circle mt-2"></i>
					</a>
				</div>
				<div id="taxonomies-menu-list-pagination" class="reboot d-flex flex-column flex-fill h-100 w-100">
					<div class="reboot pagination"></div>
					<div class="reboot form-group">
						<select id="taxonomies-menu-page-select" class="reboot form-control" aria-label="Quickly jump to a page in the Fact Menu." tabindex="13">
							<option class="reboot">Select Page</option>
						</select>
					</div>
					<div class="reboot list-group list-group-flush overflow-x-auto w-100"><span class="text-center py-5">Loading.</span></div>
				</div>
			</div>
		</div>
		<div id="back-to-top" class="reboot d-none">
			<button id="back-to-top-btn" type="button" class="btn btn-sm btn-primary">
				<i class="reboot fas fa-arrow-up"></i>
			</button>
		</div>

		<div id="dynamic-xbrl-form" class="position-relative"><!--?xml version='1.0' encoding='UTF-8'?-->

      <!-- iXBRL document created with: Toppan Merrill Bridge iXBRL 9.4.7193.41938 -->
      <!-- Based on: iXBRL 1.1 -->
      <!-- Created on: 10/30/2019 8:02:13 PM -->
      <!-- iXBRL Library version: 1.0.7193.41955 -->
      <!-- iXBRL Service Job ID: 54d66858-41d1-40b7-bdc8-d3439cea45e7 -->

  <meta content="text/html" http-equiv="content-type"><title></title><div style="margin-top:30pt;"></div><div style="display:none;"><ix:header><ix:hidden><ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" xs:nil="true" contextref="As_Of_9_30_2019_Q77aJBXiP0qCmJ4Yd2DnHw" name="us-gaap:CommitmentsAndContingencies" id="Hidden__B6YklPj_0yFmvYo_EZFdQ"></ix:nonfraction><ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" xs:nil="true" contextref="As_Of_12_31_2018_INezHDkjn0-L7OMGoLMjhA" name="us-gaap:CommitmentsAndContingencies" id="Hidden_l3wxbnaulUSchQZHHCjZig"></ix:nonfraction><ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" xs:nil="true" contextref="As_Of_9_30_2019_Q77aJBXiP0qCmJ4Yd2DnHw" name="us-gaap:CommitmentsAndContingencies" id="Hidden_4_zyB7B5WUmM7agNsBcu9A"></ix:nonfraction><ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" xs:nil="true" contextref="As_Of_12_31_2018_INezHDkjn0-L7OMGoLMjhA" name="us-gaap:CommitmentsAndContingencies" id="Hidden_szvPg2k-BE2hYYhuI0V8Ew"></ix:nonfraction><ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" xs:nil="true" contextref="As_Of_9_30_2019_Q77aJBXiP0qCmJ4Yd2DnHw" name="us-gaap:PreferredStockValue" id="Hidden_JxU33isAG0iNY1I67z5kOA"></ix:nonfraction><ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" xs:nil="true" contextref="As_Of_12_31_2018_INezHDkjn0-L7OMGoLMjhA" name="us-gaap:PreferredStockValue" id="Hidden_qaRVrxKSwkybBrB3iSJdEw"></ix:nonfraction><ix:nonnumeric contextref="Duration_1_1_2019_To_9_30_2019_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember_OXdQKT5IXk6AhArCbD7s4w" name="abt:MinimumLengthOfTimeHedgedInCashFlowHedge1" id="Hidden_sIgzcF8meUS5NzUQyiP8hg">P12M</ix:nonnumeric><ix:nonnumeric contextref="Duration_1_1_2019_To_9_30_2019_O4ushO81Z0mAnTH_cLUPFw" name="us-gaap:RevenuePracticalExpedientRemainingPerformanceObligation" id="Hidden_56EZzFCC8EGB-FdNdzhCPA">true</ix:nonnumeric><ix:nonnumeric contextref="As_Of_9_30_2019_Q77aJBXiP0qCmJ4Yd2DnHw" name="us-gaap:OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" id="Hidden_l5WU-O4xBEiP8LQMxv-tWQ">abt:DeferredIncomeTaxesandOtherAssets</ix:nonnumeric><ix:nonnumeric contextref="As_Of_9_30_2019_Q77aJBXiP0qCmJ4Yd2DnHw" name="us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" id="Hidden_ZM3V6_etzUKHnSNTxOk_EA">us-gaap:AccruedLiabilities</ix:nonnumeric><ix:nonnumeric contextref="As_Of_9_30_2019_Q77aJBXiP0qCmJ4Yd2DnHw" name="us-gaap:OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" id="Hidden_pLQQPDortk-j1LvdK0dv6A">abt:Post-EmploymentObligationsDeferredIncomeTaxesandOtherLong-termLiabilities</ix:nonnumeric><ix:nonnumeric contextref="Duration_1_1_2019_To_1_1_2019_NgyqN4UrKEaSZk1pJ_OHSg" name="us-gaap:LeasePracticalExpedientsPackage" id="Hidden_TDkfSwgTuEa-TOsL6Jp5gg">true</ix:nonnumeric><ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_1_1_2019_srt_RestatementAxis_srt_RestatementAdjustmentMember_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_us-gaap_AccountingStandardsUpdate201602Member_YQvWxBpGvkim5xhEV2VSoA" decimals="-6" name="us-gaap:OperatingLeaseRightOfUseAsset" id="Hidden_Q8gB7ewIZEenZms2FfgMnA">850000000</ix:nonfraction><ix:nonnumeric contextref="As_Of_9_30_2019_srt_RangeAxis_srt_MinimumMember_CX2tJ3HgS06yfIVVN84Uaw" name="us-gaap:LesseeOperatingLeaseTermOfContract" id="Hidden_ogS9BaRF80SjuXTnJaWVjA">P1Y</ix:nonnumeric><ix:nonnumeric contextref="Duration_1_1_2019_To_9_30_2019_O4ushO81Z0mAnTH_cLUPFw" name="us-gaap:LesseeOperatingLeaseExistenceOfOptionToTerminate" id="Hidden_t6YzEE99HUGIh8sDWNOKBg">true</ix:nonnumeric><ix:nonnumeric contextref="Duration_7_1_2019_To_9_30_2019_5CXepWtEPEKQA-bPz0Tp7A" name="us-gaap:LesseeOperatingLeaseExistenceOfOptionToTerminate" id="Hidden_ydemUA9v6EOXHrPO2sWrkw">true</ix:nonnumeric><ix:nonnumeric contextref="Duration_1_1_2019_To_9_30_2019_O4ushO81Z0mAnTH_cLUPFw" name="us-gaap:LesseeOperatingLeaseExistenceOfOptionToExtend" id="Hidden_fjaa7p9i6EuIIkQAUy3lng">true</ix:nonnumeric><ix:nonnumeric contextref="Duration_7_1_2019_To_9_30_2019_5CXepWtEPEKQA-bPz0Tp7A" name="us-gaap:LesseeOperatingLeaseExistenceOfOptionToExtend" id="Hidden_e3YpTQ7VLU2TRnh4m9Rg5w">true</ix:nonnumeric><ix:nonnumeric contextref="Duration_1_1_2019_To_9_30_2019_O4ushO81Z0mAnTH_cLUPFw" name="dei:EntityCentralIndexKey" id="Hidden_TM709_8jykKtIMH6wBbonw">0000001800</ix:nonnumeric><ix:nonnumeric contextref="Duration_1_1_2019_To_9_30_2019_O4ushO81Z0mAnTH_cLUPFw" name="dei:CurrentFiscalYearEndDate" id="Hidden_i8CsYbIlBEaIX7pW0bJK2g">--12-31</ix:nonnumeric><ix:nonnumeric contextref="Duration_1_1_2019_To_9_30_2019_O4ushO81Z0mAnTH_cLUPFw" name="dei:DocumentFiscalYearFocus" id="Hidden_9YrScaMpWkemgKh1bJC2Vw">2019</ix:nonnumeric><ix:nonnumeric contextref="Duration_1_1_2019_To_9_30_2019_O4ushO81Z0mAnTH_cLUPFw" name="dei:DocumentFiscalPeriodFocus" id="Hidden_VF1O_90LWUyLSOH_fgPPlw">Q3</ix:nonnumeric><ix:nonnumeric contextref="Duration_1_1_2019_To_9_30_2019_O4ushO81Z0mAnTH_cLUPFw" name="dei:AmendmentFlag" id="Hidden_ls622SuodkWEfW-dkUHi3Q">false</ix:nonnumeric></ix:hidden><ix:references><link:schemaref xlink:type="simple" xlink:href="abt-20190930.xsd"></link:schemaref></ix:references><ix:resources><xbrli:context id="Duration_7_1_2019_To_9_30_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockCommonMember_cuu1S_UrtUO3pGRtYhaCxA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2019-07-01</xbrli:startdate><xbrli:enddate>2019-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2019_To_9_30_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_D9P22JHh-UWMGAQ5Zzr5Qw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2019-07-01</xbrli:startdate><xbrli:enddate>2019-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2019_To_9_30_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockCommonMember_aCxW66jh1UqXVNftbIAcbQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2019-01-01</xbrli:startdate><xbrli:enddate>2019-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2019_To_9_30_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_nDCAs6-IO0yYkFh64CJlyA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2019-01-01</xbrli:startdate><xbrli:enddate>2019-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2018_To_9_30_2018_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockCommonMember_sJvnNckpS0Cm5Qfenv7QvA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2018-07-01</xbrli:startdate><xbrli:enddate>2018-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2018_To_9_30_2018_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_WodOekvYd02Aw_nJ4pAu5Q"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2018-07-01</xbrli:startdate><xbrli:enddate>2018-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2018_To_9_30_2018_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockCommonMember_b3HuzYPzF0i9-7g-9Ns9Dw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2018-01-01</xbrli:startdate><xbrli:enddate>2018-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2018_To_9_30_2018_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_3ydffv0QgEejv_lm-1uFkw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2018-01-01</xbrli:startdate><xbrli:enddate>2018-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="As_Of_9_30_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_GuALU1yk40CWLKcwQ7aHKg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_9_30_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember_jVoR3ymRq0GxvPbAMNalag"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_9_30_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember_dg1dTMhxQkOvrJfgeBrQ3Q"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_6_30_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_HT9MV5UES0avCFZnfYLj9Q"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_6_30_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember__5sB-WyiZUqz25_I1eSsnA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_6_30_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember_wW-c6097I0Suu1POOavaUQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2018_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_cNa8q0oH_UurlZT1Mupvfw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2018_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember_RDzmLIldOkuOnxLy7kOlkQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2018_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember_xpvzGw6DckqgYCN1UEKZFA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_9_30_2018_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_RzsVsvtvykWC5WZFzqW8lQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_9_30_2018_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember_CYL5Vb7ebU2opKP7GE9QZw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_9_30_2018_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember_XobcWMR9fUKTIvdfC5r_0w"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_6_30_2018_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_rZZr2P704Ei9zoEuJiP8kg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_6_30_2018_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember_6G3BYKUPtkCP0OQH5rLQcQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_6_30_2018_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember_3J1U9RR_QEGgqE-tIL4lYw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2017_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_OmXBxy3qJUGU2X_SuWL0lg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2017_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember_CeSUxyxDB0mz0dWUVZSWzQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2017_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember_qxPAiXW_BEinFD6XMkq5zw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_6_30_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedTranslationAdjustmentMember_UTnN-uuZ1EyfcmdFnkKpFA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_6_30_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_xWVS2_dlmUWYlJ8-3gDO_Q"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_6_30_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_X_wXuipbAEW5xQez5JZxWw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2018_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedTranslationAdjustmentMember_65cF7pl2qUK4LywWRC10VA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2018_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_Lgy2EE8hhUyJM-gEBs_YWw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2018_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember__fKYEvXnyk6FTU0nZfVV_Q"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_6_30_2018_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedTranslationAdjustmentMember_l6OKU6ZMHESNVFXRA2PSyQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_6_30_2018_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_cMMLNks1_USBkW1x4s71Qw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_6_30_2018_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_vJlPb8hcm0iSnnnsNQoY0g"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2017_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedTranslationAdjustmentMember_l7H_pAXqA0qtmOxmUxk1fw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2017_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_O20waITMiUGO-GV5b-rNfg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2017_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_tI1ocRnn8UuJHonG3ajMpw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2017_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_ofh3Gnzk3UyE3R25lCHDaA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2019_To_9_30_2019_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_oFOh67Kt6E6KfotbtDbBzA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2019-01-01</xbrli:startdate><xbrli:enddate>2019-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="As_Of_9_30_2019_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_AJoUbmQxD0ixUlxv_IKhUg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2019_To_9_30_2019_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember_E8NWHWr5YkKQuxb7kFQkyg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2019-01-01</xbrli:startdate><xbrli:enddate>2019-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2019_To_9_30_2019_us-gaap_AwardTypeAxis_abt_RestrictedStockAwardsMember_KfhBgacjXkqVbU7PBnxC7A"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:AwardTypeAxis">abt:RestrictedStockAwardsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2019-01-01</xbrli:startdate><xbrli:enddate>2019-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="As_Of_9_30_2019_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_abt_cnst_2021-10-01_Ya3YxLZ1-063gJOi7Pwe0g"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:typedmember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"><us-gaap:revenueremainingperformanceobligationexpectedtimingofsatisfactionstartdateaxis.domain>2021-10-01</us-gaap:revenueremainingperformanceobligationexpectedtimingofsatisfactionstartdateaxis.domain></xbrldi:typedmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_9_30_2019_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_abt_cnst_2019-10-01_vdsdJvVVQEifrRMWIGhX8w"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:typedmember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"><us-gaap:revenueremainingperformanceobligationexpectedtimingofsatisfactionstartdateaxis.domain>2019-10-01</us-gaap:revenueremainingperformanceobligationexpectedtimingofsatisfactionstartdateaxis.domain></xbrldi:typedmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2019_To_9_30_2019_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_abt_NutritionalProductsMember_us-gaap_SubsegmentsAxis_abt_PediatricNutritionalsMember_9LQvJzp5r0CYA1ui-3FGVQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:NutritionalProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:PediatricNutritionalsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2019-07-01</xbrli:startdate><xbrli:enddate>2019-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2019_To_9_30_2019_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_abt_NutritionalProductsMember_us-gaap_SubsegmentsAxis_abt_AdultNutritionalsMember_cupyFodQF0KFXZPS3bWTuw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:NutritionalProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:AdultNutritionalsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2019-07-01</xbrli:startdate><xbrli:enddate>2019-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2019_To_9_30_2019_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_abt_EstablishedPharmaceuticalProductsMember_us-gaap_SubsegmentsAxis_abt_OtherMember_jIYhftUfu0-bwjIEJagUDg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:EstablishedPharmaceuticalProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:OtherMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2019-07-01</xbrli:startdate><xbrli:enddate>2019-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2019_To_9_30_2019_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_abt_EstablishedPharmaceuticalProductsMember_us-gaap_SubsegmentsAxis_abt_KeyEmergingMarketsMember_bgy9ptAnU0-twmp7vlQX_g"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:EstablishedPharmaceuticalProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:KeyEmergingMarketsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2019-07-01</xbrli:startdate><xbrli:enddate>2019-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2019_To_9_30_2019_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_abt_DiagnosticProductsMember_us-gaap_SubsegmentsAxis_abt_RapidDiagnosticsMember_cgTz1NQZJUy98PVovLG8Tw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:DiagnosticProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:RapidDiagnosticsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2019-07-01</xbrli:startdate><xbrli:enddate>2019-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2019_To_9_30_2019_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_abt_DiagnosticProductsMember_us-gaap_SubsegmentsAxis_abt_PointOfCareMember_IlnglBHPcUWRJKq4N1YNjA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:DiagnosticProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:PointOfCareMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2019-07-01</xbrli:startdate><xbrli:enddate>2019-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2019_To_9_30_2019_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_abt_DiagnosticProductsMember_us-gaap_SubsegmentsAxis_abt_MolecularMember_qoz0Nqez5US14ZTIJFCULg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:DiagnosticProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:MolecularMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2019-07-01</xbrli:startdate><xbrli:enddate>2019-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2019_To_9_30_2019_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_abt_DiagnosticProductsMember_us-gaap_SubsegmentsAxis_abt_CoreLaboratoryMember_dl5ZvYMk4kuSWkoTlpN6Xg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:DiagnosticProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:CoreLaboratoryMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2019-07-01</xbrli:startdate><xbrli:enddate>2019-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2019_To_9_30_2019_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_abt_CardiovascularAndNeuromodulationProductsMember_us-gaap_SubsegmentsAxis_abt_VascularProductsMember_vbCXVbMlXU-8dmSsvUrnVw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:CardiovascularAndNeuromodulationProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:VascularProductsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2019-07-01</xbrli:startdate><xbrli:enddate>2019-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2019_To_9_30_2019_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_abt_CardiovascularAndNeuromodulationProductsMember_us-gaap_SubsegmentsAxis_abt_StructuralHeartMember_xtYMjKglhU24eVDSNPCqAg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:CardiovascularAndNeuromodulationProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:StructuralHeartMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2019-07-01</xbrli:startdate><xbrli:enddate>2019-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2019_To_9_30_2019_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_abt_CardiovascularAndNeuromodulationProductsMember_us-gaap_SubsegmentsAxis_abt_RhythmManagementMember_WZwSMzdqHkW5GtDxO2QxKg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:CardiovascularAndNeuromodulationProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:RhythmManagementMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2019-07-01</xbrli:startdate><xbrli:enddate>2019-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2019_To_9_30_2019_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_abt_CardiovascularAndNeuromodulationProductsMember_us-gaap_SubsegmentsAxis_abt_NeuromodulationMember_bUVk6i7h60uRzua0S3pauw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:CardiovascularAndNeuromodulationProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:NeuromodulationMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2019-07-01</xbrli:startdate><xbrli:enddate>2019-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2019_To_9_30_2019_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_abt_CardiovascularAndNeuromodulationProductsMember_us-gaap_SubsegmentsAxis_abt_HeartFailureMember_p-WU_6QEsU6mCTFr_0DKSQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:CardiovascularAndNeuromodulationProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:HeartFailureMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2019-07-01</xbrli:startdate><xbrli:enddate>2019-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2019_To_9_30_2019_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_abt_CardiovascularAndNeuromodulationProductsMember_us-gaap_SubsegmentsAxis_abt_ElectrophysiologyMember_hnD-NKsM5km1-tXMGmqsFw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:CardiovascularAndNeuromodulationProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:ElectrophysiologyMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2019-07-01</xbrli:startdate><xbrli:enddate>2019-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2019_To_9_30_2019_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_abt_NutritionalProductsMember_us-gaap_SubsegmentsAxis_abt_PediatricNutritionalsMember_SzXn4bPJCEW7BHfrolxfLQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:NutritionalProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:PediatricNutritionalsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2019-07-01</xbrli:startdate><xbrli:enddate>2019-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2019_To_9_30_2019_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_abt_NutritionalProductsMember_us-gaap_SubsegmentsAxis_abt_AdultNutritionalsMember_rzk5uCysgEyRXIMweL-Iyg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:NutritionalProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:AdultNutritionalsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2019-07-01</xbrli:startdate><xbrli:enddate>2019-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2019_To_9_30_2019_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_abt_DiagnosticProductsMember_us-gaap_SubsegmentsAxis_abt_RapidDiagnosticsMember_YILLBrX3vUOKlVcSj18zbw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:DiagnosticProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:RapidDiagnosticsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2019-07-01</xbrli:startdate><xbrli:enddate>2019-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2019_To_9_30_2019_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_abt_DiagnosticProductsMember_us-gaap_SubsegmentsAxis_abt_PointOfCareMember_XWGQFoQdEUiAvlbtHo302Q"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:DiagnosticProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:PointOfCareMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2019-07-01</xbrli:startdate><xbrli:enddate>2019-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2019_To_9_30_2019_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_abt_DiagnosticProductsMember_us-gaap_SubsegmentsAxis_abt_MolecularMember_qyRBnR6LUEeKMhibUGfV5Q"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:DiagnosticProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:MolecularMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2019-07-01</xbrli:startdate><xbrli:enddate>2019-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2019_To_9_30_2019_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_abt_DiagnosticProductsMember_us-gaap_SubsegmentsAxis_abt_CoreLaboratoryMember_aCn2AwD9EESVYY6ZFaq71Q"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:DiagnosticProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:CoreLaboratoryMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2019-07-01</xbrli:startdate><xbrli:enddate>2019-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2019_To_9_30_2019_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_abt_CardiovascularAndNeuromodulationProductsMember_us-gaap_SubsegmentsAxis_abt_VascularProductsMember_iYJ9jxGHnEaLMXd5RVPDEg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:CardiovascularAndNeuromodulationProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:VascularProductsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2019-07-01</xbrli:startdate><xbrli:enddate>2019-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2019_To_9_30_2019_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_abt_CardiovascularAndNeuromodulationProductsMember_us-gaap_SubsegmentsAxis_abt_StructuralHeartMember_50Zc3aDRgkmZiAf7S4m21w"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:CardiovascularAndNeuromodulationProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:StructuralHeartMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2019-07-01</xbrli:startdate><xbrli:enddate>2019-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2019_To_9_30_2019_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_abt_CardiovascularAndNeuromodulationProductsMember_us-gaap_SubsegmentsAxis_abt_RhythmManagementMember_fb-4dThn10yJZ8h3qklQkg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:CardiovascularAndNeuromodulationProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:RhythmManagementMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2019-07-01</xbrli:startdate><xbrli:enddate>2019-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2019_To_9_30_2019_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_abt_CardiovascularAndNeuromodulationProductsMember_us-gaap_SubsegmentsAxis_abt_NeuromodulationMember_xmnVw0TYg0iDFphAjwSofw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:CardiovascularAndNeuromodulationProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:NeuromodulationMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2019-07-01</xbrli:startdate><xbrli:enddate>2019-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2019_To_9_30_2019_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_abt_CardiovascularAndNeuromodulationProductsMember_us-gaap_SubsegmentsAxis_abt_HeartFailureMember_rYLUPr4I9kuwrvzydgFAqw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:CardiovascularAndNeuromodulationProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:HeartFailureMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2019-07-01</xbrli:startdate><xbrli:enddate>2019-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2019_To_9_30_2019_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_abt_CardiovascularAndNeuromodulationProductsMember_us-gaap_SubsegmentsAxis_abt_ElectrophysiologyMember_2fuYjLwTIUOgCvY-a3GxGw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:CardiovascularAndNeuromodulationProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:ElectrophysiologyMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2019-07-01</xbrli:startdate><xbrli:enddate>2019-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2019_To_9_30_2019_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_us-gaap_AllOtherSegmentsMember_Ts1FZsOaDE-I3KdK0RVK4w"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2019-07-01</xbrli:startdate><xbrli:enddate>2019-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2019_To_9_30_2019_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_abt_NutritionalProductsMember_oT2HLUoSakWWwYJzHT9hMQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:NutritionalProductsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2019-07-01</xbrli:startdate><xbrli:enddate>2019-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2019_To_9_30_2019_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_abt_EstablishedPharmaceuticalProductsMember_1LR40F6sFUuQLjVrNbOfHg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:EstablishedPharmaceuticalProductsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2019-07-01</xbrli:startdate><xbrli:enddate>2019-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2019_To_9_30_2019_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_abt_DiagnosticProductsMember_YSy-Xaw760iEpiYy0q8FLA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:DiagnosticProductsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2019-07-01</xbrli:startdate><xbrli:enddate>2019-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2019_To_9_30_2019_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_abt_CardiovascularAndNeuromodulationProductsMember_s0DArMiyqEu24fIc2JIKgA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:CardiovascularAndNeuromodulationProductsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2019-07-01</xbrli:startdate><xbrli:enddate>2019-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2019_To_9_30_2019_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_us-gaap_AllOtherSegmentsMember_i2mGdZr7_UqJUMRww-PqQA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2019-07-01</xbrli:startdate><xbrli:enddate>2019-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2019_To_9_30_2019_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_abt_NutritionalProductsMember_bEFmg-wCzE6foeLiaIYCsQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:NutritionalProductsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2019-07-01</xbrli:startdate><xbrli:enddate>2019-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2019_To_9_30_2019_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_abt_DiagnosticProductsMember_1j73vaBhXE6rBbcwQeS1mw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:DiagnosticProductsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2019-07-01</xbrli:startdate><xbrli:enddate>2019-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2019_To_9_30_2019_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_abt_CardiovascularAndNeuromodulationProductsMember_8iQVxUuufEucAQ1AQXnVsQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:CardiovascularAndNeuromodulationProductsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2019-07-01</xbrli:startdate><xbrli:enddate>2019-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2019_To_9_30_2019_us-gaap_StatementBusinessSegmentsAxis_abt_NutritionalProductsMember_us-gaap_SubsegmentsAxis_abt_PediatricNutritionalsMember_976RYsis3UqxojGR9f5ynQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:NutritionalProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:PediatricNutritionalsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2019-07-01</xbrli:startdate><xbrli:enddate>2019-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2019_To_9_30_2019_us-gaap_StatementBusinessSegmentsAxis_abt_NutritionalProductsMember_us-gaap_SubsegmentsAxis_abt_AdultNutritionalsMember_2BKbQ1wBj0aSU1cYOdz0Kg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:NutritionalProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:AdultNutritionalsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2019-07-01</xbrli:startdate><xbrli:enddate>2019-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2019_To_9_30_2019_us-gaap_StatementBusinessSegmentsAxis_abt_EstablishedPharmaceuticalProductsMember_us-gaap_SubsegmentsAxis_abt_OtherMember_SjDIqWEVq0y5-_mURGVcLA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:EstablishedPharmaceuticalProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:OtherMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2019-07-01</xbrli:startdate><xbrli:enddate>2019-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2019_To_9_30_2019_us-gaap_StatementBusinessSegmentsAxis_abt_EstablishedPharmaceuticalProductsMember_us-gaap_SubsegmentsAxis_abt_KeyEmergingMarketsMember_-4jRiCSDjkytdDmx88FCqw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:EstablishedPharmaceuticalProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:KeyEmergingMarketsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2019-07-01</xbrli:startdate><xbrli:enddate>2019-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2019_To_9_30_2019_us-gaap_StatementBusinessSegmentsAxis_abt_DiagnosticProductsMember_us-gaap_SubsegmentsAxis_abt_RapidDiagnosticsMember_Ve5IaWAwqkSRhhjeNnyDSw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:DiagnosticProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:RapidDiagnosticsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2019-07-01</xbrli:startdate><xbrli:enddate>2019-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2019_To_9_30_2019_us-gaap_StatementBusinessSegmentsAxis_abt_DiagnosticProductsMember_us-gaap_SubsegmentsAxis_abt_PointOfCareMember_iTjfQpuHQk295KKZSIgOXA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:DiagnosticProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:PointOfCareMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2019-07-01</xbrli:startdate><xbrli:enddate>2019-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2019_To_9_30_2019_us-gaap_StatementBusinessSegmentsAxis_abt_DiagnosticProductsMember_us-gaap_SubsegmentsAxis_abt_MolecularMember_KrZx7LO4V0KUPPVNJMP5dw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:DiagnosticProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:MolecularMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2019-07-01</xbrli:startdate><xbrli:enddate>2019-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2019_To_9_30_2019_us-gaap_StatementBusinessSegmentsAxis_abt_DiagnosticProductsMember_us-gaap_SubsegmentsAxis_abt_CoreLaboratoryMember_vPRcgszCPUugGvpswdhVlw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:DiagnosticProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:CoreLaboratoryMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2019-07-01</xbrli:startdate><xbrli:enddate>2019-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2019_To_9_30_2019_us-gaap_StatementBusinessSegmentsAxis_abt_CardiovascularAndNeuromodulationProductsMember_us-gaap_SubsegmentsAxis_abt_VascularProductsMember_b-XPV2IDikKoNi1qYrjrmw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:CardiovascularAndNeuromodulationProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:VascularProductsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2019-07-01</xbrli:startdate><xbrli:enddate>2019-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2019_To_9_30_2019_us-gaap_StatementBusinessSegmentsAxis_abt_CardiovascularAndNeuromodulationProductsMember_us-gaap_SubsegmentsAxis_abt_StructuralHeartMember_P4XTM4mlAESkH616NyY33Q"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:CardiovascularAndNeuromodulationProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:StructuralHeartMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2019-07-01</xbrli:startdate><xbrli:enddate>2019-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2019_To_9_30_2019_us-gaap_StatementBusinessSegmentsAxis_abt_CardiovascularAndNeuromodulationProductsMember_us-gaap_SubsegmentsAxis_abt_RhythmManagementMember_K9pc3Dchh06weXD6i_GKow"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:CardiovascularAndNeuromodulationProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:RhythmManagementMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2019-07-01</xbrli:startdate><xbrli:enddate>2019-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2019_To_9_30_2019_us-gaap_StatementBusinessSegmentsAxis_abt_CardiovascularAndNeuromodulationProductsMember_us-gaap_SubsegmentsAxis_abt_NeuromodulationMember_aNfGTkNG0kS2QouYGOmngQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:CardiovascularAndNeuromodulationProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:NeuromodulationMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2019-07-01</xbrli:startdate><xbrli:enddate>2019-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2019_To_9_30_2019_us-gaap_StatementBusinessSegmentsAxis_abt_CardiovascularAndNeuromodulationProductsMember_us-gaap_SubsegmentsAxis_abt_HeartFailureMember_04nztperEkSCSKRnUjx8Ow"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:CardiovascularAndNeuromodulationProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:HeartFailureMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2019-07-01</xbrli:startdate><xbrli:enddate>2019-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2019_To_9_30_2019_us-gaap_StatementBusinessSegmentsAxis_abt_CardiovascularAndNeuromodulationProductsMember_us-gaap_SubsegmentsAxis_abt_ElectrophysiologyMember_ernxN__VPU-oEqodwTAdMQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:CardiovascularAndNeuromodulationProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:ElectrophysiologyMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2019-07-01</xbrli:startdate><xbrli:enddate>2019-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2019_To_9_30_2019_srt_StatementGeographicalAxis_us-gaap_NonUsMember_wUQa4HN-5E2xVdeYhfgKqw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2019-07-01</xbrli:startdate><xbrli:enddate>2019-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2019_To_9_30_2019_srt_StatementGeographicalAxis_country_US_qX6FunLEQ02ntrQ53zJrQw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2019-07-01</xbrli:startdate><xbrli:enddate>2019-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2019_To_9_30_2019_us-gaap_StatementBusinessSegmentsAxis_abt_NutritionalProductsMember_8lkMzw_11kKsRgBxOMYN_w"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:NutritionalProductsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2019-07-01</xbrli:startdate><xbrli:enddate>2019-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2019_To_9_30_2019_us-gaap_StatementBusinessSegmentsAxis_abt_EstablishedPharmaceuticalProductsMember_UPmov4CjFEyXN-cCyAqTvQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:EstablishedPharmaceuticalProductsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2019-07-01</xbrli:startdate><xbrli:enddate>2019-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2019_To_9_30_2019_us-gaap_StatementBusinessSegmentsAxis_abt_DiagnosticProductsMember_Ubo4gT5EEU2HcN-NhX6g9w"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:DiagnosticProductsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2019-07-01</xbrli:startdate><xbrli:enddate>2019-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2019_To_9_30_2019_us-gaap_StatementBusinessSegmentsAxis_abt_CardiovascularAndNeuromodulationProductsMember_Fzj1rSlp6kmj4ESuAXv0kA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:CardiovascularAndNeuromodulationProductsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2019-07-01</xbrli:startdate><xbrli:enddate>2019-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2019_To_9_30_2019_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_abt_NutritionalProductsMember_us-gaap_SubsegmentsAxis_abt_PediatricNutritionalsMember_QqbNfDCuzEybKrjzuM5img"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:NutritionalProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:PediatricNutritionalsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2019-01-01</xbrli:startdate><xbrli:enddate>2019-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2019_To_9_30_2019_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_abt_NutritionalProductsMember_us-gaap_SubsegmentsAxis_abt_AdultNutritionalsMember_OogYjHd1sUG3RPEAQotJTA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:NutritionalProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:AdultNutritionalsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2019-01-01</xbrli:startdate><xbrli:enddate>2019-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2019_To_9_30_2019_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_abt_EstablishedPharmaceuticalProductsMember_us-gaap_SubsegmentsAxis_abt_OtherMember_udvUuA8JQk6GVtIypFNiJA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:EstablishedPharmaceuticalProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:OtherMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2019-01-01</xbrli:startdate><xbrli:enddate>2019-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2019_To_9_30_2019_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_abt_EstablishedPharmaceuticalProductsMember_us-gaap_SubsegmentsAxis_abt_KeyEmergingMarketsMember_LPUI0oDmWU-j2xWHTY_izA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:EstablishedPharmaceuticalProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:KeyEmergingMarketsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2019-01-01</xbrli:startdate><xbrli:enddate>2019-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2019_To_9_30_2019_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_abt_DiagnosticProductsMember_us-gaap_SubsegmentsAxis_abt_RapidDiagnosticsMember_0NhiyGWe9ESlX0vUlE7UNQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:DiagnosticProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:RapidDiagnosticsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2019-01-01</xbrli:startdate><xbrli:enddate>2019-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2019_To_9_30_2019_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_abt_DiagnosticProductsMember_us-gaap_SubsegmentsAxis_abt_PointOfCareMember_8RABzKisSkiroyF1jhPrpw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:DiagnosticProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:PointOfCareMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2019-01-01</xbrli:startdate><xbrli:enddate>2019-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2019_To_9_30_2019_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_abt_DiagnosticProductsMember_us-gaap_SubsegmentsAxis_abt_MolecularMember_eOYdJ2sAFkS2fbVLnkUS0A"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:DiagnosticProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:MolecularMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2019-01-01</xbrli:startdate><xbrli:enddate>2019-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2019_To_9_30_2019_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_abt_DiagnosticProductsMember_us-gaap_SubsegmentsAxis_abt_CoreLaboratoryMember_5mlkR1388EGEPz4gHTI2qQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:DiagnosticProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:CoreLaboratoryMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2019-01-01</xbrli:startdate><xbrli:enddate>2019-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2019_To_9_30_2019_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_abt_CardiovascularAndNeuromodulationProductsMember_us-gaap_SubsegmentsAxis_abt_VascularProductsMember_Hx0kTWTowk-3ycqtgcsqvA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:CardiovascularAndNeuromodulationProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:VascularProductsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2019-01-01</xbrli:startdate><xbrli:enddate>2019-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2019_To_9_30_2019_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_abt_CardiovascularAndNeuromodulationProductsMember_us-gaap_SubsegmentsAxis_abt_StructuralHeartMember_44n-r_eSQUOIEw9ippKdCQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:CardiovascularAndNeuromodulationProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:StructuralHeartMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2019-01-01</xbrli:startdate><xbrli:enddate>2019-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2019_To_9_30_2019_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_abt_CardiovascularAndNeuromodulationProductsMember_us-gaap_SubsegmentsAxis_abt_RhythmManagementMember_MQyhUqd6QUGn-psLVLhD8w"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:CardiovascularAndNeuromodulationProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:RhythmManagementMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2019-01-01</xbrli:startdate><xbrli:enddate>2019-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2019_To_9_30_2019_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_abt_CardiovascularAndNeuromodulationProductsMember_us-gaap_SubsegmentsAxis_abt_NeuromodulationMember_n0ojBhLu4kyJCenM1lWQIQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:CardiovascularAndNeuromodulationProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:NeuromodulationMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2019-01-01</xbrli:startdate><xbrli:enddate>2019-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2019_To_9_30_2019_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_abt_CardiovascularAndNeuromodulationProductsMember_us-gaap_SubsegmentsAxis_abt_HeartFailureMember_DEf0YxIGZEe_iDdnv_NBvA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:CardiovascularAndNeuromodulationProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:HeartFailureMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2019-01-01</xbrli:startdate><xbrli:enddate>2019-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2019_To_9_30_2019_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_abt_CardiovascularAndNeuromodulationProductsMember_us-gaap_SubsegmentsAxis_abt_ElectrophysiologyMember_rQmpPZxJt0-Ul22Xmx7nlQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:CardiovascularAndNeuromodulationProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:ElectrophysiologyMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2019-01-01</xbrli:startdate><xbrli:enddate>2019-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2019_To_9_30_2019_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_abt_NutritionalProductsMember_us-gaap_SubsegmentsAxis_abt_PediatricNutritionalsMember_m0_e2THpSUO0sjNQITLhvA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:NutritionalProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:PediatricNutritionalsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2019-01-01</xbrli:startdate><xbrli:enddate>2019-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2019_To_9_30_2019_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_abt_NutritionalProductsMember_us-gaap_SubsegmentsAxis_abt_AdultNutritionalsMember_TKVQehiq-kyU8-9FUZbT1A"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:NutritionalProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:AdultNutritionalsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2019-01-01</xbrli:startdate><xbrli:enddate>2019-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2019_To_9_30_2019_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_abt_DiagnosticProductsMember_us-gaap_SubsegmentsAxis_abt_RapidDiagnosticsMember_EmyWK6_OC0GET4cdIfRG3Q"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:DiagnosticProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:RapidDiagnosticsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2019-01-01</xbrli:startdate><xbrli:enddate>2019-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2019_To_9_30_2019_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_abt_DiagnosticProductsMember_us-gaap_SubsegmentsAxis_abt_PointOfCareMember_tvi2DAuyFUaqi6ZkDGnmCQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:DiagnosticProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:PointOfCareMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2019-01-01</xbrli:startdate><xbrli:enddate>2019-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2019_To_9_30_2019_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_abt_DiagnosticProductsMember_us-gaap_SubsegmentsAxis_abt_MolecularMember_CoDi1EE57EKVMVyJv498bQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:DiagnosticProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:MolecularMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2019-01-01</xbrli:startdate><xbrli:enddate>2019-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2019_To_9_30_2019_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_abt_DiagnosticProductsMember_us-gaap_SubsegmentsAxis_abt_CoreLaboratoryMember_oIZFz0vC-0GmMHYgo0iE3Q"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:DiagnosticProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:CoreLaboratoryMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2019-01-01</xbrli:startdate><xbrli:enddate>2019-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2019_To_9_30_2019_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_abt_CardiovascularAndNeuromodulationProductsMember_us-gaap_SubsegmentsAxis_abt_VascularProductsMember_xzgQqLrW7kqCB5okIBohhA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:CardiovascularAndNeuromodulationProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:VascularProductsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2019-01-01</xbrli:startdate><xbrli:enddate>2019-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2019_To_9_30_2019_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_abt_CardiovascularAndNeuromodulationProductsMember_us-gaap_SubsegmentsAxis_abt_StructuralHeartMember_6P1Vl7-fR0OsKxDX3kmXFg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:CardiovascularAndNeuromodulationProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:StructuralHeartMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2019-01-01</xbrli:startdate><xbrli:enddate>2019-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2019_To_9_30_2019_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_abt_CardiovascularAndNeuromodulationProductsMember_us-gaap_SubsegmentsAxis_abt_RhythmManagementMember_RCLLI31oW0CxXcKrNaJwcA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:CardiovascularAndNeuromodulationProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:RhythmManagementMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2019-01-01</xbrli:startdate><xbrli:enddate>2019-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2019_To_9_30_2019_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_abt_CardiovascularAndNeuromodulationProductsMember_us-gaap_SubsegmentsAxis_abt_NeuromodulationMember_BOwNApQZxEe9Prwwd4SWkA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:CardiovascularAndNeuromodulationProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:NeuromodulationMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2019-01-01</xbrli:startdate><xbrli:enddate>2019-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2019_To_9_30_2019_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_abt_CardiovascularAndNeuromodulationProductsMember_us-gaap_SubsegmentsAxis_abt_HeartFailureMember_W9069aCB3U2lmwHkJyVLJA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:CardiovascularAndNeuromodulationProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:HeartFailureMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2019-01-01</xbrli:startdate><xbrli:enddate>2019-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2019_To_9_30_2019_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_abt_CardiovascularAndNeuromodulationProductsMember_us-gaap_SubsegmentsAxis_abt_ElectrophysiologyMember_B-InUodp-0axFdMh4cyTEg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:CardiovascularAndNeuromodulationProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:ElectrophysiologyMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2019-01-01</xbrli:startdate><xbrli:enddate>2019-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2019_To_9_30_2019_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_us-gaap_AllOtherSegmentsMember_BzVUo3WeWEm2wCCm9H5Z8A"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2019-01-01</xbrli:startdate><xbrli:enddate>2019-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2019_To_9_30_2019_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_abt_NutritionalProductsMember_P40qehTnCUm7Y4NHd6R69A"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:NutritionalProductsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2019-01-01</xbrli:startdate><xbrli:enddate>2019-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2019_To_9_30_2019_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_abt_EstablishedPharmaceuticalProductsMember_CflaIMgy5UOm17GJSrclIw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:EstablishedPharmaceuticalProductsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2019-01-01</xbrli:startdate><xbrli:enddate>2019-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2019_To_9_30_2019_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_abt_DiagnosticProductsMember_MoxoL5_2GES5O8ZAxasNxg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:DiagnosticProductsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2019-01-01</xbrli:startdate><xbrli:enddate>2019-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2019_To_9_30_2019_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_abt_CardiovascularAndNeuromodulationProductsMember_ReihajC5y0603BDLWr_Clg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:CardiovascularAndNeuromodulationProductsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2019-01-01</xbrli:startdate><xbrli:enddate>2019-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2019_To_9_30_2019_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_us-gaap_AllOtherSegmentsMember_0AWmrCZiBkKVFCjCSGMKVw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2019-01-01</xbrli:startdate><xbrli:enddate>2019-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2019_To_9_30_2019_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_abt_NutritionalProductsMember_0XlMOXiE3UiWn3X2OfAkVQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:NutritionalProductsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2019-01-01</xbrli:startdate><xbrli:enddate>2019-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2019_To_9_30_2019_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_abt_DiagnosticProductsMember_tuo4ZRxP5EyPHkkO5iEr3w"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:DiagnosticProductsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2019-01-01</xbrli:startdate><xbrli:enddate>2019-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2019_To_9_30_2019_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_abt_CardiovascularAndNeuromodulationProductsMember_iRzKEq3YyUW1ZBBgem-ErA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:CardiovascularAndNeuromodulationProductsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2019-01-01</xbrli:startdate><xbrli:enddate>2019-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2019_To_9_30_2019_us-gaap_StatementBusinessSegmentsAxis_abt_NutritionalProductsMember_us-gaap_SubsegmentsAxis_abt_PediatricNutritionalsMember_URy4dMFQ6kauU2M9MC26jg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:NutritionalProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:PediatricNutritionalsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2019-01-01</xbrli:startdate><xbrli:enddate>2019-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2019_To_9_30_2019_us-gaap_StatementBusinessSegmentsAxis_abt_NutritionalProductsMember_us-gaap_SubsegmentsAxis_abt_AdultNutritionalsMember_cRT25-H8nUKJwb_14a9hRg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:NutritionalProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:AdultNutritionalsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2019-01-01</xbrli:startdate><xbrli:enddate>2019-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2019_To_9_30_2019_us-gaap_StatementBusinessSegmentsAxis_abt_EstablishedPharmaceuticalProductsMember_us-gaap_SubsegmentsAxis_abt_OtherMember_uwJHMEPVoUW0jm0X5wr_Xw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:EstablishedPharmaceuticalProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:OtherMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2019-01-01</xbrli:startdate><xbrli:enddate>2019-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2019_To_9_30_2019_us-gaap_StatementBusinessSegmentsAxis_abt_EstablishedPharmaceuticalProductsMember_us-gaap_SubsegmentsAxis_abt_KeyEmergingMarketsMember_ROT06gEF_ky5_H5eUTqmcQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:EstablishedPharmaceuticalProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:KeyEmergingMarketsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2019-01-01</xbrli:startdate><xbrli:enddate>2019-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2019_To_9_30_2019_us-gaap_StatementBusinessSegmentsAxis_abt_DiagnosticProductsMember_us-gaap_SubsegmentsAxis_abt_RapidDiagnosticsMember_cEIHxCMuEka9NVqIaOOiGw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:DiagnosticProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:RapidDiagnosticsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2019-01-01</xbrli:startdate><xbrli:enddate>2019-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2019_To_9_30_2019_us-gaap_StatementBusinessSegmentsAxis_abt_DiagnosticProductsMember_us-gaap_SubsegmentsAxis_abt_PointOfCareMember_uht8HK5xIEyDIWXOB-a7Ew"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:DiagnosticProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:PointOfCareMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2019-01-01</xbrli:startdate><xbrli:enddate>2019-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2019_To_9_30_2019_us-gaap_StatementBusinessSegmentsAxis_abt_DiagnosticProductsMember_us-gaap_SubsegmentsAxis_abt_MolecularMember_g-4s0I2g3kCV2ytoWXv6vw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:DiagnosticProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:MolecularMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2019-01-01</xbrli:startdate><xbrli:enddate>2019-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2019_To_9_30_2019_us-gaap_StatementBusinessSegmentsAxis_abt_DiagnosticProductsMember_us-gaap_SubsegmentsAxis_abt_CoreLaboratoryMember_vHvAHLT_Z0-zRt4hFSgiUg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:DiagnosticProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:CoreLaboratoryMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2019-01-01</xbrli:startdate><xbrli:enddate>2019-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2019_To_9_30_2019_us-gaap_StatementBusinessSegmentsAxis_abt_CardiovascularAndNeuromodulationProductsMember_us-gaap_SubsegmentsAxis_abt_VascularProductsMember_iDqKVkz9O063ZJZ4GwFtBQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:CardiovascularAndNeuromodulationProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:VascularProductsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2019-01-01</xbrli:startdate><xbrli:enddate>2019-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2019_To_9_30_2019_us-gaap_StatementBusinessSegmentsAxis_abt_CardiovascularAndNeuromodulationProductsMember_us-gaap_SubsegmentsAxis_abt_StructuralHeartMember_597US2EM4Ee2adQJtqyKZQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:CardiovascularAndNeuromodulationProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:StructuralHeartMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2019-01-01</xbrli:startdate><xbrli:enddate>2019-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2019_To_9_30_2019_us-gaap_StatementBusinessSegmentsAxis_abt_CardiovascularAndNeuromodulationProductsMember_us-gaap_SubsegmentsAxis_abt_RhythmManagementMember_npRdt3_XZkSzvy1yQIlP-g"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:CardiovascularAndNeuromodulationProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:RhythmManagementMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2019-01-01</xbrli:startdate><xbrli:enddate>2019-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2019_To_9_30_2019_us-gaap_StatementBusinessSegmentsAxis_abt_CardiovascularAndNeuromodulationProductsMember_us-gaap_SubsegmentsAxis_abt_NeuromodulationMember_j5FIYrXLCEK_fuLEqsre0A"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:CardiovascularAndNeuromodulationProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:NeuromodulationMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2019-01-01</xbrli:startdate><xbrli:enddate>2019-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2019_To_9_30_2019_us-gaap_StatementBusinessSegmentsAxis_abt_CardiovascularAndNeuromodulationProductsMember_us-gaap_SubsegmentsAxis_abt_HeartFailureMember_6l7Ga-hSeUSTo5mLgmQz-w"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:CardiovascularAndNeuromodulationProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:HeartFailureMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2019-01-01</xbrli:startdate><xbrli:enddate>2019-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2019_To_9_30_2019_us-gaap_StatementBusinessSegmentsAxis_abt_CardiovascularAndNeuromodulationProductsMember_us-gaap_SubsegmentsAxis_abt_ElectrophysiologyMember_8iFB3YhAP06DEJg8lFoWjQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:CardiovascularAndNeuromodulationProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:ElectrophysiologyMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2019-01-01</xbrli:startdate><xbrli:enddate>2019-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2019_To_9_30_2019_srt_StatementGeographicalAxis_us-gaap_NonUsMember_BDZKwUhqvE6BItkVxM0xJw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2019-01-01</xbrli:startdate><xbrli:enddate>2019-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2019_To_9_30_2019_srt_StatementGeographicalAxis_country_US_GDkXKrZ42Ea8pLWCW9oidg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2019-01-01</xbrli:startdate><xbrli:enddate>2019-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2019_To_9_30_2019_us-gaap_StatementBusinessSegmentsAxis_abt_NutritionalProductsMember_DB1vUa6_7kOTq3NjihMp-Q"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:NutritionalProductsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2019-01-01</xbrli:startdate><xbrli:enddate>2019-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2019_To_9_30_2019_us-gaap_StatementBusinessSegmentsAxis_abt_EstablishedPharmaceuticalProductsMember_yudMSsrKEEaqBwE_PqUYVA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:EstablishedPharmaceuticalProductsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2019-01-01</xbrli:startdate><xbrli:enddate>2019-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2019_To_9_30_2019_us-gaap_StatementBusinessSegmentsAxis_abt_DiagnosticProductsMember_99hhFMIAyki-Cl9qbcjYEg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:DiagnosticProductsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2019-01-01</xbrli:startdate><xbrli:enddate>2019-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2019_To_9_30_2019_us-gaap_StatementBusinessSegmentsAxis_abt_CardiovascularAndNeuromodulationProductsMember_6GcC8cvXM0CCyPebis87CQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:CardiovascularAndNeuromodulationProductsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2019-01-01</xbrli:startdate><xbrli:enddate>2019-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_abt_NutritionalProductsMember_us-gaap_SubsegmentsAxis_abt_PediatricNutritionalsMember_AWD3p8tjeE2vg-6-IKXLjg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:NutritionalProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:PediatricNutritionalsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2018-07-01</xbrli:startdate><xbrli:enddate>2018-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_abt_NutritionalProductsMember_us-gaap_SubsegmentsAxis_abt_AdultNutritionalsMember__WHL05nK9U2cDb4T0gqFaw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:NutritionalProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:AdultNutritionalsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2018-07-01</xbrli:startdate><xbrli:enddate>2018-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_abt_EstablishedPharmaceuticalProductsMember_us-gaap_SubsegmentsAxis_abt_OtherMember_8vDABO9tpUGGEsEVBaZ5_g"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:EstablishedPharmaceuticalProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:OtherMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2018-07-01</xbrli:startdate><xbrli:enddate>2018-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_abt_EstablishedPharmaceuticalProductsMember_us-gaap_SubsegmentsAxis_abt_KeyEmergingMarketsMember_ldKKNNrrkU-XqX8a-hQ-Iw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:EstablishedPharmaceuticalProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:KeyEmergingMarketsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2018-07-01</xbrli:startdate><xbrli:enddate>2018-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_abt_DiagnosticProductsMember_us-gaap_SubsegmentsAxis_abt_RapidDiagnosticsMember_rTCEsB7JGk6j4XMMe-VrYw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:DiagnosticProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:RapidDiagnosticsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2018-07-01</xbrli:startdate><xbrli:enddate>2018-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_abt_DiagnosticProductsMember_us-gaap_SubsegmentsAxis_abt_PointOfCareMember_QEJKvSON60uX0RgaFoxJ7A"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:DiagnosticProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:PointOfCareMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2018-07-01</xbrli:startdate><xbrli:enddate>2018-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_abt_DiagnosticProductsMember_us-gaap_SubsegmentsAxis_abt_MolecularMember__D_PE8I3OEindYu1NbLgcQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:DiagnosticProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:MolecularMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2018-07-01</xbrli:startdate><xbrli:enddate>2018-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_abt_DiagnosticProductsMember_us-gaap_SubsegmentsAxis_abt_CoreLaboratoryMember_72Zj7dwptkS48ifHmIUvAQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:DiagnosticProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:CoreLaboratoryMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2018-07-01</xbrli:startdate><xbrli:enddate>2018-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_abt_CardiovascularAndNeuromodulationProductsMember_us-gaap_SubsegmentsAxis_abt_VascularProductsMember_yQyV75axvUmUkNWa5diU2g"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:CardiovascularAndNeuromodulationProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:VascularProductsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2018-07-01</xbrli:startdate><xbrli:enddate>2018-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_abt_CardiovascularAndNeuromodulationProductsMember_us-gaap_SubsegmentsAxis_abt_StructuralHeartMember_LzWdJR5pp0a9zla2NJyq-w"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:CardiovascularAndNeuromodulationProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:StructuralHeartMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2018-07-01</xbrli:startdate><xbrli:enddate>2018-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_abt_CardiovascularAndNeuromodulationProductsMember_us-gaap_SubsegmentsAxis_abt_RhythmManagementMember_3IvlwllLt02baa4uZqWbAw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:CardiovascularAndNeuromodulationProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:RhythmManagementMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2018-07-01</xbrli:startdate><xbrli:enddate>2018-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_abt_CardiovascularAndNeuromodulationProductsMember_us-gaap_SubsegmentsAxis_abt_NeuromodulationMember_mTNBfr7pHU6c2G82UlK06w"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:CardiovascularAndNeuromodulationProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:NeuromodulationMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2018-07-01</xbrli:startdate><xbrli:enddate>2018-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_abt_CardiovascularAndNeuromodulationProductsMember_us-gaap_SubsegmentsAxis_abt_HeartFailureMember_9po6MiXhEEijh4ATr4rlHQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:CardiovascularAndNeuromodulationProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:HeartFailureMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2018-07-01</xbrli:startdate><xbrli:enddate>2018-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_abt_CardiovascularAndNeuromodulationProductsMember_us-gaap_SubsegmentsAxis_abt_ElectrophysiologyMember_Fj3XVsBe8kSQAPAhhC6YAg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:CardiovascularAndNeuromodulationProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:ElectrophysiologyMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2018-07-01</xbrli:startdate><xbrli:enddate>2018-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_abt_NutritionalProductsMember_us-gaap_SubsegmentsAxis_abt_PediatricNutritionalsMember_qhqfrridv0ivQk77VRHKKA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:NutritionalProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:PediatricNutritionalsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2018-07-01</xbrli:startdate><xbrli:enddate>2018-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_abt_NutritionalProductsMember_us-gaap_SubsegmentsAxis_abt_AdultNutritionalsMember_idKAm6SioEOnFYB0NkODzw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:NutritionalProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:AdultNutritionalsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2018-07-01</xbrli:startdate><xbrli:enddate>2018-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_abt_DiagnosticProductsMember_us-gaap_SubsegmentsAxis_abt_RapidDiagnosticsMember_xCWqGccXaUGfN-uFZtCLlQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:DiagnosticProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:RapidDiagnosticsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2018-07-01</xbrli:startdate><xbrli:enddate>2018-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_abt_DiagnosticProductsMember_us-gaap_SubsegmentsAxis_abt_PointOfCareMember_wUeud0_4V064hlhBcYuAdA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:DiagnosticProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:PointOfCareMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2018-07-01</xbrli:startdate><xbrli:enddate>2018-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_abt_DiagnosticProductsMember_us-gaap_SubsegmentsAxis_abt_MolecularMember_NttXxMfel0yxCy1XlmxrfQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:DiagnosticProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:MolecularMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2018-07-01</xbrli:startdate><xbrli:enddate>2018-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_abt_DiagnosticProductsMember_us-gaap_SubsegmentsAxis_abt_CoreLaboratoryMember_7vzsfQNtQU2J1_dt3kF9ug"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:DiagnosticProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:CoreLaboratoryMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2018-07-01</xbrli:startdate><xbrli:enddate>2018-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_abt_CardiovascularAndNeuromodulationProductsMember_us-gaap_SubsegmentsAxis_abt_VascularProductsMember_l8ldpU3g4EC2TrAJQyIdpA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:CardiovascularAndNeuromodulationProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:VascularProductsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2018-07-01</xbrli:startdate><xbrli:enddate>2018-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_abt_CardiovascularAndNeuromodulationProductsMember_us-gaap_SubsegmentsAxis_abt_StructuralHeartMember_RTVWuCshF0OfYrMaxjAR_w"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:CardiovascularAndNeuromodulationProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:StructuralHeartMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2018-07-01</xbrli:startdate><xbrli:enddate>2018-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_abt_CardiovascularAndNeuromodulationProductsMember_us-gaap_SubsegmentsAxis_abt_RhythmManagementMember_m3yA-5zDp0qmDHq5UFFOAg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:CardiovascularAndNeuromodulationProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:RhythmManagementMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2018-07-01</xbrli:startdate><xbrli:enddate>2018-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_abt_CardiovascularAndNeuromodulationProductsMember_us-gaap_SubsegmentsAxis_abt_NeuromodulationMember_lv5cAAyQSUC2df2WvUTMCA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:CardiovascularAndNeuromodulationProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:NeuromodulationMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2018-07-01</xbrli:startdate><xbrli:enddate>2018-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_abt_CardiovascularAndNeuromodulationProductsMember_us-gaap_SubsegmentsAxis_abt_HeartFailureMember_iOvQXiIto06t2GN8FWWNOQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:CardiovascularAndNeuromodulationProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:HeartFailureMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2018-07-01</xbrli:startdate><xbrli:enddate>2018-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_abt_CardiovascularAndNeuromodulationProductsMember_us-gaap_SubsegmentsAxis_abt_ElectrophysiologyMember_FIHIQBg5KUmiQggufzOCcQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:CardiovascularAndNeuromodulationProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:ElectrophysiologyMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2018-07-01</xbrli:startdate><xbrli:enddate>2018-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_us-gaap_AllOtherSegmentsMember_L0KZBzlFjkuEZSn8UtIQyA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2018-07-01</xbrli:startdate><xbrli:enddate>2018-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_abt_NutritionalProductsMember_raxyrZJf9UmFP239tyvKpA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:NutritionalProductsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2018-07-01</xbrli:startdate><xbrli:enddate>2018-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_abt_EstablishedPharmaceuticalProductsMember_tLWz-zYE_02qimeg1PI_6g"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:EstablishedPharmaceuticalProductsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2018-07-01</xbrli:startdate><xbrli:enddate>2018-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_abt_DiagnosticProductsMember_VylmzYtm4060eyorbe0okQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:DiagnosticProductsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2018-07-01</xbrli:startdate><xbrli:enddate>2018-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_abt_CardiovascularAndNeuromodulationProductsMember_SmbbHTawSUGZQKKkbDMLLA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:CardiovascularAndNeuromodulationProductsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2018-07-01</xbrli:startdate><xbrli:enddate>2018-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_us-gaap_AllOtherSegmentsMember_mz5NtRWGr0exz2I2pFOEFw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2018-07-01</xbrli:startdate><xbrli:enddate>2018-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_abt_NutritionalProductsMember_dExPpXJUbkyGeCOfkVHWpQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:NutritionalProductsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2018-07-01</xbrli:startdate><xbrli:enddate>2018-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_abt_DiagnosticProductsMember_q7bwROz7nE-ltUPo0yBJ-Q"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:DiagnosticProductsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2018-07-01</xbrli:startdate><xbrli:enddate>2018-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_abt_CardiovascularAndNeuromodulationProductsMember_X0be1Nj3qkyFgBrHlTc1xQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:CardiovascularAndNeuromodulationProductsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2018-07-01</xbrli:startdate><xbrli:enddate>2018-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2018_To_9_30_2018_us-gaap_StatementBusinessSegmentsAxis_abt_NutritionalProductsMember_us-gaap_SubsegmentsAxis_abt_PediatricNutritionalsMember_NUwCDw5ye0mfcQLDron2EQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:NutritionalProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:PediatricNutritionalsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2018-07-01</xbrli:startdate><xbrli:enddate>2018-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2018_To_9_30_2018_us-gaap_StatementBusinessSegmentsAxis_abt_NutritionalProductsMember_us-gaap_SubsegmentsAxis_abt_AdultNutritionalsMember_Q4P0qz_KqUiyKdntC-48SA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:NutritionalProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:AdultNutritionalsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2018-07-01</xbrli:startdate><xbrli:enddate>2018-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2018_To_9_30_2018_us-gaap_StatementBusinessSegmentsAxis_abt_EstablishedPharmaceuticalProductsMember_us-gaap_SubsegmentsAxis_abt_OtherMember_Jrn3NzfC4Uyw_ky4SQbBqQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:EstablishedPharmaceuticalProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:OtherMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2018-07-01</xbrli:startdate><xbrli:enddate>2018-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2018_To_9_30_2018_us-gaap_StatementBusinessSegmentsAxis_abt_EstablishedPharmaceuticalProductsMember_us-gaap_SubsegmentsAxis_abt_KeyEmergingMarketsMember_JgFC37IEWUigmQ2Wu8cPKg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:EstablishedPharmaceuticalProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:KeyEmergingMarketsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2018-07-01</xbrli:startdate><xbrli:enddate>2018-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2018_To_9_30_2018_us-gaap_StatementBusinessSegmentsAxis_abt_DiagnosticProductsMember_us-gaap_SubsegmentsAxis_abt_RapidDiagnosticsMember_-1-7phaylE2_xVddWdDF3g"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:DiagnosticProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:RapidDiagnosticsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2018-07-01</xbrli:startdate><xbrli:enddate>2018-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2018_To_9_30_2018_us-gaap_StatementBusinessSegmentsAxis_abt_DiagnosticProductsMember_us-gaap_SubsegmentsAxis_abt_PointOfCareMember_vxjRnR9x6E-sXpauakPIuA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:DiagnosticProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:PointOfCareMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2018-07-01</xbrli:startdate><xbrli:enddate>2018-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2018_To_9_30_2018_us-gaap_StatementBusinessSegmentsAxis_abt_DiagnosticProductsMember_us-gaap_SubsegmentsAxis_abt_MolecularMember_fe6HW_Z8xUKRcRmkrFEMsQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:DiagnosticProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:MolecularMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2018-07-01</xbrli:startdate><xbrli:enddate>2018-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2018_To_9_30_2018_us-gaap_StatementBusinessSegmentsAxis_abt_DiagnosticProductsMember_us-gaap_SubsegmentsAxis_abt_CoreLaboratoryMember_Kwmp14-MBU2HLyQAyIXRew"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:DiagnosticProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:CoreLaboratoryMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2018-07-01</xbrli:startdate><xbrli:enddate>2018-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2018_To_9_30_2018_us-gaap_StatementBusinessSegmentsAxis_abt_CardiovascularAndNeuromodulationProductsMember_us-gaap_SubsegmentsAxis_abt_VascularProductsMember_JP_Nd1U9u0mAgC8xFdvSEg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:CardiovascularAndNeuromodulationProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:VascularProductsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2018-07-01</xbrli:startdate><xbrli:enddate>2018-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2018_To_9_30_2018_us-gaap_StatementBusinessSegmentsAxis_abt_CardiovascularAndNeuromodulationProductsMember_us-gaap_SubsegmentsAxis_abt_StructuralHeartMember_4kEn6XWAA0-l3kW_blDigg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:CardiovascularAndNeuromodulationProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:StructuralHeartMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2018-07-01</xbrli:startdate><xbrli:enddate>2018-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2018_To_9_30_2018_us-gaap_StatementBusinessSegmentsAxis_abt_CardiovascularAndNeuromodulationProductsMember_us-gaap_SubsegmentsAxis_abt_RhythmManagementMember_7HSNIF4euk2vfuOkKtrpEA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:CardiovascularAndNeuromodulationProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:RhythmManagementMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2018-07-01</xbrli:startdate><xbrli:enddate>2018-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2018_To_9_30_2018_us-gaap_StatementBusinessSegmentsAxis_abt_CardiovascularAndNeuromodulationProductsMember_us-gaap_SubsegmentsAxis_abt_NeuromodulationMember_SK9yHyWHYUatIEUbcFcRig"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:CardiovascularAndNeuromodulationProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:NeuromodulationMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2018-07-01</xbrli:startdate><xbrli:enddate>2018-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2018_To_9_30_2018_us-gaap_StatementBusinessSegmentsAxis_abt_CardiovascularAndNeuromodulationProductsMember_us-gaap_SubsegmentsAxis_abt_HeartFailureMember_ryer5-DKE02MjUBiUR047g"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:CardiovascularAndNeuromodulationProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:HeartFailureMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2018-07-01</xbrli:startdate><xbrli:enddate>2018-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2018_To_9_30_2018_us-gaap_StatementBusinessSegmentsAxis_abt_CardiovascularAndNeuromodulationProductsMember_us-gaap_SubsegmentsAxis_abt_ElectrophysiologyMember_xlB1a_zUh0O7blChJvVDOA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:CardiovascularAndNeuromodulationProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:ElectrophysiologyMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2018-07-01</xbrli:startdate><xbrli:enddate>2018-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_us-gaap_NonUsMember_AqYCjXibuES-Z_E4tis87A"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2018-07-01</xbrli:startdate><xbrli:enddate>2018-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_country_US_B8o1dDBmBkGc0Yqk6NufRA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2018-07-01</xbrli:startdate><xbrli:enddate>2018-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2018_To_9_30_2018_us-gaap_StatementBusinessSegmentsAxis_abt_NutritionalProductsMember_57RnstSlk0yNMWL17Wj6LA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:NutritionalProductsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2018-07-01</xbrli:startdate><xbrli:enddate>2018-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2018_To_9_30_2018_us-gaap_StatementBusinessSegmentsAxis_abt_EstablishedPharmaceuticalProductsMember_J2gj0gwvx0yLwbtJGADptg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:EstablishedPharmaceuticalProductsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2018-07-01</xbrli:startdate><xbrli:enddate>2018-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2018_To_9_30_2018_us-gaap_StatementBusinessSegmentsAxis_abt_DiagnosticProductsMember_Gh2Wf3zVFUCfVJ_wsdJ1RA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:DiagnosticProductsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2018-07-01</xbrli:startdate><xbrli:enddate>2018-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2018_To_9_30_2018_us-gaap_StatementBusinessSegmentsAxis_abt_CardiovascularAndNeuromodulationProductsMember_hRE3mhMnK0Wq8-WRIGY3wA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:CardiovascularAndNeuromodulationProductsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2018-07-01</xbrli:startdate><xbrli:enddate>2018-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_abt_NutritionalProductsMember_us-gaap_SubsegmentsAxis_abt_PediatricNutritionalsMember_FOyum4V_-0mPsycrZvLv1g"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:NutritionalProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:PediatricNutritionalsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2018-01-01</xbrli:startdate><xbrli:enddate>2018-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_abt_NutritionalProductsMember_us-gaap_SubsegmentsAxis_abt_AdultNutritionalsMember_YFBvcSbr80CYnNULiJsG4g"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:NutritionalProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:AdultNutritionalsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2018-01-01</xbrli:startdate><xbrli:enddate>2018-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_abt_EstablishedPharmaceuticalProductsMember_us-gaap_SubsegmentsAxis_abt_OtherMember_3z7ssMZwx0ekO38AvlwJUg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:EstablishedPharmaceuticalProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:OtherMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2018-01-01</xbrli:startdate><xbrli:enddate>2018-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_abt_EstablishedPharmaceuticalProductsMember_us-gaap_SubsegmentsAxis_abt_KeyEmergingMarketsMember_5pvQOTwNiU6K-rx3ltiOAw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:EstablishedPharmaceuticalProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:KeyEmergingMarketsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2018-01-01</xbrli:startdate><xbrli:enddate>2018-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_abt_DiagnosticProductsMember_us-gaap_SubsegmentsAxis_abt_RapidDiagnosticsMember_XwhdtA2DYUenS6x0ANFORg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:DiagnosticProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:RapidDiagnosticsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2018-01-01</xbrli:startdate><xbrli:enddate>2018-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_abt_DiagnosticProductsMember_us-gaap_SubsegmentsAxis_abt_PointOfCareMember_z-S6-8NvWkq2QojMzbyehA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:DiagnosticProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:PointOfCareMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2018-01-01</xbrli:startdate><xbrli:enddate>2018-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_abt_DiagnosticProductsMember_us-gaap_SubsegmentsAxis_abt_MolecularMember_bNdp6W-Tz0-uUi8GZjdC1w"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:DiagnosticProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:MolecularMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2018-01-01</xbrli:startdate><xbrli:enddate>2018-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_abt_DiagnosticProductsMember_us-gaap_SubsegmentsAxis_abt_CoreLaboratoryMember_XsdpDnHvS0iyhvTnOObq2g"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:DiagnosticProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:CoreLaboratoryMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2018-01-01</xbrli:startdate><xbrli:enddate>2018-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_abt_CardiovascularAndNeuromodulationProductsMember_us-gaap_SubsegmentsAxis_abt_VascularProductsMember_HFbuFHW5ukWZ8eGGXRi8RQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:CardiovascularAndNeuromodulationProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:VascularProductsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2018-01-01</xbrli:startdate><xbrli:enddate>2018-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_abt_CardiovascularAndNeuromodulationProductsMember_us-gaap_SubsegmentsAxis_abt_StructuralHeartMember_CMmYjisOuEKLSHbdQsNJCw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:CardiovascularAndNeuromodulationProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:StructuralHeartMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2018-01-01</xbrli:startdate><xbrli:enddate>2018-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_abt_CardiovascularAndNeuromodulationProductsMember_us-gaap_SubsegmentsAxis_abt_RhythmManagementMember_fiXAovA1wUakFhWTkQnN4g"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:CardiovascularAndNeuromodulationProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:RhythmManagementMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2018-01-01</xbrli:startdate><xbrli:enddate>2018-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_abt_CardiovascularAndNeuromodulationProductsMember_us-gaap_SubsegmentsAxis_abt_NeuromodulationMember_T-CdJpKIk0iiTl4HRoAF9Q"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:CardiovascularAndNeuromodulationProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:NeuromodulationMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2018-01-01</xbrli:startdate><xbrli:enddate>2018-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_abt_CardiovascularAndNeuromodulationProductsMember_us-gaap_SubsegmentsAxis_abt_HeartFailureMember_C7e69yvncEC_86ClR_66yw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:CardiovascularAndNeuromodulationProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:HeartFailureMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2018-01-01</xbrli:startdate><xbrli:enddate>2018-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_abt_CardiovascularAndNeuromodulationProductsMember_us-gaap_SubsegmentsAxis_abt_ElectrophysiologyMember_6l87SjJ4mU2Ern3wEGByig"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:CardiovascularAndNeuromodulationProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:ElectrophysiologyMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2018-01-01</xbrli:startdate><xbrli:enddate>2018-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_abt_NutritionalProductsMember_us-gaap_SubsegmentsAxis_abt_PediatricNutritionalsMember_bGXusL3u9k6U8TMi8HVW8w"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:NutritionalProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:PediatricNutritionalsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2018-01-01</xbrli:startdate><xbrli:enddate>2018-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_abt_NutritionalProductsMember_us-gaap_SubsegmentsAxis_abt_AdultNutritionalsMember_dlk89i5CYk2ZIySFgrHtDw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:NutritionalProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:AdultNutritionalsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2018-01-01</xbrli:startdate><xbrli:enddate>2018-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_abt_DiagnosticProductsMember_us-gaap_SubsegmentsAxis_abt_RapidDiagnosticsMember_4JPb8wEqjk20sp0pcatwIg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:DiagnosticProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:RapidDiagnosticsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2018-01-01</xbrli:startdate><xbrli:enddate>2018-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_abt_DiagnosticProductsMember_us-gaap_SubsegmentsAxis_abt_PointOfCareMember_OQDh2H2FvUiLUV_svBJUuQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:DiagnosticProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:PointOfCareMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2018-01-01</xbrli:startdate><xbrli:enddate>2018-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_abt_DiagnosticProductsMember_us-gaap_SubsegmentsAxis_abt_MolecularMember_We37m3Q7JUy1xeLeSVAwkg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:DiagnosticProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:MolecularMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2018-01-01</xbrli:startdate><xbrli:enddate>2018-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_abt_DiagnosticProductsMember_us-gaap_SubsegmentsAxis_abt_CoreLaboratoryMember_ByIiCW_7zECHUy_GfwafIg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:DiagnosticProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:CoreLaboratoryMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2018-01-01</xbrli:startdate><xbrli:enddate>2018-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_abt_CardiovascularAndNeuromodulationProductsMember_us-gaap_SubsegmentsAxis_abt_VascularProductsMember_GaNh01bgSES8ox3IgpmDcA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:CardiovascularAndNeuromodulationProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:VascularProductsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2018-01-01</xbrli:startdate><xbrli:enddate>2018-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_abt_CardiovascularAndNeuromodulationProductsMember_us-gaap_SubsegmentsAxis_abt_StructuralHeartMember_RMMBYOluM0uAaJHVaqsj6A"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:CardiovascularAndNeuromodulationProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:StructuralHeartMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2018-01-01</xbrli:startdate><xbrli:enddate>2018-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_abt_CardiovascularAndNeuromodulationProductsMember_us-gaap_SubsegmentsAxis_abt_RhythmManagementMember_-CcPBQOMHke9S9fOwnBNpQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:CardiovascularAndNeuromodulationProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:RhythmManagementMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2018-01-01</xbrli:startdate><xbrli:enddate>2018-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_abt_CardiovascularAndNeuromodulationProductsMember_us-gaap_SubsegmentsAxis_abt_NeuromodulationMember_qqxTMb7T_0uAViBwaew1Mw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:CardiovascularAndNeuromodulationProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:NeuromodulationMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2018-01-01</xbrli:startdate><xbrli:enddate>2018-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_abt_CardiovascularAndNeuromodulationProductsMember_us-gaap_SubsegmentsAxis_abt_HeartFailureMember_-8orpn_WQEaZFY0qly7FoQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:CardiovascularAndNeuromodulationProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:HeartFailureMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2018-01-01</xbrli:startdate><xbrli:enddate>2018-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_abt_CardiovascularAndNeuromodulationProductsMember_us-gaap_SubsegmentsAxis_abt_ElectrophysiologyMember_uH30gnf4Xk2idPxcoUpsKA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:CardiovascularAndNeuromodulationProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:ElectrophysiologyMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2018-01-01</xbrli:startdate><xbrli:enddate>2018-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_us-gaap_AllOtherSegmentsMember_HlN_IlGwYkGhZzjQ6w-Lmw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2018-01-01</xbrli:startdate><xbrli:enddate>2018-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_abt_NutritionalProductsMember_Mr0cnbPnjE26CUPDMINkmg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:NutritionalProductsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2018-01-01</xbrli:startdate><xbrli:enddate>2018-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_abt_EstablishedPharmaceuticalProductsMember_VBkoNFFtyUe92H90R2_2YA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:EstablishedPharmaceuticalProductsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2018-01-01</xbrli:startdate><xbrli:enddate>2018-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_abt_DiagnosticProductsMember_uZdDKX3HLkqBln3Nxdz5zw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:DiagnosticProductsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2018-01-01</xbrli:startdate><xbrli:enddate>2018-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_abt_CardiovascularAndNeuromodulationProductsMember_DIzJJ0DKaUmVhq6Hnzp8pA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:CardiovascularAndNeuromodulationProductsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2018-01-01</xbrli:startdate><xbrli:enddate>2018-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_us-gaap_AllOtherSegmentsMember_yanEVFf890u2tgjT9wNV8w"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2018-01-01</xbrli:startdate><xbrli:enddate>2018-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_abt_NutritionalProductsMember_CFr9InAyH0-KqXb8IZGU8w"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:NutritionalProductsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2018-01-01</xbrli:startdate><xbrli:enddate>2018-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_abt_DiagnosticProductsMember_d2w5vkkpmEioOWl8FtTS-Q"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:DiagnosticProductsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2018-01-01</xbrli:startdate><xbrli:enddate>2018-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_abt_CardiovascularAndNeuromodulationProductsMember_xrTvDfYJU0OdWlo07U8VFA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:CardiovascularAndNeuromodulationProductsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2018-01-01</xbrli:startdate><xbrli:enddate>2018-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2018_To_9_30_2018_us-gaap_StatementBusinessSegmentsAxis_abt_NutritionalProductsMember_us-gaap_SubsegmentsAxis_abt_PediatricNutritionalsMember_zBtjQdRUhE2g4SMtz5VZTQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:NutritionalProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:PediatricNutritionalsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2018-01-01</xbrli:startdate><xbrli:enddate>2018-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2018_To_9_30_2018_us-gaap_StatementBusinessSegmentsAxis_abt_NutritionalProductsMember_us-gaap_SubsegmentsAxis_abt_AdultNutritionalsMember_RIjQ9XJYtkyEqZun4o2llA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:NutritionalProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:AdultNutritionalsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2018-01-01</xbrli:startdate><xbrli:enddate>2018-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2018_To_9_30_2018_us-gaap_StatementBusinessSegmentsAxis_abt_EstablishedPharmaceuticalProductsMember_us-gaap_SubsegmentsAxis_abt_OtherMember_2ipXfDTKvkakuX16A9Uwxg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:EstablishedPharmaceuticalProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:OtherMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2018-01-01</xbrli:startdate><xbrli:enddate>2018-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2018_To_9_30_2018_us-gaap_StatementBusinessSegmentsAxis_abt_EstablishedPharmaceuticalProductsMember_us-gaap_SubsegmentsAxis_abt_KeyEmergingMarketsMember_2s7wtAp3qU-Chjo9CboO_A"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:EstablishedPharmaceuticalProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:KeyEmergingMarketsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2018-01-01</xbrli:startdate><xbrli:enddate>2018-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2018_To_9_30_2018_us-gaap_StatementBusinessSegmentsAxis_abt_DiagnosticProductsMember_us-gaap_SubsegmentsAxis_abt_RapidDiagnosticsMember_x8r1CxqLtEW9ljpb9_59AA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:DiagnosticProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:RapidDiagnosticsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2018-01-01</xbrli:startdate><xbrli:enddate>2018-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2018_To_9_30_2018_us-gaap_StatementBusinessSegmentsAxis_abt_DiagnosticProductsMember_us-gaap_SubsegmentsAxis_abt_PointOfCareMember_uVJFPGaxmUGSwuVX6qn6-w"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:DiagnosticProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:PointOfCareMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2018-01-01</xbrli:startdate><xbrli:enddate>2018-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2018_To_9_30_2018_us-gaap_StatementBusinessSegmentsAxis_abt_DiagnosticProductsMember_us-gaap_SubsegmentsAxis_abt_MolecularMember_nOI7tga5uU-RzB9AsnsvfQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:DiagnosticProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:MolecularMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2018-01-01</xbrli:startdate><xbrli:enddate>2018-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2018_To_9_30_2018_us-gaap_StatementBusinessSegmentsAxis_abt_DiagnosticProductsMember_us-gaap_SubsegmentsAxis_abt_CoreLaboratoryMember_YGWOOwbOg0mFaueUZlE8RQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:DiagnosticProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:CoreLaboratoryMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2018-01-01</xbrli:startdate><xbrli:enddate>2018-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2018_To_9_30_2018_us-gaap_StatementBusinessSegmentsAxis_abt_CardiovascularAndNeuromodulationProductsMember_us-gaap_SubsegmentsAxis_abt_VascularProductsMember_dRdpUmU-iU2CvlXiwo7kAg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:CardiovascularAndNeuromodulationProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:VascularProductsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2018-01-01</xbrli:startdate><xbrli:enddate>2018-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2018_To_9_30_2018_us-gaap_StatementBusinessSegmentsAxis_abt_CardiovascularAndNeuromodulationProductsMember_us-gaap_SubsegmentsAxis_abt_StructuralHeartMember_WI2emWZX0kCq01Hbzp5u9g"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:CardiovascularAndNeuromodulationProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:StructuralHeartMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2018-01-01</xbrli:startdate><xbrli:enddate>2018-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2018_To_9_30_2018_us-gaap_StatementBusinessSegmentsAxis_abt_CardiovascularAndNeuromodulationProductsMember_us-gaap_SubsegmentsAxis_abt_RhythmManagementMember_nSpxl2P3lEiCflnYuHWuog"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:CardiovascularAndNeuromodulationProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:RhythmManagementMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2018-01-01</xbrli:startdate><xbrli:enddate>2018-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2018_To_9_30_2018_us-gaap_StatementBusinessSegmentsAxis_abt_CardiovascularAndNeuromodulationProductsMember_us-gaap_SubsegmentsAxis_abt_NeuromodulationMember_HRvHEXdV80e4RGEPZftXyA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:CardiovascularAndNeuromodulationProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:NeuromodulationMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2018-01-01</xbrli:startdate><xbrli:enddate>2018-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2018_To_9_30_2018_us-gaap_StatementBusinessSegmentsAxis_abt_CardiovascularAndNeuromodulationProductsMember_us-gaap_SubsegmentsAxis_abt_HeartFailureMember_e8OON38b70qdpShAoZQzkw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:CardiovascularAndNeuromodulationProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:HeartFailureMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2018-01-01</xbrli:startdate><xbrli:enddate>2018-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2018_To_9_30_2018_us-gaap_StatementBusinessSegmentsAxis_abt_CardiovascularAndNeuromodulationProductsMember_us-gaap_SubsegmentsAxis_abt_ElectrophysiologyMember_kRjVH9SREkKr8yW5iOTf2A"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:CardiovascularAndNeuromodulationProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:ElectrophysiologyMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2018-01-01</xbrli:startdate><xbrli:enddate>2018-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_us-gaap_NonUsMember_7ac9eNGy-0Gsc4xouGtflg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2018-01-01</xbrli:startdate><xbrli:enddate>2018-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_country_US_ukRLAyTp0kmpYTxoa2DqxQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2018-01-01</xbrli:startdate><xbrli:enddate>2018-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2018_To_9_30_2018_us-gaap_StatementBusinessSegmentsAxis_abt_NutritionalProductsMember_KMUzb4jAPkyU8PkU49lN2A"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:NutritionalProductsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2018-01-01</xbrli:startdate><xbrli:enddate>2018-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2018_To_9_30_2018_us-gaap_StatementBusinessSegmentsAxis_abt_EstablishedPharmaceuticalProductsMember_48RJq_PWeUmNmmAC7FfiVA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:EstablishedPharmaceuticalProductsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2018-01-01</xbrli:startdate><xbrli:enddate>2018-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2018_To_9_30_2018_us-gaap_StatementBusinessSegmentsAxis_abt_DiagnosticProductsMember_xkFfRuL34kKosrhzdwxSRQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:DiagnosticProductsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2018-01-01</xbrli:startdate><xbrli:enddate>2018-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2018_To_9_30_2018_us-gaap_StatementBusinessSegmentsAxis_abt_CardiovascularAndNeuromodulationProductsMember_uiw4JYwlAEudlK8OtDkuGA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:CardiovascularAndNeuromodulationProductsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2018-01-01</xbrli:startdate><xbrli:enddate>2018-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="As_Of_9_30_2019_us-gaap_RestructuringCostAndReserveAxis_abt_RestructuringPlanFrom2016To2019Member_E-pYV7ivokmSZFV8XbRIPA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:RestructuringCostAndReserveAxis">abt:RestructuringPlanFrom2016To2019Member</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_9_30_2019_us-gaap_RestructuringCostAndReserveAxis_abt_RestructuringPlan2017To2019StjudeAndAlereMember_q0pnQ18-YEuHt43XHzsrkA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:RestructuringCostAndReserveAxis">abt:RestructuringPlan2017To2019StjudeAndAlereMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2018_us-gaap_RestructuringCostAndReserveAxis_abt_RestructuringPlanFrom2016To2019Member_7eMMCbXeYk-atM_ubYsnUA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:RestructuringCostAndReserveAxis">abt:RestructuringPlanFrom2016To2019Member</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2018_us-gaap_RestructuringCostAndReserveAxis_abt_RestructuringPlan2017To2019StjudeAndAlereMember_Fb8XUZ5dakWllMJpk3jgdQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:RestructuringCostAndReserveAxis">abt:RestructuringPlan2017To2019StjudeAndAlereMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2019_To_9_30_2019_us-gaap_IncomeStatementLocationAxis_us-gaap_SellingGeneralAndAdministrativeExpensesMember_us-gaap_RestructuringCostAndReserveAxis_abt_RestructuringPlanFrom2016To2019Member_hXefKCu4AEauZ3mXVC2eKQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:RestructuringCostAndReserveAxis">abt:RestructuringPlanFrom2016To2019Member</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2019-01-01</xbrli:startdate><xbrli:enddate>2019-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2019_To_9_30_2019_us-gaap_IncomeStatementLocationAxis_us-gaap_SellingGeneralAndAdministrativeExpensesMember_us-gaap_RestructuringCostAndReserveAxis_abt_RestructuringPlan2017To2019StjudeAndAlereMember_IZFYhFP0dEuk_E4iS5hi9A"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:RestructuringCostAndReserveAxis">abt:RestructuringPlan2017To2019StjudeAndAlereMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2019-01-01</xbrli:startdate><xbrli:enddate>2019-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2019_To_9_30_2019_us-gaap_IncomeStatementLocationAxis_us-gaap_ResearchAndDevelopmentExpenseMember_us-gaap_RestructuringCostAndReserveAxis_abt_RestructuringPlanFrom2016To2019Member_Z97JbKaNV0ackA_Pb1ZDmg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:RestructuringCostAndReserveAxis">abt:RestructuringPlanFrom2016To2019Member</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2019-01-01</xbrli:startdate><xbrli:enddate>2019-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2019_To_9_30_2019_us-gaap_IncomeStatementLocationAxis_us-gaap_ResearchAndDevelopmentExpenseMember_us-gaap_RestructuringCostAndReserveAxis_abt_RestructuringPlan2017To2019StjudeAndAlereMember_8TVhyOFuH0KUpdd182ROmw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:RestructuringCostAndReserveAxis">abt:RestructuringPlan2017To2019StjudeAndAlereMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2019-01-01</xbrli:startdate><xbrli:enddate>2019-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2019_To_9_30_2019_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember_us-gaap_RestructuringCostAndReserveAxis_abt_RestructuringPlanFrom2016To2019Member_jjdDvedzc0mSQzR7w5ZX2g"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:RestructuringCostAndReserveAxis">abt:RestructuringPlanFrom2016To2019Member</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2019-01-01</xbrli:startdate><xbrli:enddate>2019-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2019_To_9_30_2019_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember_us-gaap_RestructuringCostAndReserveAxis_abt_RestructuringPlan2017To2019StjudeAndAlereMember_JP-ZjJPCSEK7ootjdi_kaw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:RestructuringCostAndReserveAxis">abt:RestructuringPlan2017To2019StjudeAndAlereMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2019-01-01</xbrli:startdate><xbrli:enddate>2019-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2019_To_3_31_2019_us-gaap_BusinessAcquisitionAxis_abt_CepheaValveTechnologiesInc.Member_Ke1rNcqUMkOQeqAPYEGSMQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:BusinessAcquisitionAxis">abt:CepheaValveTechnologiesInc.Member</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2019-01-01</xbrli:startdate><xbrli:enddate>2019-03-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_2_24_2019_To_2_24_2019_us-gaap_DebtInstrumentAxis_abt_LongTermNotesDueIn2020At2.80PercentMember_OvmFiM0KakOZD1aXcBSa-w"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:DebtInstrumentAxis">abt:LongTermNotesDueIn2020At2.80PercentMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2019-02-24</xbrli:startdate><xbrli:enddate>2019-02-24</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2019_To_9_30_2019_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember_OaDghxREG0uobIbjFOFDdQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2019-07-01</xbrli:startdate><xbrli:enddate>2019-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2019_To_9_30_2019_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember_f92R9C_oiUWyvriT6Shvgg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2019-01-01</xbrli:startdate><xbrli:enddate>2019-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2018_To_9_30_2018_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember_tMykbeJAIUGQ7YdHOvPtvA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2018-07-01</xbrli:startdate><xbrli:enddate>2018-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2018_To_9_30_2018_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember_rkBIsOpOKkibOdH_cYMofQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2018-01-01</xbrli:startdate><xbrli:enddate>2018-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2019_To_9_30_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember_PKX7uJq7f0yruS1mzV5oTw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2019-07-01</xbrli:startdate><xbrli:enddate>2019-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2019_To_9_30_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember_-8Bw1WAG10q8sKd7yi0Z7w"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2019-01-01</xbrli:startdate><xbrli:enddate>2019-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2018_To_9_30_2018_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember_HIpKaN8RWUSDv6jpeJLxWQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2018-07-01</xbrli:startdate><xbrli:enddate>2018-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2018_To_9_30_2018_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember_wI_ZJ6bF_UeFpesDvVl5PQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2018-01-01</xbrli:startdate><xbrli:enddate>2018-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2019_To_9_30_2019_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_FairValueHedgingMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember_-cEhq1VeyUW5kwGWV_fCww"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2019-07-01</xbrli:startdate><xbrli:enddate>2019-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2019_To_9_30_2019_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember_q3XZa8hMBEWuiq7vj3A2nw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2019-07-01</xbrli:startdate><xbrli:enddate>2019-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2019_To_9_30_2019_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_FairValueHedgingMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember_f9-khleCD0ie4NuOzNmLoQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2019-01-01</xbrli:startdate><xbrli:enddate>2019-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2019_To_9_30_2019_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember_v24RB4FtHkOllQj-3c5MOA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2019-01-01</xbrli:startdate><xbrli:enddate>2019-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2018_To_9_30_2018_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_FairValueHedgingMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember_TOgEmx4ZnUyLlxWakY7ATQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2018-07-01</xbrli:startdate><xbrli:enddate>2018-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2018_To_9_30_2018_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember_SHhbDIAoWU2fbpNhC66XDA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2018-07-01</xbrli:startdate><xbrli:enddate>2018-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2018_To_9_30_2018_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_FairValueHedgingMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember_KVlOnIcop0W0p5XoJA3m9w"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2018-01-01</xbrli:startdate><xbrli:enddate>2018-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2018_To_9_30_2018_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember_JvrolFTPeUmRoiE1y7qEUw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2018-01-01</xbrli:startdate><xbrli:enddate>2018-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2019_To_9_30_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedTranslationAdjustmentMember_QTmknphONka7wd6TxuDRwA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2019-07-01</xbrli:startdate><xbrli:enddate>2019-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2019_To_9_30_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_0kVXboVkfEqGj4zXmlxZ1Q"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2019-07-01</xbrli:startdate><xbrli:enddate>2019-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2019_To_9_30_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_v7pihJwn_EmhBMZynyJ6qQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2019-07-01</xbrli:startdate><xbrli:enddate>2019-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2019_To_9_30_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedTranslationAdjustmentMember_ahRQcVKo5Ee9ibEOt4b1vg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2019-01-01</xbrli:startdate><xbrli:enddate>2019-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2019_To_9_30_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_F4mEkPCE_E-rP4hjc0l1ww"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2019-01-01</xbrli:startdate><xbrli:enddate>2019-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2019_To_9_30_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_MmI0pTMZD0KzxQcfC1yCPA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2019-01-01</xbrli:startdate><xbrli:enddate>2019-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2018_To_9_30_2018_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedTranslationAdjustmentMember_-leGWOkeKEawi-QLq6LVGw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2018-07-01</xbrli:startdate><xbrli:enddate>2018-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2018_To_9_30_2018_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_FcH8pG6M70SGkwFo_nAkaA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2018-07-01</xbrli:startdate><xbrli:enddate>2018-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2018_To_9_30_2018_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_HRtfunmfOUeJPnNKwhj38w"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2018-07-01</xbrli:startdate><xbrli:enddate>2018-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2018_To_9_30_2018_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedTranslationAdjustmentMember_BTp83-aWHUWu-2eP47pxBg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2018-01-01</xbrli:startdate><xbrli:enddate>2018-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2018_To_9_30_2018_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_RV18NRdLfUSZpzm0ZOAU_A"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2018-01-01</xbrli:startdate><xbrli:enddate>2018-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2018_To_9_30_2018_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_HuQINilLHkCUG87EDKyxJA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2018-01-01</xbrli:startdate><xbrli:enddate>2018-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="As_Of_1_1_2019_srt_RestatementAxis_srt_RestatementAdjustmentMember_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_us-gaap_AccountingStandardsUpdate201602Member_YQvWxBpGvkim5xhEV2VSoA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201602Member</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-01-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2019_To_9_30_2019_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_abt_NutritionalProductsMember_nni-LDY7YkiSXaaKiZziQw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:NutritionalProductsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2019-07-01</xbrli:startdate><xbrli:enddate>2019-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2019_To_9_30_2019_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_abt_EstablishedPharmaceuticalProductsMember_keh92wNn8kaKtQ9J5JbgwA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:EstablishedPharmaceuticalProductsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2019-07-01</xbrli:startdate><xbrli:enddate>2019-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2019_To_9_30_2019_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_abt_DiagnosticProductsMember_FnP06bxi60-w30Oo_2zs4g"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:DiagnosticProductsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2019-07-01</xbrli:startdate><xbrli:enddate>2019-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2019_To_9_30_2019_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_abt_CardiovascularAndNeuromodulationProductsMember_rH7Zs0lLdUCD9w4VvAC-lw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:CardiovascularAndNeuromodulationProductsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2019-07-01</xbrli:startdate><xbrli:enddate>2019-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2019_To_9_30_2019_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_jRxvW21N206hpcGBDrYIEw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2019-07-01</xbrli:startdate><xbrli:enddate>2019-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2019_To_9_30_2019_us-gaap_StatementBusinessSegmentsAxis_us-gaap_AllOtherSegmentsMember_6xuLziuqYUu7G9wnH5DWIQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2019-07-01</xbrli:startdate><xbrli:enddate>2019-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2019_To_9_30_2019_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_abt_NutritionalProductsMember_ogKwSHLFqUC88g-lA6iueA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:NutritionalProductsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2019-01-01</xbrli:startdate><xbrli:enddate>2019-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2019_To_9_30_2019_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_abt_EstablishedPharmaceuticalProductsMember_rJA5x0gXxkGHub8Kg-iK0w"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:EstablishedPharmaceuticalProductsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2019-01-01</xbrli:startdate><xbrli:enddate>2019-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2019_To_9_30_2019_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_abt_DiagnosticProductsMember_RTLOqDB56EK401Q7B97VVg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:DiagnosticProductsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2019-01-01</xbrli:startdate><xbrli:enddate>2019-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2019_To_9_30_2019_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_abt_CardiovascularAndNeuromodulationProductsMember_DqQTOcfsnkKBI-L6UijMkA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:CardiovascularAndNeuromodulationProductsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2019-01-01</xbrli:startdate><xbrli:enddate>2019-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2019_To_9_30_2019_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_RpOultrMfkWf8eSh9ZHUJg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2019-01-01</xbrli:startdate><xbrli:enddate>2019-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2019_To_9_30_2019_us-gaap_StatementBusinessSegmentsAxis_us-gaap_AllOtherSegmentsMember_bEC5ujKIG064i9f7edUrGg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2019-01-01</xbrli:startdate><xbrli:enddate>2019-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2018_To_9_30_2018_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_abt_NutritionalProductsMember_m1Tmoie0pUagbwg4aIQj5Q"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:NutritionalProductsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2018-07-01</xbrli:startdate><xbrli:enddate>2018-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2018_To_9_30_2018_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_abt_EstablishedPharmaceuticalProductsMember_oXOcmR6rpECCikSKHRh5dQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:EstablishedPharmaceuticalProductsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2018-07-01</xbrli:startdate><xbrli:enddate>2018-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2018_To_9_30_2018_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_abt_DiagnosticProductsMember_8muEd-xSoUCoq2Pl8AzzUw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:DiagnosticProductsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2018-07-01</xbrli:startdate><xbrli:enddate>2018-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2018_To_9_30_2018_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_abt_CardiovascularAndNeuromodulationProductsMember_JvEaRnkAC0WA20wSIW-m6Q"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:CardiovascularAndNeuromodulationProductsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2018-07-01</xbrli:startdate><xbrli:enddate>2018-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2018_To_9_30_2018_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_RwywU8gxUEGoaKIjGkIOSA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2018-07-01</xbrli:startdate><xbrli:enddate>2018-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2018_To_9_30_2018_us-gaap_StatementBusinessSegmentsAxis_us-gaap_AllOtherSegmentsMember_m4XzPpMweEeW0W5huKZbPA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2018-07-01</xbrli:startdate><xbrli:enddate>2018-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2018_To_9_30_2018_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_abt_NutritionalProductsMember_On0QXDSsaUuuRKag9KNMtg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:NutritionalProductsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2018-01-01</xbrli:startdate><xbrli:enddate>2018-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2018_To_9_30_2018_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_abt_EstablishedPharmaceuticalProductsMember_4X5ZASo2QUypfnofJHcSZQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:EstablishedPharmaceuticalProductsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2018-01-01</xbrli:startdate><xbrli:enddate>2018-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2018_To_9_30_2018_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_abt_DiagnosticProductsMember_ImQQ9QI3kUGd0c3G4jsDMQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:DiagnosticProductsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2018-01-01</xbrli:startdate><xbrli:enddate>2018-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2018_To_9_30_2018_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_abt_CardiovascularAndNeuromodulationProductsMember_9rCo2bjOCUC_2432Z5UMFw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:CardiovascularAndNeuromodulationProductsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2018-01-01</xbrli:startdate><xbrli:enddate>2018-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2018_To_9_30_2018_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_IukYM-KoVUWSdFGyAxl5_A"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2018-01-01</xbrli:startdate><xbrli:enddate>2018-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2018_To_9_30_2018_us-gaap_StatementBusinessSegmentsAxis_us-gaap_AllOtherSegmentsMember_ZR9EI4Kh7UeN1hu1pcbUqQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2018-01-01</xbrli:startdate><xbrli:enddate>2018-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="As_Of_9_30_2019_srt_RangeAxis_srt_MinimumMember_us-gaap_LossContingenciesByNatureOfContingencyAxis_abt_LegalProceedingsAndEnvironmentalExposuresMember_I5vPWeZRqk-P4NsBXTp0oA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">abt:LegalProceedingsAndEnvironmentalExposuresMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_9_30_2019_srt_RangeAxis_srt_MaximumMember_us-gaap_LossContingenciesByNatureOfContingencyAxis_abt_LegalProceedingsAndEnvironmentalExposuresMember_TuM9GVdwQEKD34JXMhYUwA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">abt:LegalProceedingsAndEnvironmentalExposuresMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_9_30_2019_us-gaap_LossContingenciesByNatureOfContingencyAxis_abt_LegalProceedingsAndEnvironmentalExposuresMember_6vWgLBy-skicYXf8KTe4vw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">abt:LegalProceedingsAndEnvironmentalExposuresMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_9_30_2019_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_EstimateOfFairValueFairValueDisclosureMember_us-gaap_InvestmentTypeAxis_us-gaap_OtherAggregatedInvestmentsMember_P7JTdZ1jJUOn-y7zA6RR2w"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:InvestmentTypeAxis">us-gaap:OtherAggregatedInvestmentsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_9_30_2019_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_EstimateOfFairValueFairValueDisclosureMember_us-gaap_InvestmentTypeAxis_us-gaap_EquitySecuritiesMember_g7gwhwY-LUeXkEPOZVCoFQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_9_30_2019_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_CarryingReportedAmountFairValueDisclosureMember_us-gaap_InvestmentTypeAxis_us-gaap_OtherAggregatedInvestmentsMember_rQcPakxmUkut_lJbDmRdmw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:InvestmentTypeAxis">us-gaap:OtherAggregatedInvestmentsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_9_30_2019_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_CarryingReportedAmountFairValueDisclosureMember_us-gaap_InvestmentTypeAxis_us-gaap_EquitySecuritiesMember_5I6guGkvEEeOvzmRp9OCOA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_9_30_2019_us-gaap_InvestmentTypeAxis_us-gaap_OtherInvestmentsMember_RqEewlvYWUOOc7tV6AAOvA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:InvestmentTypeAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_9_30_2019_us-gaap_InvestmentTypeAxis_us-gaap_EquitySecuritiesMember_3nNMizmWaEa6tPmsSbXC9Q"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2018_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_EstimateOfFairValueFairValueDisclosureMember_us-gaap_InvestmentTypeAxis_us-gaap_OtherAggregatedInvestmentsMember_NNh-icx5SkaSUKVwiFXgEw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:InvestmentTypeAxis">us-gaap:OtherAggregatedInvestmentsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2018_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_EstimateOfFairValueFairValueDisclosureMember_us-gaap_InvestmentTypeAxis_us-gaap_EquitySecuritiesMember_P7Ou1KW7Hk6AJ-5yBe7BgQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2018_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_CarryingReportedAmountFairValueDisclosureMember_us-gaap_InvestmentTypeAxis_us-gaap_OtherAggregatedInvestmentsMember_RAAT8gNePEOGPotd79zykg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:InvestmentTypeAxis">us-gaap:OtherAggregatedInvestmentsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2018_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_CarryingReportedAmountFairValueDisclosureMember_us-gaap_InvestmentTypeAxis_us-gaap_EquitySecuritiesMember_KKskyI4iaUyJWLlAlXrwxw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2018_us-gaap_InvestmentTypeAxis_us-gaap_OtherInvestmentsMember_CxtEgQasPkCsxRBKjx4EJg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:InvestmentTypeAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2018_us-gaap_InvestmentTypeAxis_us-gaap_EquitySecuritiesMember_1rLGYajW7ECYIIg9ayCVvA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2019_To_1_1_2019_NgyqN4UrKEaSZk1pJ_OHSg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startdate>2019-01-01</xbrli:startdate><xbrli:enddate>2019-01-01</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2018_To_9_30_2018_us-gaap_StatementOperatingActivitiesSegmentAxis_us-gaap_SegmentDiscontinuedOperationsMember_qVc5axf-dk2sztcbRDmn3Q"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">us-gaap:SegmentDiscontinuedOperationsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2018-01-01</xbrli:startdate><xbrli:enddate>2018-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="As_Of_9_30_2019_us-gaap_StatementBusinessSegmentsAxis_abt_NutritionalProductsMember_YoPRByOmokqwB0d5qJ5VbQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:NutritionalProductsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_9_30_2019_us-gaap_StatementBusinessSegmentsAxis_abt_EstablishedPharmaceuticalProductsMember_UnYrsB57Nkagfm2uHBTc5w"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:EstablishedPharmaceuticalProductsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_9_30_2019_us-gaap_StatementBusinessSegmentsAxis_abt_DiagnosticProductsMember_ri__PwPJn06gNt3sCbH5ag"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:DiagnosticProductsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_9_30_2019_us-gaap_StatementBusinessSegmentsAxis_abt_CardiovascularAndNeuromodulationProductsMember_mLmh_6-3VkiqgiDyhwOAjA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:CardiovascularAndNeuromodulationProductsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_9_30_2019_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_EstimateOfFairValueFairValueDisclosureMember_-Q-LIZ0OPkSZIwT0yHkPXA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_9_30_2019_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_CarryingReportedAmountFairValueDisclosureMember_aSz4hVbPbkajcgZye1Napw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2018_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_EstimateOfFairValueFairValueDisclosureMember_T9iW39RvE0KqQjvg5INJMg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2018_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_CarryingReportedAmountFairValueDisclosureMember_313ViIP4YEWf51iTcGQTlw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_9_30_2019_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_FairValueHedgingMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember_m_aY3BlibEu5mFrN4z-K3A"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_9_30_2019_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember_iqx5P_Re402relQSOxoCQw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_9_30_2019_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember_OWSwzCnJhEykAb_M6QaL6g"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2018_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_FairValueHedgingMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember_pzqC_GsZqkG9JSKompp5RA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2018_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember__kXMQQ6af0ClMJyFgxeKow"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2018_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember_xdx2l_dh2ES7V9IUsP-UMg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_9_30_2019_us-gaap_BalanceSheetLocationAxis_us-gaap_AccruedLiabilitiesMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember_OnxvvpO_8E2IGaj-4RWbjQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_9_30_2019_us-gaap_BalanceSheetLocationAxis_us-gaap_AccruedLiabilitiesMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember_8AkAOFGOA0yntAAIwKSYPw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2018_us-gaap_BalanceSheetLocationAxis_abt_PostemploymentObligationsDeferredIncomeTaxesAndOtherLongTermLiabilitiesMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_FairValueHedgingMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember_gsmrr18YxkKh2iRP6H_wgA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:BalanceSheetLocationAxis">abt:PostemploymentObligationsDeferredIncomeTaxesAndOtherLongTermLiabilitiesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2018_us-gaap_BalanceSheetLocationAxis_us-gaap_AccruedLiabilitiesMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember_4SJ2lgc4MU6nf-Fk4-J1_Q"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2018_us-gaap_BalanceSheetLocationAxis_us-gaap_AccruedLiabilitiesMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember_VzE3asdseku4XPLX0uzykg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_9_30_2019_us-gaap_BalanceSheetLocationAxis_abt_DeferredIncomeTaxesAndOtherAssetsMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_FairValueHedgingMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember_a8_qiANHDkSJpz_fTHYXBQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:BalanceSheetLocationAxis">abt:DeferredIncomeTaxesAndOtherAssetsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_9_30_2019_us-gaap_BalanceSheetLocationAxis_abt_PrepaidExpensesAndOtherReceivablesMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember_ovW4USmZ0k29DzOuU2JY5w"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:BalanceSheetLocationAxis">abt:PrepaidExpensesAndOtherReceivablesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_9_30_2019_us-gaap_BalanceSheetLocationAxis_abt_PrepaidExpensesAndOtherReceivablesMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember_D9fu9Wl98Eu8Dzr0qJyDdA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:BalanceSheetLocationAxis">abt:PrepaidExpensesAndOtherReceivablesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2018_us-gaap_BalanceSheetLocationAxis_abt_PrepaidExpensesAndOtherReceivablesMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember_QGA5BKfpPECDcDSYOgK6rg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:BalanceSheetLocationAxis">abt:PrepaidExpensesAndOtherReceivablesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2018_us-gaap_BalanceSheetLocationAxis_abt_PrepaidExpensesAndOtherReceivablesMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember_z1WuvwgbbkWpw_g8_D6jYQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:BalanceSheetLocationAxis">abt:PrepaidExpensesAndOtherReceivablesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2019_To_9_30_2019_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember_lK6ibUzmhUyQKDST8N8Wcw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2019-07-01</xbrli:startdate><xbrli:enddate>2019-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2019_To_9_30_2019_us-gaap_RetirementPlanTypeAxis_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_peLAPtPdO0i7sEgvdxD48g"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2019-07-01</xbrli:startdate><xbrli:enddate>2019-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2019_To_9_30_2019_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember_lB8RTt7VykWlXZnoI4XA6w"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2019-01-01</xbrli:startdate><xbrli:enddate>2019-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2019_To_9_30_2019_us-gaap_RetirementPlanTypeAxis_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_zZGCXN2-QUiC_W6F9cgj6A"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2019-01-01</xbrli:startdate><xbrli:enddate>2019-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2018_To_9_30_2018_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember_UQ4wAcf7eka8fnkFZEvV-A"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2018-07-01</xbrli:startdate><xbrli:enddate>2018-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2018_To_9_30_2018_us-gaap_RetirementPlanTypeAxis_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_hjSt1qqsSUyf4oneowhAAQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2018-07-01</xbrli:startdate><xbrli:enddate>2018-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2018_To_9_30_2018_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember_n53CHi7vukugJ6IfhgDWmQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2018-01-01</xbrli:startdate><xbrli:enddate>2018-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2018_To_9_30_2018_us-gaap_RetirementPlanTypeAxis_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_Y_TwTX3MfUCiGOSbOE4-kA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2018-01-01</xbrli:startdate><xbrli:enddate>2018-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="As_Of_9_30_2019_srt_RangeAxis_srt_MinimumMember_CX2tJ3HgS06yfIVVN84Uaw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_9_30_2019_srt_RangeAxis_srt_MaximumMember_TIf3O5zuGEK_gbVC_qJfFA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_2_24_2019_us-gaap_DebtInstrumentAxis_abt_LongTermNotesDueIn2020At2.80PercentMember_RRQASgqPwUa9r9QrzxbkyQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:DebtInstrumentAxis">abt:LongTermNotesDueIn2020At2.80PercentMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-02-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_9_30_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedTranslationAdjustmentMember_QperScMcXkef0ElUQzi7oQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_9_30_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_z5hAWCvHIUKcOkDryiupIA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_9_30_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_kY8gy1aksESiVApQoJqTYA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_9_30_2018_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedTranslationAdjustmentMember_2cysz9O7IEursrDHfLQHWA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_9_30_2018_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_CWADNgfhz0q-L3-mkZGWzA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_9_30_2018_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_q2xiHapVJUO_5rhTSwvlNA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_1_1_2018_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_nIVdNru5t0SvEe2LP2xN_A"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-01-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_1_1_2018_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember_GuYuIVBYqk2k9ru3-XIPNA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-01-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_1_1_2018_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_dImliaxYGkubUQ6JT8eo1A"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-01-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_9_30_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockCommonMember_hG_cgbpoj0WKrcwXEwI4nw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_9_30_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_0ZqOMZr03U6jT4sbB6tWag"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_6_30_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockCommonMember_x_an6TAYEkK2uj3GRXjq-g"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_6_30_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_bYaCiLkFBUqiDWLIdb0NvA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2018_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockCommonMember_PFELMvj3PE2LE_37JacnLQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2018_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_cymtBbrE6025s_ku5j0wGg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_9_30_2018_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockCommonMember_KNWPmWmuEEGL3GZ2zmgCww"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_9_30_2018_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_CgmFvyJEkEiX7ioe_6TFpQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_6_30_2018_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockCommonMember_2AsFLtHoeU6kuJPNMEIYQg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_6_30_2018_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_lyA3n3n15UyL8v-1o3UXJQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2017_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockCommonMember_U58xz9lIuUexE1EuykMJkg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2017_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_eYcQio7byUWpb080LoJfiA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_9_30_2019_us-gaap_BusinessAcquisitionAxis_abt_StJudeMedicalInc.Member_us-gaap_InvestmentTypeAxis_us-gaap_EquitySecuritiesMember_8vo-99w8KkiVW35UmBSvVQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:BusinessAcquisitionAxis">abt:StJudeMedicalInc.Member</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_9_30_2018_m4UuMI1ubEOozG-BjuDXyA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2018-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2017_ioSxrd0aWkWAGJFTYQ9J4A"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_3_31_2019_us-gaap_BusinessAcquisitionAxis_abt_CepheaValveTechnologiesInc.Member_QiXyi0x5aky0u96TQUbx9g"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:BusinessAcquisitionAxis">abt:CepheaValveTechnologiesInc.Member</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_9_30_2019_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_5s1_qJcZbkOGM8oz400wTQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_9_30_2019_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_ul-yLL0ZFEuq6vE5Os0W9w"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_9_30_2019_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_QB0ZMuPwIEKXfWRHKPnjMg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_9_30_2019_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_kkmtQBxmAUeEg6e6Pmxiuw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2018_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_CO3UAdKD2kCSe3FNpfmZcQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2018_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_RyqZHLXBfUKcYRtWgHbEBA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2018_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_nRdEWmxCjE6Tsq35dV79tA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2018_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember__3b9oiVbFkuHXAmmv2aTGQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2019_To_9_30_2019_dei_EntityListingsExchangeAxis_exch_XNYS_iKXTz1QINEycdLuHek9Tgw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2019-01-01</xbrli:startdate><xbrli:enddate>2019-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2019_To_9_30_2019_dei_EntityListingsExchangeAxis_exch_XCHI_qplh5iM290eZvAdYkqPxeg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="dei:EntityListingsExchangeAxis">exch:XCHI</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2019-01-01</xbrli:startdate><xbrli:enddate>2019-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2019_To_9_30_2019_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_abt_cnst_2021-10-01_h_f9OLOKA0-A7E_9UlfP_A"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:typedmember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"><us-gaap:revenueremainingperformanceobligationexpectedtimingofsatisfactionstartdateaxis.domain>2021-10-01</us-gaap:revenueremainingperformanceobligationexpectedtimingofsatisfactionstartdateaxis.domain></xbrldi:typedmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2019-01-01</xbrli:startdate><xbrli:enddate>2019-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2019_To_9_30_2019_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_abt_cnst_2019-10-01_T8BFLnHyn0u8l7-D6g-oYw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:typedmember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"><us-gaap:revenueremainingperformanceobligationexpectedtimingofsatisfactionstartdateaxis.domain>2019-10-01</us-gaap:revenueremainingperformanceobligationexpectedtimingofsatisfactionstartdateaxis.domain></xbrldi:typedmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2019-01-01</xbrli:startdate><xbrli:enddate>2019-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2019_To_9_30_2019_us-gaap_RestructuringCostAndReserveAxis_abt_RestructuringPlanFrom2016To2019Member_NzEXx0HK5kKauLcx72p8kA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:RestructuringCostAndReserveAxis">abt:RestructuringPlanFrom2016To2019Member</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2019-01-01</xbrli:startdate><xbrli:enddate>2019-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2019_To_9_30_2019_us-gaap_RestructuringCostAndReserveAxis_abt_RestructuringPlan2017To2019StjudeAndAlereMember_lJdOhY467UKrCdJ7FcN3_Q"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:RestructuringCostAndReserveAxis">abt:RestructuringPlan2017To2019StjudeAndAlereMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2019-01-01</xbrli:startdate><xbrli:enddate>2019-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2018_INezHDkjn0-L7OMGoLMjhA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2019_To_9_30_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember_8dcnPpqxiEqWqrPFr9fb2A"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2019-07-01</xbrli:startdate><xbrli:enddate>2019-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2019_To_9_30_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember_WGxLi1ZZJEGxOLW3HWt_BA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2019-01-01</xbrli:startdate><xbrli:enddate>2019-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2018_To_9_30_2018_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember_MDaPbk6Pp0CW8ZqCyRVuqQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2018-07-01</xbrli:startdate><xbrli:enddate>2018-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2018_To_9_30_2018_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember_UKF0F7TwxEmPBF3_dHnPCQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2018-01-01</xbrli:startdate><xbrli:enddate>2018-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2019_To_9_30_2019_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember_OXdQKT5IXk6AhArCbD7s4w"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2019-01-01</xbrli:startdate><xbrli:enddate>2019-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="As_Of_9_30_2019_Q77aJBXiP0qCmJ4Yd2DnHw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2019_To_9_30_2019_srt_RangeAxis_srt_MaximumMember_55egElMjA0O-wU66kRvjAw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2019-07-01</xbrli:startdate><xbrli:enddate>2019-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2019_To_9_30_2019_srt_RangeAxis_srt_MaximumMember_oEw0uzOe0kevCxfIgw_0NA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2019-01-01</xbrli:startdate><xbrli:enddate>2019-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2019_To_9_30_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_-Mcpo0fYlk-1D8jAQhbURQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2019-07-01</xbrli:startdate><xbrli:enddate>2019-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2019_To_9_30_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_TbTemeaAq0O3vbmDORpxkA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2019-01-01</xbrli:startdate><xbrli:enddate>2019-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2018_To_9_30_2018_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_KONZl2KQv065QMNw3SBbFw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2018-07-01</xbrli:startdate><xbrli:enddate>2018-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2018_To_9_30_2018_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_7oF9FC4C_UuCepzsqjn7aw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2018-01-01</xbrli:startdate><xbrli:enddate>2018-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="As_Of_9_30_2019_abt_DebtInstrumentRedemptionAuthorizationAxis_abt_DebtRedemptionFebruary2018Member_rwgB-m8Hbka3hsTA8ibAFQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="abt:DebtInstrumentRedemptionAuthorizationAxis">abt:DebtRedemptionFebruary2018Member</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2019_To_9_30_2019_abt_DebtInstrumentRedemptionAuthorizationAxis_abt_DebtRedemptionSeptember2019Member_8fm8KC_d9kyDDuTmLvZr5w"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="abt:DebtInstrumentRedemptionAuthorizationAxis">abt:DebtRedemptionSeptember2019Member</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2019-01-01</xbrli:startdate><xbrli:enddate>2019-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2019_To_9_30_2019_srt_ConsolidationItemsAxis_us-gaap_MaterialReconcilingItemsMember__wUjSJgFbEu6Pote3jc1PA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2019-07-01</xbrli:startdate><xbrli:enddate>2019-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2019_To_9_30_2019_5CXepWtEPEKQA-bPz0Tp7A"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startdate>2019-07-01</xbrli:startdate><xbrli:enddate>2019-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2019_To_9_30_2019_srt_ConsolidationItemsAxis_us-gaap_MaterialReconcilingItemsMember_eeQRmzzg7UiQsV7K0trnSg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2019-01-01</xbrli:startdate><xbrli:enddate>2019-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2019_To_9_30_2019_O4ushO81Z0mAnTH_cLUPFw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startdate>2019-01-01</xbrli:startdate><xbrli:enddate>2019-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2018_To_9_30_2018_srt_ConsolidationItemsAxis_us-gaap_MaterialReconcilingItemsMember_tjHvMEY3JkKkdQKEDCWrLg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2018-07-01</xbrli:startdate><xbrli:enddate>2018-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_7_1_2018_To_9_30_2018_lS4NEZw67ECck2zY72MWgg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startdate>2018-07-01</xbrli:startdate><xbrli:enddate>2018-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2018_To_9_30_2018_srt_ConsolidationItemsAxis_us-gaap_MaterialReconcilingItemsMember_sAEGWGP4ekuJbwi-Szm8Ww"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2018-01-01</xbrli:startdate><xbrli:enddate>2018-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2018_To_9_30_2018_3n65uNcjAUKkwLDxHE9Yow"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startdate>2018-01-01</xbrli:startdate><xbrli:enddate>2018-09-30</xbrli:enddate></xbrli:period></xbrli:context><xbrli:unit id="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:unit id="Unit_Standard_pure_0hvT7e8qLkipZ3XmLkD-nQ"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:unit id="Unit_Standard_shares__pDT34XXdk2QZR7p6i5hkA"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:unit id="Unit_Divide_USD_shares_xJ2idvgWWEuE1nW1pOVAfA"><xbrli:divide><xbrli:unitnumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitnumerator><xbrli:unitdenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitdenominator></xbrli:divide></xbrli:unit><xbrli:unit id="Unit_Standard_segment_AyAgmVE9iUqrEIsDqeoAeg"><xbrli:measure>abt:segment</xbrli:measure></xbrli:unit></ix:resources></ix:header></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-family:'Times New Roman';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_edaee2b1_baef_49ce_a56f_2ea6b904538a"></a><p style="font-family:'Times New Roman';font-size:12pt;padding-bottom:1pt;padding-top:1pt;text-align:center;border-bottom:1.0pt solid #000000;border-top:3.0pt solid #000000;margin:0pt;"><b style="font-size:18pt;font-weight:bold;"> </b><span style="font-size:1pt;font-weight:bold;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:12pt;text-align:center;margin:0pt;"><span style="font-size:5pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:12pt;text-align:center;margin:0pt;"><b style="font-size:18pt;font-weight:bold;">UNITED STATES</b></p><p style="font-family:'Times New Roman';font-size:12pt;text-align:center;margin:0pt;"><b style="font-size:18pt;font-weight:bold;">SECURITIES AND EXCHANGE COMMISSION</b></p><p style="font-family:'Times New Roman';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">WASHINGTON, D.C. 20549</b></p><p style="font-family:'Times New Roman';font-size:12pt;text-align:center;margin:0pt;"><span style="font-size:5pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:12pt;text-align:center;margin:0pt;"><b style="font-size:18pt;font-weight:bold;">FORM&nbsp;</b><ix:nonnumeric contextref="Duration_1_1_2019_To_9_30_2019_O4ushO81Z0mAnTH_cLUPFw" name="dei:DocumentType" id="Narr_ERYsrZ7BqU6l55eXiSATtw"><b style="font-size:18pt;font-weight:bold;">10-Q</b></ix:nonnumeric></p><p style="font-family:'Times New Roman';font-size:12pt;text-align:center;margin:0pt;"><span style="font-size:5pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">(Mark One)</b></p><p style="font-family:'Times New Roman';font-size:12pt;text-align:center;margin:0pt;"><span style="font-size:5pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:12pt;padding-left:43.2pt;text-indent:-43.2pt;margin:0pt;"><b style="font-weight:bold;">&nbsp;&nbsp; &nbsp;</b><ix:nonnumeric format="ixt-sec:boolballotbox" contextref="Duration_1_1_2019_To_9_30_2019_O4ushO81Z0mAnTH_cLUPFw" name="dei:DocumentQuarterlyReport" id="Narr_xQLWTd9Trk29CPSo4Kye3A"><b style="font-family:'Segoe UI Symbol';font-weight:bold;">☒</b></ix:nonnumeric><b style="font-weight:bold;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;QUARTERLY REPORT PURSUANT TO SECTION&nbsp;13 OR 15(d)&nbsp;OF THE SECURITIES EXCHANGE ACT OF 1934</b></p><p style="font-family:'Times New Roman';font-size:12pt;text-align:center;margin:0pt;"><span style="font-size:5pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">For the quarterly period ended </b><ix:nonnumeric format="ixt:datemonthdayyearen" contextref="Duration_1_1_2019_To_9_30_2019_O4ushO81Z0mAnTH_cLUPFw" name="dei:DocumentPeriodEndDate" id="Narr_W-ydwE1ZS0SRL-VVpLPy_g"><b style="font-weight:bold;">September 30, 2019</b></ix:nonnumeric></p><p style="font-family:'Times New Roman';font-size:12pt;text-align:center;margin:0pt;"><span style="font-size:5pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">OR</b></p><p style="font-family:'Times New Roman';font-size:12pt;text-align:center;margin:0pt;"><span style="font-size:5pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:12pt;padding-left:43.2pt;text-indent:-43.2pt;margin:0pt;"><b style="font-weight:bold;">&nbsp;&nbsp; &nbsp;</b><ix:nonnumeric format="ixt-sec:boolballotbox" contextref="Duration_1_1_2019_To_9_30_2019_O4ushO81Z0mAnTH_cLUPFw" name="dei:DocumentTransitionReport" id="Narr_Uj78ntnHN0iZ6MoXur27nQ"><b style="font-family:'Segoe UI Symbol';font-weight:bold;">☐</b></ix:nonnumeric><b style="font-weight:bold;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;TRANSITION REPORT PURSUANT TO SECTION&nbsp;13 OR 15(d)&nbsp;OF THE SECURITIES EXCHANGE ACT OF 1934</b></p><p style="font-family:'Times New Roman';font-size:12pt;text-align:center;margin:0pt;"><span style="font-size:5pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">For the transition period from &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; to &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</b></p><p style="font-family:'Times New Roman';font-size:12pt;text-align:center;margin:0pt;"><span style="font-size:5pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Commission File No.&nbsp;</b><ix:nonnumeric contextref="Duration_1_1_2019_To_9_30_2019_O4ushO81Z0mAnTH_cLUPFw" name="dei:EntityFileNumber" id="Narr_Aas4_6fM10qSjfgRS5WeyQ"><b style="font-weight:bold;">1-2189</b></ix:nonnumeric></p><p style="font-family:'Times New Roman';font-size:12pt;text-align:center;margin:0pt;"><span style="font-size:5pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:12pt;text-align:center;margin:0pt;"><ix:nonnumeric contextref="Duration_1_1_2019_To_9_30_2019_O4ushO81Z0mAnTH_cLUPFw" name="dei:EntityRegistrantName" id="Narr_VG9sPFw_tEaBy366Eu5WUQ"><b style="font-size:18pt;font-weight:bold;">ABBOTT LABORATORIES</b></ix:nonnumeric></p><p style="font-family:'Times New Roman';font-size:12pt;text-align:center;margin:0pt;"><span style="font-size:5pt;visibility:hidden;">​</span></p><a id="_b77b0fd6_543f_4eab_8285_f5e2b426fe89"></a><a id="Tc_a-RQM_BmnkakK8kM5XeXAQ_0_0"></a><a id="Tc_wHDQcM-3kU2ehv7XxVbnEw_0_2"></a><table style="border-collapse:collapse;font-size:16pt;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tbody><tr><td style="vertical-align:top;width:49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;padding-left:10pt;text-align:center;text-indent:-10pt;margin:0pt 0pt 0pt 39.75pt;"><b style="font-weight:bold;">An </b><ix:nonnumeric format="ixt-sec:stateprovnameen" contextref="Duration_1_1_2019_To_9_30_2019_O4ushO81Z0mAnTH_cLUPFw" name="dei:EntityIncorporationStateCountryCode" id="Narr_jfBt1JZ08UemdYLm4yY-NQ"><b style="font-weight:bold;">Illinois</b></ix:nonnumeric><b style="font-weight:bold;"> Corporation</b></p></td><td style="vertical-align:bottom;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&nbsp;&nbsp;&nbsp;&nbsp;</b></p></td><td style="vertical-align:top;width:49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">I.R.S. Employer Identification No.</b></p></td></tr><tr><td style="vertical-align:top;width:49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;padding-left:10pt;text-align:center;text-indent:-10pt;margin:0pt;"><span style="font-size:10pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:top;width:49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:center;margin:0pt;"><ix:nonnumeric contextref="Duration_1_1_2019_To_9_30_2019_O4ushO81Z0mAnTH_cLUPFw" name="dei:EntityTaxIdentificationNumber" id="Tc__O-_WVexaUOSXqrOQRZ-0Q_1_2"><b style="font-weight:bold;">36-0698440</b></ix:nonnumeric></p></td></tr></tbody></table><p style="font-family:'Times New Roman';font-size:12pt;text-align:center;margin:0pt;"><span style="font-size:5pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:10pt;text-align:center;margin:0pt;"><ix:nonnumeric contextref="Duration_1_1_2019_To_9_30_2019_O4ushO81Z0mAnTH_cLUPFw" name="dei:EntityAddressAddressLine1" id="Narr_fri64myAw0Oz2YTgiSppVQ"><b style="font-weight:bold;">100 Abbott Park Road</b></ix:nonnumeric></p><p style="font-family:'Times New Roman';font-size:10pt;text-align:center;margin:0pt;"><ix:nonnumeric contextref="Duration_1_1_2019_To_9_30_2019_O4ushO81Z0mAnTH_cLUPFw" name="dei:EntityAddressCityOrTown" id="Narr_kE_sx-DlH0Wsebba5tvx3g"><b style="font-weight:bold;">Abbott Park</b></ix:nonnumeric><b style="font-weight:bold;">,&nbsp;</b><ix:nonnumeric format="ixt-sec:stateprovnameen" contextref="Duration_1_1_2019_To_9_30_2019_O4ushO81Z0mAnTH_cLUPFw" name="dei:EntityAddressStateOrProvince" id="Narr_P0NOa7vwLEux7F4dAvo_4Q"><b style="font-weight:bold;">Illinois</b></ix:nonnumeric><b style="font-weight:bold;"> </b><ix:nonnumeric contextref="Duration_1_1_2019_To_9_30_2019_O4ushO81Z0mAnTH_cLUPFw" name="dei:EntityAddressPostalZipCode" id="Narr_2xqby2Duk0uNOQOa4V6ebw"><b style="font-weight:bold;">60064-6400</b></ix:nonnumeric></p><p style="font-family:'Times New Roman';font-size:12pt;text-align:center;margin:0pt;"><span style="font-size:5pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:10pt;text-align:center;margin:0pt;">Telephone:&nbsp;&nbsp;<b style="font-weight:bold;">(</b><ix:nonnumeric contextref="Duration_1_1_2019_To_9_30_2019_O4ushO81Z0mAnTH_cLUPFw" name="dei:CityAreaCode" id="Narr_jYivGpOVGkKgp2TbEi8CLw"><b style="font-weight:bold;">224</b></ix:nonnumeric><b style="font-weight:bold;">) </b><ix:nonnumeric contextref="Duration_1_1_2019_To_9_30_2019_O4ushO81Z0mAnTH_cLUPFw" name="dei:LocalPhoneNumber" id="Narr_pqUxobR7KUGFe1nJt2iJlQ"><b style="font-weight:bold;">667-6100</b></ix:nonnumeric></p><p style="font-family:'Times New Roman';font-size:12pt;text-align:center;margin:0pt;"><span style="font-size:5pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Securities Registered Pursuant to Section&nbsp;12(b) of the Act:</b></p><p style="font-family:'Times New Roman';font-size:12pt;text-align:center;margin:0pt;"><span style="font-size:5pt;visibility:hidden;">​</span></p><a id="_a6a5558c_d1e9_4693_af42_60babb52627f"></a><a id="Tc_b9Y47C5gyk20H4YxjNVkcw_0_0"></a><a id="Tc_E4C2gVsj50WxrBoAk9LfJA_0_2"></a><a id="Tc_-x6-fV0MqkevANMUUoW7Gw_0_4"></a><a id="Tc_ZVfO076FCEOv8QLHnuUArA_1_4"></a><table style="border-collapse:collapse;font-size:16pt;margin-left:auto;margin-right:auto;padding-left:3.6pt;padding-right:3.6pt;width:100%;"><tbody><tr><td style="vertical-align:bottom;width:36.83%;border-bottom:1px solid #000000;margin:0pt;padding:0pt 3.59pt 0pt 3.59pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Title of Each Class</b></p></td><td style="vertical-align:top;width:2.82%;margin:0pt;padding:0pt 3.59pt 0pt 3.59pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&nbsp;&nbsp;&nbsp;&nbsp;</b></p></td><td style="vertical-align:top;width:21.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt 3.59pt 0pt 3.59pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Trading Symbol(s)</b></p></td><td style="vertical-align:top;width:2.82%;margin:0pt;padding:0pt 3.59pt 0pt 3.59pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&nbsp;&nbsp;&nbsp;&nbsp;</b></p></td><td style="vertical-align:bottom;width:35.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt 3.59pt 0pt 3.59pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Name of Each Exchange on Which Registered</b></p></td></tr><tr><td style="vertical-align:top;width:36.83%;border-top:1px solid #000000;margin:0pt;padding:0pt 3.59pt 0pt 3.59pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:2pt 0pt 0pt 0pt;"><ix:nonnumeric contextref="Duration_1_1_2019_To_9_30_2019_O4ushO81Z0mAnTH_cLUPFw" name="dei:Security12bTitle" id="Tc_yRsLx4ztjUGXI1Q-5e1Ufw_1_0">Common Shares, Without Par Value<br></ix:nonnumeric><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:top;width:2.82%;margin:0pt;padding:0pt 3.59pt 0pt 3.59pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:center;margin:2pt 0pt 0pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;width:21.65%;border-top:1px solid #000000;margin:0pt;padding:0pt 3.59pt 0pt 3.59pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:2pt 0pt 0pt 0pt;"><ix:nonnumeric contextref="Duration_1_1_2019_To_9_30_2019_dei_EntityListingsExchangeAxis_exch_XNYS_iKXTz1QINEycdLuHek9Tgw" name="dei:TradingSymbol" id="Tc_KD41UfyR8kywT_NZiVH5OQ_1_2">ABT</ix:nonnumeric></p></td><td style="vertical-align:top;width:2.82%;margin:0pt;padding:0pt 3.59pt 0pt 3.59pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:35.86%;border-top:1px solid #000000;margin:0pt;padding:0pt 3.59pt 0pt 3.59pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><ix:nonnumeric format="ixt-sec:exchnameen" contextref="Duration_1_1_2019_To_9_30_2019_dei_EntityListingsExchangeAxis_exch_XNYS_iKXTz1QINEycdLuHek9Tgw" name="dei:SecurityExchangeName" id="Narr_3OfWZrkrYkWiXl5gGfZXAw">New York Stock Exchange</ix:nonnumeric><br><ix:nonnumeric format="ixt-sec:exchnameen" contextref="Duration_1_1_2019_To_9_30_2019_dei_EntityListingsExchangeAxis_exch_XCHI_qplh5iM290eZvAdYkqPxeg" name="dei:SecurityExchangeName" id="Narr_nBs3ARRWGUev_qkg6xAiTg">Chicago Stock Exchange, Inc.</ix:nonnumeric></p></td></tr></tbody></table><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:5pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:10pt;text-indent:18pt;margin:0pt;">Indicate by check mark whether the registrant: (l)&nbsp;has filed all reports required to be filed by Section&nbsp;13 or 15(d)&nbsp;of the Securities Exchange Act of l934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2)&nbsp;<span style="white-space:pre-wrap;">has been subject to such filing requirements for the past 90 days.  </span><ix:nonnumeric contextref="Duration_1_1_2019_To_9_30_2019_O4ushO81Z0mAnTH_cLUPFw" name="dei:EntityCurrentReportingStatus" id="Narr_M-Z6qpnZpkeSQ2A5KeDrOw">Yes</ix:nonnumeric> <span style="font-family:'Wingdings';"><span style="font-family:'Times New Roman';">⌧</span></span><span style="white-space:pre-wrap;">  No </span><span style="font-family:'Wingdings';"><span style="font-family:'Times New Roman';">◻</span></span></p><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:5pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="white-space:pre-wrap;">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 229.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).  </span><ix:nonnumeric contextref="Duration_1_1_2019_To_9_30_2019_O4ushO81Z0mAnTH_cLUPFw" name="dei:EntityInteractiveDataCurrent" id="Narr_M9MAJ5d6ZkqZBFzAEluHaA">Yes</ix:nonnumeric> <span style="font-family:'Wingdings';"><span style="font-family:'Times New Roman';">⌧</span></span><span style="white-space:pre-wrap;">  No </span><span style="font-family:'Wingdings';"><span style="font-family:'Times New Roman';">◻</span></span></p><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:5pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="white-space:pre-wrap;">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company.  See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.</span></p><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:5pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:5pt;visibility:hidden;">​</span></p><a id="_96a88a80_e436_440e_ae6d_f051c4fb9809"></a><a id="Tc_g-p74-qDIU2meZjjJbeXAg_1_1"></a><a id="Tc_O66-GEUwikq5pMYgHXLHkA_1_2"></a><a id="Tc_SqLXZ0ADc06m5h003iOvZw_1_3"></a><a id="Tc_6q0Xj1Fd9Eq769zESuOrfw_2_0"></a><a id="Tc_S7O0pMNJw0OxWrmWNKqUdw_2_1"></a><a id="Tc_OGLG5HvwIEi8XK0OrQYpeA_2_2"></a><a id="Tc_m8S42jvsHk2Cm7k1VgxXFQ_3_2"></a><table style="border-collapse:collapse;font-size:16pt;width:99.91%;"><tbody><tr style="height:1pt;"><td style="vertical-align:top;width:24.99%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:top;width:25%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:top;width:25%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:top;width:25%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:top;width:24.99%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;"><ix:nonnumeric contextref="Duration_1_1_2019_To_9_30_2019_O4ushO81Z0mAnTH_cLUPFw" name="dei:EntityFilerCategory" id="Tc_PX-myrRAP0GNdEy6R2MkIw_1_0">Large Accelerated Filer</ix:nonnumeric></p></td><td style="vertical-align:top;width:25%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;"><span style="font-family:'Segoe UI Symbol';">☒</span></p></td><td style="vertical-align:top;width:25%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">Accelerated Filer</p></td><td style="vertical-align:top;width:25%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;"><span style="font-family:'Segoe UI Symbol';">☐</span></p></td></tr><tr><td style="vertical-align:top;width:24.99%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">Non-Accelerated Filer</p></td><td style="vertical-align:top;width:25%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;"><span style="font-family:'Segoe UI Symbol';">☐</span></p></td><td style="vertical-align:top;width:25%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">Smaller reporting company</p></td><td style="vertical-align:top;width:25%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;"><ix:nonnumeric format="ixt-sec:boolballotbox" contextref="Duration_1_1_2019_To_9_30_2019_O4ushO81Z0mAnTH_cLUPFw" name="dei:EntitySmallBusiness" id="Tc_PosxgO9Ue0aEwLg__OWiRw_2_3"><span style="font-family:'Segoe UI Symbol';">☐</span></ix:nonnumeric></p></td></tr><tr><td style="vertical-align:top;width:24.99%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;width:25%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;width:25%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">Emerging growth company</p></td><td style="vertical-align:top;width:25%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;"><ix:nonnumeric format="ixt-sec:boolballotbox" contextref="Duration_1_1_2019_To_9_30_2019_O4ushO81Z0mAnTH_cLUPFw" name="dei:EntityEmergingGrowthCompany" id="Tc_dyHOT2qsSUOwNlAIEqfPaw_3_3"><span style="font-family:'Segoe UI Symbol';">☐</span></ix:nonnumeric></p></td></tr></tbody></table><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="white-space:pre-wrap;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  </span><span style="font-family:'Wingdings';"><span style="font-family:'Times New Roman';">◻</span></span></p><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:5pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:10pt;text-indent:18pt;margin:0pt;">Indicate by check mark whether the registrant is a shell company (as defined in Rule&nbsp;<span style="white-space:pre-wrap;">12b-2 of the Exchange Act).  Yes </span><ix:nonnumeric format="ixt-sec:boolballotbox" contextref="Duration_1_1_2019_To_9_30_2019_O4ushO81Z0mAnTH_cLUPFw" name="dei:EntityShellCompany" id="Narr_qQ_E-1l70EqjiD7q06hq1A"><span style="font-family:'Segoe UI Symbol';">☐</span></ix:nonnumeric><span style="white-space:pre-wrap;">  No </span><span style="font-family:'Segoe UI Symbol';">☒</span></p><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:5pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:10pt;text-indent:18pt;margin:0pt;">As of September 30, 2019, Abbott Laboratories had <ix:nonfraction unitref="Unit_Standard_shares__pDT34XXdk2QZR7p6i5hkA" format="ixt:numdotdecimal" scale="0" contextref="As_Of_9_30_2019_Q77aJBXiP0qCmJ4Yd2DnHw" decimals="INF" name="dei:EntityCommonStockSharesOutstanding" id="Narr_-eSqm7OhgUuiuxx0uwdKzA">1,768,455,705</ix:nonfraction> common shares without par value outstanding.</p><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:5pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:12pt;padding-bottom:1pt;padding-top:1pt;border-bottom:3.0pt solid #000000;border-top:1px solid #000000;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:5pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="display:none;font-size:12pt;line-height:0pt;margin:0pt;"><span style="font-family:'Times New Roman';font-size:0pt;visibility:hidden;">​</span></p><a id="_66f48aad_1ff7_40a7_a703_86c119a17965"></a></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-family:'Times New Roman';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">Abbott Laboratories</p><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><a id="TOC"></a><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">Table of Contents</p><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><table style="background-color:auto;border-collapse:collapse;font-size:16pt;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tbody><tr><td style="background-color:auto;vertical-align:top;width:93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:top;width:7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0pt;">Page</p></td></tr><tr><td style="background-color:auto;vertical-align:top;width:93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-family:'Times New Roman Bold';font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;width:7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0pt;"><span style="font-family:'Times New Roman Bold';font-size:8pt;visibility:hidden;">​</span></p></td></tr><tr><td style="background-color:auto;vertical-align:top;width:93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><a href="#PARTIFINANCIALINFORMATION_894041"><b style="font-family:'Times New Roman';font-size:10pt;font-style:normal;font-weight:bold;text-align:left;">Part&nbsp;I - Financial Information</b></a></p></td><td style="background-color:auto;vertical-align:bottom;width:7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td></tr><tr><td style="background-color:auto;vertical-align:top;width:93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;width:7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td></tr><tr><td style="background-color:auto;vertical-align:top;width:93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">Item 1. Financial Statements and Supplementary Data</p></td><td style="background-color:auto;vertical-align:bottom;width:7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td></tr><tr><td style="background-color:auto;vertical-align:top;width:93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;width:7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td></tr><tr><td style="background-color:auto;vertical-align:top;width:93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;padding-left:10pt;text-indent:-10pt;margin:0pt 0pt 0pt 30pt;"><a href="#StatementofEarnings_149166"><span style="font-family:'Times New Roman';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Condensed Consolidated Statement of Earnings</span></a></p></td><td style="background-color:auto;vertical-align:bottom;width:7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0pt;">3</p></td></tr><tr><td style="background-color:auto;vertical-align:top;width:93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;padding-left:10pt;text-indent:-10pt;margin:0pt 0pt 0pt 30pt;"><a href="#StatementofComprehensiveIncome_730613"><span style="font-family:'Times New Roman';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Condensed Consolidated Statement of Comprehensive Income</span></a></p></td><td style="background-color:auto;vertical-align:bottom;width:7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0pt;">4</p></td></tr><tr><td style="background-color:auto;vertical-align:top;width:93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;padding-left:10pt;text-indent:-10pt;margin:0pt 0pt 0pt 30pt;"><a href="#ConsolidatedBalanceSheet_174855"><span style="font-family:'Times New Roman';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Condensed Consolidated Balance Sheet</span></a></p></td><td style="background-color:auto;vertical-align:bottom;width:7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0pt;">5</p></td></tr><tr><td style="background-color:auto;vertical-align:top;width:93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;padding-left:10pt;text-indent:-10pt;margin:0pt 0pt 0pt 30pt;"><a href="#StatementofShareholdersInvestment_244625"><span style="font-family:'Times New Roman';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Condensed Consolidated Statement of Shareholders’ Investment</span></a></p></td><td style="background-color:auto;vertical-align:bottom;width:7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0pt;">6</p></td></tr><tr><td style="background-color:auto;vertical-align:top;width:93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;padding-left:10pt;text-indent:-10pt;margin:0pt 0pt 0pt 30pt;"><a href="#StatementofCashFlows_285621"><span style="font-family:'Times New Roman';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Condensed Consolidated Statement of Cash Flows</span></a></p></td><td style="background-color:auto;vertical-align:bottom;width:7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0pt;">8</p></td></tr><tr><td style="background-color:auto;vertical-align:top;width:93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;padding-left:10pt;text-indent:-10pt;margin:0pt 0pt 0pt 30pt;"><a href="#Note1BasisofPresentation_992483"><span style="font-family:'Times New Roman';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Notes to the Condensed Consolidated Financial Statements</span></a></p></td><td style="background-color:auto;vertical-align:bottom;width:7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0pt;">9</p></td></tr><tr><td style="background-color:auto;vertical-align:top;width:93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;padding-left:10pt;text-indent:-10pt;margin:0pt 0pt 0pt 30pt;"><span style="font-size:10pt;margin-left:0pt;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;width:7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td></tr><tr><td style="background-color:auto;vertical-align:top;width:93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><a href="#Item2ManagementsDiscussionandAnalysisofF"><span style="font-family:'Times New Roman';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations</span></a></p></td><td style="background-color:auto;vertical-align:bottom;width:7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0pt;">21</p></td></tr><tr><td style="background-color:auto;vertical-align:top;width:93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;width:7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td></tr><tr><td style="background-color:auto;vertical-align:top;width:93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><a href="#Item4ControlsandProcedures_983028"><span style="font-family:'Times New Roman';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Item 4. Controls and Procedures</span></a></p></td><td style="background-color:auto;vertical-align:bottom;width:7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0pt;">26</p></td></tr><tr><td style="background-color:auto;vertical-align:top;width:93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;width:7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td></tr><tr><td style="background-color:auto;vertical-align:top;width:93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><a href="#PARTIIOTHERINFORMATION_986810"><b style="font-family:'Times New Roman';font-size:10pt;font-style:normal;font-weight:bold;text-align:left;">Part&nbsp;II - Other Information</b></a></p></td><td style="background-color:auto;vertical-align:bottom;width:7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td></tr><tr><td style="background-color:auto;vertical-align:top;width:93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;width:7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td></tr><tr><td style="background-color:auto;vertical-align:top;width:93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><a href="#Item1LegalProceedings_556418"><span style="font-family:'Times New Roman';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Item 1. Legal Proceedings</span></a></p></td><td style="background-color:auto;vertical-align:bottom;width:7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0pt;">26</p></td></tr><tr><td style="background-color:auto;vertical-align:top;width:93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;width:7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td></tr><tr><td style="background-color:auto;vertical-align:top;width:93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><a href="#Item2UnregisteredSalesofEquitySecurities"><span style="font-family:'Times New Roman';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Item 2. Unregistered Sales of Equity Securities and Use of Proceeds</span></a></p></td><td style="background-color:auto;vertical-align:bottom;width:7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0pt;">27</p></td></tr><tr><td style="background-color:auto;vertical-align:top;width:93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;width:7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td></tr><tr><td style="background-color:auto;vertical-align:top;width:93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><a href="#Item6Exhibits_559085"><span style="font-family:'Times New Roman';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Item 6. Exhibits</span></a></p></td><td style="background-color:auto;vertical-align:bottom;width:7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0pt;">28</p></td></tr><tr><td style="background-color:auto;vertical-align:top;width:93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;width:7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td></tr><tr><td style="background-color:auto;vertical-align:top;width:93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><a href="#SIGNATURE_450348"><span style="font-family:'Times New Roman';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Signature</span></a></p></td><td style="background-color:auto;vertical-align:bottom;width:7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0pt;">29</p></td></tr></tbody></table><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><a id="_d60ce08d_b751_46e2_9490_f26aa8216a14"></a></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">2</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-family:'Times New Roman';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:center;margin:0pt;">Abbott Laboratories and Subsidiaries</p><a id="StatementofEarnings_149166"></a><p style="font-family:'Times New Roman';font-size:10pt;text-align:center;margin:0pt;">Condensed Consolidated Statement of Earnings</p><p style="font-family:'Times New Roman';font-size:10pt;text-align:center;margin:0pt;">(Unaudited)</p><p style="font-family:'Times New Roman';font-size:10pt;text-align:center;margin:0pt;"><i style="font-style:italic;">(dollars in millions except per share data; shares in thousands)</i></p><p style="font-family:'Times New Roman';font-size:12pt;text-align:justify;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p><a id="_530d7199_3d0d_40b8_8c8c_999eb90f6bab"></a><a id="Tc_DA4fPejhP0yTmFYRYMRRlg_1_2"></a><a id="Tc_y5MZytR6XECXF_dlOEIbPQ_1_8"></a><a id="Tc_6Co3UxA9pUKxubePHHJr_Q_2_2"></a><a id="Tc_ZHkYm2USNk2rEM6wlIwLCg_2_5"></a><a id="Tc_WsCMHCtU10yTbSr8oLw77g_2_8"></a><a id="Tc_EzZxeUs_sEWQHjQCguA1OQ_2_11"></a><a id="Tc_w5l4NYKYhU2iR1CKkyaGqA_3_0"></a><a id="Tc_TFf8DDT7GE-VHSCALmU0DQ_3_2"></a><a id="Tc_7xmJFtto80SJgywRpoWtdQ_3_5"></a><a id="Tc_kEtIjO3K3U6-azV5Jhr_1g_3_8"></a><a id="Tc_jrXRa_ETvEyXK-KPS9xi4w_3_11"></a><a id="Tc_5-5GKE51WEKDg9_c4YwvFw_5_0"></a><a id="Tc_sobctUgSmU6cfj_lHy4GNQ_6_0"></a><a id="Tc_p2E451H_O02A9l4uybc7iw_7_0"></a><a id="Tc_FFoxTtfatUWCn9Ne5uHihA_8_0"></a><a id="Tc_Fl8dN56Hm0m7atKEK3d36g_9_0"></a><a id="Tc_G-ba-0zJDEm1AInRzhu1jg_11_0"></a><a id="Tc_FaRdFpdcT0SBZ-fT1P8lCw_13_0"></a><a id="Tc_kHHXg0eGx0C3NlvDaHtU2A_14_0"></a><a id="Tc_kGLMZzwd80CKVR25C0pX5w_15_0"></a><a id="Tc_joi8vWTSdU6pnxxYDSBQlA_16_0"></a><a id="Tc_4-3mgKPilEyV0wOqHtECqQ_16_3"></a><a id="Tc_oUsaJY2q1UCg_lUDb3NNbw_16_9"></a><a id="Tc_xI3dpdi6PEidmdo3z7ToBw_17_0"></a><a id="Tc_5kZgWbL2lUO46IVK1qlhXQ_18_0"></a><a id="Tc_vQVj8dTiIUSHpXNWThinVw_19_0"></a><a id="Tc_5SeGNoZTbUyaBUy8hL5HJA_20_0"></a><a id="Tc_cMAJ015qFkG2mOgK7qOixw_22_0"></a><a id="Tc_mSu0QHYRQE2Ne8KoZD1fdg_22_3"></a><a id="Tc_FiJkL6j_V06wbhSLGAJfBg_22_9"></a><a id="Tc_QrKs2OUxGU2sdLdw01lvsg_24_0"></a><a id="Tc_VzbJQRzrvUSGDjrjZC2vUQ_24_2"></a><a id="Tc_KJ3oRLg5jky-2J-VJQBfiQ_24_5"></a><a id="Tc_s6ajmovXbEqZ2xCjuZ5IOA_24_8"></a><a id="Tc_Qd5CBFg6JEOOEWIhZ-2Kxw_24_11"></a><a id="Tc_WuA_dQh1N0icBABtwFNIRQ_26_0"></a><a id="Tc_4sXia6jY6E-lyCvQmv01JA_27_0"></a><a id="Tc_qLIQguFdFEWyfUiC82Y84Q_27_2"></a><a id="Tc_0wcb1YfTPkyo7n7YBJXR1Q_27_5"></a><a id="Tc_MNcdZj7VI0qsqUM4h6Tsvg_27_8"></a><a id="Tc_YXHDxM1hQUCDj9lMDGxM2w_27_11"></a><a id="Tc_xLZ2wYhar0iPaMPZ-DCTrQ_28_0"></a><a id="Tc_zrVsObLRxECy3Iu_OHmRvA_28_3"></a><a id="Tc__BHTRYg4YU-6VLRfhDthGg_28_9"></a><a id="Tc_XYRHyBRzgkWX03S9Y_VX3Q_29_0"></a><a id="Tc_NEq36IMqjU6_YgnYFk8OrQ_29_2"></a><a id="Tc_dJCRicA1WUGqKyPnT5A9aA_29_5"></a><a id="Tc_CE5nkajtUkS5LDf1fJztVw_29_8"></a><a id="Tc_nmtwy0khtke32II0fr2mRA_29_11"></a><a id="Tc_xG_1zTGmV0SffU3E6WAytQ_31_0"></a><a id="Tc_V6TVZJ1v30aWzj5yPmr2Ow_32_0"></a><a id="Tc_FwI1QKRryEmP1g5_fslc4A_32_2"></a><a id="Tc_t_yIdVi6BE-WHkqTDwZ22g_32_5"></a><a id="Tc_H9VvmyGtpE6OrKxg95tOIQ_32_8"></a><a id="Tc_ai5H_BYQZUeaQ8Q3z0DQWA_32_11"></a><a id="Tc_ZtQB__RYQkaC4cpi-L889Q_33_0"></a><a id="Tc_kA3IvtA_bUajVMD1Z9eA-g_33_3"></a><a id="Tc_4ypadXQMoE-ovh-6ZQTNpw_33_9"></a><a id="Tc_Htqhk4Ry6USexcMS_PDuTA_34_0"></a><a id="Tc_u1uA1gfhu0Cc4InkGheG6A_34_2"></a><a id="Tc_eRiHVbtcJkCGQU7cLr2zYg_34_5"></a><a id="Tc_5dd5LlEYIU-JFULdrf4wTw_34_8"></a><a id="Tc_ZYYqzT8vnkCt5SP9Hh4wrQ_34_11"></a><a id="Tc_NxscFbKVsk2EpNC41y1O2Q_36_0"></a><a id="Tc_3aIqNEEUrEiDVlU5gIE5kQ_37_0"></a><a id="Tc_6xJxDot6XEOQ2OquN1HctQ_38_0"></a><a id="Tc_M5fpXl-M-EK5eEHHffCRYg_40_0"></a><table style="border-collapse:collapse;font-size:16pt;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tbody><tr style="height:1pt;"><td style="vertical-align:bottom;width:52.75%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.75%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.75%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.43%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="background-color:auto;vertical-align:bottom;width:52.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="5" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:22.55%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Three Months Ended September&nbsp;30</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="5" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:21.73%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Nine Months Ended September&nbsp;30</b></p></td></tr><tr><td style="background-color:auto;vertical-align:bottom;width:52.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&nbsp;&nbsp;&nbsp;&nbsp;</b></p></td><td colspan="2" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:10.17%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2019</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&nbsp;&nbsp;&nbsp;&nbsp;</b></p></td><td colspan="2" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:10.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2018</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&nbsp;&nbsp;&nbsp;&nbsp;</b></p></td><td colspan="2" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:9.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2019</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&nbsp;&nbsp;&nbsp;&nbsp;</b></p></td><td colspan="2" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:9.78%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2018</b></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:52.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">Net sales</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.75%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2019_To_9_30_2019_5CXepWtEPEKQA-bPz0Tp7A" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_Sn-WPYLALEmuC7A_E0YgGQ_3_3">8,076</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.4%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.75%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2018_To_9_30_2018_lS4NEZw67ECck2zY72MWgg" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_r_IJbGJGMEezj51-CKK8oQ_3_6">7,656</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_O4ushO81Z0mAnTH_cLUPFw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_SjkFvHfBg0-1qeUD5DB6JQ_3_9">23,590</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.42%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2018_To_9_30_2018_3n65uNcjAUKkwLDxHE9Yow" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_6Kx_Rs2YCE2881QI9gjsdA_3_12">22,813</ix:nonfraction></p></td></tr><tr><td style="vertical-align:bottom;width:52.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:52.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">Cost of products sold, excluding amortization of intangible assets</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2019_To_9_30_2019_5CXepWtEPEKQA-bPz0Tp7A" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="Tc_tpJMXu90ekun951Wjf0Wtg_5_3">3,358</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2018_To_9_30_2018_lS4NEZw67ECck2zY72MWgg" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="Tc_mlkQxzx3gUi4fLTToDTasA_5_6">3,166</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_O4ushO81Z0mAnTH_cLUPFw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="Tc_tHbS05L7h0-E9F-jy6UknA_5_9">9,797</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2018_To_9_30_2018_3n65uNcjAUKkwLDxHE9Yow" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="Tc_VxxhwvUreUmLjmnviGiRMw_5_12">9,515</ix:nonfraction></p></td></tr><tr><td style="vertical-align:bottom;width:52.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">Amortization of intangible assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2019_To_9_30_2019_5CXepWtEPEKQA-bPz0Tp7A" decimals="-6" format="ixt:numdotdecimal" name="abt:AmortizationOfIntangibleAssetsExcludingDiscontinuedOperations" scale="6" id="Tc_tMMW_dGu1EOg0NcTisEu9w_6_3">484</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2018_To_9_30_2018_lS4NEZw67ECck2zY72MWgg" decimals="-6" format="ixt:numdotdecimal" name="abt:AmortizationOfIntangibleAssetsExcludingDiscontinuedOperations" scale="6" id="Tc_kUpM6mOk9EuVrTfYYqUGbw_6_6">544</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_O4ushO81Z0mAnTH_cLUPFw" decimals="-6" format="ixt:numdotdecimal" name="abt:AmortizationOfIntangibleAssetsExcludingDiscontinuedOperations" scale="6" id="Tc_x8BiiXPRl0qA3Hoqe_VJGQ_6_9">1,453</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2018_To_9_30_2018_3n65uNcjAUKkwLDxHE9Yow" decimals="-6" format="ixt:numdotdecimal" name="abt:AmortizationOfIntangibleAssetsExcludingDiscontinuedOperations" scale="6" id="Tc_DQCgRuyVA0a8O3bBhCsZbg_6_12">1,690</ix:nonfraction></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:52.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">Research and development</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2019_To_9_30_2019_5CXepWtEPEKQA-bPz0Tp7A" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="Tc_Ufjq3rdzL0K7aX-R3i4bkA_7_3">596</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2018_To_9_30_2018_lS4NEZw67ECck2zY72MWgg" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="Tc_DZYgj5YNC0egNA1_leO7LQ_7_6">574</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_O4ushO81Z0mAnTH_cLUPFw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="Tc_9tKNLCX_hEyBFNUQCpBDlw_7_9">1,845</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2018_To_9_30_2018_3n65uNcjAUKkwLDxHE9Yow" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="Tc_VQ0V2WlLfEymni3BXU8ORw_7_12">1,738</ix:nonfraction></p></td></tr><tr><td style="vertical-align:bottom;width:52.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">Selling, general and administrative</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.75%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2019_To_9_30_2019_5CXepWtEPEKQA-bPz0Tp7A" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="Tc_paNl2cQmfkC-Z3QTR9Yh9A_8_3">2,440</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.75%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2018_To_9_30_2018_lS4NEZw67ECck2zY72MWgg" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="Tc_KwCBDCWtXUqASEojqqyifw_8_6">2,377</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_O4ushO81Z0mAnTH_cLUPFw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="Tc_st55U54uBkibi8kPDjmtnw_8_9">7,352</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.42%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2018_To_9_30_2018_3n65uNcjAUKkwLDxHE9Yow" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="Tc_TdSF29S_ZE2Sa1RVtzcfQg_8_12">7,385</ix:nonfraction></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:52.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt 0pt 0pt 18pt;">Total operating cost and expenses</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.75%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2019_To_9_30_2019_5CXepWtEPEKQA-bPz0Tp7A" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CostsAndExpenses" scale="6" id="Tc_GwRW0-hgQ0WKUTX6IdcUug_9_3">6,878</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.4%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.75%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2018_To_9_30_2018_lS4NEZw67ECck2zY72MWgg" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CostsAndExpenses" scale="6" id="Tc_ST7upZk2XU2_-0wJkn9gmw_9_6">6,661</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_O4ushO81Z0mAnTH_cLUPFw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CostsAndExpenses" scale="6" id="Tc_c0XVtF_uDE2QB41IrSGbSQ_9_9">20,447</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.42%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2018_To_9_30_2018_3n65uNcjAUKkwLDxHE9Yow" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CostsAndExpenses" scale="6" id="Tc_ams-uwUIMkmqu9Xfpqyp8w_9_12">20,328</ix:nonfraction></p></td></tr><tr><td style="vertical-align:bottom;width:52.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt 0pt 0pt 18pt;"><span style="font-size:10pt;margin-left:0pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:52.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">Operating earnings</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2019_To_9_30_2019_5CXepWtEPEKQA-bPz0Tp7A" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="Tc_IdWENx15Xkio9eWlO66_SQ_11_3">1,198</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2018_To_9_30_2018_lS4NEZw67ECck2zY72MWgg" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="Tc_D3nx8RT3O0e9ItEgCq9Ttw_11_6">995</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_O4ushO81Z0mAnTH_cLUPFw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="Tc_5CfpK-fP4UO9IgSjzFjjWA_11_9">3,143</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2018_To_9_30_2018_3n65uNcjAUKkwLDxHE9Yow" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="Tc_LMOlPMoFo0SHxSglpD7TIA_11_12">2,485</ix:nonfraction></p></td></tr><tr><td style="vertical-align:bottom;width:52.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:52.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">Interest expense</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2019_To_9_30_2019_5CXepWtEPEKQA-bPz0Tp7A" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:InterestExpense" scale="6" id="Tc_nxNSOzP-bU-MOSOKTdqbTg_13_3">167</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2018_To_9_30_2018_lS4NEZw67ECck2zY72MWgg" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:InterestExpense" scale="6" id="Tc_b_BMHsZKQ0u9A7ISN9f9mg_13_6">203</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_O4ushO81Z0mAnTH_cLUPFw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:InterestExpense" scale="6" id="Tc_zIDBHeH7QkeZkT7v5mIrNg_13_9">506</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2018_To_9_30_2018_3n65uNcjAUKkwLDxHE9Yow" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:InterestExpense" scale="6" id="Tc_le7KgCLT_0GkJh3hZFaaDA_13_12">640</ix:nonfraction></p></td></tr><tr><td style="vertical-align:bottom;width:52.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">Interest (income)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2019_To_9_30_2019_5CXepWtEPEKQA-bPz0Tp7A" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:InvestmentIncomeInterest" scale="6" id="Tc_sAkxRVeT40uTdpATg-HIlQ_14_3">24</ix:nonfraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2018_To_9_30_2018_lS4NEZw67ECck2zY72MWgg" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:InvestmentIncomeInterest" scale="6" id="Tc_B89RRBUgL0S9TqCvlGp3Ww_14_6">22</ix:nonfraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_O4ushO81Z0mAnTH_cLUPFw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:InvestmentIncomeInterest" scale="6" id="Tc_G8fjNj9L_EuCYAvMPmbU9w_14_9">69</ix:nonfraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2018_To_9_30_2018_3n65uNcjAUKkwLDxHE9Yow" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:InvestmentIncomeInterest" scale="6" id="Tc_GSarU22JZkSUwE7pbldC_g_14_12">71</ix:nonfraction>)</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:52.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">Net foreign exchange (gain) loss</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2019_To_9_30_2019_5CXepWtEPEKQA-bPz0Tp7A" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" sign="-" scale="6" id="Tc_PDm6dDZJjkqhQPinikhO9g_15_3">7</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2018_To_9_30_2018_lS4NEZw67ECck2zY72MWgg" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" sign="-" scale="6" id="Tc_sXTTgzrvpUyklWj1WyIBvQ_15_6">11</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_O4ushO81Z0mAnTH_cLUPFw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" sign="-" scale="6" id="Tc_vATE9jbDf0GJmdGCOpHniA_15_9">9</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2018_To_9_30_2018_3n65uNcjAUKkwLDxHE9Yow" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" sign="-" scale="6" id="Tc_1lqGw-ta-kaP2o26c26kIA_15_12">2</ix:nonfraction></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:52.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;"><span style="white-space:pre-wrap;">Net loss  on extinguishment of debt</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2018_To_9_30_2018_lS4NEZw67ECck2zY72MWgg" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" sign="-" scale="6" id="Tc_YyyKbQJnFUamB1_j9cP1eA_16_6">67</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2018_To_9_30_2018_3n65uNcjAUKkwLDxHE9Yow" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" sign="-" scale="6" id="Tc_dFGr9gYmm0OPao5N6WeM8g_16_12">81</ix:nonfraction></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:52.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">Other (income) expense, net</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.75%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2019_To_9_30_2019_5CXepWtEPEKQA-bPz0Tp7A" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="Tc_O16EcVwyDUGu6oqEbp0VpA_17_3">55</ix:nonfraction>)</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.4%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.75%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2018_To_9_30_2018_lS4NEZw67ECck2zY72MWgg" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherNonoperatingIncomeExpense" sign="-" scale="6" id="Tc_18X9iVIRuE--tYMwrPR-XQ_17_6">18</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_O4ushO81Z0mAnTH_cLUPFw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="Tc_6Jw-TBGRFEGM9PEDCqHvVA_17_9">140</ix:nonfraction>)</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.42%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2018_To_9_30_2018_3n65uNcjAUKkwLDxHE9Yow" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="Tc_UV86ZW14pEGm8qlVJQ_GYg_17_12">93</ix:nonfraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:52.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt 0pt 0pt 12pt;">Earnings from continuing operations before taxes</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2019_To_9_30_2019_5CXepWtEPEKQA-bPz0Tp7A" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="Tc_iEX1URAOqU-knY7kxmv-bg_18_3">1,103</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2018_To_9_30_2018_lS4NEZw67ECck2zY72MWgg" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="Tc_uvHxnOAogU6ccvzmC86HRw_18_6">718</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_O4ushO81Z0mAnTH_cLUPFw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="Tc_fl2r189J4Uea5x-pyvP25g_18_9">2,837</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2018_To_9_30_2018_3n65uNcjAUKkwLDxHE9Yow" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="Tc_NoYVw0pKeE-Wkj88qNIYsg_18_12">1,926</ix:nonfraction></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:52.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">Taxes on earnings from continuing operations</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.75%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2019_To_9_30_2019_5CXepWtEPEKQA-bPz0Tp7A" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="Tc_r68mmoBYKUeME5_3XURixg_19_3">143</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.4%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.75%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2018_To_9_30_2018_lS4NEZw67ECck2zY72MWgg" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="Tc_BzOJOxTGHE-uibj7B-pASg_19_6">166</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_O4ushO81Z0mAnTH_cLUPFw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="Tc_8YoJOU2csUWRLuqNtNQJ3Q_19_9">199</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.42%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2018_To_9_30_2018_3n65uNcjAUKkwLDxHE9Yow" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="Tc_kcJCtqxfy0eTmlvjBIrqRA_19_12">247</ix:nonfraction></p></td></tr><tr><td style="vertical-align:bottom;width:52.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">Earnings from continuing operations</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2019_To_9_30_2019_5CXepWtEPEKQA-bPz0Tp7A" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="Tc_JZWa2YFAZEycQ6DyhGKJoQ_20_3">960</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2018_To_9_30_2018_lS4NEZw67ECck2zY72MWgg" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="Tc_6r_cuIHk2k2nPWKqqsJYFQ_20_6">552</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_O4ushO81Z0mAnTH_cLUPFw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="Tc_sPA4u22W-EiB_Va4LCLCvw_20_9">2,638</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2018_To_9_30_2018_3n65uNcjAUKkwLDxHE9Yow" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="Tc_NQAEnBcLUES95315hizjeg_20_12">1,679</ix:nonfraction></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:52.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:52.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">Earnings from discontinued operations, net of tax</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2018_To_9_30_2018_lS4NEZw67ECck2zY72MWgg" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" scale="6" id="Tc_G_6PnFUE_UWWanIcw6rFwg_22_6">11</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2018_To_9_30_2018_3n65uNcjAUKkwLDxHE9Yow" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" scale="6" id="Tc_JVjhOgnK8EWMZWm-RaPeCg_22_12">35</ix:nonfraction></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:52.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.75%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.4%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.75%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.42%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:52.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">Net Earnings</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.75%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2019_To_9_30_2019_5CXepWtEPEKQA-bPz0Tp7A" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="6" id="Tc_V7nIEr_6sUaypYItQSNeaw_24_3">960</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.75%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2018_To_9_30_2018_lS4NEZw67ECck2zY72MWgg" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="6" id="Tc_wagw2iFYhUq5PauoG4stow_24_6">563</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.43%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_O4ushO81Z0mAnTH_cLUPFw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="6" id="Tc_1Ej7YOfS3UiqrMNbWEVztA_24_9">2,638</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.42%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2018_To_9_30_2018_3n65uNcjAUKkwLDxHE9Yow" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="6" id="Tc_2p5g80WYTkyuUfg846p0dg_24_12">1,714</ix:nonfraction></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:52.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:52.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">Basic Earnings Per Common Share —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:52.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt 0pt 0pt 12pt;">Continuing operations</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonfraction unitref="Unit_Divide_USD_shares_xJ2idvgWWEuE1nW1pOVAfA" contextref="Duration_7_1_2019_To_9_30_2019_5CXepWtEPEKQA-bPz0Tp7A" decimals="2" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="Tc_gbNOb87RcEO0IIMuP7M3aQ_27_3">0.54</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonfraction unitref="Unit_Divide_USD_shares_xJ2idvgWWEuE1nW1pOVAfA" contextref="Duration_7_1_2018_To_9_30_2018_lS4NEZw67ECck2zY72MWgg" decimals="2" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="Tc_9LYALrFSlk6bkWa3jKPCCQ_27_6">0.31</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonfraction unitref="Unit_Divide_USD_shares_xJ2idvgWWEuE1nW1pOVAfA" contextref="Duration_1_1_2019_To_9_30_2019_O4ushO81Z0mAnTH_cLUPFw" decimals="2" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="Tc_M2FyEMwlR0qJKkTBkRb6_Q_27_9">1.48</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonfraction unitref="Unit_Divide_USD_shares_xJ2idvgWWEuE1nW1pOVAfA" contextref="Duration_1_1_2018_To_9_30_2018_3n65uNcjAUKkwLDxHE9Yow" decimals="2" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="Tc_HcFWdQFCyU2gZ0JXqprNJQ_27_12">0.95</ix:nonfraction></p></td></tr><tr><td style="vertical-align:bottom;width:52.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt 0pt 0pt 12pt;">Discontinued operations</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.75%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.75%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonfraction unitref="Unit_Divide_USD_shares_xJ2idvgWWEuE1nW1pOVAfA" contextref="Duration_7_1_2018_To_9_30_2018_lS4NEZw67ECck2zY72MWgg" decimals="2" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" scale="0" id="Tc_uAsujy6MbEy3XxQtkkUGTw_28_6">0.01</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.42%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonfraction unitref="Unit_Divide_USD_shares_xJ2idvgWWEuE1nW1pOVAfA" contextref="Duration_1_1_2018_To_9_30_2018_3n65uNcjAUKkwLDxHE9Yow" decimals="2" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" scale="0" id="Tc_Sc_E6WAE5k2fCaMfqrWxYw_28_12">0.02</ix:nonfraction></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:52.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt 0pt 0pt 12pt;">Net earnings</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.75%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonfraction unitref="Unit_Divide_USD_shares_xJ2idvgWWEuE1nW1pOVAfA" contextref="Duration_7_1_2019_To_9_30_2019_5CXepWtEPEKQA-bPz0Tp7A" decimals="2" format="ixt:numdotdecimal" name="us-gaap:EarningsPerShareBasic" scale="0" id="Tc_wD09pwwME0uFYIFFgAbuNA_29_3">0.54</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.4%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.75%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonfraction unitref="Unit_Divide_USD_shares_xJ2idvgWWEuE1nW1pOVAfA" contextref="Duration_7_1_2018_To_9_30_2018_lS4NEZw67ECck2zY72MWgg" decimals="2" format="ixt:numdotdecimal" name="us-gaap:EarningsPerShareBasic" scale="0" id="Tc_4UJd0PGtO0udyeNWPzRp-g_29_6">0.32</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.36%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.43%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonfraction unitref="Unit_Divide_USD_shares_xJ2idvgWWEuE1nW1pOVAfA" contextref="Duration_1_1_2019_To_9_30_2019_O4ushO81Z0mAnTH_cLUPFw" decimals="2" format="ixt:numdotdecimal" name="us-gaap:EarningsPerShareBasic" scale="0" id="Tc_S1Xygr5QO0y2exXAdHsN6A_29_9">1.48</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.36%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.42%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonfraction unitref="Unit_Divide_USD_shares_xJ2idvgWWEuE1nW1pOVAfA" contextref="Duration_1_1_2018_To_9_30_2018_3n65uNcjAUKkwLDxHE9Yow" decimals="2" format="ixt:numdotdecimal" name="us-gaap:EarningsPerShareBasic" scale="0" id="Tc_F9DjjbVB0EaAc9L5p1JQog_29_12">0.97</ix:nonfraction></p></td></tr><tr><td style="vertical-align:bottom;width:52.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:52.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">Diluted Earnings Per Common Share —</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:52.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt 0pt 0pt 12pt;">Continuing operations</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonfraction unitref="Unit_Divide_USD_shares_xJ2idvgWWEuE1nW1pOVAfA" contextref="Duration_7_1_2019_To_9_30_2019_5CXepWtEPEKQA-bPz0Tp7A" decimals="2" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="Tc_HZOVYGeq9kGiu_67tGvdeA_32_3">0.53</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonfraction unitref="Unit_Divide_USD_shares_xJ2idvgWWEuE1nW1pOVAfA" contextref="Duration_7_1_2018_To_9_30_2018_lS4NEZw67ECck2zY72MWgg" decimals="2" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="Tc_0ErrPySeTESElL-zMwJRLw_32_6">0.31</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonfraction unitref="Unit_Divide_USD_shares_xJ2idvgWWEuE1nW1pOVAfA" contextref="Duration_1_1_2019_To_9_30_2019_O4ushO81Z0mAnTH_cLUPFw" decimals="2" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="Tc_IgsR72bOYEiK4D7nPmuSqg_32_9">1.47</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonfraction unitref="Unit_Divide_USD_shares_xJ2idvgWWEuE1nW1pOVAfA" contextref="Duration_1_1_2018_To_9_30_2018_3n65uNcjAUKkwLDxHE9Yow" decimals="2" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="Tc_KHbGltlFN0CJ3lDLLlbAFQ_32_12">0.94</ix:nonfraction></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:52.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt 0pt 0pt 12pt;">Discontinued operations</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.75%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.4%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.75%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonfraction unitref="Unit_Divide_USD_shares_xJ2idvgWWEuE1nW1pOVAfA" contextref="Duration_7_1_2018_To_9_30_2018_lS4NEZw67ECck2zY72MWgg" decimals="2" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" scale="0" id="Tc_IEgyBHfhA0OXq6WZeBYRqA_33_6">0.01</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.42%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonfraction unitref="Unit_Divide_USD_shares_xJ2idvgWWEuE1nW1pOVAfA" contextref="Duration_1_1_2018_To_9_30_2018_3n65uNcjAUKkwLDxHE9Yow" decimals="2" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" scale="0" id="Tc_8-L9Z-evGESFKWwkkcFNwQ_33_12">0.02</ix:nonfraction></p></td></tr><tr><td style="vertical-align:bottom;width:52.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt 0pt 0pt 12pt;">Net earnings</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.75%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonfraction unitref="Unit_Divide_USD_shares_xJ2idvgWWEuE1nW1pOVAfA" contextref="Duration_7_1_2019_To_9_30_2019_5CXepWtEPEKQA-bPz0Tp7A" decimals="2" format="ixt:numdotdecimal" name="us-gaap:EarningsPerShareDiluted" scale="0" id="Tc_LvkZ6iApC0u_GBF7JSpFQA_34_3">0.53</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.75%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonfraction unitref="Unit_Divide_USD_shares_xJ2idvgWWEuE1nW1pOVAfA" contextref="Duration_7_1_2018_To_9_30_2018_lS4NEZw67ECck2zY72MWgg" decimals="2" format="ixt:numdotdecimal" name="us-gaap:EarningsPerShareDiluted" scale="0" id="Tc_LfuhZLbPOEGfeJlF7HB4Zg_34_6">0.32</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.43%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonfraction unitref="Unit_Divide_USD_shares_xJ2idvgWWEuE1nW1pOVAfA" contextref="Duration_1_1_2019_To_9_30_2019_O4ushO81Z0mAnTH_cLUPFw" decimals="2" format="ixt:numdotdecimal" name="us-gaap:EarningsPerShareDiluted" scale="0" id="Tc_EVWeVFpel0yNyAnta9dtXQ_34_9">1.47</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.42%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonfraction unitref="Unit_Divide_USD_shares_xJ2idvgWWEuE1nW1pOVAfA" contextref="Duration_1_1_2018_To_9_30_2018_3n65uNcjAUKkwLDxHE9Yow" decimals="2" format="ixt:numdotdecimal" name="us-gaap:EarningsPerShareDiluted" scale="0" id="Tc_hX6Jv9Aa5kuY3v0XuQqd3g_34_12">0.96</ix:nonfraction></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:52.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:52.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">Average Number of Common Shares Outstanding Used for Basic Earnings Per Common Share</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_shares__pDT34XXdk2QZR7p6i5hkA" contextref="Duration_7_1_2019_To_9_30_2019_5CXepWtEPEKQA-bPz0Tp7A" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="Tc_MhQLNtCftU-Topwvslb-xA_36_3">1,771,521</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_shares__pDT34XXdk2QZR7p6i5hkA" contextref="Duration_7_1_2018_To_9_30_2018_lS4NEZw67ECck2zY72MWgg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="Tc_s5mWXF4ZkESS7Zy6F53OHA_36_6">1,759,585</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_shares__pDT34XXdk2QZR7p6i5hkA" contextref="Duration_1_1_2019_To_9_30_2019_O4ushO81Z0mAnTH_cLUPFw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="Tc_Sin5ERFgOUi-zXPO_fPiLQ_36_9">1,767,985</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_shares__pDT34XXdk2QZR7p6i5hkA" contextref="Duration_1_1_2018_To_9_30_2018_3n65uNcjAUKkwLDxHE9Yow" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="Tc_77JvyoAwakGW3gA0OhTSnw_36_12">1,757,018</ix:nonfraction></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:52.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">Dilutive Common Stock Options</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.75%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_shares__pDT34XXdk2QZR7p6i5hkA" contextref="Duration_7_1_2019_To_9_30_2019_5CXepWtEPEKQA-bPz0Tp7A" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="Tc_6XPMpgzATUmm5TJBqL7GAA_37_3">12,646</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.4%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.75%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_shares__pDT34XXdk2QZR7p6i5hkA" contextref="Duration_7_1_2018_To_9_30_2018_lS4NEZw67ECck2zY72MWgg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="Tc_x1XLcyqqe0yd8baVGVtotw_37_6">12,095</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_shares__pDT34XXdk2QZR7p6i5hkA" contextref="Duration_1_1_2019_To_9_30_2019_O4ushO81Z0mAnTH_cLUPFw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="Tc_0ecd3i1uEEyLabvdmKJzFg_37_9">12,818</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.42%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_shares__pDT34XXdk2QZR7p6i5hkA" contextref="Duration_1_1_2018_To_9_30_2018_3n65uNcjAUKkwLDxHE9Yow" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="Tc_a_UTJW7EOUuAoBoyMKekjQ_37_12">11,692</ix:nonfraction></p></td></tr><tr><td style="vertical-align:bottom;width:52.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">Average Number of Common Shares Outstanding Plus Dilutive Common Stock Options</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.75%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_shares__pDT34XXdk2QZR7p6i5hkA" contextref="Duration_7_1_2019_To_9_30_2019_5CXepWtEPEKQA-bPz0Tp7A" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="Tc_zhyfw_jkME62LZ_B-80fSQ_38_3">1,784,167</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.75%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_shares__pDT34XXdk2QZR7p6i5hkA" contextref="Duration_7_1_2018_To_9_30_2018_lS4NEZw67ECck2zY72MWgg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="Tc_jTlo-73dDUuKS323Xe_m8w_38_6">1,771,680</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.43%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_shares__pDT34XXdk2QZR7p6i5hkA" contextref="Duration_1_1_2019_To_9_30_2019_O4ushO81Z0mAnTH_cLUPFw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="Tc_hTaJhRDEk0SbCRU-2kAzcw_38_9">1,780,803</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.42%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_shares__pDT34XXdk2QZR7p6i5hkA" contextref="Duration_1_1_2018_To_9_30_2018_3n65uNcjAUKkwLDxHE9Yow" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="Tc_QXxhWzPa60mI8XMIpKQIUw_38_12">1,768,710</ix:nonfraction></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:52.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:52.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">Outstanding Common Stock Options Having No Dilutive Effect</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.41%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.75%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_shares__pDT34XXdk2QZR7p6i5hkA" contextref="Duration_7_1_2019_To_9_30_2019_5CXepWtEPEKQA-bPz0Tp7A" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="Tc_R4iMK9ucq0OtgoXy11SGcg_40_3">61</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.75%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_shares__pDT34XXdk2QZR7p6i5hkA" contextref="Duration_7_1_2018_To_9_30_2018_lS4NEZw67ECck2zY72MWgg" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="Tc_-Uzs6vvlf06qQtk979chOA_40_6">44</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.43%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_shares__pDT34XXdk2QZR7p6i5hkA" contextref="Duration_1_1_2019_To_9_30_2019_O4ushO81Z0mAnTH_cLUPFw" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="Tc_5Ny8MsSrw0-PLQ7M57BJVw_40_9">61</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.42%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_shares__pDT34XXdk2QZR7p6i5hkA" contextref="Duration_1_1_2018_To_9_30_2018_3n65uNcjAUKkwLDxHE9Yow" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="Tc_KZiRU5tbG0KLLEffatp6cg_40_12">44</ix:nonfraction></p></td></tr></tbody></table><p style="font-family:'Times New Roman';font-size:12pt;text-align:justify;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:10pt;text-align:justify;margin:0pt;">The accompanying notes to the condensed consolidated financial statements are an integral part of this statement.</p><p style="font-family:'Times New Roman';font-size:12pt;text-align:justify;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p><p style="display:none;font-size:12pt;line-height:0pt;text-align:justify;margin:0pt;"><span style="font-family:'Times New Roman';font-size:0pt;visibility:hidden;">​</span></p><a id="_0ffc5e9a_f086_4d5c_9c8d_ba00b722abf7"></a></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">3</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-family:'Times New Roman';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:center;margin:0pt;">Abbott Laboratories and Subsidiaries</p><a id="StatementofComprehensiveIncome_730613"></a><p style="font-family:'Times New Roman';font-size:10pt;text-align:center;margin:0pt;">Condensed Consolidated Statement of Comprehensive Income</p><p style="font-family:'Times New Roman';font-size:10pt;text-align:center;margin:0pt;">(Unaudited)</p><p style="font-family:'Times New Roman';font-size:10pt;text-align:center;margin:0pt;"><i style="font-style:italic;">(dollars in millions)</i></p><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><a id="_c2cd78f6_19b2_42ff_acd0_59946af9b5da"></a><a id="Tc_aYLppc_KAkqlxLxhVItKlw_1_2"></a><a id="Tc_u1LQqvjT7kS8AvH04LTEEA_1_8"></a><a id="Tc_htlb7zo_m0iw3LcrvnNEMg_2_2"></a><a id="Tc_UzG94eWuV0qvm0kAdVnfqQ_2_5"></a><a id="Tc_5yOX7sFJukaXV3Zz0LBnDg_2_8"></a><a id="Tc_WpD7kaI_0kWuVRkJouzBbw_2_11"></a><a id="Tc_haDywNxLpUmiDVA9e_yxlQ_3_0"></a><a id="Tc_6VE5zZG3Zk-_don1qPRQYA_3_2"></a><a id="Tc_UAi8oHJyUk-LwDVIklwulQ_3_5"></a><a id="Tc_JgltRhC5ZUmZGkSfAE06vw_3_8"></a><a id="Tc_LVrhs3MZ2k2j_Bx3Jp0tXg_3_11"></a><a id="Tc_gdb0x5bPxE-hMD0XeuMeSw_4_0"></a><a id="Tc_ilAzct0MCUONd1inuqyZAw_5_0"></a><a id="Tc_rKj3r0PnzkGeQWiLcB3iLw_6_0"></a><a id="Tc_WHbDsIXXlUi71L5oXzh0hQ_7_0"></a><a id="Tc_VxaCpbrt1kys1UJvpmtmHA_8_0"></a><a id="Tc_kJk7OYIxKUqt2i9ASlS2oQ_8_2"></a><a id="Tc_U5TB-MXefk2ZoEJFHzH2xQ_8_5"></a><a id="Tc_VFpNb24bU0iwAskmOpNJuw_8_8"></a><a id="Tc_3SgS0ZB2m0KtC96ZmOuj_g_8_11"></a><table style="border-collapse:collapse;font-size:16pt;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tbody><tr style="height:1pt;"><td style="vertical-align:bottom;width:52.75%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.75%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.75%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.47%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.35%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="background-color:auto;vertical-align:bottom;width:52.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="5" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:22.55%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Three Months Ended September&nbsp;30</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="5" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:21.73%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Nine Months Ended September&nbsp;30</b></p></td></tr><tr><td style="background-color:auto;vertical-align:bottom;width:52.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&nbsp;&nbsp;&nbsp;&nbsp;</b></p></td><td colspan="2" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:10.18%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2019</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&nbsp;&nbsp;&nbsp;&nbsp;</b></p></td><td colspan="2" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:10.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2018</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&nbsp;&nbsp;&nbsp;&nbsp;</b></p></td><td colspan="2" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:9.83%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2019</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&nbsp;&nbsp;&nbsp;&nbsp;</b></p></td><td colspan="2" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:9.74%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2018</b></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:52.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">Net Earnings</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.42%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.75%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2019_To_9_30_2019_5CXepWtEPEKQA-bPz0Tp7A" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="6" id="Tc_CtoFqb9mzkK8BtIPqqkk6Q_3_3">960</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.75%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2018_To_9_30_2018_lS4NEZw67ECck2zY72MWgg" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="6" id="Tc_endbxbcbwEKkHJHgp6ivnQ_3_6">563</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_O4ushO81Z0mAnTH_cLUPFw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="6" id="Tc_p_j32p85fkGC44L72P338w_3_9">2,638</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.35%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2018_To_9_30_2018_3n65uNcjAUKkwLDxHE9Yow" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="6" id="Tc_ePVEeH5mykWSBzGiYAv2WA_3_12">1,714</ix:nonfraction></p></td></tr><tr><td style="vertical-align:bottom;width:52.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">Foreign currency translation gain (loss) adjustments </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"> (<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2019_To_9_30_2019_5CXepWtEPEKQA-bPz0Tp7A" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" sign="-" scale="6" id="Tc_I0fugZeD3UmMDwfgKw9Gig_4_3">478</ix:nonfraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"> (<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2018_To_9_30_2018_lS4NEZw67ECck2zY72MWgg" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" sign="-" scale="6" id="Tc_KtldKaKel0ye94I5AYGPLw_4_6">153</ix:nonfraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"> (<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_O4ushO81Z0mAnTH_cLUPFw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" sign="-" scale="6" id="Tc_3uYrjzm2ZEG1eGaxWolX9Q_4_9">265</ix:nonfraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"> (<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2018_To_9_30_2018_3n65uNcjAUKkwLDxHE9Yow" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" sign="-" scale="6" id="Tc_0RKnVkHgcUS6HFKlOxo7Fg_4_12">1,179</ix:nonfraction>)</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:52.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">Net actuarial gains (losses) and amortization of net actuarial losses and prior service costs and credits, net of taxes of $<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2019_To_9_30_2019_5CXepWtEPEKQA-bPz0Tp7A" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" sign="-" scale="6" id="Narr_P5zd-DA0sEWQnp-3JkDHZw">7</ix:nonfraction> and $<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_O4ushO81Z0mAnTH_cLUPFw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" sign="-" scale="6" id="Narr_ZqKnYFLZrEi6Xo6G-MtoSQ">21</ix:nonfraction> in 2019 and $<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2018_To_9_30_2018_lS4NEZw67ECck2zY72MWgg" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" sign="-" scale="6" id="Narr_pxV1DQhvRkS3EcxyP5Il6w">16</ix:nonfraction> and $<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2018_To_9_30_2018_3n65uNcjAUKkwLDxHE9Yow" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" sign="-" scale="6" id="Narr_rpmywgJX80uPKPwzEs_bug">48</ix:nonfraction> in 2018</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2019_To_9_30_2019_5CXepWtEPEKQA-bPz0Tp7A" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" sign="-" scale="6" id="Tc_KY5RhlLV0UCcYBA9_6AY_A_5_3">31</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2018_To_9_30_2018_lS4NEZw67ECck2zY72MWgg" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" sign="-" scale="6" id="Tc__YIEw9PDH0SNU5p0o_Y5Sg_5_6">22</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_O4ushO81Z0mAnTH_cLUPFw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" sign="-" scale="6" id="Tc_s13-SVU7ZUWgrEz_MDwlxA_5_9">80</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2018_To_9_30_2018_3n65uNcjAUKkwLDxHE9Yow" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" sign="-" scale="6" id="Tc_LBM2r1r-00aOnPFWHB913Q_5_12">106</ix:nonfraction></p></td></tr><tr><td style="vertical-align:bottom;width:52.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">Net gains (losses) for derivative instruments designated as cash flow hedges and other, net of taxes of $<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2019_To_9_30_2019_5CXepWtEPEKQA-bPz0Tp7A" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" scale="6" id="Narr_kdthlAASNUGwNrcHmALkoQ">23</ix:nonfraction> and $<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_O4ushO81Z0mAnTH_cLUPFw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" scale="6" id="Narr_eaYGoCTx0kyP74hOWLAs8w">8</ix:nonfraction> in 2019 and $<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2018_To_9_30_2018_lS4NEZw67ECck2zY72MWgg" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" scale="6" id="Narr_8yVRlMlAYEeeqy81Q3TUMA">16</ix:nonfraction> and $<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2018_To_9_30_2018_3n65uNcjAUKkwLDxHE9Yow" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" scale="6" id="Narr_TzEFFoZ8dUC1GyPvCDNwmw">44</ix:nonfraction> in 2018</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.75%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2019_To_9_30_2019_5CXepWtEPEKQA-bPz0Tp7A" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent" scale="6" id="Tc_E83L_eyTXUSlTn6cKdP_PQ_6_3">49</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.75%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2018_To_9_30_2018_lS4NEZw67ECck2zY72MWgg" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent" scale="6" id="Tc_Mj61CjRJEk-yigtSjuBjkQ_6_6">35</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_O4ushO81Z0mAnTH_cLUPFw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent" scale="6" id="Tc_75d_49uvN0SkxXCve7f2-Q_6_9">8</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.35%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2018_To_9_30_2018_3n65uNcjAUKkwLDxHE9Yow" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent" scale="6" id="Tc_5PcBJFACXEem5yfK2IFmrA_6_12">121</ix:nonfraction></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:52.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">Other comprehensive (loss)</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.42%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.75%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"> (<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2019_To_9_30_2019_5CXepWtEPEKQA-bPz0Tp7A" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" sign="-" scale="6" id="Tc_pWr7umpZ3UWPdqkiMsngBQ_7_3">398</ix:nonfraction>)</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.75%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"> (<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2018_To_9_30_2018_lS4NEZw67ECck2zY72MWgg" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" sign="-" scale="6" id="Tc_2yXWUaHIAkeek0eYWm7vhQ_7_6">96</ix:nonfraction>)</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"> (<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_O4ushO81Z0mAnTH_cLUPFw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" sign="-" scale="6" id="Tc_oKa9ONi93kGZC7VdG14XDg_7_9">177</ix:nonfraction>)</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.35%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"> (<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2018_To_9_30_2018_3n65uNcjAUKkwLDxHE9Yow" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" sign="-" scale="6" id="Tc_GpJ4IpEU6kqx1pFrjo2C9g_7_12">952</ix:nonfraction>)</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:52.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">Comprehensive Income</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.75%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2019_To_9_30_2019_5CXepWtEPEKQA-bPz0Tp7A" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="Tc_ptMN_8WEyESLaZJdZ2ad3Q_8_3">562</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.39%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.75%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2018_To_9_30_2018_lS4NEZw67ECck2zY72MWgg" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="Tc_SxXZJ_59TUm0ML1oQza0Fg_8_6">467</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.47%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_O4ushO81Z0mAnTH_cLUPFw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="Tc_NQEZBllo5ki7LKDATLOx3w_8_9">2,461</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.35%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.39%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2018_To_9_30_2018_3n65uNcjAUKkwLDxHE9Yow" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="Tc_y9NQuCwZRE-58pahyhEppg_8_12">762</ix:nonfraction></p></td></tr></tbody></table><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><a id="_c5bcda8f_3512_402c_9f4c_398f7361ad09"></a><a id="Tc_NH7O8HBKDUm6k4kGjqZqdw_1_2"></a><a id="Tc_cQ4UepMDaUqJiXY0viV5Wg_1_5"></a><a id="Tc_bQXHfikAZkixI2z0TYyoJw_2_2"></a><a id="Tc_npOjhKHyhUG927p4KX460A_2_5"></a><a id="Tc_v409qvv6p0KkwQZQhdsB6g_3_0"></a><a id="Tc_kPLca3vddUahaE-lrp_gDw_4_0"></a><a id="Tc_zQPRZvllnEC_atu_Ny2VCQ_4_2"></a><a id="Tc_Zrdfd8TePE2Hclm_LRfMWA_4_5"></a><a id="Tc_UvxjOI_1k0Wy5CKhQ-1OpQ_5_0"></a><a id="Tc_IrzvvJw3tESzvGBfkBk2ig_6_0"></a><a id="Tc_4SIRtKlOGU6RUkwoNFpQ7g_7_0"></a><a id="Tc_ocaWzp73K0yF8QRKt5AkPQ_7_2"></a><a id="Tc_3-faL407Zk2y1qJ09sVShg_7_5"></a><table style="border-collapse:collapse;font-size:16pt;margin-left:-0.5416641%;padding-left:0pt;padding-right:0pt;width:101.08%;"><tbody><tr style="height:1pt;"><td style="vertical-align:bottom;width:73.89%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="background-color:auto;vertical-align:bottom;width:73.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:10.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">September&nbsp;30,&nbsp;</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:10.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&nbsp;31,&nbsp;</b></p></td></tr><tr><td style="background-color:auto;vertical-align:bottom;width:73.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&nbsp;&nbsp;&nbsp;&nbsp;</b></p></td><td colspan="2" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:10.72%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2019</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&nbsp;&nbsp;&nbsp;&nbsp;</b></p></td><td colspan="2" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:10.7%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2018</b></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:73.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="white-space:pre-wrap;">Supplemental Accumulated Other Comprehensive Income (Loss) Information, net of tax:  </span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:73.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">Cumulative foreign currency translation (loss) adjustments</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"> (<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_9_30_2019_Q77aJBXiP0qCmJ4Yd2DnHw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" sign="-" scale="6" id="Tc_jK5vKA6G9kmXetwxYnUghQ_4_3">5,177</ix:nonfraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"> (<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_12_31_2018_INezHDkjn0-L7OMGoLMjhA" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" sign="-" scale="6" id="Tc_8X05R2-p1Emnjl3czEh6Zg_4_6">4,912</ix:nonfraction>)</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:73.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">Net actuarial (losses) and prior service (costs) and credits </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"> (<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_9_30_2019_Q77aJBXiP0qCmJ4Yd2DnHw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" scale="6" id="Tc_giGGkVfqfUmdmTL4ZwbrLA_5_3">2,646</ix:nonfraction>)</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"> (<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_12_31_2018_INezHDkjn0-L7OMGoLMjhA" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" scale="6" id="Tc_w99rCWlgC0WsF8HK_flpMg_5_6">2,726</ix:nonfraction>)</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:73.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">Cumulative gains (losses) on derivative instruments designated as cash flow hedges and other</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_9_30_2019_Q77aJBXiP0qCmJ4Yd2DnHw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax" scale="6" id="Tc_LzWtz_Px8ECDPgqW5CphJQ_6_3">60</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_12_31_2018_INezHDkjn0-L7OMGoLMjhA" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax" scale="6" id="Tc_421zNSrng0KETU9K3XdhpQ_6_6">52</ix:nonfraction></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:73.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">Accumulated other comprehensive income (loss)</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"> (<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_9_30_2019_Q77aJBXiP0qCmJ4Yd2DnHw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" sign="-" scale="6" id="Tc_f0xByhH-i02fouoeR65Ikg_7_3">7,763</ix:nonfraction>)</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"> (<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_12_31_2018_INezHDkjn0-L7OMGoLMjhA" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" sign="-" scale="6" id="Tc_D3xmCXJ2bECd47fqzRe4oQ_7_6">7,586</ix:nonfraction>)</p></td></tr></tbody></table><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">The accompanying notes to the condensed consolidated financial statements are an integral part of this statement.</p><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="display:none;font-size:12pt;line-height:0pt;margin:0pt;"><span style="font-family:'Times New Roman';font-size:0pt;visibility:hidden;">​</span></p><a id="_6adf0ab2_eb36_4be9_8269_327d2817a623"></a></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">4</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-family:'Times New Roman';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:center;margin:0pt;">Abbott Laboratories and Subsidiaries</p><a id="ConsolidatedBalanceSheet_174855"></a><p style="font-family:'Times New Roman';font-size:10pt;text-align:center;margin:0pt;">Condensed Consolidated Balance Sheet</p><p style="font-family:'Times New Roman';font-size:10pt;text-align:center;margin:0pt;">(Unaudited)</p><p style="font-family:'Times New Roman';font-size:10pt;text-align:center;margin:0pt;"><i style="font-style:italic;">(dollars in millions)</i></p><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><a id="_58af162f_e1ef_47d0_b772_a37848191118"></a><a id="Tc_LRrWkolO60OVr2aY-Psf3A_1_2"></a><a id="Tc_libKsQf-1EmlMw3l-aShIA_1_5"></a><a id="Tc_Olrml7IlmEq9aGhGFHQcNg_2_2"></a><a id="Tc_oaoN3Ukqpkujzkq1kuvVsA_2_5"></a><a id="Tc_LTXlY1N4fESzWHVch86bjg_3_0"></a><a id="Tc_t7FqtpBP5k6WzY0Iqu9RSw_4_0"></a><a id="Tc_Uwc-XOH_vkKS5qH545qnrw_5_0"></a><a id="Tc_HSuUPvFQ4UyPQkHdu3tATQ_5_2"></a><a id="Tc_GYQZSaDhWkC-2GHw-94K4w_5_5"></a><a id="Tc_3N7bPID_skSNv-loNYSM-A_6_0"></a><a id="Tc_zmFz5fqCaEaIzqt8j40Twg_7_0"></a><a id="Tc_TL-LzyiY9kGFjGDwmO7OtA_8_0"></a><a id="Tc_TJw6v3vv2UmNxb5ui3d3CA_9_0"></a><a id="Tc_bSCwvOgRjEeZ9wRTh-VG9A_10_0"></a><a id="Tc_xVbadnC2B0OhyitVSJ4RWQ_11_0"></a><a id="Tc_eI7nfm4au0KARkucRzOkIg_12_0"></a><a id="Tc_Yp6-baM22Em8wKNFQwIhYA_13_0"></a><a id="Tc_VIEU0FGo5ESL8uOftvboIw_14_0"></a><a id="Tc_Cce9xhYCY0ewlLAX653ZYQ_15_0"></a><a id="Tc_sONMsveKkEWL4-ogO24Wvw_16_0"></a><a id="Tc_8iRgVubDMEqUUHdH_D0Y8A_17_0"></a><a id="Tc_3YgbAhxpE0Kof8opU7DE3Q_18_0"></a><a id="Tc_V1e_qR658E-5EYa-JEZIBQ_19_0"></a><a id="Tc_H5MsazIf-0a6tyQTu38_ZA_20_0"></a><a id="Tc_-folcCzeHk2Z1KIWbZaSiw_21_0"></a><a id="Tc_W0K7YN3lXEu9NcjjVNxO4g_22_2"></a><a id="Tc_pVbyGR-22kKN68YI4A7bzA_22_5"></a><a id="Tc_NvsueaM2iEWBt3BhaLIy1A_23_0"></a><a id="Tc_5gS4TzSFdEG4q_7WDj0vEw_24_0"></a><a id="Tc_oyCoHSgAA0ibkp8YWwifNg_25_0"></a><a id="Tc_De9QWKXfZEGST31pPtNT_A_25_2"></a><a id="Tc_8E_4zueCQ0yaQ4PApZu37A_25_5"></a><a id="Tc_EIEwRckJjEKYNul77ra2XQ_26_0"></a><a id="Tc_8DpGtzQFE0G_JLZeWG2HaA_27_0"></a><a id="Tc_KKu1oAhW1UWVZhDtSd8_pg_28_0"></a><a id="Tc__bSoalUJyUy_kV95mbVn4A_29_0"></a><a id="Tc_eSLgTs-ECEeuK47O9yGgqA_30_0"></a><a id="Tc_IALYZUC9OE-0hE5w_A4GIw_31_0"></a><a id="Tc_DRuePSLjrUizZY4x5P0Etw_32_0"></a><a id="Tc_HcRY0S60bEu8WFzKC0OaaA_33_0"></a><a id="Tc_hCstSAArjkqzB5asJ1t4GA_34_0"></a><a id="Tc_JgU6_M28lEu5ijvtnR__Kg_35_0"></a><a id="Tc_aRPd8ug9R0GR7EfWXU09pg_36_0"></a><a id="Tc_BMDLaC8STEG-fR29fxeWnA_37_0"></a><a id="Tc_ekmPusQDo0SCNBG1_iAhFQ_37_3"></a><a id="Tc_cbqoUBJT40OdyWlbxZxulw_37_6"></a><a id="Tc_jGAsaMJMcEG3g7K4Q7xjAw_38_0"></a><a id="Tc_0_yIe4lUv0ybCCYilXdaCw_39_0"></a><a id="Tc_KqR4Lrgzt0a3lLo_xnM0ew_40_0"></a><a id="Tc_OIyiXIwCrkW0zncHcY9Nfg_41_0"></a><a id="Tc_lB6Sx39Nrkq-ciav06dcNA_42_0"></a><a id="Tc_tlQPB7z2m0y3eBn_8qo7EA_43_0"></a><a id="Tc_jK2L4eEMT0WQYipr8Lp6aA_44_0"></a><a id="Tc_kIutuq2jM0OTarUbAW_6rg_45_2"></a><a id="Tc_3GnwLZFu102sPS9V8b1nTw_45_5"></a><table style="border-collapse:collapse;font-size:16pt;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tbody><tr style="height:1pt;"><td style="vertical-align:bottom;width:73.88%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="background-color:auto;vertical-align:bottom;width:73.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:10.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">September&nbsp;30,&nbsp;</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:10.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&nbsp;31,&nbsp;</b></p></td></tr><tr><td style="background-color:auto;vertical-align:bottom;width:73.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&nbsp;&nbsp;&nbsp;&nbsp;</b></p></td><td colspan="2" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:10.72%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2019</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&nbsp;&nbsp;&nbsp;&nbsp;</b></p></td><td colspan="2" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:10.7%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2018</b></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:73.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">Assets</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:73.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">Current Assets:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:73.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">Cash and cash equivalents</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_9_30_2019_Q77aJBXiP0qCmJ4Yd2DnHw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="Tc_oVV-WLD1eUWYpmLr16EUxw_5_3">4,091</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_12_31_2018_INezHDkjn0-L7OMGoLMjhA" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="Tc_K0Unxzi1s0-T_vuMMa-5ew_5_6">3,844</ix:nonfraction></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:73.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">Short-term investments</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_9_30_2019_Q77aJBXiP0qCmJ4Yd2DnHw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ShortTermInvestments" scale="6" id="Tc_-gDn3FFTDEafpxEkGj8GOg_6_3">244</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_12_31_2018_INezHDkjn0-L7OMGoLMjhA" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ShortTermInvestments" scale="6" id="Tc_ZI7s_lCKmUGsWlQ-2Xe-nw_6_6">242</ix:nonfraction></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:73.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">Trade receivables, less allowances of $<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_9_30_2019_Q77aJBXiP0qCmJ4Yd2DnHw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="6" id="Narr_jNR5mOvZF0mczMTA8R3MdA">354</ix:nonfraction> in 2019 and $<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_12_31_2018_INezHDkjn0-L7OMGoLMjhA" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="6" id="Narr_vqry_VD5Gk-YlMvDcRwjTQ">314</ix:nonfraction> in 2018</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_9_30_2019_Q77aJBXiP0qCmJ4Yd2DnHw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccountsReceivableNetCurrent" scale="6" id="Tc_vXJ_O7ECi0-QyrOJxhJQcQ_7_3">5,450</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_12_31_2018_INezHDkjn0-L7OMGoLMjhA" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccountsReceivableNetCurrent" scale="6" id="Tc_bClm0CXtKUiq1LQhYy6UTA_7_6">5,182</ix:nonfraction></p></td></tr><tr><td style="vertical-align:bottom;width:73.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">Inventories: </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:73.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 12pt;">Finished products</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_9_30_2019_Q77aJBXiP0qCmJ4Yd2DnHw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:InventoryFinishedGoodsNetOfReserves" scale="6" id="Tc_cuu8q5VZXkCdCMm-LqIPvA_9_3">2,846</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_12_31_2018_INezHDkjn0-L7OMGoLMjhA" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:InventoryFinishedGoodsNetOfReserves" scale="6" id="Tc_jm3TNuia7EObBHVFxNIf8A_9_6">2,407</ix:nonfraction></p></td></tr><tr><td style="vertical-align:bottom;width:73.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 12pt;">Work in process</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_9_30_2019_Q77aJBXiP0qCmJ4Yd2DnHw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:InventoryWorkInProcessNetOfReserves" scale="6" id="Tc_lzpBZMJWYkKY-V7UW5FpSA_10_3">584</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_12_31_2018_INezHDkjn0-L7OMGoLMjhA" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:InventoryWorkInProcessNetOfReserves" scale="6" id="Tc_22p5mMrMME6WEgtSz_cw2g_10_6">499</ix:nonfraction></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:73.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 12pt;">Materials</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_9_30_2019_Q77aJBXiP0qCmJ4Yd2DnHw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:InventoryRawMaterialsNetOfReserves" scale="6" id="Tc_Odu5lwsGzEGEct0DmBS-JA_11_3">962</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_12_31_2018_INezHDkjn0-L7OMGoLMjhA" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:InventoryRawMaterialsNetOfReserves" scale="6" id="Tc_yVzoHDloPU-7EqbdRvbQFg_11_6">890</ix:nonfraction></p></td></tr><tr><td style="vertical-align:bottom;width:73.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 18pt;">Total inventories</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_9_30_2019_Q77aJBXiP0qCmJ4Yd2DnHw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:InventoryNet" scale="6" id="Tc_QNAmXNX-hEi40oK4BLD7mg_12_3">4,392</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_12_31_2018_INezHDkjn0-L7OMGoLMjhA" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:InventoryNet" scale="6" id="Tc_EfUw7Cpc1EmC4C6c6dXovQ_12_6">3,796</ix:nonfraction></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:73.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">Prepaid expenses and other receivables</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_9_30_2019_Q77aJBXiP0qCmJ4Yd2DnHw" decimals="-6" format="ixt:numdotdecimal" name="abt:PrepaidExpenseAndOtherReceivables" scale="6" id="Tc_ARbpFc23YkSzyYxIEd8C3g_13_3">1,942</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_12_31_2018_INezHDkjn0-L7OMGoLMjhA" decimals="-6" format="ixt:numdotdecimal" name="abt:PrepaidExpenseAndOtherReceivables" scale="6" id="Tc_sylS1ewpvUul5tAHAm-Smw_13_6">1,568</ix:nonfraction></p></td></tr><tr><td style="vertical-align:bottom;width:73.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 18pt;">Total Current Assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_9_30_2019_Q77aJBXiP0qCmJ4Yd2DnHw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AssetsCurrent" scale="6" id="Tc_VA59CUGlAUWCubiVU2jxFA_14_3">16,119</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_12_31_2018_INezHDkjn0-L7OMGoLMjhA" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AssetsCurrent" scale="6" id="Tc_UKlR6d_4hUeoVMRRkCsBeQ_14_6">14,632</ix:nonfraction></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:73.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">Investments</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_9_30_2019_Q77aJBXiP0qCmJ4Yd2DnHw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermInvestments" scale="6" id="Tc_Ax7UmUS60EeRCGFGml5vJA_15_3">874</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_12_31_2018_INezHDkjn0-L7OMGoLMjhA" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermInvestments" scale="6" id="Tc_zsffpYmss0S43VuEm8Avsw_15_6">897</ix:nonfraction></p></td></tr><tr><td style="vertical-align:bottom;width:73.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">Property and equipment, at cost</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_9_30_2019_Q77aJBXiP0qCmJ4Yd2DnHw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="Tc_90bxW37V9Eiix48pgjQYCA_16_3">16,343</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_12_31_2018_INezHDkjn0-L7OMGoLMjhA" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="Tc_4LOKRBPnSEWCADjK4fvAWw_16_6">15,706</ix:nonfraction></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:73.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 12pt;">Less: accumulated depreciation and amortization</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_9_30_2019_Q77aJBXiP0qCmJ4Yd2DnHw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" scale="6" id="Tc_D8wvC1JzpUKG-S_FBxMTtQ_17_3">8,518</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_12_31_2018_INezHDkjn0-L7OMGoLMjhA" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" scale="6" id="Tc_1kwigUg0RU2uewrjn6n0uw_17_6">8,143</ix:nonfraction></p></td></tr><tr><td style="vertical-align:bottom;width:73.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 12pt;">Net property and equipment</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_9_30_2019_Q77aJBXiP0qCmJ4Yd2DnHw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="Tc_SZPnor44pkqlXUFu7OZ8NA_18_3">7,825</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_12_31_2018_INezHDkjn0-L7OMGoLMjhA" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="Tc_KaeHkMmgh0ygXt_oacBvug_18_6">7,563</ix:nonfraction></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:73.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">Intangible assets, net of amortization</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_9_30_2019_Q77aJBXiP0qCmJ4Yd2DnHw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="Tc_6VuvC4uL9EKQYeRtwtF3eQ_19_3">17,465</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_12_31_2018_INezHDkjn0-L7OMGoLMjhA" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="Tc_DiYdQH_6rE2A9SdxKW2TUw_19_6">18,942</ix:nonfraction></p></td></tr><tr><td style="vertical-align:bottom;width:73.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">Goodwill</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_9_30_2019_Q77aJBXiP0qCmJ4Yd2DnHw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="Tc_AGfBnEOBDkWSkKuJHCkVPQ_20_3">23,046</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_12_31_2018_INezHDkjn0-L7OMGoLMjhA" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="Tc_SXuBpm4f5kuLUzEnOHcw_Q_20_6">23,254</ix:nonfraction></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:73.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">Deferred income taxes and other assets </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_9_30_2019_Q77aJBXiP0qCmJ4Yd2DnHw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DeferredIncomeTaxesAndOtherAssetsNoncurrent" scale="6" id="Tc_cTWtfxqdbEWgEsuI4w6Ncg_21_3">3,210</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_12_31_2018_INezHDkjn0-L7OMGoLMjhA" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DeferredIncomeTaxesAndOtherAssetsNoncurrent" scale="6" id="Tc_kUhwc66_50yqq-9C4EmqNg_21_6">1,885</ix:nonfraction></p></td></tr><tr><td style="vertical-align:bottom;width:73.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_9_30_2019_Q77aJBXiP0qCmJ4Yd2DnHw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="6" id="Tc_iGMbrZUCokm0-D25bPXdBw_22_3">68,539</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_12_31_2018_INezHDkjn0-L7OMGoLMjhA" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="6" id="Tc_f8lb9mz3J0i40Hr0wjws6w_22_6">67,173</ix:nonfraction></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:73.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">Liabilities and Shareholders’ Investment</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:73.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">Current Liabilities: </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:73.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">Short-term borrowings </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_9_30_2019_Q77aJBXiP0qCmJ4Yd2DnHw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ShortTermBorrowings" scale="6" id="Tc_CN-hlL5zMUq5aESRxvgGoQ_25_3">204</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_12_31_2018_INezHDkjn0-L7OMGoLMjhA" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ShortTermBorrowings" scale="6" id="Tc_Md31HbkcfUGxJv-aSv9XwQ_25_6">200</ix:nonfraction></p></td></tr><tr><td style="vertical-align:bottom;width:73.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">Trade accounts payable</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_9_30_2019_Q77aJBXiP0qCmJ4Yd2DnHw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccountsPayableTradeCurrent" scale="6" id="Tc_6UcMMhyxl0iji-8oD6Iz1w_26_3">3,029</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_12_31_2018_INezHDkjn0-L7OMGoLMjhA" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccountsPayableTradeCurrent" scale="6" id="Tc_68Y32tQNN0O3qF8ScNVCIw_26_6">2,975</ix:nonfraction></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:73.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">Salaries, wages and commissions</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_9_30_2019_Q77aJBXiP0qCmJ4Yd2DnHw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="6" id="Tc_lxRPqVhpE02pKl5oaro_Ag_27_3">1,258</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_12_31_2018_INezHDkjn0-L7OMGoLMjhA" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="6" id="Tc_xu3AhLJ2SEOWWMfna8WTBw_27_6">1,182</ix:nonfraction></p></td></tr><tr><td style="vertical-align:bottom;width:73.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">Other accrued liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_9_30_2019_Q77aJBXiP0qCmJ4Yd2DnHw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherAccruedLiabilitiesCurrent" scale="6" id="Tc_pnZqlL07q0ubny4kNv6TSw_28_3">4,112</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_12_31_2018_INezHDkjn0-L7OMGoLMjhA" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherAccruedLiabilitiesCurrent" scale="6" id="Tc_-abpjT7mfkOsqSAca1pHKA_28_6">3,780</ix:nonfraction></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:73.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">Dividends payable</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_9_30_2019_Q77aJBXiP0qCmJ4Yd2DnHw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DividendsPayableCurrent" scale="6" id="Tc_-QtEsqI_QUmYwadhLTI5bg_29_3">567</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_12_31_2018_INezHDkjn0-L7OMGoLMjhA" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DividendsPayableCurrent" scale="6" id="Tc_-4GAdHm48ke91a1mj0Na8Q_29_6">563</ix:nonfraction></p></td></tr><tr><td style="vertical-align:bottom;width:73.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">Income taxes payable</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_9_30_2019_Q77aJBXiP0qCmJ4Yd2DnHw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccruedIncomeTaxesCurrent" scale="6" id="Tc_JVL_Ob7zlk2iqZ9PN6rXMA_30_3">67</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_12_31_2018_INezHDkjn0-L7OMGoLMjhA" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccruedIncomeTaxesCurrent" scale="6" id="Tc_Qxm-o7J1z0CxKLLOcewTbg_30_6">305</ix:nonfraction></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:73.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">Current portion of long-term debt</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_9_30_2019_Q77aJBXiP0qCmJ4Yd2DnHw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtCurrent" scale="6" id="Tc_AbxH4lWf_kye6Q3mz7kQOw_31_3">1,254</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_12_31_2018_INezHDkjn0-L7OMGoLMjhA" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtCurrent" scale="6" id="Tc_nM-4_n5t40m9GAFqDCpRLg_31_6">7</ix:nonfraction></p></td></tr><tr><td style="vertical-align:bottom;width:73.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 18pt;">Total Current Liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_9_30_2019_Q77aJBXiP0qCmJ4Yd2DnHw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesCurrent" scale="6" id="Tc_rT9mhSRDg0ixmYvXugnH2w_32_3">10,491</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_12_31_2018_INezHDkjn0-L7OMGoLMjhA" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesCurrent" scale="6" id="Tc_Cv7keG68V0WYUoLA3J1WBw_32_6">9,012</ix:nonfraction></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:73.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">Long-term debt</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_9_30_2019_Q77aJBXiP0qCmJ4Yd2DnHw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="Tc_KUbz1ERPNEy3AJpVEzgu9A_33_3">17,639</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_12_31_2018_INezHDkjn0-L7OMGoLMjhA" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="Tc_cy-BH4it7kGP0yxig4-CAA_33_6">19,359</ix:nonfraction></p></td></tr><tr><td style="vertical-align:bottom;width:73.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">Post-employment obligations, deferred income taxes and other long-term liabilities </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_9_30_2019_Q77aJBXiP0qCmJ4Yd2DnHw" decimals="-6" format="ixt:numdotdecimal" name="abt:PostEmploymentObligationsDeferredIncomeTaxesAndOtherLongTermLiabilities" scale="6" id="Tc_8bB_NfU8PkeWvdYqR5m6XQ_34_3">8,390</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_12_31_2018_INezHDkjn0-L7OMGoLMjhA" decimals="-6" format="ixt:numdotdecimal" name="abt:PostEmploymentObligationsDeferredIncomeTaxesAndOtherLongTermLiabilities" scale="6" id="Tc_B7EzXAWEFkOgHx8PTOLx6w_34_6">8,080</ix:nonfraction></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:73.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">Commitments and Contingencies</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:73.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">Shareholders’ Investment:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:73.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 12pt;">Preferred shares, <ix:nonfraction unitref="Unit_Divide_USD_shares_xJ2idvgWWEuE1nW1pOVAfA" contextref="As_Of_9_30_2019_Q77aJBXiP0qCmJ4Yd2DnHw" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="Narr_QLM7ek2ZCUS668GyRYXnXQ"><ix:nonfraction unitref="Unit_Divide_USD_shares_xJ2idvgWWEuE1nW1pOVAfA" contextref="As_Of_12_31_2018_INezHDkjn0-L7OMGoLMjhA" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="Narr_B_nFy3qGpka2kokS1PuQVw">one</ix:nonfraction></ix:nonfraction> dollar par value Authorized — <ix:nonfraction unitref="Unit_Standard_shares__pDT34XXdk2QZR7p6i5hkA" contextref="As_Of_9_30_2019_Q77aJBXiP0qCmJ4Yd2DnHw" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:PreferredStockSharesAuthorized" scale="0" id="Narr_tvF4M1KP_U2k3kK1rfDyjA"><ix:nonfraction unitref="Unit_Standard_shares__pDT34XXdk2QZR7p6i5hkA" contextref="As_Of_12_31_2018_INezHDkjn0-L7OMGoLMjhA" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:PreferredStockSharesAuthorized" scale="0" id="Narr_Mmso_IL3okaUxvqvdsYwDg">1,000,000</ix:nonfraction></ix:nonfraction> shares, <ix:nonfraction unitref="Unit_Standard_shares__pDT34XXdk2QZR7p6i5hkA" contextref="As_Of_9_30_2019_Q77aJBXiP0qCmJ4Yd2DnHw" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:PreferredStockSharesIssued" scale="0" id="Narr_aNEdE3AHTEyAApP1pMUz7Q"><ix:nonfraction unitref="Unit_Standard_shares__pDT34XXdk2QZR7p6i5hkA" contextref="As_Of_12_31_2018_INezHDkjn0-L7OMGoLMjhA" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:PreferredStockSharesIssued" scale="0" id="Narr_povww4sSUUuyTGzb_P3D9A">none</ix:nonfraction></ix:nonfraction> issued</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> —</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:73.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 12pt;">Common shares, without par value Authorized — <ix:nonfraction unitref="Unit_Standard_shares__pDT34XXdk2QZR7p6i5hkA" contextref="As_Of_9_30_2019_Q77aJBXiP0qCmJ4Yd2DnHw" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesAuthorized" scale="0" id="Narr_3iXsYKEg6EazveuZsIyEmA"><ix:nonfraction unitref="Unit_Standard_shares__pDT34XXdk2QZR7p6i5hkA" contextref="As_Of_12_31_2018_INezHDkjn0-L7OMGoLMjhA" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesAuthorized" scale="0" id="Narr_xMonDJuJz0SPcjhnzjIk_A">2,400,000,000</ix:nonfraction></ix:nonfraction> shares <br>Issued at stated capital amount — Shares: 2019: <ix:nonfraction unitref="Unit_Standard_shares__pDT34XXdk2QZR7p6i5hkA" contextref="As_Of_9_30_2019_Q77aJBXiP0qCmJ4Yd2DnHw" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesIssued" scale="0" id="Narr_6OhF8ShlOUSnsnTLeTpiAA">1,976,705,285</ix:nonfraction>; 2018: <ix:nonfraction unitref="Unit_Standard_shares__pDT34XXdk2QZR7p6i5hkA" contextref="As_Of_12_31_2018_INezHDkjn0-L7OMGoLMjhA" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesIssued" scale="0" id="Narr_ldpwET3M5Uq1y2vbfJ8VcQ">1,971,189,465</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_9_30_2019_Q77aJBXiP0qCmJ4Yd2DnHw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CommonStockValue" scale="6" id="Tc_lset31kf2EmUT0yMhnMsNw_38_3">23,771</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_12_31_2018_INezHDkjn0-L7OMGoLMjhA" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CommonStockValue" scale="6" id="Tc_eKDtXqMkk0iN3JMhrvDdVQ_38_6">23,512</ix:nonfraction></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:73.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 12pt;">Common shares held in treasury, at cost — Shares: 2019: <ix:nonfraction unitref="Unit_Standard_shares__pDT34XXdk2QZR7p6i5hkA" contextref="As_Of_9_30_2019_Q77aJBXiP0qCmJ4Yd2DnHw" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockCommonShares" scale="0" id="Narr_T2GJcgYD_UuGCpcxGgi0VA">208,249,580</ix:nonfraction>; 2018: <ix:nonfraction unitref="Unit_Standard_shares__pDT34XXdk2QZR7p6i5hkA" contextref="As_Of_12_31_2018_INezHDkjn0-L7OMGoLMjhA" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockCommonShares" scale="0" id="Narr_srYGZcx5LUG26hALw6M1Ag">215,570,043</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"> (<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_9_30_2019_Q77aJBXiP0qCmJ4Yd2DnHw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockCommonValue" scale="6" id="Tc_Y1NQOwHgSEi2-2q-4NUqag_39_3">9,631</ix:nonfraction>)</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"> (<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_12_31_2018_INezHDkjn0-L7OMGoLMjhA" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockCommonValue" scale="6" id="Tc_JnBLc_5YcE2KiEE6Z0yIkg_39_6">9,962</ix:nonfraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:73.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 12pt;">Earnings employed in the business</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_9_30_2019_Q77aJBXiP0qCmJ4Yd2DnHw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="6" id="Tc_ZsevBsQ78kaBF6JJ0C5LUA_40_3">25,440</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_12_31_2018_INezHDkjn0-L7OMGoLMjhA" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="6" id="Tc_Y75AhHmTvUGSKTantY_PPg_40_6">24,560</ix:nonfraction></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:73.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 12pt;">Accumulated other comprehensive income (loss)</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"> (<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_9_30_2019_Q77aJBXiP0qCmJ4Yd2DnHw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" sign="-" scale="6" id="Tc_UOWxUMw7pkW8H7N9lZyNUQ_41_3">7,763</ix:nonfraction>)</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"> (<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_12_31_2018_INezHDkjn0-L7OMGoLMjhA" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" sign="-" scale="6" id="Tc_gv5obrmbm0G5qQjKoAeDrw_41_6">7,586</ix:nonfraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:73.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 18pt;">Total Abbott Shareholders’ Investment</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_9_30_2019_Q77aJBXiP0qCmJ4Yd2DnHw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="6" id="Tc_-X1mA5shH0CDPWs9trBZyQ_42_3">31,817</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_12_31_2018_INezHDkjn0-L7OMGoLMjhA" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="6" id="Tc_vg227xW6skW1OMbq8eUjEw_42_6">30,524</ix:nonfraction></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:73.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 12pt;">Noncontrolling Interests in Subsidiaries</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_9_30_2019_Q77aJBXiP0qCmJ4Yd2DnHw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:MinorityInterest" scale="6" id="Tc_3GoUZYCoWUeU9Da2OajTpQ_43_3">202</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_12_31_2018_INezHDkjn0-L7OMGoLMjhA" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:MinorityInterest" scale="6" id="Tc_eqYeZ7w2dk2-1O5gDEyURQ_43_6">198</ix:nonfraction></p></td></tr><tr><td style="vertical-align:bottom;width:73.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 18pt;">Total Shareholders’ Investment</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_9_30_2019_Q77aJBXiP0qCmJ4Yd2DnHw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="Tc_el8MnxCsfUeTqzuFMwvTlQ_44_3">32,019</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_12_31_2018_INezHDkjn0-L7OMGoLMjhA" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="Tc_gDTvC2cXx0OkZlFFlQKI6Q_44_6">30,722</ix:nonfraction></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:73.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_9_30_2019_Q77aJBXiP0qCmJ4Yd2DnHw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="6" id="Tc_gKP9LIpZIUKQrfy97ZendQ_45_3">68,539</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_12_31_2018_INezHDkjn0-L7OMGoLMjhA" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="6" id="Tc_Um2RlmNAmU2mLgPwQ1gUuA_45_6">67,173</ix:nonfraction></p></td></tr></tbody></table><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">The accompanying notes to the condensed consolidated financial statements are an integral part of this statement.</p><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="display:none;font-size:12pt;line-height:0pt;margin:0pt;"><span style="font-family:'Times New Roman';font-size:0pt;visibility:hidden;">​</span></p><a id="_b939ebc9_1650_460f_aadb_0825d8b9969c"></a></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">5</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-family:'Times New Roman';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:center;margin:0pt;">Abbott Laboratories and Subsidiaries</p><a id="StatementofShareholdersInvestment_244625"></a><p style="font-family:'Times New Roman';font-size:10pt;text-align:center;margin:0pt;">Condensed Consolidated Statement of Shareholders’ Investment</p><p style="font-family:'Times New Roman';font-size:10pt;text-align:center;margin:0pt;">(Unaudited)</p><p style="font-family:'Times New Roman';font-size:10pt;text-align:center;margin:0pt;"><i style="font-style:italic;">(in millions except shares and per share data)</i></p><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><a id="_588242a9_4d3f_4348_8101_49382969b062"></a><a id="Tc_szoC8k6VcUmODMnM1olsOA_1_2"></a><a id="Tc_uxbG3phRL0af2o0hei0gLg_2_2"></a><a id="Tc_p3oaMzLCTEeUdhHqkLBFfw_2_5"></a><a id="Tc_QqG0PVpSv0KeQPhp8umkJQ_3_0"></a><a id="Tc_MpBU5Z--YESL5yWCUTZ51w_4_0"></a><a id="Tc_zcBRTNMgG0-kr8-KV7Ax6g_5_0"></a><a id="Tc_tEAB3_-6E0arLz7oV4xkjQ_5_2"></a><a id="Tc_40CIrg_XoU235ei-IXH3CA_5_5"></a><a id="Tc_VOzqWCOT2E2ePK_Yb4ij1g_6_0"></a><a id="Tc_ld26C5I27UiyWNg6agQ46w_7_0"></a><a id="Tc_LFRh5gwjBkyzUlPuD3ZYgw_8_0"></a><a id="Tc_0lzYiHGJH0mnxC8-NXyRfQ_9_0"></a><a id="Tc_25oFeRYLoE-Zc9MWxt3wPw_10_0"></a><a id="Tc_Fdfh5hj-0kuoirwhM6LPiA_11_0"></a><a id="Tc_BVWJRe4ZakeX66nfaZs4uQ_11_2"></a><a id="Tc_3yCMrk8W2ke0Z4WbQrDxPw_11_5"></a><a id="Tc_wQ1zUpoi-kS9rcR388apfA_13_0"></a><a id="Tc_ZEnLnMnZvk2MF6cijwC8zw_14_0"></a><a id="Tc_Y1IipMJ1RE28_V4z9UJCtw_15_0"></a><a id="Tc_x8NyuSPItUK05nvvTA34-A_15_2"></a><a id="Tc_84By2B3c60KvojYh-VwYbw_15_5"></a><a id="Tc_bmRlGcbTzECnCaaHOkzv8w_16_0"></a><a id="Tc_c6BSOexZ7ECBnqOBXnEqeg_17_0"></a><a id="Tc_egu39N4LgEmbOxeU_I97mQ_18_0"></a><a id="Tc_z-Fd7wsNiUKnQrIiJdrgNw_19_0"></a><a id="Tc_4j3CT-jfqkul23972Pr8ZQ_19_3"></a><a id="Tc_5ObdTV60yU6EkOvRuWkA2Q_19_6"></a><a id="Tc_B__a4sXjV0OCduaFD0hgvg_20_0"></a><a id="Tc_y4N1H13mSESwAUsPKksrtg_21_0"></a><a id="Tc_KxugIKL0H0SpuRR595e9UQ_21_2"></a><a id="Tc_hv5qJq4NoU-kiCLpJDNLTw_21_5"></a><a id="Tc_0k5bXQo-0kC0SG6RzCt2Og_23_0"></a><a id="Tc_15v-D6cPoU6jdm2jXMlAcw_24_0"></a><a id="Tc_mbRO_vtx4k2TAVTqAmo0cg_24_2"></a><a id="Tc_4oy9du33tUCLcwzVKqBBvg_24_5"></a><a id="Tc_jLuLmGOZLUq4ulEhXoBpSw_25_0"></a><a id="Tc_PBuRwKqyLkiEGHodBCIduQ_26_0"></a><a id="Tc_xRR6fw8PXkeBjRNhBysMZQ_27_0"></a><a id="Tc_95cHfkYx_kaVDlI8KYj8UQ_28_0"></a><a id="Tc_OEt13zy0rUGhQKYEGbP1uA_28_2"></a><a id="Tc_KFiWVC91PU-9c1v_qst6PQ_28_5"></a><a id="Tc_1IsgdjnDEk6PiVtlJ2ko1Q_30_0"></a><a id="Tc_QLQMSahsJEqR4QaXY3apdA_31_0"></a><a id="Tc_RUViJY-170CMef_gihd5cQ_31_2"></a><a id="Tc_ighj50oeQUKCYV0DfmpMVA_31_5"></a><a id="Tc_S1tKihgnnkCGPBdfOwq4BA_32_0"></a><a id="Tc_1iUVZ6CO30asZwHVXEOQzw_33_0"></a><a id="Tc_1Kt6p2q_gkmh40AAhfgRhQ_33_2"></a><a id="Tc_BsCvYZhIckGLmrusiQkegw_33_5"></a><a id="Tc_NJdtXGoX3U2ZK7BapthVlg_35_0"></a><a id="Tc_h4_R7xMKIkWWeEMp-7LGSQ_36_0"></a><a id="Tc_8hZbbBnQ20KMwdR33jXThA_36_2"></a><a id="Tc_WotCFoxc6kKK8Uo1FKHFZg_36_5"></a><a id="Tc_yhquuSXuR0yyR9cqzx_ypQ_37_0"></a><a id="Tc_AiP0gqkszU-JXCXxA1dbZQ_38_0"></a><a id="Tc_0iPYrD88kE6SMWv2mfJA6A_38_2"></a><a id="Tc_HKjvFC-xIEqhCB9qcdy2Dg_38_5"></a><table style="border-collapse:collapse;font-size:16pt;padding-left:0pt;padding-right:0pt;width:100%;"><tbody><tr style="height:1pt;"><td style="vertical-align:bottom;width:73.88%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:1pt;margin:0pt;"> <span style="visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="background-color:auto;vertical-align:bottom;width:73.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="5" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:23.76%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Three Months Ended September&nbsp;30</b></p></td></tr><tr><td style="background-color:auto;vertical-align:bottom;width:73.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0pt;">&nbsp;&nbsp;&nbsp;&nbsp;</p></td><td colspan="2" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:10.72%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2019</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0pt;">&nbsp;&nbsp;&nbsp;&nbsp;</p></td><td colspan="2" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:10.7%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2018</b></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:73.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">Common Shares:</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&nbsp;&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&nbsp;&nbsp;</p></td></tr><tr><td style="vertical-align:bottom;width:73.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">Balance at June 30</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&nbsp;&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&nbsp;&nbsp;</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:73.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">Shares: 2019: <ix:nonfraction unitref="Unit_Standard_shares__pDT34XXdk2QZR7p6i5hkA" contextref="As_Of_6_30_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_bYaCiLkFBUqiDWLIdb0NvA" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" id="Narr_PE5q8_79EkCIau_S-D8mQQ">1,976,248,129</ix:nonfraction>; 2018: <ix:nonfraction unitref="Unit_Standard_shares__pDT34XXdk2QZR7p6i5hkA" contextref="As_Of_6_30_2018_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_lyA3n3n15UyL8v-1o3UXJQ" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" id="Narr_E2JCXD7DvEykBXoEpfWi7g">1,969,575,366</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_6_30_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_bYaCiLkFBUqiDWLIdb0NvA" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="Tc_Q1bJ_IYsZESTe-6yCdOnHQ_5_3">23,665</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_6_30_2018_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_lyA3n3n15UyL8v-1o3UXJQ" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="Tc_IuGk7IgFVkqd4X9BZoLTMw_5_6">23,317</ix:nonfraction></p></td></tr><tr><td style="vertical-align:bottom;width:73.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">Issued under incentive stock programs</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&nbsp;&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&nbsp;&nbsp;</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:73.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">Shares: 2019: <ix:nonfraction unitref="Unit_Standard_shares__pDT34XXdk2QZR7p6i5hkA" contextref="Duration_7_1_2019_To_9_30_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_D9P22JHh-UWMGAQ5Zzr5Qw" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="0" id="Narr_JfwwvBaVL0efRUGu5BvyRQ">457,156</ix:nonfraction>; 2018: <ix:nonfraction unitref="Unit_Standard_shares__pDT34XXdk2QZR7p6i5hkA" contextref="Duration_7_1_2018_To_9_30_2018_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_WodOekvYd02Aw_nJ4pAu5Q" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="0" id="Narr_ysBK6WokdUKXyeWvITCx4Q">1,015,106</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2019_To_9_30_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_D9P22JHh-UWMGAQ5Zzr5Qw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="Tc_tcYqei__t0iBZ7NrGiif4A_7_3">18</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2018_To_9_30_2018_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_WodOekvYd02Aw_nJ4pAu5Q" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="Tc_7VK8LaPgG0OsJGm7NrGb9w_7_6">33</ix:nonfraction></p></td></tr><tr><td style="vertical-align:bottom;width:73.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">Share-based compensation</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2019_To_9_30_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_D9P22JHh-UWMGAQ5Zzr5Qw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="Tc_vTJBxd7h-Eu22FWVyNe_VQ_8_3">93</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2018_To_9_30_2018_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_WodOekvYd02Aw_nJ4pAu5Q" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="Tc_atFtlKsBKU6Vnvxph_A-Dw_8_6">83</ix:nonfraction></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:73.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">Issuance of restricted stock awards</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2019_To_9_30_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_D9P22JHh-UWMGAQ5Zzr5Qw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" sign="-" scale="6" id="Tc_nqMtuAfch02eTOKkR_60Qw_9_3">5</ix:nonfraction>)</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2018_To_9_30_2018_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_WodOekvYd02Aw_nJ4pAu5Q" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" sign="-" scale="6" id="Tc_qJd-FfDhoEiKZ01pmN_ebg_9_6">5</ix:nonfraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:73.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">Balance at September 30</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:73.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">Shares: 2019: <ix:nonfraction unitref="Unit_Standard_shares__pDT34XXdk2QZR7p6i5hkA" contextref="As_Of_9_30_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_0ZqOMZr03U6jT4sbB6tWag" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" id="Narr_r0k60oYHwk-RCxWWopFPyg">1,976,705,285</ix:nonfraction>; 2018: <ix:nonfraction unitref="Unit_Standard_shares__pDT34XXdk2QZR7p6i5hkA" contextref="As_Of_9_30_2018_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_CgmFvyJEkEiX7ioe_6TFpQ" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" id="Narr_Iir3_gLEKUyQ96ieBlKf3g">1,970,590,472</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_9_30_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_0ZqOMZr03U6jT4sbB6tWag" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="Tc_AtPgARtb30KERW5jF1Kaow_11_3">23,771</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_9_30_2018_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_CgmFvyJEkEiX7ioe_6TFpQ" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="Tc_xFVWTyOiukenMRDheUcfOA_11_6">23,428</ix:nonfraction></p></td></tr><tr><td style="vertical-align:bottom;width:73.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:73.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">Common Shares Held in Treasury:</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&nbsp;&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&nbsp;&nbsp;</p></td></tr><tr><td style="vertical-align:bottom;width:73.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">Balance at June 30</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:73.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">Shares: 2019: <ix:nonfraction unitref="Unit_Standard_shares__pDT34XXdk2QZR7p6i5hkA" contextref="As_Of_6_30_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockCommonMember_x_an6TAYEkK2uj3GRXjq-g" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" id="Narr_sgMZlpfrMUeNl11RKjprMg">208,850,514</ix:nonfraction>; 2018: <ix:nonfraction unitref="Unit_Standard_shares__pDT34XXdk2QZR7p6i5hkA" contextref="As_Of_6_30_2018_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockCommonMember_2AsFLtHoeU6kuJPNMEIYQg" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" id="Narr_v9YlF5epeECm2ad_U3BZJQ">215,256,082</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_6_30_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockCommonMember_x_an6TAYEkK2uj3GRXjq-g" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" sign="-" scale="6" id="Tc_yFHitpUBDUKRZLBY-1j_1A_15_3">9,659</ix:nonfraction>)</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_6_30_2018_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockCommonMember_2AsFLtHoeU6kuJPNMEIYQg" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" sign="-" scale="6" id="Tc_0DiEolDyhUSJHbznkUMCiQ_15_6">9,907</ix:nonfraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:73.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">Issued under incentive stock programs</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:73.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">Shares: 2019: <ix:nonfraction unitref="Unit_Standard_shares__pDT34XXdk2QZR7p6i5hkA" contextref="Duration_7_1_2019_To_9_30_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockCommonMember_cuu1S_UrtUO3pGRtYhaCxA" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="0" id="Narr_sJvHG93iTkWFjIlj92h3jQ">605,458</ix:nonfraction>; 2018: <ix:nonfraction unitref="Unit_Standard_shares__pDT34XXdk2QZR7p6i5hkA" contextref="Duration_7_1_2018_To_9_30_2018_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockCommonMember_sJvnNckpS0Cm5Qfenv7QvA" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="0" id="Narr_9QeRjhMzTkeolbJ_L15o1w">1,002,519</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2019_To_9_30_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockCommonMember_cuu1S_UrtUO3pGRtYhaCxA" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="Tc_KDiXD1uPLkiVNAEkBUA0JQ_17_3">28</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2018_To_9_30_2018_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockCommonMember_sJvnNckpS0Cm5Qfenv7QvA" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="Tc_yNTWEwN4CECpwTL4UcLwdA_17_6">49</ix:nonfraction></p></td></tr><tr><td style="vertical-align:bottom;width:73.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">Purchased</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:73.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">Shares: 2019: <ix:nonfraction unitref="Unit_Standard_shares__pDT34XXdk2QZR7p6i5hkA" contextref="Duration_7_1_2019_To_9_30_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockCommonMember_cuu1S_UrtUO3pGRtYhaCxA" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockSharesAcquired" scale="0" id="Narr_yuS09JxExEqzcF7lpX6vEQ">4,524</ix:nonfraction>; 2018: <ix:nonfraction unitref="Unit_Standard_shares__pDT34XXdk2QZR7p6i5hkA" contextref="Duration_7_1_2018_To_9_30_2018_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockCommonMember_sJvnNckpS0Cm5Qfenv7QvA" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockSharesAcquired" scale="0" id="Narr_xPse4V0Hhk2a_usZne46yQ">3,877</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:73.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">Balance at September 30</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:73.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">Shares: 2019: <ix:nonfraction unitref="Unit_Standard_shares__pDT34XXdk2QZR7p6i5hkA" contextref="As_Of_9_30_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockCommonMember_hG_cgbpoj0WKrcwXEwI4nw" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" id="Narr_MSwF01uwUEuG63ksznKBEw">208,249,580</ix:nonfraction>; 2018: <ix:nonfraction unitref="Unit_Standard_shares__pDT34XXdk2QZR7p6i5hkA" contextref="As_Of_9_30_2018_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockCommonMember_KNWPmWmuEEGL3GZ2zmgCww" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" id="Narr_sQE20YNrmU2TSgX0-pYagA">214,257,440</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_9_30_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockCommonMember_hG_cgbpoj0WKrcwXEwI4nw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" sign="-" scale="6" id="Tc__JRfqEUnQU-KeTk_WhDoUA_21_3">9,631</ix:nonfraction>)</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_9_30_2018_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockCommonMember_KNWPmWmuEEGL3GZ2zmgCww" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" sign="-" scale="6" id="Tc_GWj0ytJIC0KlwhMixQrkQA_21_6">9,858</ix:nonfraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:73.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:73.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">Earnings Employed in the Business:</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&nbsp;&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&nbsp;&nbsp;</p></td></tr><tr><td style="vertical-align:bottom;width:73.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">Balance at June 30</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_6_30_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_HT9MV5UES0avCFZnfYLj9Q" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="Tc_EyMmRX6XKECsb2VxqqA--w_24_3">25,045</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_6_30_2018_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_rZZr2P704Ei9zoEuJiP8kg" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="Tc_wc265Nrx9kKzG3RYMcYJ9g_24_6">24,080</ix:nonfraction></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:73.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">Net earnings</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2019_To_9_30_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_-Mcpo0fYlk-1D8jAQhbURQ" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="6" id="Tc_RKZLxfMor024HDRho0pB-A_25_3">960</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2018_To_9_30_2018_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_KONZl2KQv065QMNw3SBbFw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="6" id="Tc_6YyTYeXX50OYGMokqKOCUw_25_6">563</ix:nonfraction></p></td></tr><tr><td style="vertical-align:bottom;width:73.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">Cash dividends declared on common shares (per share&nbsp;— 2019: $<ix:nonfraction unitref="Unit_Divide_USD_shares_xJ2idvgWWEuE1nW1pOVAfA" contextref="Duration_7_1_2019_To_9_30_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_-Mcpo0fYlk-1D8jAQhbURQ" decimals="2" format="ixt:numdotdecimal" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="Narr__K1S8Hbw50G-a33vNCWJ7g">0.32</ix:nonfraction>; 2018: $<ix:nonfraction unitref="Unit_Divide_USD_shares_xJ2idvgWWEuE1nW1pOVAfA" contextref="Duration_7_1_2018_To_9_30_2018_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_KONZl2KQv065QMNw3SBbFw" decimals="2" format="ixt:numdotdecimal" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="Narr_0wfgC9NJikaEzgRVOcCgEg">0.28</ix:nonfraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2019_To_9_30_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_-Mcpo0fYlk-1D8jAQhbURQ" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DividendsCommonStockCash" scale="6" id="Tc_IhRvD5nfAEWf521HKkr7hA_26_3">570</ix:nonfraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2018_To_9_30_2018_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_KONZl2KQv065QMNw3SBbFw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DividendsCommonStockCash" scale="6" id="Tc__cuKUlGqR0iUsTRVOY0qAA_26_6">495</ix:nonfraction>)</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:73.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">Effect of common and treasury share transactions</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2019_To_9_30_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_-Mcpo0fYlk-1D8jAQhbURQ" decimals="-6" format="ixt:numdotdecimal" name="abt:EffectOfCommonAndTreasuryShareTransactions" sign="-" scale="6" id="Tc_IdoQQbGqYEqlpOrYVqov4g_27_3">5</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2018_To_9_30_2018_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_KONZl2KQv065QMNw3SBbFw" decimals="-6" format="ixt:numdotdecimal" name="abt:EffectOfCommonAndTreasuryShareTransactions" scale="6" id="Tc_-KOAvoGuAkCjs07Q0FHVfA_27_6">4</ix:nonfraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:73.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">Balance at September 30</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_9_30_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_GuALU1yk40CWLKcwQ7aHKg" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="Tc_ELTrAP-hXUC1kkyfFPBnqw_28_3">25,440</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_9_30_2018_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_RzsVsvtvykWC5WZFzqW8lQ" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="Tc_vU4nR4kZ80qpPhwKQDwTcA_28_6">24,144</ix:nonfraction></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:73.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:73.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">Accumulated Other Comprehensive Income (Loss):</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&nbsp;&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&nbsp;&nbsp;</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:73.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">Balance at June 30</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_6_30_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember_wW-c6097I0Suu1POOavaUQ" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" sign="-" scale="6" id="Tc_ZoLmIt2xo0KI9GqfUAxL9Q_31_3">7,365</ix:nonfraction>)</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_6_30_2018_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember_3J1U9RR_QEGgqE-tIL4lYw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" sign="-" scale="6" id="Tc_QxopH2ZHt0yGW-iJd-deaA_31_6">6,913</ix:nonfraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:73.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">Other comprehensive income (loss)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2019_To_9_30_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember_PKX7uJq7f0yruS1mzV5oTw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" sign="-" scale="6" id="Tc_TAGWZW4l10ahvATaefmN6g_32_3">398</ix:nonfraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2018_To_9_30_2018_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember_HIpKaN8RWUSDv6jpeJLxWQ" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" sign="-" scale="6" id="Tc_EgOnxoN0WEer1XBOOazB1g_32_6">96</ix:nonfraction>)</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:73.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">Balance at September 30</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_9_30_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember_dg1dTMhxQkOvrJfgeBrQ3Q" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" sign="-" scale="6" id="Tc_ZpKmt5tf1UaliI-Brt9T1Q_33_3">7,763</ix:nonfraction>)</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_9_30_2018_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember_XobcWMR9fUKTIvdfC5r_0w" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" sign="-" scale="6" id="Tc_VRcwIfHSDkuPt_57HJJqRg_33_6">7,009</ix:nonfraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:73.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:73.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">Noncontrolling Interests in Subsidiaries:</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&nbsp;&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">&nbsp;&nbsp;</p></td></tr><tr><td style="vertical-align:bottom;width:73.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">Balance at June 30</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_6_30_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember__5sB-WyiZUqz25_I1eSsnA" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="Tc_Zcfe4Q9V_0CcCRHrgxNFNw_36_3">208</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_6_30_2018_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember_6G3BYKUPtkCP0OQH5rLQcQ" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="Tc_IiUPu3S580aQwPAy2i3gpg_36_6">197</ix:nonfraction></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:73.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">Noncontrolling Interests’ share of income, business combinations, net of distributions <br>and share repurchases</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2019_To_9_30_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember_8dcnPpqxiEqWqrPFr9fb2A" decimals="-6" format="ixt:numdotdecimal" name="abt:NoncontrollingInterestsShareOfIncomeNetOfDistributionsAndShareRepurchasesAndBusinessCombinations" sign="-" scale="6" id="Tc_oc2AZcATL0ilWbauP8Answ_37_3">6</ix:nonfraction>)</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2018_To_9_30_2018_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember_MDaPbk6Pp0CW8ZqCyRVuqQ" decimals="-6" format="ixt:numdotdecimal" name="abt:NoncontrollingInterestsShareOfIncomeNetOfDistributionsAndShareRepurchasesAndBusinessCombinations" sign="-" scale="6" id="Tc_dKrfwHfgbkuJEHMnqcYTvQ_37_6">4</ix:nonfraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:73.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">Balance at September 30</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_9_30_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember_jVoR3ymRq0GxvPbAMNalag" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="Tc_G5-U8FoMIEyLMiAZG3sz2Q_38_3">202</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_9_30_2018_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember_CYL5Vb7ebU2opKP7GE9QZw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="Tc_yQOIvOQaikGvbdzWZGkDcA_38_6">193</ix:nonfraction></p></td></tr></tbody></table><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">The accompanying notes to condensed consolidated financial statements are an integral part of this statement. </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">6</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-family:'Times New Roman';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:center;margin:0pt;">Abbott Laboratories and Subsidiaries</p><p style="font-family:'Times New Roman';font-size:10pt;text-align:center;margin:0pt;">Condensed Consolidated Statement of Shareholders’ Investment</p><p style="font-family:'Times New Roman';font-size:10pt;text-align:center;margin:0pt;">(Unaudited)</p><p style="font-family:'Times New Roman';font-size:10pt;text-align:center;margin:0pt;"><i style="font-style:italic;">(in millions except shares and per share data)</i></p><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><a id="_9c774280_4d09_4766_a13c_8a729a91f7f8"></a><a id="Tc_AMXoVnXetkSjQd1mBSSLag_1_2"></a><a id="Tc_dLHscvMVcEmk0U5Jf9d_Qw_2_2"></a><a id="Tc_9XKTvvgvGE6U-KdUpoVC8Q_2_5"></a><a id="Tc_S6sFWkPfKkOppqwljqmJ8Q_3_0"></a><a id="Tc_S_VOnn8_2ECJbHyy1CXDEQ_4_0"></a><a id="Tc__hkVaL8u1EKFfYE9lt7KkQ_5_0"></a><a id="Tc_0sM7RC6kuEmxcFb7p-lsJg_5_2"></a><a id="Tc_xrvH1Gx9WUykkW69rYYbzg_5_5"></a><a id="Tc_UtLwSaY_bEK981M7RTspNQ_6_0"></a><a id="Tc_kceI6qqLv0GSjXL3Hv6QAg_7_0"></a><a id="Tc_oyH1UFfu3UGNOD4Jpefrxw_8_0"></a><a id="Tc_3SjeZKMxmECwFW_mKu0Xcw_9_0"></a><a id="Tc_eHFRSyGBZEKyygQceTwfeg_10_0"></a><a id="Tc_kLVmCRQ0OEmTQiWuT_9AYw_11_0"></a><a id="Tc_L5MZNsyNVEO90g3mdbdcOw_11_2"></a><a id="Tc_8nqv2k53b02Amtav_5_jog_11_5"></a><a id="Tc_rSjQX-oLbkOVrjPL8wn6-g_13_0"></a><a id="Tc_1saIkuD0GEuX-kUwWtzeew_14_0"></a><a id="Tc_01elO0-qMEuYTgkbP_S6GA_15_0"></a><a id="Tc_HJwuxaPalUCqejEW5gu30g_15_2"></a><a id="Tc_D9TIsNIfw06MmoqP2nktVg_15_5"></a><a id="Tc_pQDzs6j2G0eR--eFJyf9TQ_16_0"></a><a id="Tc_2kPAyp_8AkGwyYKBfVnRPA_17_0"></a><a id="Tc_mJlLma5Ix0aeRXnNdnN9Vg_18_0"></a><a id="Tc_-3_YD13JxUiyL8yBydpBzg_19_0"></a><a id="Tc_yyFyD3Cju0q5RW6nHJlw5w_20_0"></a><a id="Tc_5TTFKRhM_EqZ7btuGTUDnw_21_0"></a><a id="Tc_GarS2f9xR0uAj_uD-2RyJA_21_2"></a><a id="Tc_gPXt2qc_90ykfWtjAYeOaQ_21_5"></a><a id="Tc__MpcZdd9akK5TJbNFB1oDQ_23_0"></a><a id="Tc_wTQwyrZ6EE6OAkqAld3QSg_24_0"></a><a id="Tc_LkleA9Kbx061eM7c11RVdw_24_2"></a><a id="Tc_0nv9aW1Ro0WVoMkoRsJIXA_24_5"></a><a id="Tc_ukh-3kUgg0O0MNvUhQ3r9Q_25_0"></a><a id="Tc_cg0kva5c4Ua4riRq3cWhmw_25_3"></a><a id="Tc_6OP4oezQHkWT62339k8jLg_26_0"></a><a id="Tc_RyuqKBpaeUqWv_MJ0TKyOw_27_0"></a><a id="Tc_Q3D_EJzW4k2egb5yKf4O-Q_28_0"></a><a id="Tc_NazfWOpFL06nc-_TrzIJzg_29_0"></a><a id="Tc_NkO6xbGPhUmDV-I5LTCxhQ_29_2"></a><a id="Tc_dm6FJ8W1n0aAdKZ0Dpo80w_29_5"></a><a id="Tc_wCyv5v0iDkqGtxNeD69T0g_31_0"></a><a id="Tc_se90Y1wHqk2iJQ5o0oM-Cg_32_0"></a><a id="Tc_mNLyI2HlXk-jDVT34viWdw_32_2"></a><a id="Tc_U8ynFl4QHEKx8AwSK_qW6w_32_5"></a><a id="Tc_nOLLMcmXG0yp3srAr4YLSw_33_0"></a><a id="Tc_c3JwwMY6fUaXqJKEKTEMrQ_33_3"></a><a id="Tc_90IiJZuDqEKGFMB75ed3cg_34_0"></a><a id="Tc_XO6fomYNJkWURfEEllK9Gw_35_0"></a><a id="Tc_gL3WHhPWTE6T59WwpVLXNA_35_2"></a><a id="Tc_SIecz5olv0mACYy-k84mIw_35_5"></a><a id="Tc_Mll1pbLuoUGRoT00JSTTDQ_37_0"></a><a id="Tc_kpQptuHbUEOHoU49NDG0iA_38_0"></a><a id="Tc_ag4IkhCFRUSzPXYVJQNRGg_38_2"></a><a id="Tc_LC6VTPgZrkyAu0Xs8uvSKQ_38_5"></a><a id="Tc_cT02_ubikEeNyvCNJTu0KA_39_0"></a><a id="Tc_SzCIZT7XEEuVhyoE8ZIxYg_40_0"></a><a id="Tc_3FbBelXCgUambaBN8R7FsA_40_2"></a><a id="Tc_QLaD7PO_Q0WFlXUBg908BQ_40_5"></a><table style="border-collapse:collapse;font-size:16pt;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tbody><tr style="height:1pt;"><td style="vertical-align:top;width:75.89%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.52%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.12%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="background-color:auto;vertical-align:bottom;width:75.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="5" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:21.73%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Nine Months Ended September&nbsp;30</b></p></td></tr><tr><td style="background-color:auto;vertical-align:bottom;width:75.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;&nbsp;&nbsp;&nbsp;</p></td><td colspan="2" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:9.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2019</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;&nbsp;&nbsp;&nbsp;</p></td><td colspan="2" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:9.63%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2018</b></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:top;width:75.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">Common Shares:</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:top;width:75.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">Balance at January 1</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:75.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">Shares: 2019: <ix:nonfraction unitref="Unit_Standard_shares__pDT34XXdk2QZR7p6i5hkA" contextref="As_Of_12_31_2018_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_cymtBbrE6025s_ku5j0wGg" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" id="Narr_U_UHeVTYLEu5Z011Tm_VYw">1,971,189,465</ix:nonfraction>; 2018: <ix:nonfraction unitref="Unit_Standard_shares__pDT34XXdk2QZR7p6i5hkA" contextref="As_Of_12_31_2017_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_eYcQio7byUWpb080LoJfiA" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" id="Narr_Mept0rNVJEi9D3GMcJI-Pg">1,965,908,188</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_12_31_2018_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_cymtBbrE6025s_ku5j0wGg" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="Tc_G-NF_pmcsUmTC6u22tw2oQ_5_3">23,512</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_12_31_2017_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_eYcQio7byUWpb080LoJfiA" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="Tc_OORPwhCW90Cty6FyxYc4SA_5_6">23,206</ix:nonfraction></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:75.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">Issued under incentive stock programs</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:top;width:75.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">Shares: 2019: <ix:nonfraction unitref="Unit_Standard_shares__pDT34XXdk2QZR7p6i5hkA" contextref="Duration_1_1_2019_To_9_30_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_nDCAs6-IO0yYkFh64CJlyA" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="0" id="Narr_i1ocSKSHwUedLp5o7vw7lw">5,515,820</ix:nonfraction>; 2018: <ix:nonfraction unitref="Unit_Standard_shares__pDT34XXdk2QZR7p6i5hkA" contextref="Duration_1_1_2018_To_9_30_2018_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_3ydffv0QgEejv_lm-1uFkw" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="0" id="Narr_YRa2s38YikSQZJXhBykziA">4,682,284</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_nDCAs6-IO0yYkFh64CJlyA" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="Tc_UbHYiMGRc0-ERE5TVyIdgQ_7_3">205</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2018_To_9_30_2018_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_3ydffv0QgEejv_lm-1uFkw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="Tc_OAzI9qN5Sk-yJpNfix30OQ_7_6">145</ix:nonfraction></p></td></tr><tr><td style="vertical-align:top;width:75.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">Share-based compensation</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_nDCAs6-IO0yYkFh64CJlyA" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="Tc_GH4L1bJ1kES18cskMZIR-w_8_3">436</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2018_To_9_30_2018_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_3ydffv0QgEejv_lm-1uFkw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="Tc_3W9lFGtWIkOIz_cNQiDnVg_8_6">398</ix:nonfraction></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:top;width:75.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">Issuance of restricted stock awards</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.52%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"> (<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_nDCAs6-IO0yYkFh64CJlyA" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" sign="-" scale="6" id="Tc_pQyp_owWUUWINOnTkUPFCA_9_3">382</ix:nonfraction>)</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"> (<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2018_To_9_30_2018_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_3ydffv0QgEejv_lm-1uFkw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" sign="-" scale="6" id="Tc_FdVMW0k8ykWoqgd5pFXJZw_9_6">321</ix:nonfraction>)</p></td></tr><tr><td style="vertical-align:top;width:75.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">Balance at September 30</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:75.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">Shares: 2019: <ix:nonfraction unitref="Unit_Standard_shares__pDT34XXdk2QZR7p6i5hkA" contextref="As_Of_9_30_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_0ZqOMZr03U6jT4sbB6tWag" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" id="Narr_ePciu2-uWEmhjw86Ydk2Bg">1,976,705,285</ix:nonfraction>; 2018: <ix:nonfraction unitref="Unit_Standard_shares__pDT34XXdk2QZR7p6i5hkA" contextref="As_Of_9_30_2018_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_CgmFvyJEkEiX7ioe_6TFpQ" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" id="Narr_-WEfU6PHJ0W9tyiMIdrDjQ">1,970,590,472</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.52%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_9_30_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_0ZqOMZr03U6jT4sbB6tWag" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="Tc_vcqBkm6t50a0O3xIMfbX4A_11_3">23,771</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.51%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.12%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_9_30_2018_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_CgmFvyJEkEiX7ioe_6TFpQ" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="Tc_UvvejKhhXUiubCGkTeaMYw_11_6">23,428</ix:nonfraction></p></td></tr><tr><td style="vertical-align:top;width:75.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:top;width:75.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">Common Shares Held in Treasury:</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:top;width:75.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">Balance at January 1</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:75.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">Shares: 2019: <ix:nonfraction unitref="Unit_Standard_shares__pDT34XXdk2QZR7p6i5hkA" contextref="As_Of_12_31_2018_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockCommonMember_PFELMvj3PE2LE_37JacnLQ" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" id="Narr_bsFv-21JtUGG2lokyXfybg">215,570,043</ix:nonfraction>; 2018: <ix:nonfraction unitref="Unit_Standard_shares__pDT34XXdk2QZR7p6i5hkA" contextref="As_Of_12_31_2017_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockCommonMember_U58xz9lIuUexE1EuykMJkg" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" id="Narr_roBQsFRg7EiCvWqWau0cxw">222,305,719</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"> (<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_12_31_2018_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockCommonMember_PFELMvj3PE2LE_37JacnLQ" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" sign="-" scale="6" id="Tc_h4IOLvt9iEOAN1RXv4S8Bw_15_3">9,962</ix:nonfraction>)</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"> (<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_12_31_2017_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockCommonMember_U58xz9lIuUexE1EuykMJkg" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" sign="-" scale="6" id="Tc_sSze5k4n8Uu-q5g4kLbLng_15_6">10,225</ix:nonfraction>)</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:75.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">Issued under incentive stock programs</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:top;width:75.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">Shares: 2019: <ix:nonfraction unitref="Unit_Standard_shares__pDT34XXdk2QZR7p6i5hkA" contextref="Duration_1_1_2019_To_9_30_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockCommonMember_aCxW66jh1UqXVNftbIAcbQ" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="0" id="Narr_kaaW0HAQSUqFq4756W7LuQ">7,591,844</ix:nonfraction>; 2018: <ix:nonfraction unitref="Unit_Standard_shares__pDT34XXdk2QZR7p6i5hkA" contextref="Duration_1_1_2018_To_9_30_2018_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockCommonMember_b3HuzYPzF0i9-7g-9Ns9Dw" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="0" id="Narr_qd2tzOeS80OV4yLHldtrjQ">8,296,855</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockCommonMember_aCxW66jh1UqXVNftbIAcbQ" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="Tc_Y5cxfRch6ky_nM_NSrIGGg_17_3">352</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2018_To_9_30_2018_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockCommonMember_b3HuzYPzF0i9-7g-9Ns9Dw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="Tc_9yjS-NidlEqUIbJcclOtKg_17_6">382</ix:nonfraction></p></td></tr><tr><td style="vertical-align:top;width:75.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">Purchased</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:top;width:75.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">Shares: 2019: <ix:nonfraction unitref="Unit_Standard_shares__pDT34XXdk2QZR7p6i5hkA" contextref="Duration_1_1_2019_To_9_30_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockCommonMember_aCxW66jh1UqXVNftbIAcbQ" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockSharesAcquired" scale="0" id="Narr__mKa5dEbPkGXgW68Je_85w">271,381</ix:nonfraction>; 2018: <ix:nonfraction unitref="Unit_Standard_shares__pDT34XXdk2QZR7p6i5hkA" contextref="Duration_1_1_2018_To_9_30_2018_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockCommonMember_b3HuzYPzF0i9-7g-9Ns9Dw" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockSharesAcquired" scale="0" id="Narr_5wfxdINUV0SQM2LdzKlImQ">248,576</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.52%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"> (<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockCommonMember_aCxW66jh1UqXVNftbIAcbQ" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="Tc_eMlxGbJyEUW3iXlGbz2k8w_19_3">21</ix:nonfraction>)</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"> (<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2018_To_9_30_2018_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockCommonMember_b3HuzYPzF0i9-7g-9Ns9Dw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="Tc__ZOPKgd-Mkiq3fc_Iz0ryg_19_6">15</ix:nonfraction>)</p></td></tr><tr><td style="vertical-align:top;width:75.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">Balance at September 30</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:75.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">Shares: 2019: <ix:nonfraction unitref="Unit_Standard_shares__pDT34XXdk2QZR7p6i5hkA" contextref="As_Of_9_30_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockCommonMember_hG_cgbpoj0WKrcwXEwI4nw" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" id="Narr_rfOT6PrtNUy3N2FZbWVKUQ">208,249,580</ix:nonfraction>; 2018: <ix:nonfraction unitref="Unit_Standard_shares__pDT34XXdk2QZR7p6i5hkA" contextref="As_Of_9_30_2018_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockCommonMember_KNWPmWmuEEGL3GZ2zmgCww" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" id="Narr_5nfBh8Lgm06Hyos-hq_8rQ">214,257,440</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.52%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"> (<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_9_30_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockCommonMember_hG_cgbpoj0WKrcwXEwI4nw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" sign="-" scale="6" id="Tc_dagETNM950CRl6q5C2vpVw_21_3">9,631</ix:nonfraction>)</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.51%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.12%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"> (<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_9_30_2018_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockCommonMember_KNWPmWmuEEGL3GZ2zmgCww" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" sign="-" scale="6" id="Tc_nv0At_iP0Ueg6UsnX63QJA_21_6">9,858</ix:nonfraction>)</p></td></tr><tr><td style="vertical-align:top;width:75.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:top;width:75.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">Earnings Employed in the Business:</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:top;width:75.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">Balance at January 1</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_12_31_2018_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_cNa8q0oH_UurlZT1Mupvfw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="Tc_AzQ22VGLkUedzbsHhPfJuw_24_3">24,560</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_12_31_2017_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_OmXBxy3qJUGU2X_SuWL0lg" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="Tc_sEW5jUGxdUG1qf8v3drG0g_24_6">23,978</ix:nonfraction></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:top;width:75.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">Impact of adoption of new accounting standards</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> —</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_1_1_2018_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_nIVdNru5t0SvEe2LP2xN_A" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption" scale="6" id="Tc_SV-8K7RkzU6JqtRuAcmFLg_25_6">15</ix:nonfraction></p></td></tr><tr><td style="vertical-align:top;width:75.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">Net earnings</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_TbTemeaAq0O3vbmDORpxkA" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="6" id="Tc_w1hERlj2yEqR-dFOWSGI7A_26_3">2,638</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2018_To_9_30_2018_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_7oF9FC4C_UuCepzsqjn7aw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="6" id="Tc_z45Jdl5N80u_wddb6C4jIQ_26_6">1,714</ix:nonfraction></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:top;width:75.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">Cash dividends declared on common shares (per share&nbsp;— 2019: $<ix:nonfraction unitref="Unit_Divide_USD_shares_xJ2idvgWWEuE1nW1pOVAfA" contextref="Duration_1_1_2019_To_9_30_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_TbTemeaAq0O3vbmDORpxkA" decimals="2" format="ixt:numdotdecimal" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="Narr_7o0qV5eTJ02RsnTodG2tYQ">0.96</ix:nonfraction>; 2018: $<ix:nonfraction unitref="Unit_Divide_USD_shares_xJ2idvgWWEuE1nW1pOVAfA" contextref="Duration_1_1_2018_To_9_30_2018_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_7oF9FC4C_UuCepzsqjn7aw" decimals="2" format="ixt:numdotdecimal" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="Narr_Y9OVkUQw502YLgK64h9SFA">0.84</ix:nonfraction>)</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"> (<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_TbTemeaAq0O3vbmDORpxkA" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DividendsCommonStockCash" scale="6" id="Tc_lGw3t53Y50Cih9omjMakcQ_27_3">1,706</ix:nonfraction>)</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"> (<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2018_To_9_30_2018_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_7oF9FC4C_UuCepzsqjn7aw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DividendsCommonStockCash" scale="6" id="Tc_p1a8bhT6SUm_w9gqwuKzmQ_27_6">1,483</ix:nonfraction>)</p></td></tr><tr><td style="vertical-align:top;width:75.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">Effect of common and treasury share transactions</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.52%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"> (<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_TbTemeaAq0O3vbmDORpxkA" decimals="-6" format="ixt:numdotdecimal" name="abt:EffectOfCommonAndTreasuryShareTransactions" scale="6" id="Tc_U7kUYvScTU2t31P773NuPw_28_3">52</ix:nonfraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"> (<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2018_To_9_30_2018_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_7oF9FC4C_UuCepzsqjn7aw" decimals="-6" format="ixt:numdotdecimal" name="abt:EffectOfCommonAndTreasuryShareTransactions" scale="6" id="Tc_9iAtNX9-tUyNXKGYKx6T2A_28_6">80</ix:nonfraction>)</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:top;width:75.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">Balance at September 30</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.52%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_9_30_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_GuALU1yk40CWLKcwQ7aHKg" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="Tc_PJFIoz9Ug0mLJmSBy0_5ew_29_3">25,440</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.51%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.12%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_9_30_2018_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_RzsVsvtvykWC5WZFzqW8lQ" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="Tc_nQYzQClLY0qmG6C-Oy0zzQ_29_6">24,144</ix:nonfraction></p></td></tr><tr><td style="vertical-align:top;width:75.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:top;width:75.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">Accumulated Other Comprehensive Income (Loss):</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:top;width:75.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">Balance at January 1</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"> (<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_12_31_2018_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember_xpvzGw6DckqgYCN1UEKZFA" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" sign="-" scale="6" id="Tc_vVePNH9fzUCULtEYwMQPRQ_32_3">7,586</ix:nonfraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"> (<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_12_31_2017_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember_qxPAiXW_BEinFD6XMkq5zw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" sign="-" scale="6" id="Tc_XEjoLEGWpUyrd16dbNUrcg_32_6">6,062</ix:nonfraction>)</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:top;width:75.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">Impact of adoption of new accounting standard</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> —</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_1_1_2018_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember_GuYuIVBYqk2k9ru3-XIPNA" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption" scale="6" id="Tc__YPBNxLoKEifaWXWPG78wg_33_6">5</ix:nonfraction></p></td></tr><tr><td style="vertical-align:top;width:75.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">Other comprehensive income (loss)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.52%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"> (<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember_-8Bw1WAG10q8sKd7yi0Z7w" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" sign="-" scale="6" id="Tc_hFrV2ooqWUOzok__kHQN8w_34_3">177</ix:nonfraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"> (<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2018_To_9_30_2018_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember_wI_ZJ6bF_UeFpesDvVl5PQ" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" sign="-" scale="6" id="Tc_mFa-Mb9LPUSXOyuyZK74rg_34_6">952</ix:nonfraction>)</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:top;width:75.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">Balance at September 30</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.52%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"> (<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_9_30_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember_dg1dTMhxQkOvrJfgeBrQ3Q" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" sign="-" scale="6" id="Tc_EqSfwgnrZkm-Yg9lyF-gug_35_3">7,763</ix:nonfraction>)</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.51%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.12%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"> (<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_9_30_2018_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember_XobcWMR9fUKTIvdfC5r_0w" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" sign="-" scale="6" id="Tc_hopZ5kk9HU2h8cXlQHkmgQ_35_6">7,009</ix:nonfraction>)</p></td></tr><tr><td style="vertical-align:top;width:75.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:top;width:75.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">Noncontrolling Interests in Subsidiaries:</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:top;width:75.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">Balance at January 1</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_12_31_2018_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember_RDzmLIldOkuOnxLy7kOlkQ" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="Tc_C9WKXh_de0SmrucqesmQtg_38_3">198</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_12_31_2017_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember_CeSUxyxDB0mz0dWUVZSWzQ" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="Tc_milvbB_c_E-Ducg7PWSPOw_38_6">201</ix:nonfraction></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:top;width:75.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">Noncontrolling Interests’ share of income, business combinations, net of distributions <br>and share repurchases</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.52%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember_WGxLi1ZZJEGxOLW3HWt_BA" decimals="-6" format="ixt:numdotdecimal" name="abt:NoncontrollingInterestsShareOfIncomeNetOfDistributionsAndShareRepurchasesAndBusinessCombinations" scale="6" id="Tc_5-N3G5v-LEm8f614AfZA5A_39_3">4</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"> (<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2018_To_9_30_2018_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember_UKF0F7TwxEmPBF3_dHnPCQ" decimals="-6" format="ixt:numdotdecimal" name="abt:NoncontrollingInterestsShareOfIncomeNetOfDistributionsAndShareRepurchasesAndBusinessCombinations" sign="-" scale="6" id="Tc_uGJiBEQYHU6BHvzsQGRJ-Q_39_6">8</ix:nonfraction>)</p></td></tr><tr><td style="vertical-align:top;width:75.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">Balance at September 30</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.52%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_9_30_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember_jVoR3ymRq0GxvPbAMNalag" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="Tc_2MZjfoYMnUKvOpZvdX9iLw_40_3">202</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.12%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_9_30_2018_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember_CYL5Vb7ebU2opKP7GE9QZw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="Tc_GL14fgJwhkmt8drRHX08sg_40_6">193</ix:nonfraction></p></td></tr></tbody></table><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">The accompanying notes to condensed consolidated financial statements are an integral part of this statement.</p><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><a id="_78686dd9_fed7_45b4_b303_bbfa8e7e48e4"></a></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">7</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-family:'Times New Roman';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:center;margin:0pt;">Abbott Laboratories and Subsidiaries</p><a id="StatementofCashFlows_285621"></a><p style="font-family:'Times New Roman';font-size:10pt;text-align:center;margin:0pt;">Condensed Consolidated Statement of Cash Flows</p><p style="font-family:'Times New Roman';font-size:10pt;text-align:center;margin:0pt;">(Unaudited)</p><p style="font-family:'Times New Roman';font-size:10pt;text-align:center;margin:0pt;"><i style="font-style:italic;">(dollars in millions)</i></p><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><a id="_4b756316_7189_4537_8da8_6a19c2014b21"></a><a id="Tc_tfTNU64sgUmSSSrqomYZrQ_1_2"></a><a id="Tc_51FhFyi5SE2Jbyilk4M-rw_2_2"></a><a id="Tc_9-2LzaBp00C0FycfV1AOyQ_2_5"></a><a id="Tc_5bfq9sBChkCDLD58bvwSYA_3_0"></a><a id="Tc_qFPK-6127kir_u-snGx8QQ_4_0"></a><a id="Tc_-elbYryLyESC6c53mge0-w_4_2"></a><a id="Tc_sNEqsL-L4EGIC5RdylJkiQ_4_5"></a><a id="Tc_K_ifG6DEMEuWeVZcAZt_iQ_5_0"></a><a id="Tc_6VjFM1bqLUaqHO0igkXmsg_6_0"></a><a id="Tc_639Q-qkWmkKy1_xwx6UAJQ_7_0"></a><a id="Tc_sCkjX3J8S0G4SYREKu3RJA_8_0"></a><a id="Tc_ETmUSuFqZEyN8eBzzxmvbg_9_0"></a><a id="Tc_Bv5Hmw6kOka8PjXkznSSyQ_9_3"></a><a id="Tc_bHYLusE9uUSQ5GC5mkLTCQ_10_0"></a><a id="Tc_x7y_KH-GZkSet18unJPDrA_11_0"></a><a id="Tc_QOiWFNQpQ0SOGw0tqHsRNQ_12_0"></a><a id="Tc_LC3XK5m250uQilF9I6bWtw_13_0"></a><a id="Tc_duc1xeJySkWfy5YTfS_xNg_15_0"></a><a id="Tc_He_wfw8Pz0K0DVmDrUHDOA_16_0"></a><a id="Tc_VcXgIHUMpEucXFN40NKpSw_17_0"></a><a id="Tc_ts5T41mdS0q9yFf0u2gqIw_18_0"></a><a id="Tc_-zSgP_mMl0mLpz5vzPBWeA_19_0"></a><a id="Tc_UIZEp80Dc0CO-_cEgUtBAQ_20_0"></a><a id="Tc_goVYi0RMw0G5e3erzDXvcA_21_0"></a><a id="Tc_bRcUTTEY6Eu75fprUjhC6w_23_0"></a><a id="Tc_owGri5LfkkCVM_188fWvBg_24_0"></a><a id="Tc_kTx7B4w5hES-3TwpYpi7fA_25_0"></a><a id="Tc_lqhCdqd6BkS6gPNR5GFy-Q_25_3"></a><a id="Tc_qQzJMoZF1ka5c9ifDc0KQw_26_0"></a><a id="Tc_Y8AyNYWATUemygXWwAiLjw_27_0"></a><a id="Tc_l_Ll55lM20WyfdmDmiEi8Q_28_0"></a><a id="Tc_1Gh5YmV_tE2q1u_Q9gkazw_29_0"></a><a id="Tc_JcjDBcPBuUaAoJaPxt7AJw_30_0"></a><a id="Tc_t6gztZb0Okapsp-VjEqLDA_32_0"></a><a id="Tc__AjfIYQAOki0-lZ9fV7zdg_34_0"></a><a id="Tc_TqMSdeJo0kiCTk-ViSsSyw_35_0"></a><a id="Tc_YV7X2Noz4UeLVE03sU4Esw_36_0"></a><a id="Tc_-QCnJcNaQ0aB7CCMcif-ug_36_2"></a><a id="Tc_NRQqaOCu30qE2HQLgb7dcQ_36_5"></a><table style="border-collapse:collapse;font-size:16pt;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tbody><tr style="height:1pt;"><td style="vertical-align:bottom;width:73.88%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="background-color:auto;vertical-align:bottom;width:73.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="5" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:23.76%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Nine Months Ended September&nbsp;30</b></p></td></tr><tr><td style="background-color:auto;vertical-align:bottom;width:73.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&nbsp;&nbsp;&nbsp;&nbsp;</b></p></td><td colspan="2" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:10.72%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2019</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&nbsp;&nbsp;&nbsp;&nbsp;</b></p></td><td colspan="2" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:10.7%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2018</b></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:73.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">Cash Flow From (Used in) Operating Activities:</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:73.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 12pt;">Net earnings</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_O4ushO81Z0mAnTH_cLUPFw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="6" id="Tc_tyYIoOXaz06jWHL7b21AXQ_4_3">2,638</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2018_To_9_30_2018_3n65uNcjAUKkwLDxHE9Yow" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="6" id="Tc_brM4FY47Mkafd1FlrbeaMg_4_6">1,714</ix:nonfraction></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:73.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 12pt;">Adjustments to reconcile net earnings to net cash from operating activities -</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:73.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 18pt;">Depreciation </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_O4ushO81Z0mAnTH_cLUPFw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Depreciation" scale="6" id="Tc_sMcOwpfmAkG6uy9A4NwQ0A_6_3">805</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2018_To_9_30_2018_3n65uNcjAUKkwLDxHE9Yow" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Depreciation" scale="6" id="Tc_jF4TmKWr8kOooZWAhhnswg_6_6">825</ix:nonfraction></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:73.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 18pt;">Amortization of intangible assets</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_O4ushO81Z0mAnTH_cLUPFw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="Tc_DChlN0W4QkqjHCdbqijKxA_7_3">1,453</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2018_To_9_30_2018_3n65uNcjAUKkwLDxHE9Yow" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="Tc_o6d5W_VLEkSTC4Ea7Y5NOA_7_6">1,690</ix:nonfraction></p></td></tr><tr><td style="vertical-align:bottom;width:73.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 18pt;"> Share-based compensation</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_O4ushO81Z0mAnTH_cLUPFw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensation" scale="6" id="Tc_6Mm_S7R0H0WUJzvi6vV0Pw_8_3">434</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2018_To_9_30_2018_3n65uNcjAUKkwLDxHE9Yow" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensation" scale="6" id="Tc_eVCEunF32Eq7TBD4dXkaBQ_8_6">396</ix:nonfraction></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:73.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 18pt;">Amortization of inventory step-up</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> —</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2018_To_9_30_2018_3n65uNcjAUKkwLDxHE9Yow" decimals="-6" format="ixt:numdotdecimal" name="abt:AmortizationOfInventoryStepUp" scale="6" id="Tc_dz1S7nb6DEaxc6POUKeMEQ_9_6">32</ix:nonfraction></p></td></tr><tr><td style="vertical-align:bottom;width:73.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 12pt;">Trade receivables</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"> (<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_O4ushO81Z0mAnTH_cLUPFw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="6" id="Tc_thfGURFH1kGqV79MIryyyQ_10_3">357</ix:nonfraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"> (<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2018_To_9_30_2018_3n65uNcjAUKkwLDxHE9Yow" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="6" id="Tc_CmWxAsnJbEaQEHx9jR69Zw_10_6">280</ix:nonfraction>)</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:73.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 12pt;">Inventories</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"> (<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_O4ushO81Z0mAnTH_cLUPFw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="Tc_4hCaN2qLAEa_bR2IWCur1Q_11_3">730</ix:nonfraction>)</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"> (<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2018_To_9_30_2018_3n65uNcjAUKkwLDxHE9Yow" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="Tc_JvmKMlgG7EqajXNXxOrEXA_11_6">450</ix:nonfraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:73.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 12pt;">Other, net</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"> (<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_O4ushO81Z0mAnTH_cLUPFw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet" scale="6" id="Tc_yeHqmLPj6kCfYBl1HoLBZw_12_3">523</ix:nonfraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2018_To_9_30_2018_3n65uNcjAUKkwLDxHE9Yow" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet" sign="-" scale="6" id="Tc_Rx_CDl4DL0qDYpgL5RkUcg_12_6">608</ix:nonfraction></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:73.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 18pt;">Net Cash From Operating Activities</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_O4ushO81Z0mAnTH_cLUPFw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="Tc_iYlXwINYhEK49XS70lQnQg_13_3">3,720</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2018_To_9_30_2018_3n65uNcjAUKkwLDxHE9Yow" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="Tc_PkmeIna_N0CCYfFnbIRScQ_13_6">4,535</ix:nonfraction></p></td></tr><tr><td style="vertical-align:bottom;width:73.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:73.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">Cash Flow From (Used in) Investing Activities:</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:73.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 12pt;">Acquisitions of property and equipment</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"> (<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_O4ushO81Z0mAnTH_cLUPFw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="Tc_XpkEzonpn0OqX-4WkD11-A_16_3">1,204</ix:nonfraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"> (<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2018_To_9_30_2018_3n65uNcjAUKkwLDxHE9Yow" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="Tc_XRMMsMxwIEqUO_J9c8TJGw_16_6">927</ix:nonfraction>)</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:73.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 12pt;">Acquisitions of businesses and technologies, net of cash acquired</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"> (<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_O4ushO81Z0mAnTH_cLUPFw" decimals="-6" format="ixt:numdotdecimal" name="abt:PaymentsToAcquireBusinessesNetOfCashAcquiredAndResearchAndDevelopmentInProcess" scale="6" id="Tc_3tDCrKAggkiFEdoGOWiuwg_17_3">171</ix:nonfraction>)</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"> (<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2018_To_9_30_2018_3n65uNcjAUKkwLDxHE9Yow" decimals="-6" format="ixt:numdotdecimal" name="abt:PaymentsToAcquireBusinessesNetOfCashAcquiredAndResearchAndDevelopmentInProcess" scale="6" id="Tc_T_sxjXeynkG-86d-YfBm8w_17_6">43</ix:nonfraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:73.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 12pt;">Proceeds from business dispositions</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_O4ushO81Z0mAnTH_cLUPFw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets" scale="6" id="Tc_wBBIyk0seUqWpgHE2E6L6w_18_3">48</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2018_To_9_30_2018_3n65uNcjAUKkwLDxHE9Yow" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets" scale="6" id="Tc_aTobsUvyZ0W8Ehylvpq6-Q_18_6">48</ix:nonfraction></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:73.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 12pt;">Sales (purchases) of other investment securities, net </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"> (<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_O4ushO81Z0mAnTH_cLUPFw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PaymentsForProceedsFromInvestments" scale="6" id="Tc_Jijov_whiUGA3irQa4ZJfQ_19_3">22</ix:nonfraction>)</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"> (<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2018_To_9_30_2018_3n65uNcjAUKkwLDxHE9Yow" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PaymentsForProceedsFromInvestments" scale="6" id="Tc_f3saRsDolky8Yglzl0MdcQ_19_6">23</ix:nonfraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:73.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 12pt;">Other</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_O4ushO81Z0mAnTH_cLUPFw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" sign="-" scale="6" id="Tc_s4D9jejYtEOqzKCYcpGw2g_20_3">23</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2018_To_9_30_2018_3n65uNcjAUKkwLDxHE9Yow" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" sign="-" scale="6" id="Tc_gD3JpF7dWkKTaGV8Ywobkw_20_6">85</ix:nonfraction></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:73.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 18pt;">Net Cash (Used in) Investing Activities</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"> (<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_O4ushO81Z0mAnTH_cLUPFw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" sign="-" scale="6" id="Tc_XAIVKscjEUGrK9rRS9uQbQ_21_3">1,326</ix:nonfraction>)</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"> (<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2018_To_9_30_2018_3n65uNcjAUKkwLDxHE9Yow" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" sign="-" scale="6" id="Tc_JzHCecISBEejYjdlbqfAVw_21_6">860</ix:nonfraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:73.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:73.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">Cash Flow From (Used in) Financing Activities:</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:73.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 12pt;">Net borrowings (repayments) of short-term debt and other</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_O4ushO81Z0mAnTH_cLUPFw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromRepaymentsOfShortTermDebt" scale="6" id="Tc_eY5Yi3d_yUylR82P2WNAtQ_24_3">52</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2018_To_9_30_2018_3n65uNcjAUKkwLDxHE9Yow" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromRepaymentsOfShortTermDebt" scale="6" id="Tc_WLwbHPFo3k-bwLXRePKZ2Q_24_6">22</ix:nonfraction></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:73.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 12pt;">Proceeds from issuance of long-term debt</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> —</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2018_To_9_30_2018_3n65uNcjAUKkwLDxHE9Yow" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" scale="6" id="Tc_9XKLGfm-lUm5x1GVBhmosw_25_6">4,011</ix:nonfraction></p></td></tr><tr><td style="vertical-align:bottom;width:73.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 12pt;">Repayments of long-term debt</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"> (<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_O4ushO81Z0mAnTH_cLUPFw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfLongTermDebt" scale="6" id="Tc_Mp3I04lshEGQ-7Oy63q1vg_26_3">523</ix:nonfraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"> (<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2018_To_9_30_2018_3n65uNcjAUKkwLDxHE9Yow" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfLongTermDebt" scale="6" id="Tc_-2UT_7QYx06VWx0zzlC9GQ_26_6">8,279</ix:nonfraction>)</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:73.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 12pt;">Purchases of common shares</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"> (<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_O4ushO81Z0mAnTH_cLUPFw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="6" id="Tc_ygqMfLASgUa6PfobPuZLrg_27_3">222</ix:nonfraction>)</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"> (<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2018_To_9_30_2018_3n65uNcjAUKkwLDxHE9Yow" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="6" id="Tc_1dNMbxE-XkW5MSl-mRM9sQ_27_6">134</ix:nonfraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:73.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 12pt;">Proceeds from stock options exercised</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_O4ushO81Z0mAnTH_cLUPFw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromStockOptionsExercised" scale="6" id="Tc_IEve6yTBfkGIp7HYd26FwA_28_3">291</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2018_To_9_30_2018_3n65uNcjAUKkwLDxHE9Yow" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromStockOptionsExercised" scale="6" id="Tc_4XwUI0sLY0ejBsqtxf10Xw_28_6">244</ix:nonfraction></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:73.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 12pt;">Dividends paid</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"> (<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_O4ushO81Z0mAnTH_cLUPFw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PaymentsOfDividendsCommonStock" scale="6" id="Tc_xRbW0ImKJEezovg_kGYQ3g_29_3">1,702</ix:nonfraction>)</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"> (<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2018_To_9_30_2018_3n65uNcjAUKkwLDxHE9Yow" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PaymentsOfDividendsCommonStock" scale="6" id="Tc_A42sLPPwK02U6lbdNwCREg_29_6">1,479</ix:nonfraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:73.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 18pt;">Net Cash (Used in) Financing Activities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"> (<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_O4ushO81Z0mAnTH_cLUPFw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" sign="-" scale="6" id="Tc_2b0yE8akQUKCMsOTSRFqMw_30_3">2,104</ix:nonfraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"> (<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2018_To_9_30_2018_3n65uNcjAUKkwLDxHE9Yow" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" sign="-" scale="6" id="Tc_HAsu8TkqfUealv7s1NwIuQ_30_6">5,615</ix:nonfraction>)</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:73.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:73.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">Effect of exchange rate changes on cash and cash equivalents</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"> (<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_O4ushO81Z0mAnTH_cLUPFw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" sign="-" scale="6" id="Tc_wzQmhGDJBEuTiD0X6nmYtQ_32_3">43</ix:nonfraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"> (<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2018_To_9_30_2018_3n65uNcjAUKkwLDxHE9Yow" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" sign="-" scale="6" id="Tc_L-3yHIWVcEynOJnQvCOQEg_32_6">98</ix:nonfraction>)</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:73.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:73.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">Net Increase (Decrease) in Cash and Cash Equivalents</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_O4ushO81Z0mAnTH_cLUPFw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="Tc_fAyCB6mPJEuARDaZkGnsQA_34_3">247</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"> (<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2018_To_9_30_2018_3n65uNcjAUKkwLDxHE9Yow" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" sign="-" scale="6" id="Tc_aIvFYEvAdkG_zT0GrUKyEw_34_6">2,038</ix:nonfraction>)</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:73.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">Cash and Cash Equivalents, Beginning of Year</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_12_31_2018_INezHDkjn0-L7OMGoLMjhA" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="Tc_-HnLOGc9KUimBgb9z1Je-Q_35_3">3,844</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_12_31_2017_ioSxrd0aWkWAGJFTYQ9J4A" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="Tc_zHgDlZxNIkyGrqEwYmLE1A_35_6">9,407</ix:nonfraction></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:73.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">Cash and Cash Equivalents, End of Period</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_9_30_2019_Q77aJBXiP0qCmJ4Yd2DnHw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="Tc_X7oDdJtFUE6J6pJ-5VOHlQ_36_3">4,091</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.22%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_9_30_2018_m4UuMI1ubEOozG-BjuDXyA" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="Tc_E0UMF8xyhEKft3WjCikZ3w_36_6">7,369</ix:nonfraction></p></td></tr></tbody></table><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">The accompanying notes to the condensed consolidated financial statements are an integral part of this statement.</p><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="display:none;font-size:12pt;line-height:0pt;text-align:center;margin:0pt;"><span style="font-family:'Times New Roman';font-size:0pt;visibility:hidden;">​</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">8</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><a href="#TOC"><span style="font-family:'Times New Roman';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Table of Contents</span></a></p><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:10pt;text-align:center;margin:0pt;">Abbott Laboratories and Subsidiaries</p><p style="font-family:'Times New Roman';font-size:10pt;text-align:center;margin:0pt;">Notes to the Condensed Consolidated Financial Statements</p><p style="font-family:'Times New Roman';font-size:10pt;text-align:center;margin:0pt;">September 30, 2019</p><p style="font-family:'Times New Roman';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;">(Unaudited)</p></div><div style="clear:both;max-width:100%;position:relative;"><a id="Note1BasisofPresentation_992483"></a><ix:nonnumeric contextref="Duration_1_1_2019_To_9_30_2019_O4ushO81Z0mAnTH_cLUPFw" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" id="Tb_ad8L4AOZykad28hWqV4mLw" escape="true"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">Note 1 — Basis of Presentation</p><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:10pt;text-align:justify;margin:0pt;">The accompanying unaudited, condensed consolidated financial statements have been prepared pursuant to rules&nbsp;and regulations of the Securities and Exchange Commission and, therefore, do not include all information and footnote disclosures normally included in audited financial statements. &nbsp;However, in the opinion of management, all adjustments (which include only normal adjustments) necessary to present fairly the results of operations, financial position and cash flows have been made. &nbsp;It is suggested that these statements be read in conjunction with the financial statements included in Abbott’s Annual Report on Form&nbsp;10-K for the year ended December 31, 2018. &nbsp;The condensed consolidated financial statements include the accounts of the parent company and subsidiaries, after elimination of intercompany transactions.</p></ix:nonnumeric><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><a id="_0922a8ac_e496_4e27_9c05_e78eb0cee1c6"></a><a id="_7fd0aaa8_624f_4e46_a3cf_2050b6281ef8"></a><ix:nonnumeric contextref="Duration_1_1_2019_To_9_30_2019_O4ushO81Z0mAnTH_cLUPFw" name="us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" id="Tb_X4h4bAmGCEWhpgKnaX5rXQ" escape="true"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">Note 2 — New Accounting Standards</p><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><ix:nonnumeric contextref="Duration_1_1_2019_To_9_30_2019_O4ushO81Z0mAnTH_cLUPFw" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="Tb_nnGvWjzXC0S0O5xVYz4RBA" escape="true"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;"><i style="font-style:italic;">Recently Adopted Accounting Standards</i></p><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:10pt;text-align:justify;margin:0pt;">In February 2016, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) 2016-02, <i style="font-style:italic;">Leases</i>, which requires lessees to measure and recognize a lease asset and liability on the balance sheet for most leases, including operating leases. &nbsp;Abbott adopted the new standard as of January 1, 2019 using the modified retrospective approach and applied the standard’s transition provisions as of January 1, 2019. &nbsp;As a result, no changes were made to the December 31, 2018 Consolidated Balance Sheet. Abbott elected to apply the package of practical expedients related to transition. These practical expedients allowed Abbott to carry forward its historical assessments of whether any existing contracts are or contain leases, the lease classification for each lease existing at January 1, 2019, and whether any initial direct costs for such leases qualified for capitalization. </p><p style="font-family:'Times New Roman';font-size:12pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:10pt;text-align:justify;margin:0pt;">The new lease accounting standard does not have a material impact on the amounts reported in the Condensed Consolidated Statement of Earnings but does have a material impact on the amounts reported in the Condensed Consolidated Balance Sheet. &nbsp;Adoption of the new standard resulted in the recording of approximately $<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_1_1_2019_srt_RestatementAxis_srt_RestatementAdjustmentMember_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_us-gaap_AccountingStandardsUpdate201602Member_YQvWxBpGvkim5xhEV2VSoA" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiability" scale="6" id="Narr_WAK4oJGLIUqzKBxw0TVNRg">850</ix:nonfraction> million of new right of use (ROU) assets and additional liabilities for operating leases on the Condensed Consolidated Balance Sheet as of January 1, 2019.</p></ix:nonnumeric><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><ix:nonnumeric contextref="Duration_1_1_2019_To_9_30_2019_O4ushO81Z0mAnTH_cLUPFw" name="abt:NewAccountingPronouncementsNotYetAdoptedPolicyTextBlock" id="Tb_6BC8sciGUEWQJSVlD8IqOQ" escape="true"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;"><i style="font-style:italic;">Recent Accounting Standards Not Yet Adopted</i></p><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:10pt;text-align:justify;margin:0pt;">In June 2016, the FASB issued ASU 2016-13, <i style="font-style:italic;">Financial Instruments – Credit Losses</i> which changes the methodology to be used to measure credit losses for certain financial instruments and financial assets, including trade receivables. The new methodology requires the recognition of an allowance that reflects the current estimate of credit losses expected to be incurred over the life of the financial asset. &nbsp;The new standard will be effective for Abbott at the beginning of 2020, with early adoption permitted. Abbott is currently assessing the impact of this new standard on its consolidated financial statements.</p></ix:nonnumeric></ix:nonnumeric><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><ix:nonnumeric contextref="Duration_1_1_2019_To_9_30_2019_O4ushO81Z0mAnTH_cLUPFw" name="us-gaap:RevenueFromContractWithCustomerTextBlock" id="Tb_nHylNyAPqEWRP1ke_nPG7w" continuedat="Tb_nHylNyAPqEWRP1ke_nPG7w_cont1" escape="true"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">Note 3 — Revenue</p><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:10pt;text-align:justify;margin:0pt;">Abbott’s revenues are derived primarily from the sale of a broad line of health care products under short-term receivable arrangements. &nbsp;Abbott has <ix:nonfraction unitref="Unit_Standard_segment_AyAgmVE9iUqrEIsDqeoAeg" contextref="Duration_1_1_2018_To_9_30_2018_3n65uNcjAUKkwLDxHE9Yow" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:NumberOfReportableSegments" scale="0" id="Narr_xctNkxtMU0OENRmGsuDIfw"><ix:nonfraction unitref="Unit_Standard_segment_AyAgmVE9iUqrEIsDqeoAeg" contextref="Duration_7_1_2018_To_9_30_2018_lS4NEZw67ECck2zY72MWgg" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:NumberOfReportableSegments" scale="0" id="Narr_j6BBY3iARkSCY4xzksARLg"><ix:nonfraction unitref="Unit_Standard_segment_AyAgmVE9iUqrEIsDqeoAeg" contextref="Duration_1_1_2019_To_9_30_2019_O4ushO81Z0mAnTH_cLUPFw" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:NumberOfReportableSegments" scale="0" id="Narr_iDm9gK_YuECBGjXWDnkUQg"><ix:nonfraction unitref="Unit_Standard_segment_AyAgmVE9iUqrEIsDqeoAeg" contextref="Duration_7_1_2019_To_9_30_2019_5CXepWtEPEKQA-bPz0Tp7A" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:NumberOfReportableSegments" scale="0" id="Narr_oBpPM5q6BEWVd2S6_iO7fA">four</ix:nonfraction></ix:nonfraction></ix:nonfraction></ix:nonfraction> reportable segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Cardiovascular and Neuromodulation Products. &nbsp;Diabetes Care is a non-reportable segment and is included in Other.</p><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></ix:nonnumeric></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">9</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><a href="#TOC"><span style="font-family:'Times New Roman';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Table of Contents</span></a></p><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:10pt;text-align:center;margin:0pt;">Abbott Laboratories and Subsidiaries</p><p style="font-family:'Times New Roman';font-size:10pt;text-align:center;margin:0pt;">Notes to the Condensed Consolidated Financial Statements</p><p style="font-family:'Times New Roman';font-size:10pt;text-align:center;margin:0pt;">September 30, 2019</p><p style="font-family:'Times New Roman';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;">(Unaudited)</p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_475c3b57_750d_488a_94c9_d1f71d66a412"></a><a id="Tc_5piRKVD4IEmYiwrRacbMuA_1_2"></a><a id="Tc_coqSO3Vq70G7ColAR9r7GA_1_11"></a><a id="Tc_g3afIJplzEuPf3LFYMnsGA_2_0"></a><a id="Tc_Cnda_iZg0EGz7YHycK85dA_2_2"></a><a id="Tc_3_VcPxhXTE-nipArgPkymA_2_5"></a><a id="Tc_cxYtmZrnA0adaHkcgKA9JA_2_8"></a><a id="Tc_AAYoCnlhCUuzr6IEzCVkKg_2_11"></a><a id="Tc_EGdvOHaB-kumk-qIi1CR5w_2_14"></a><a id="Tc_8XiwFHE2-EWRbHy6V30yIA_2_17"></a><a id="Tc_1n0q-4hMnUCO7Hja3zefuQ_3_0"></a><a id="Tc_lvKxb3R6BkqQGIlSz4jh_A_4_0"></a><a id="Tc_AHtLLqGP60S_qVDfid6PFg_4_2"></a><a id="Tc_bPjYo8hH8kqnWvo_0Q5xWA_4_3"></a><a id="Tc_uVi3nDLc6EuiGJ7ddsZj9g_4_5"></a><a id="Tc_qq27lTU5vUODTnt-9mC_YA_4_8"></a><a id="Tc_ed9ujeyF1kWGjwLLAXQp8w_4_11"></a><a id="Tc_rAU_zEFN5UWjx26dsN1aBw_4_12"></a><a id="Tc_GuM88cwGPUe5gWttAbAgJQ_4_14"></a><a id="Tc_G2iPZ9OCRkyGWJtbibXEzQ_4_17"></a><a id="Tc_kushaRod_kCm8nmKLZKEXg_5_0"></a><a id="Tc_iNpW6gBAmUWAKr9N_JbwiA_5_3"></a><a id="Tc_n0DxMna6hkWH62LENrS6aA_5_12"></a><a id="Tc_fVnPsO6vbUq6XD19T1sNjw_6_0"></a><a id="Tc_Ijp7vOkkFEaJ-d27RJKclA_6_3"></a><a id="Tc_OUZJPeHHAkqukv4kCHu6lA_6_12"></a><a id="Tc_b5KsmfZRYES_fzGSF7wa1A_8_0"></a><a id="Tc_VWohxlVmOUiZrERL5VCMyQ_9_0"></a><a id="Tc_Kxtx2RBtDUWYyarWB2Ehdw_10_0"></a><a id="Tc_xBCxPfiblUCXWilbpn1uYQ_11_0"></a><a id="Tc_JpJHL7dSF0mHTZGD1ssDBw_13_0"></a><a id="Tc_gmc_fGBw70KK9IgJSjLk0w_14_0"></a><a id="Tc_4DCCWbqV5EuffaeFbFREjA_15_0"></a><a id="Tc_KEmgCjxK_k-0wjT20YrD9w_16_0"></a><a id="Tc_NXO8MqmbZk2vSKeC6lJKiw_17_0"></a><a id="Tc_WKIv8DkzfU-2_9RRNaOVjw_18_0"></a><a id="Tc_HZYNJBXsYEWDqina3EVAAA_20_0"></a><a id="Tc_rhMV-66qik-IQng89eGaGA_21_0"></a><a id="Tc_WhVGjbxT6EGFW6DW7Ug63Q_22_0"></a><a id="Tc_ne6QRBFE2kezmaSMt61ZCQ_23_0"></a><a id="Tc_oqjGLcDr-Um_AjhWizeuRg_24_0"></a><a id="Tc_svAhSvpy6USqWBPMyBTRsg_25_0"></a><a id="Tc_xpXTh0DFEE2f9D0ERVDKAQ_26_0"></a><a id="Tc_rPpreuzJB0StxzLmZRy5hw_27_0"></a><a id="Tc_Pll8xsXMdEq3UOAqf-BCXw_29_0"></a><a id="Tc_cL9PgigC_UmYWe8pRYU0XA_30_0"></a><a id="Tc_Ty2qsiBj2k6cbXN0vvJ42w_30_2"></a><a id="Tc_ld_VMuTnEUyVNrk5bkN1CQ_30_5"></a><a id="Tc_3zfH3xjHhEegc0OGcS8Iow_30_8"></a><a id="Tc_xKQK0swSQ0mwnN8EskHZZw_30_11"></a><a id="Tc_e5rqwFkcD0iBTfFLMl4tsg_30_14"></a><a id="Tc_k3mYpSq-8UGiwZ_nODRC6A_30_17"></a><a id="_2ca29822_14b1_4f18_8867_82c7f9f3a66a"></a><a id="Tc_Z4MGvrX7MEmZ8AYJJX-2Ng_1_2"></a><a id="Tc_Wfrq7nc8YUy3ffX044hHJQ_1_11"></a><a id="Tc_JcczNvYW00KHf5rtf4RLJA_2_0"></a><a id="Tc_z1fLpLh3_02rkTp1TX9fHg_2_2"></a><a id="Tc_8q27MRus60Kv13npuQuWdA_2_5"></a><a id="Tc_lnvH95wKmUOilCPHBTHFmQ_2_8"></a><a id="Tc_VFdQjqAMs0-1MZqfPizFhw_2_11"></a><a id="Tc_ld5qP2hhp0eZKOhTIhOMmQ_2_14"></a><a id="Tc_eIwIkaj4uEmo6-OYyBigdA_2_17"></a><a id="Tc_V4fDiWkAokm6f2uP7LR1OQ_3_0"></a><a id="Tc_xracf3RA6EKfRgDU__FYXQ_4_0"></a><a id="Tc_TzDsoPZCv0GXizw3YvSH4w_4_2"></a><a id="Tc_lRKVxVzNnE6jXMK2R9qgxw_4_3"></a><a id="Tc_-SCR41rfRkWE8TA6XMDAEA_4_5"></a><a id="Tc_YAXglZ_WRkKo8vcGcd2ngA_4_8"></a><a id="Tc_nKo-ypNCjkabp-_jrlu4dw_4_11"></a><a id="Tc_0EosIS4HCEOFmaetIP2JBw_4_12"></a><a id="Tc_GMWVpgOUSUWhVFHkNzDj7g_4_14"></a><a id="Tc_G1aLzWArpEGUwJ6AtwBoOw_4_17"></a><a id="Tc_DvnfQqx4s0O0bz50J2TuNw_5_0"></a><a id="Tc_hTqE7oN81UKQbw5dK4sVRQ_5_3"></a><a id="Tc_-UjIKRAMM0WzehkmUEPtOg_5_12"></a><a id="Tc_0hcFcX89XUqYFi983p2WkA_6_0"></a><a id="Tc_V_AUZ8g0CUWrCjHrUzQFSQ_6_3"></a><a id="Tc_RU9EEEWIIk6cz3ZLJZyrrA_6_12"></a><a id="Tc_4cw7LL0ExkCTi3plycAHEg_8_0"></a><a id="Tc_-aM_Q-wyJE-mXxQFpzf3OQ_9_0"></a><a id="Tc_QgswLohzUUecqGY4JzLHUA_10_0"></a><a id="Tc_q82xABI62kCm3qepsrLzng_11_0"></a><a id="Tc_dJd3iDXeqUqOgNwMmiYZaA_13_0"></a><a id="Tc_B7-WBvvg1EmWhsKQHp2KiA_14_0"></a><a id="Tc_1v8wn79cKUKc7XSaxAp65w_15_0"></a><a id="Tc_uRVh4DVnTkKtJSC-EagyFg_16_0"></a><a id="Tc_45X4oVySvku4Sn91G0xMog_17_0"></a><a id="Tc_Bfw_B9yt1E2XXu1001IohQ_18_0"></a><a id="Tc_Iw2WeluTXU6xTjT3Ip9suQ_20_0"></a><a id="Tc_1wIkUOkzxke06Jk4x96Rcw_21_0"></a><a id="Tc_U9jYHWNO6kGNoq04lX9koQ_22_0"></a><a id="Tc_dEOdDLqT9Eehn6pujo7kyg_23_0"></a><a id="Tc_S0hAYn_4B0S0V_K9P7Y1yg_24_0"></a><a id="Tc_C9w9Pb7ChEOclmhAVYNLow_25_0"></a><a id="Tc_6AnHXegOS06-i5FUvUvCmQ_26_0"></a><a id="Tc_zYwCNFuuuUiR5VjFWR1LEg_27_0"></a><a id="Tc_oqylDJyp6UePYVE1d2CJiA_29_0"></a><a id="Tc_oAlutg_dskqTwFj580DJaQ_30_0"></a><a id="Tc_mISno51YQke481RVy5m2KQ_30_2"></a><a id="Tc_bQBtFr2v9EKwdXjnhLV6OA_30_5"></a><a id="Tc_wA8BP6kQR0-PSKwjJdZSlg_30_8"></a><a id="Tc_comYn4seVUiKLA4XAhTMsw_30_11"></a><a id="Tc_NwFpMe58Hkyv6L7AGDi3xw_30_14"></a><a id="Tc_ZUTV3xsJ1U-FkBm7UeSiDQ_30_17"></a><ix:continuation id="Tb_nHylNyAPqEWRP1ke_nPG7w_cont1" continuedat="Tb_nHylNyAPqEWRP1ke_nPG7w_cont2"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">The following tables provide detail by sales category:</p><ix:nonnumeric contextref="Duration_1_1_2019_To_9_30_2019_O4ushO81Z0mAnTH_cLUPFw" name="us-gaap:DisaggregationOfRevenueTableTextBlock" id="Tb_tIxc8iC20EOJRGVH_TQTLw" escape="true"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tbody><tr style="height:1pt;"><td style="vertical-align:bottom;width:33.47%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="background-color:auto;vertical-align:bottom;width:33.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="8" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:31.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Three&nbsp;Months&nbsp;Ended September&nbsp;30,&nbsp;2019</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="8" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:31.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Three&nbsp;Months&nbsp;Ended September&nbsp;30,&nbsp;2018</b></p></td></tr><tr><td style="background-color:auto;vertical-align:bottom;width:33.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">(in&nbsp;millions)</p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;&nbsp;&nbsp;&nbsp;</p></td><td colspan="2" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:9.09%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">U.S.</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;&nbsp;&nbsp;&nbsp;</p></td><td colspan="2" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:9.09%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Int’l</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;&nbsp;&nbsp;&nbsp;</p></td><td colspan="2" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:9.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;&nbsp;&nbsp;&nbsp;</p></td><td colspan="2" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:9.09%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">U.S.</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;&nbsp;&nbsp;&nbsp;</p></td><td colspan="2" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:9.09%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Int’l</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;&nbsp;&nbsp;&nbsp;</p></td><td colspan="2" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:9.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total</b></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:33.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">Established Pharmaceutical Products —</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;">&nbsp;&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;">&nbsp;&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;">&nbsp;&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;">&nbsp;&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;">&nbsp;&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;">&nbsp;&nbsp;</p></td></tr><tr><td style="vertical-align:bottom;width:33.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 6pt;">Key Emerging Markets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2019_To_9_30_2019_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_abt_EstablishedPharmaceuticalProductsMember_us-gaap_SubsegmentsAxis_abt_KeyEmergingMarketsMember_bgy9ptAnU0-twmp7vlQX_g" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_678Jvo67CEKIjsrBX_H-2g_4_6">891</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2019_To_9_30_2019_us-gaap_StatementBusinessSegmentsAxis_abt_EstablishedPharmaceuticalProductsMember_us-gaap_SubsegmentsAxis_abt_KeyEmergingMarketsMember_-4jRiCSDjkytdDmx88FCqw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_ZZMdqx9jsECxMDh-6PwrXA_4_9">891</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_abt_EstablishedPharmaceuticalProductsMember_us-gaap_SubsegmentsAxis_abt_KeyEmergingMarketsMember_ldKKNNrrkU-XqX8a-hQ-Iw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_Zh4d9VJhVUSFOrBn2PBpRw_4_15">866</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2018_To_9_30_2018_us-gaap_StatementBusinessSegmentsAxis_abt_EstablishedPharmaceuticalProductsMember_us-gaap_SubsegmentsAxis_abt_KeyEmergingMarketsMember_JgFC37IEWUigmQ2Wu8cPKg" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_ar3OuDepb06Gcf9Lg4R1OA_4_18">866</ix:nonfraction></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:33.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 6pt;">Other</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> —</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2019_To_9_30_2019_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_abt_EstablishedPharmaceuticalProductsMember_us-gaap_SubsegmentsAxis_abt_OtherMember_jIYhftUfu0-bwjIEJagUDg" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_3VrqAvpFPUSerKvKW9CG3Q_5_6">321</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2019_To_9_30_2019_us-gaap_StatementBusinessSegmentsAxis_abt_EstablishedPharmaceuticalProductsMember_us-gaap_SubsegmentsAxis_abt_OtherMember_SjDIqWEVq0y5-_mURGVcLA" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_Lj7d5kDKMUyYi9F2i8OTXg_5_9">321</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> —</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_abt_EstablishedPharmaceuticalProductsMember_us-gaap_SubsegmentsAxis_abt_OtherMember_8vDABO9tpUGGEsEVBaZ5_g" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_lxNEJ7tHd02X12X_qNnoFg_5_15">293</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2018_To_9_30_2018_us-gaap_StatementBusinessSegmentsAxis_abt_EstablishedPharmaceuticalProductsMember_us-gaap_SubsegmentsAxis_abt_OtherMember_Jrn3NzfC4Uyw_ky4SQbBqQ" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_CjoDywxI5kq0yfnGbvxmkg_5_18">293</ix:nonfraction></p></td></tr><tr><td style="vertical-align:bottom;width:33.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">Total</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2019_To_9_30_2019_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_abt_EstablishedPharmaceuticalProductsMember_1LR40F6sFUuQLjVrNbOfHg" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_R9UzsRmVrU-3fPxpaQRO0w_6_6">1,212</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2019_To_9_30_2019_us-gaap_StatementBusinessSegmentsAxis_abt_EstablishedPharmaceuticalProductsMember_UPmov4CjFEyXN-cCyAqTvQ" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_U8cqrIxY4U2RSrUyTRKM2w_6_9">1,212</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_abt_EstablishedPharmaceuticalProductsMember_tLWz-zYE_02qimeg1PI_6g" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_fXDcnqCQdkWFZQ7i5y4gaQ_6_15">1,159</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2018_To_9_30_2018_us-gaap_StatementBusinessSegmentsAxis_abt_EstablishedPharmaceuticalProductsMember_J2gj0gwvx0yLwbtJGADptg" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_za9FWtmOakW16DKzArSm_Q_6_18">1,159</ix:nonfraction></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:33.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:33.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">Nutritionals —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;">&nbsp;&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;">&nbsp;&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;">&nbsp;&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;">&nbsp;&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;">&nbsp;&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;">&nbsp;&nbsp;</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:33.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 6pt;">Pediatric Nutritionals</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2019_To_9_30_2019_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_abt_NutritionalProductsMember_us-gaap_SubsegmentsAxis_abt_PediatricNutritionalsMember_SzXn4bPJCEW7BHfrolxfLQ" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_1JEcoVB_ZkazJChSD7q52w_9_3">478</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2019_To_9_30_2019_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_abt_NutritionalProductsMember_us-gaap_SubsegmentsAxis_abt_PediatricNutritionalsMember_9LQvJzp5r0CYA1ui-3FGVQ" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_HSaPAjkcSUy20lmr4fev7g_9_6">566</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2019_To_9_30_2019_us-gaap_StatementBusinessSegmentsAxis_abt_NutritionalProductsMember_us-gaap_SubsegmentsAxis_abt_PediatricNutritionalsMember_976RYsis3UqxojGR9f5ynQ" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_0T2mcFs8p0izSnn81MQuDw_9_9">1,044</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_abt_NutritionalProductsMember_us-gaap_SubsegmentsAxis_abt_PediatricNutritionalsMember_qhqfrridv0ivQk77VRHKKA" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_pfaY7gwnh0GzMFCs6X8lqg_9_12">459</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_abt_NutritionalProductsMember_us-gaap_SubsegmentsAxis_abt_PediatricNutritionalsMember_AWD3p8tjeE2vg-6-IKXLjg" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_Ax6yTDIFyEiPE2DwNfPMxw_9_15">580</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2018_To_9_30_2018_us-gaap_StatementBusinessSegmentsAxis_abt_NutritionalProductsMember_us-gaap_SubsegmentsAxis_abt_PediatricNutritionalsMember_NUwCDw5ye0mfcQLDron2EQ" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_NRzX59QpFE2waudzPXteRw_9_18">1,039</ix:nonfraction></p></td></tr><tr><td style="vertical-align:bottom;width:33.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 6pt;">Adult Nutritionals</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2019_To_9_30_2019_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_abt_NutritionalProductsMember_us-gaap_SubsegmentsAxis_abt_AdultNutritionalsMember_rzk5uCysgEyRXIMweL-Iyg" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_9Jm2ftxJvEazI3_8l3Cp3w_10_3">310</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2019_To_9_30_2019_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_abt_NutritionalProductsMember_us-gaap_SubsegmentsAxis_abt_AdultNutritionalsMember_cupyFodQF0KFXZPS3bWTuw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_sMcW4naDSk6eGh2CdNCC_g_10_6">520</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2019_To_9_30_2019_us-gaap_StatementBusinessSegmentsAxis_abt_NutritionalProductsMember_us-gaap_SubsegmentsAxis_abt_AdultNutritionalsMember_2BKbQ1wBj0aSU1cYOdz0Kg" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_g_M17X4yyEaG6ZPjSyRejA_10_9">830</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_abt_NutritionalProductsMember_us-gaap_SubsegmentsAxis_abt_AdultNutritionalsMember_idKAm6SioEOnFYB0NkODzw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_V7qSfS2IG0aLLnqbtSuAqw_10_12">315</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_abt_NutritionalProductsMember_us-gaap_SubsegmentsAxis_abt_AdultNutritionalsMember__WHL05nK9U2cDb4T0gqFaw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_7_AYUIMHqkqATwoLn-2SSg_10_15">484</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2018_To_9_30_2018_us-gaap_StatementBusinessSegmentsAxis_abt_NutritionalProductsMember_us-gaap_SubsegmentsAxis_abt_AdultNutritionalsMember_Q4P0qz_KqUiyKdntC-48SA" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_qmOGMF5gakK7fn-TFIQ9Ng_10_18">799</ix:nonfraction></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:33.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">Total</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2019_To_9_30_2019_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_abt_NutritionalProductsMember_bEFmg-wCzE6foeLiaIYCsQ" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_SOpOotl12UCvPYCohIjqcA_11_3">788</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2019_To_9_30_2019_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_abt_NutritionalProductsMember_oT2HLUoSakWWwYJzHT9hMQ" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_ZsVqP4_o60eS_zf0fbhJrQ_11_6">1,086</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2019_To_9_30_2019_us-gaap_StatementBusinessSegmentsAxis_abt_NutritionalProductsMember_8lkMzw_11kKsRgBxOMYN_w" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_5XVvCKDML0qj3wqW8UhlZg_11_9">1,874</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_abt_NutritionalProductsMember_dExPpXJUbkyGeCOfkVHWpQ" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_1g15hSyqck2OoVvqZUv7og_11_12">774</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_abt_NutritionalProductsMember_raxyrZJf9UmFP239tyvKpA" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_-lkxvOts1U26yW29ed70XQ_11_15">1,064</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2018_To_9_30_2018_us-gaap_StatementBusinessSegmentsAxis_abt_NutritionalProductsMember_57RnstSlk0yNMWL17Wj6LA" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_JEyj9ikkDk6eRWYTvBc3-g_11_18">1,838</ix:nonfraction></p></td></tr><tr><td style="vertical-align:bottom;width:33.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:33.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">Diagnostics —</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;">&nbsp;&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;">&nbsp;&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;">&nbsp;&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;">&nbsp;&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;">&nbsp;&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;">&nbsp;&nbsp;</p></td></tr><tr><td style="vertical-align:bottom;width:33.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 6pt;">Core Laboratory</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2019_To_9_30_2019_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_abt_DiagnosticProductsMember_us-gaap_SubsegmentsAxis_abt_CoreLaboratoryMember_aCn2AwD9EESVYY6ZFaq71Q" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_0nA3u27yQ0i7txB8oxz0Xw_14_3">272</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2019_To_9_30_2019_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_abt_DiagnosticProductsMember_us-gaap_SubsegmentsAxis_abt_CoreLaboratoryMember_dl5ZvYMk4kuSWkoTlpN6Xg" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_XLgAyh1JOUaw8QzNrrR-jQ_14_6">905</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2019_To_9_30_2019_us-gaap_StatementBusinessSegmentsAxis_abt_DiagnosticProductsMember_us-gaap_SubsegmentsAxis_abt_CoreLaboratoryMember_vPRcgszCPUugGvpswdhVlw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_T-omFxdVp0K7RjroyPOcVA_14_9">1,177</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_abt_DiagnosticProductsMember_us-gaap_SubsegmentsAxis_abt_CoreLaboratoryMember_7vzsfQNtQU2J1_dt3kF9ug" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_Z7NZNoCdqEq_b4KeE35h2g_14_12">249</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_abt_DiagnosticProductsMember_us-gaap_SubsegmentsAxis_abt_CoreLaboratoryMember_72Zj7dwptkS48ifHmIUvAQ" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_VcuT-UGpxUetkNyr6TTkbQ_14_15">837</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2018_To_9_30_2018_us-gaap_StatementBusinessSegmentsAxis_abt_DiagnosticProductsMember_us-gaap_SubsegmentsAxis_abt_CoreLaboratoryMember_Kwmp14-MBU2HLyQAyIXRew" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_VKcW2MDpuU-Aqa5kjaTFcg_14_18">1,086</ix:nonfraction></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:33.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 6pt;">Molecular</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2019_To_9_30_2019_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_abt_DiagnosticProductsMember_us-gaap_SubsegmentsAxis_abt_MolecularMember_qyRBnR6LUEeKMhibUGfV5Q" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_yjVayVgL_kKwvDsBU9R8WQ_15_3">35</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2019_To_9_30_2019_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_abt_DiagnosticProductsMember_us-gaap_SubsegmentsAxis_abt_MolecularMember_qoz0Nqez5US14ZTIJFCULg" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_pMCl0Dygh0KFcNLLWucDiQ_15_6">76</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2019_To_9_30_2019_us-gaap_StatementBusinessSegmentsAxis_abt_DiagnosticProductsMember_us-gaap_SubsegmentsAxis_abt_MolecularMember_KrZx7LO4V0KUPPVNJMP5dw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_8COPlEh_yUGgGIMlS_D5sA_15_9">111</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_abt_DiagnosticProductsMember_us-gaap_SubsegmentsAxis_abt_MolecularMember_NttXxMfel0yxCy1XlmxrfQ" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_s8p0njtn-k62Q1DA_PWEAQ_15_12">37</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_abt_DiagnosticProductsMember_us-gaap_SubsegmentsAxis_abt_MolecularMember__D_PE8I3OEindYu1NbLgcQ" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_rXKZXB_A0UCyvzws6xRTqA_15_15">84</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2018_To_9_30_2018_us-gaap_StatementBusinessSegmentsAxis_abt_DiagnosticProductsMember_us-gaap_SubsegmentsAxis_abt_MolecularMember_fe6HW_Z8xUKRcRmkrFEMsQ" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_7Y4NrZBtSU6F1Tnzntu3Kg_15_18">121</ix:nonfraction></p></td></tr><tr><td style="vertical-align:bottom;width:33.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 6pt;">Point of Care</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2019_To_9_30_2019_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_abt_DiagnosticProductsMember_us-gaap_SubsegmentsAxis_abt_PointOfCareMember_XWGQFoQdEUiAvlbtHo302Q" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_roxGNcsaekuirQYGkqyY8Q_16_3">112</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2019_To_9_30_2019_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_abt_DiagnosticProductsMember_us-gaap_SubsegmentsAxis_abt_PointOfCareMember_IlnglBHPcUWRJKq4N1YNjA" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_4YtV98VxmkCm0UGSCz7K6w_16_6">32</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2019_To_9_30_2019_us-gaap_StatementBusinessSegmentsAxis_abt_DiagnosticProductsMember_us-gaap_SubsegmentsAxis_abt_PointOfCareMember_iTjfQpuHQk295KKZSIgOXA" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_i0K5l58qS0aq9-2-69o3VQ_16_9">144</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_abt_DiagnosticProductsMember_us-gaap_SubsegmentsAxis_abt_PointOfCareMember_wUeud0_4V064hlhBcYuAdA" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_vWjUnbbCgUe1_9qexOJxVA_16_12">106</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_abt_DiagnosticProductsMember_us-gaap_SubsegmentsAxis_abt_PointOfCareMember_QEJKvSON60uX0RgaFoxJ7A" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_cPnxohQ_lEGDEwieMwXbPQ_16_15">30</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2018_To_9_30_2018_us-gaap_StatementBusinessSegmentsAxis_abt_DiagnosticProductsMember_us-gaap_SubsegmentsAxis_abt_PointOfCareMember_vxjRnR9x6E-sXpauakPIuA" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_bzmKjgo_yUutPTLzen8nmA_16_18">136</ix:nonfraction></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:33.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 6pt;">Rapid Diagnostics</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2019_To_9_30_2019_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_abt_DiagnosticProductsMember_us-gaap_SubsegmentsAxis_abt_RapidDiagnosticsMember_YILLBrX3vUOKlVcSj18zbw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_suGbyvg1G0O5N_CO8cGyyA_17_3">283</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2019_To_9_30_2019_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_abt_DiagnosticProductsMember_us-gaap_SubsegmentsAxis_abt_RapidDiagnosticsMember_cgTz1NQZJUy98PVovLG8Tw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_lFBBHprcHEiyn4wfPy1LDg_17_6">194</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2019_To_9_30_2019_us-gaap_StatementBusinessSegmentsAxis_abt_DiagnosticProductsMember_us-gaap_SubsegmentsAxis_abt_RapidDiagnosticsMember_Ve5IaWAwqkSRhhjeNnyDSw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_GkDkUCa9jkmdJsQ4j8aMzA_17_9">477</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_abt_DiagnosticProductsMember_us-gaap_SubsegmentsAxis_abt_RapidDiagnosticsMember_xCWqGccXaUGfN-uFZtCLlQ" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_9l9yq5EFB0--NEzRxaoIMg_17_12">274</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_abt_DiagnosticProductsMember_us-gaap_SubsegmentsAxis_abt_RapidDiagnosticsMember_rTCEsB7JGk6j4XMMe-VrYw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_Z9v8ROhe4EmHB8yTzVU4IA_17_15">207</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2018_To_9_30_2018_us-gaap_StatementBusinessSegmentsAxis_abt_DiagnosticProductsMember_us-gaap_SubsegmentsAxis_abt_RapidDiagnosticsMember_-1-7phaylE2_xVddWdDF3g" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_XB_ZWzn4mEa0S4sjPECEZQ_17_18">481</ix:nonfraction></p></td></tr><tr><td style="vertical-align:bottom;width:33.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">Total</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2019_To_9_30_2019_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_abt_DiagnosticProductsMember_1j73vaBhXE6rBbcwQeS1mw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_CNFgJfkLLEeAc1VXIp9EDQ_18_3">702</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2019_To_9_30_2019_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_abt_DiagnosticProductsMember_YSy-Xaw760iEpiYy0q8FLA" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_mEpV18nhjUC5aLij4kXQnQ_18_6">1,207</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2019_To_9_30_2019_us-gaap_StatementBusinessSegmentsAxis_abt_DiagnosticProductsMember_Ubo4gT5EEU2HcN-NhX6g9w" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_6QiNVD1VaUmpTJGvqRvFNQ_18_9">1,909</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_abt_DiagnosticProductsMember_q7bwROz7nE-ltUPo0yBJ-Q" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_1HbxVnz0TUSrtJlAq1_kGw_18_12">666</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_abt_DiagnosticProductsMember_VylmzYtm4060eyorbe0okQ" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_pxAY8hBYn0-YoPfQTpNeDQ_18_15">1,158</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2018_To_9_30_2018_us-gaap_StatementBusinessSegmentsAxis_abt_DiagnosticProductsMember_Gh2Wf3zVFUCfVJ_wsdJ1RA" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_LN8s-ctu5UWLTJMMtbHLjA_18_18">1,824</ix:nonfraction></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:33.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:33.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">Cardiovascular and Neuromodulation —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;">&nbsp;&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;">&nbsp;&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;">&nbsp;&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;">&nbsp;&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;">&nbsp;&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;">&nbsp;&nbsp;</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:33.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 6pt;">Rhythm Management</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2019_To_9_30_2019_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_abt_CardiovascularAndNeuromodulationProductsMember_us-gaap_SubsegmentsAxis_abt_RhythmManagementMember_fb-4dThn10yJZ8h3qklQkg" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_qM0LmJNAb0amY_YuQ-v4TQ_21_3">265</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2019_To_9_30_2019_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_abt_CardiovascularAndNeuromodulationProductsMember_us-gaap_SubsegmentsAxis_abt_RhythmManagementMember_WZwSMzdqHkW5GtDxO2QxKg" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_XJQk1L_PvkCm4-ovspEooQ_21_6">273</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2019_To_9_30_2019_us-gaap_StatementBusinessSegmentsAxis_abt_CardiovascularAndNeuromodulationProductsMember_us-gaap_SubsegmentsAxis_abt_RhythmManagementMember_K9pc3Dchh06weXD6i_GKow" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_Vx93WY4J10SFxNEW5BnHKg_21_9">538</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_abt_CardiovascularAndNeuromodulationProductsMember_us-gaap_SubsegmentsAxis_abt_RhythmManagementMember_m3yA-5zDp0qmDHq5UFFOAg" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_cyLU71bx4ESVHcMjR3Cpdw_21_12">272</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_abt_CardiovascularAndNeuromodulationProductsMember_us-gaap_SubsegmentsAxis_abt_RhythmManagementMember_3IvlwllLt02baa4uZqWbAw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_4FZcKvCdC0mr3igxfZdHxA_21_15">261</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2018_To_9_30_2018_us-gaap_StatementBusinessSegmentsAxis_abt_CardiovascularAndNeuromodulationProductsMember_us-gaap_SubsegmentsAxis_abt_RhythmManagementMember_7HSNIF4euk2vfuOkKtrpEA" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_WL2X0kIxsUWXgD2kKD8tWQ_21_18">533</ix:nonfraction></p></td></tr><tr><td style="vertical-align:bottom;width:33.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 6pt;">Electrophysiology</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2019_To_9_30_2019_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_abt_CardiovascularAndNeuromodulationProductsMember_us-gaap_SubsegmentsAxis_abt_ElectrophysiologyMember_2fuYjLwTIUOgCvY-a3GxGw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_62MLrbbmCEOjDb4CoINt2Q_22_3">185</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2019_To_9_30_2019_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_abt_CardiovascularAndNeuromodulationProductsMember_us-gaap_SubsegmentsAxis_abt_ElectrophysiologyMember_hnD-NKsM5km1-tXMGmqsFw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_CocaNTaj20GYW-HlwV4hyg_22_6">242</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2019_To_9_30_2019_us-gaap_StatementBusinessSegmentsAxis_abt_CardiovascularAndNeuromodulationProductsMember_us-gaap_SubsegmentsAxis_abt_ElectrophysiologyMember_ernxN__VPU-oEqodwTAdMQ" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_HN3AMbPyHEu6D9hPxd5yGg_22_9">427</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_abt_CardiovascularAndNeuromodulationProductsMember_us-gaap_SubsegmentsAxis_abt_ElectrophysiologyMember_FIHIQBg5KUmiQggufzOCcQ" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_VzmZDx4eUEyE70bxFgcF0w_22_12">169</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_abt_CardiovascularAndNeuromodulationProductsMember_us-gaap_SubsegmentsAxis_abt_ElectrophysiologyMember_Fj3XVsBe8kSQAPAhhC6YAg" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc__Bk3WXHvoEGrI_rbAlUv9Q_22_15">212</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2018_To_9_30_2018_us-gaap_StatementBusinessSegmentsAxis_abt_CardiovascularAndNeuromodulationProductsMember_us-gaap_SubsegmentsAxis_abt_ElectrophysiologyMember_xlB1a_zUh0O7blChJvVDOA" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_UCtivAqm-EW9SzZKMf2lQA_22_18">381</ix:nonfraction></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:33.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 6pt;">Heart Failure</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2019_To_9_30_2019_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_abt_CardiovascularAndNeuromodulationProductsMember_us-gaap_SubsegmentsAxis_abt_HeartFailureMember_rYLUPr4I9kuwrvzydgFAqw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_9W1Id8Gr-UmgFS4xX9LG2w_23_3">136</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2019_To_9_30_2019_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_abt_CardiovascularAndNeuromodulationProductsMember_us-gaap_SubsegmentsAxis_abt_HeartFailureMember_p-WU_6QEsU6mCTFr_0DKSQ" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_6nATV6jno02TUEaMmyC69Q_23_6">50</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2019_To_9_30_2019_us-gaap_StatementBusinessSegmentsAxis_abt_CardiovascularAndNeuromodulationProductsMember_us-gaap_SubsegmentsAxis_abt_HeartFailureMember_04nztperEkSCSKRnUjx8Ow" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_ZyK_4M14GkmOgxrwy5i0LQ_23_9">186</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_abt_CardiovascularAndNeuromodulationProductsMember_us-gaap_SubsegmentsAxis_abt_HeartFailureMember_iOvQXiIto06t2GN8FWWNOQ" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_akQFdC1IQ0GRmRf5cUHm-A_23_12">111</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_abt_CardiovascularAndNeuromodulationProductsMember_us-gaap_SubsegmentsAxis_abt_HeartFailureMember_9po6MiXhEEijh4ATr4rlHQ" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_FWPwnjVpMEGk9t0OeVu0xg_23_15">41</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2018_To_9_30_2018_us-gaap_StatementBusinessSegmentsAxis_abt_CardiovascularAndNeuromodulationProductsMember_us-gaap_SubsegmentsAxis_abt_HeartFailureMember_ryer5-DKE02MjUBiUR047g" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_Wuubx0W_7E-F3MEhUq5ASg_23_18">152</ix:nonfraction></p></td></tr><tr><td style="vertical-align:bottom;width:33.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 6pt;">Vascular</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2019_To_9_30_2019_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_abt_CardiovascularAndNeuromodulationProductsMember_us-gaap_SubsegmentsAxis_abt_VascularProductsMember_iYJ9jxGHnEaLMXd5RVPDEg" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_5CTQpIvoyUSxnbSkkAm9Zw_24_3">251</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2019_To_9_30_2019_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_abt_CardiovascularAndNeuromodulationProductsMember_us-gaap_SubsegmentsAxis_abt_VascularProductsMember_vbCXVbMlXU-8dmSsvUrnVw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_HF84NNjnpUy_VSAO0s_ZoA_24_6">446</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2019_To_9_30_2019_us-gaap_StatementBusinessSegmentsAxis_abt_CardiovascularAndNeuromodulationProductsMember_us-gaap_SubsegmentsAxis_abt_VascularProductsMember_b-XPV2IDikKoNi1qYrjrmw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_xGMXUeeYYU2pOg9SqsEFQg_24_9">697</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_abt_CardiovascularAndNeuromodulationProductsMember_us-gaap_SubsegmentsAxis_abt_VascularProductsMember_l8ldpU3g4EC2TrAJQyIdpA" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_Inp9082StE6c2j_SmSwpPA_24_12">284</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_abt_CardiovascularAndNeuromodulationProductsMember_us-gaap_SubsegmentsAxis_abt_VascularProductsMember_yQyV75axvUmUkNWa5diU2g" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_1047K-qZkUW3vHYSPm_PRQ_24_15">436</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2018_To_9_30_2018_us-gaap_StatementBusinessSegmentsAxis_abt_CardiovascularAndNeuromodulationProductsMember_us-gaap_SubsegmentsAxis_abt_VascularProductsMember_JP_Nd1U9u0mAgC8xFdvSEg" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_I1s1BknhkUmQoGa9VE7d5Q_24_18">720</ix:nonfraction></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:33.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 6pt;">Structural Heart</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2019_To_9_30_2019_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_abt_CardiovascularAndNeuromodulationProductsMember_us-gaap_SubsegmentsAxis_abt_StructuralHeartMember_50Zc3aDRgkmZiAf7S4m21w" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_wrUM5ptkEEu6_7408LMWiA_25_3">158</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2019_To_9_30_2019_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_abt_CardiovascularAndNeuromodulationProductsMember_us-gaap_SubsegmentsAxis_abt_StructuralHeartMember_xtYMjKglhU24eVDSNPCqAg" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_aXrbVbDv20eBIQiHh8v2kw_25_6">190</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2019_To_9_30_2019_us-gaap_StatementBusinessSegmentsAxis_abt_CardiovascularAndNeuromodulationProductsMember_us-gaap_SubsegmentsAxis_abt_StructuralHeartMember_P4XTM4mlAESkH616NyY33Q" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_zrHnwO4E2ki81BGLVrN4-w_25_9">348</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_abt_CardiovascularAndNeuromodulationProductsMember_us-gaap_SubsegmentsAxis_abt_StructuralHeartMember_RTVWuCshF0OfYrMaxjAR_w" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_PEtjh5nhXE-pKfQLjQb8eg_25_12">126</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_abt_CardiovascularAndNeuromodulationProductsMember_us-gaap_SubsegmentsAxis_abt_StructuralHeartMember_LzWdJR5pp0a9zla2NJyq-w" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_4rO6UIQezEe3R-4vRyb6yQ_25_15">179</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2018_To_9_30_2018_us-gaap_StatementBusinessSegmentsAxis_abt_CardiovascularAndNeuromodulationProductsMember_us-gaap_SubsegmentsAxis_abt_StructuralHeartMember_4kEn6XWAA0-l3kW_blDigg" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_GZHQLiuKtE6SZ8PpWeAYZA_25_18">305</ix:nonfraction></p></td></tr><tr><td style="vertical-align:bottom;width:33.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 6pt;">Neuromodulation</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2019_To_9_30_2019_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_abt_CardiovascularAndNeuromodulationProductsMember_us-gaap_SubsegmentsAxis_abt_NeuromodulationMember_xmnVw0TYg0iDFphAjwSofw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_LOlCrlvlN0KPwQh2WYb6FQ_26_3">165</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2019_To_9_30_2019_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_abt_CardiovascularAndNeuromodulationProductsMember_us-gaap_SubsegmentsAxis_abt_NeuromodulationMember_bUVk6i7h60uRzua0S3pauw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_GPMSKbuIj0m4yJoQNpXhSQ_26_6">39</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2019_To_9_30_2019_us-gaap_StatementBusinessSegmentsAxis_abt_CardiovascularAndNeuromodulationProductsMember_us-gaap_SubsegmentsAxis_abt_NeuromodulationMember_aNfGTkNG0kS2QouYGOmngQ" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_YDOhqP1NPEyT169wLv2T7w_26_9">204</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_abt_CardiovascularAndNeuromodulationProductsMember_us-gaap_SubsegmentsAxis_abt_NeuromodulationMember_lv5cAAyQSUC2df2WvUTMCA" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_IsjtNp4DP0qZDGUUzyrh9g_26_12">172</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_abt_CardiovascularAndNeuromodulationProductsMember_us-gaap_SubsegmentsAxis_abt_NeuromodulationMember_mTNBfr7pHU6c2G82UlK06w" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_OPT36ERPskSn5wW-Pa4rYQ_26_15">40</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2018_To_9_30_2018_us-gaap_StatementBusinessSegmentsAxis_abt_CardiovascularAndNeuromodulationProductsMember_us-gaap_SubsegmentsAxis_abt_NeuromodulationMember_SK9yHyWHYUatIEUbcFcRig" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_HCsLmayenE6Yy8saNXopvA_26_18">212</ix:nonfraction></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:33.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">Total</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2019_To_9_30_2019_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_abt_CardiovascularAndNeuromodulationProductsMember_8iQVxUuufEucAQ1AQXnVsQ" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_qOWBkVFrTkWkU3oly7AEPg_27_3">1,160</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2019_To_9_30_2019_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_abt_CardiovascularAndNeuromodulationProductsMember_s0DArMiyqEu24fIc2JIKgA" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_GH694mUlXUevOWhkbuT3rw_27_6">1,240</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2019_To_9_30_2019_us-gaap_StatementBusinessSegmentsAxis_abt_CardiovascularAndNeuromodulationProductsMember_Fzj1rSlp6kmj4ESuAXv0kA" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_06iT9kESaESM5zlmTKBx9A_27_9">2,400</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_abt_CardiovascularAndNeuromodulationProductsMember_X0be1Nj3qkyFgBrHlTc1xQ" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_A129Yc5WbEmlniNJUKchtg_27_12">1,134</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_abt_CardiovascularAndNeuromodulationProductsMember_SmbbHTawSUGZQKKkbDMLLA" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_vjOPOLT1lU6KiyLC4Wx9Dg_27_15">1,169</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2018_To_9_30_2018_us-gaap_StatementBusinessSegmentsAxis_abt_CardiovascularAndNeuromodulationProductsMember_hRE3mhMnK0Wq8-WRIGY3wA" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_HvJh-5YfX06v7lc4NeOH3g_27_18">2,303</ix:nonfraction></p></td></tr><tr><td style="vertical-align:bottom;width:33.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:33.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">Other</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2019_To_9_30_2019_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_us-gaap_AllOtherSegmentsMember_i2mGdZr7_UqJUMRww-PqQA" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_WjqHFWZxzUu2v_WM3XBZTA_29_3">184</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2019_To_9_30_2019_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_us-gaap_AllOtherSegmentsMember_Ts1FZsOaDE-I3KdK0RVK4w" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_GvKmTZXs0UOoruXdZhlJiw_29_6">497</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2019_To_9_30_2019_us-gaap_StatementBusinessSegmentsAxis_us-gaap_AllOtherSegmentsMember_6xuLziuqYUu7G9wnH5DWIQ" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_brzMBpf5TU-tiUm5rN0KMg_29_9">681</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_us-gaap_AllOtherSegmentsMember_mz5NtRWGr0exz2I2pFOEFw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_THSXj--PSkKjTzR9jRhuCA_29_12">133</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_us-gaap_AllOtherSegmentsMember_L0KZBzlFjkuEZSn8UtIQyA" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_4cwA-_7Y_0WqCQuyy9RJ8Q_29_15">399</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2018_To_9_30_2018_us-gaap_StatementBusinessSegmentsAxis_us-gaap_AllOtherSegmentsMember_m4XzPpMweEeW0W5huKZbPA" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_9U_D8Lr0xkKSR3MwF7GQgg_29_18">532</ix:nonfraction></p></td></tr><tr><td style="vertical-align:bottom;width:33.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">Total</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2019_To_9_30_2019_srt_StatementGeographicalAxis_country_US_qX6FunLEQ02ntrQ53zJrQw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_wUC7yPZr80OjUk6OHvEB_g_30_3">2,834</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2019_To_9_30_2019_srt_StatementGeographicalAxis_us-gaap_NonUsMember_wUQa4HN-5E2xVdeYhfgKqw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_sDrOWB4tkkeYyqj815p1zQ_30_6">5,242</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.86%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2019_To_9_30_2019_5CXepWtEPEKQA-bPz0Tp7A" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_OiLMc1WeFU2XGAajurzH2w_30_9">8,076</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_country_US_B8o1dDBmBkGc0Yqk6NufRA" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_JwHPWjBpdk-5YZZ89ZQyJg_30_12">2,707</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_us-gaap_NonUsMember_AqYCjXibuES-Z_E4tis87A" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_ENHG39WdH0yFuIiu_YpXUA_30_15">4,949</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.86%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2018_To_9_30_2018_lS4NEZw67ECck2zY72MWgg" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_Ixj7uJWJdUS4fIzvx6mYXg_30_18">7,656</ix:nonfraction></p></td></tr></tbody></table><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tbody><tr style="height:1pt;"><td style="vertical-align:bottom;width:33.47%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="background-color:auto;vertical-align:bottom;width:33.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="8" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:31.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Nine Months Ended September&nbsp;30,&nbsp;2019</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="8" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:31.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Nine Months Ended September&nbsp;30,&nbsp;2018</b></p></td></tr><tr><td style="background-color:auto;vertical-align:bottom;width:33.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">(in millions)</p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&nbsp;&nbsp;&nbsp;&nbsp;</b></p></td><td colspan="2" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:9.09%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">U.S.</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&nbsp;&nbsp;&nbsp;&nbsp;</b></p></td><td colspan="2" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:9.09%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Int’l</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&nbsp;&nbsp;&nbsp;&nbsp;</b></p></td><td colspan="2" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:9.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total&nbsp;</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&nbsp;&nbsp;&nbsp;&nbsp;</b></p></td><td colspan="2" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:9.09%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">U.S.</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&nbsp;&nbsp;&nbsp;&nbsp;</b></p></td><td colspan="2" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:9.09%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Int’l</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&nbsp;&nbsp;&nbsp;&nbsp;</b></p></td><td colspan="2" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:9.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total</b></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:33.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">Established Pharmaceutical Products —</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;">&nbsp;&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;">&nbsp;&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;">&nbsp;&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;">&nbsp;&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;">&nbsp;&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;">&nbsp;&nbsp;</p></td></tr><tr><td style="vertical-align:bottom;width:33.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 6pt;">Key Emerging Markets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_abt_EstablishedPharmaceuticalProductsMember_us-gaap_SubsegmentsAxis_abt_KeyEmergingMarketsMember_LPUI0oDmWU-j2xWHTY_izA" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_tB3C9jEJxE-dJTr76Se2tw_4_6">2,496</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_us-gaap_StatementBusinessSegmentsAxis_abt_EstablishedPharmaceuticalProductsMember_us-gaap_SubsegmentsAxis_abt_KeyEmergingMarketsMember_ROT06gEF_ky5_H5eUTqmcQ" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_TzjR-Artyk6IBj7JxI6d8w_4_9">2,496</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_abt_EstablishedPharmaceuticalProductsMember_us-gaap_SubsegmentsAxis_abt_KeyEmergingMarketsMember_5pvQOTwNiU6K-rx3ltiOAw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_qEZ5AlpwfUuhpEU0miO4YQ_4_15">2,525</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2018_To_9_30_2018_us-gaap_StatementBusinessSegmentsAxis_abt_EstablishedPharmaceuticalProductsMember_us-gaap_SubsegmentsAxis_abt_KeyEmergingMarketsMember_2s7wtAp3qU-Chjo9CboO_A" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_bbWBooa4XESaTkx2ycs-Tw_4_18">2,525</ix:nonfraction></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:33.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 6pt;">Other</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> —</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_abt_EstablishedPharmaceuticalProductsMember_us-gaap_SubsegmentsAxis_abt_OtherMember_udvUuA8JQk6GVtIypFNiJA" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_U5Bws8nQCEKbu5sAFP_PAw_5_6">816</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_us-gaap_StatementBusinessSegmentsAxis_abt_EstablishedPharmaceuticalProductsMember_us-gaap_SubsegmentsAxis_abt_OtherMember_uwJHMEPVoUW0jm0X5wr_Xw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_6mcA7DbTbk-kFcLL0r2r3Q_5_9">816</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> —</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_abt_EstablishedPharmaceuticalProductsMember_us-gaap_SubsegmentsAxis_abt_OtherMember_3z7ssMZwx0ekO38AvlwJUg" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_YXYy6BpUZkCNAnATg_MY1A_5_15">807</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2018_To_9_30_2018_us-gaap_StatementBusinessSegmentsAxis_abt_EstablishedPharmaceuticalProductsMember_us-gaap_SubsegmentsAxis_abt_OtherMember_2ipXfDTKvkakuX16A9Uwxg" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_jZ5x342sEkSS8gk4QL4hyg_5_18">807</ix:nonfraction></p></td></tr><tr><td style="vertical-align:bottom;width:33.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">Total</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_abt_EstablishedPharmaceuticalProductsMember_CflaIMgy5UOm17GJSrclIw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_3VhX3T3UB0mAmDJQW5zLHg_6_6">3,312</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_us-gaap_StatementBusinessSegmentsAxis_abt_EstablishedPharmaceuticalProductsMember_yudMSsrKEEaqBwE_PqUYVA" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_1DoZW-DPp0C6tRMZWe3qCQ_6_9">3,312</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_abt_EstablishedPharmaceuticalProductsMember_VBkoNFFtyUe92H90R2_2YA" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_W9E9QDfbnkC8xJ_q9wzy5Q_6_15">3,332</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2018_To_9_30_2018_us-gaap_StatementBusinessSegmentsAxis_abt_EstablishedPharmaceuticalProductsMember_48RJq_PWeUmNmmAC7FfiVA" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_r4B9cizG9U-B5qhGekDrcg_6_18">3,332</ix:nonfraction></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:33.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:33.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">Nutritionals&nbsp;—</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;">&nbsp;&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;">&nbsp;&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;">&nbsp;&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;">&nbsp;&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;">&nbsp;&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;">&nbsp;&nbsp;</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:33.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 6pt;">Pediatric Nutritionals</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_abt_NutritionalProductsMember_us-gaap_SubsegmentsAxis_abt_PediatricNutritionalsMember_m0_e2THpSUO0sjNQITLhvA" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_md1U_yEdik-sVtUghzDhQQ_9_3">1,406</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_abt_NutritionalProductsMember_us-gaap_SubsegmentsAxis_abt_PediatricNutritionalsMember_QqbNfDCuzEybKrjzuM5img" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_nTpp2WGRz0a6K8awE3_pbQ_9_6">1,718</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_us-gaap_StatementBusinessSegmentsAxis_abt_NutritionalProductsMember_us-gaap_SubsegmentsAxis_abt_PediatricNutritionalsMember_URy4dMFQ6kauU2M9MC26jg" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_W7BGM0bKU0e862LIpxQ-mQ_9_9">3,124</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_abt_NutritionalProductsMember_us-gaap_SubsegmentsAxis_abt_PediatricNutritionalsMember_bGXusL3u9k6U8TMi8HVW8w" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_iswn7dY-LUSAphZxB5LDqA_9_12">1,376</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_abt_NutritionalProductsMember_us-gaap_SubsegmentsAxis_abt_PediatricNutritionalsMember_FOyum4V_-0mPsycrZvLv1g" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_YBdjL0vfP0eQhHpJG4pmkQ_9_15">1,708</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2018_To_9_30_2018_us-gaap_StatementBusinessSegmentsAxis_abt_NutritionalProductsMember_us-gaap_SubsegmentsAxis_abt_PediatricNutritionalsMember_zBtjQdRUhE2g4SMtz5VZTQ" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_Xe-vEABZdEqjVqE3kDwk-w_9_18">3,084</ix:nonfraction></p></td></tr><tr><td style="vertical-align:bottom;width:33.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 6pt;">Adult Nutritionals</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_abt_NutritionalProductsMember_us-gaap_SubsegmentsAxis_abt_AdultNutritionalsMember_TKVQehiq-kyU8-9FUZbT1A" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_HglnwAc04k2sE5yV7jfL2g_10_3">915</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_abt_NutritionalProductsMember_us-gaap_SubsegmentsAxis_abt_AdultNutritionalsMember_OogYjHd1sUG3RPEAQotJTA" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_HCEhPx2EDU-xnigu5g12oA_10_6">1,502</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_us-gaap_StatementBusinessSegmentsAxis_abt_NutritionalProductsMember_us-gaap_SubsegmentsAxis_abt_AdultNutritionalsMember_cRT25-H8nUKJwb_14a9hRg" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_IAwftEwWuEGdAQ-0VKdQZw_10_9">2,417</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_abt_NutritionalProductsMember_us-gaap_SubsegmentsAxis_abt_AdultNutritionalsMember_dlk89i5CYk2ZIySFgrHtDw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_TjbGGmTEwkWgREbkv9O2nw_10_12">937</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_abt_NutritionalProductsMember_us-gaap_SubsegmentsAxis_abt_AdultNutritionalsMember_YFBvcSbr80CYnNULiJsG4g" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_l8LgYjv7w0KVXCbULBcmxg_10_15">1,431</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2018_To_9_30_2018_us-gaap_StatementBusinessSegmentsAxis_abt_NutritionalProductsMember_us-gaap_SubsegmentsAxis_abt_AdultNutritionalsMember_RIjQ9XJYtkyEqZun4o2llA" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_bp3nbN5Fg0-b_khkaZ43xQ_10_18">2,368</ix:nonfraction></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:33.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">Total</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_abt_NutritionalProductsMember_0XlMOXiE3UiWn3X2OfAkVQ" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_eLNV83eDsUGBWAmAFxE1ZQ_11_3">2,321</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_abt_NutritionalProductsMember_P40qehTnCUm7Y4NHd6R69A" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_dNkd0JZss0uWeUiuCYnvuw_11_6">3,220</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_us-gaap_StatementBusinessSegmentsAxis_abt_NutritionalProductsMember_DB1vUa6_7kOTq3NjihMp-Q" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_h5A0zbeFoESQZvxlmlnvEA_11_9">5,541</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_abt_NutritionalProductsMember_CFr9InAyH0-KqXb8IZGU8w" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_Knzx71dvvE67NhRJ8k6VVg_11_12">2,313</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_abt_NutritionalProductsMember_Mr0cnbPnjE26CUPDMINkmg" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_o7Z0QI-kbkaECrt9g0bWQA_11_15">3,139</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2018_To_9_30_2018_us-gaap_StatementBusinessSegmentsAxis_abt_NutritionalProductsMember_KMUzb4jAPkyU8PkU49lN2A" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_2_Xeva6ZVEmN2CPOFG1EUA_11_18">5,452</ix:nonfraction></p></td></tr><tr><td style="vertical-align:bottom;width:33.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:33.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">Diagnostics&nbsp;—</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;">&nbsp;&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;">&nbsp;&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;">&nbsp;&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;">&nbsp;&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;">&nbsp;&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;">&nbsp;&nbsp;</p></td></tr><tr><td style="vertical-align:bottom;width:33.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 6pt;">Core Laboratory</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_abt_DiagnosticProductsMember_us-gaap_SubsegmentsAxis_abt_CoreLaboratoryMember_oIZFz0vC-0GmMHYgo0iE3Q" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_Xj4dQ-0BxUSnfmP3hmbVzw_14_3">793</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_abt_DiagnosticProductsMember_us-gaap_SubsegmentsAxis_abt_CoreLaboratoryMember_5mlkR1388EGEPz4gHTI2qQ" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_6XtMKpT-Ek2dJ2V2u2qn-w_14_6">2,614</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_us-gaap_StatementBusinessSegmentsAxis_abt_DiagnosticProductsMember_us-gaap_SubsegmentsAxis_abt_CoreLaboratoryMember_vHvAHLT_Z0-zRt4hFSgiUg" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_noZsP6DZFUanLmR3tdi4aw_14_9">3,407</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_abt_DiagnosticProductsMember_us-gaap_SubsegmentsAxis_abt_CoreLaboratoryMember_ByIiCW_7zECHUy_GfwafIg" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_5l70MG-ezk6jdl5o3SCORQ_14_12">725</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_abt_DiagnosticProductsMember_us-gaap_SubsegmentsAxis_abt_CoreLaboratoryMember_XsdpDnHvS0iyhvTnOObq2g" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_NCFlECXnSkOTDYpkNFFFVg_14_15">2,508</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2018_To_9_30_2018_us-gaap_StatementBusinessSegmentsAxis_abt_DiagnosticProductsMember_us-gaap_SubsegmentsAxis_abt_CoreLaboratoryMember_YGWOOwbOg0mFaueUZlE8RQ" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_T9p0be8Zf0aaUtLY6bl0tA_14_18">3,233</ix:nonfraction></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:33.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 6pt;">Molecular</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_abt_DiagnosticProductsMember_us-gaap_SubsegmentsAxis_abt_MolecularMember_CoDi1EE57EKVMVyJv498bQ" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_TITHqErRf0G94wnvfLM_1Q_15_3">113</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_abt_DiagnosticProductsMember_us-gaap_SubsegmentsAxis_abt_MolecularMember_eOYdJ2sAFkS2fbVLnkUS0A" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_yzTMn_wH2kC6VZAxtd94ug_15_6">213</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_us-gaap_StatementBusinessSegmentsAxis_abt_DiagnosticProductsMember_us-gaap_SubsegmentsAxis_abt_MolecularMember_g-4s0I2g3kCV2ytoWXv6vw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_vn6R-pHEWUWXOfgeQBJHww_15_9">326</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_abt_DiagnosticProductsMember_us-gaap_SubsegmentsAxis_abt_MolecularMember_We37m3Q7JUy1xeLeSVAwkg" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_kxmJ4rILaEmaL6N23RBdUA_15_12">114</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_abt_DiagnosticProductsMember_us-gaap_SubsegmentsAxis_abt_MolecularMember_bNdp6W-Tz0-uUi8GZjdC1w" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_EACMT4XCrkSvKlxxr7hZhA_15_15">247</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2018_To_9_30_2018_us-gaap_StatementBusinessSegmentsAxis_abt_DiagnosticProductsMember_us-gaap_SubsegmentsAxis_abt_MolecularMember_nOI7tga5uU-RzB9AsnsvfQ" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_cj6LJcqQkEKOGK5J0W5VBg_15_18">361</ix:nonfraction></p></td></tr><tr><td style="vertical-align:bottom;width:33.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 6pt;">Point of Care</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_abt_DiagnosticProductsMember_us-gaap_SubsegmentsAxis_abt_PointOfCareMember_tvi2DAuyFUaqi6ZkDGnmCQ" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_YcI0v70ts0Sgnc5A6H7GEQ_16_3">334</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_abt_DiagnosticProductsMember_us-gaap_SubsegmentsAxis_abt_PointOfCareMember_8RABzKisSkiroyF1jhPrpw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_oBIHoA2Fwk-bWdx4ySHPiQ_16_6">90</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_us-gaap_StatementBusinessSegmentsAxis_abt_DiagnosticProductsMember_us-gaap_SubsegmentsAxis_abt_PointOfCareMember_uht8HK5xIEyDIWXOB-a7Ew" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_hBc7uHgeAESHWugdEOpypA_16_9">424</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_abt_DiagnosticProductsMember_us-gaap_SubsegmentsAxis_abt_PointOfCareMember_OQDh2H2FvUiLUV_svBJUuQ" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_dMrBJLFuTUiAaHFjuWgoHg_16_12">324</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_abt_DiagnosticProductsMember_us-gaap_SubsegmentsAxis_abt_PointOfCareMember_z-S6-8NvWkq2QojMzbyehA" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_rw_rH1ZMik26DvyMHcHy1w_16_15">92</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2018_To_9_30_2018_us-gaap_StatementBusinessSegmentsAxis_abt_DiagnosticProductsMember_us-gaap_SubsegmentsAxis_abt_PointOfCareMember_uVJFPGaxmUGSwuVX6qn6-w" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_4CYyvKqHXkSbPD_VHLjyxA_16_18">416</ix:nonfraction></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:33.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 6pt;">Rapid Diagnostics</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_abt_DiagnosticProductsMember_us-gaap_SubsegmentsAxis_abt_RapidDiagnosticsMember_EmyWK6_OC0GET4cdIfRG3Q" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_gRTzHqnS4k-cQVTB5O2JLw_17_3">881</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_abt_DiagnosticProductsMember_us-gaap_SubsegmentsAxis_abt_RapidDiagnosticsMember_0NhiyGWe9ESlX0vUlE7UNQ" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_i4bp7TzUX0i57ruy-VNcsg_17_6">617</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_us-gaap_StatementBusinessSegmentsAxis_abt_DiagnosticProductsMember_us-gaap_SubsegmentsAxis_abt_RapidDiagnosticsMember_cEIHxCMuEka9NVqIaOOiGw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_6ffclT9uSEWmZVXSjFczFQ_17_9">1,498</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_abt_DiagnosticProductsMember_us-gaap_SubsegmentsAxis_abt_RapidDiagnosticsMember_4JPb8wEqjk20sp0pcatwIg" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_e0OgJsji3Ey30dCBVB1Xuw_17_12">855</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_abt_DiagnosticProductsMember_us-gaap_SubsegmentsAxis_abt_RapidDiagnosticsMember_XwhdtA2DYUenS6x0ANFORg" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_qWnCKzqgzkuRPiha0LPw3Q_17_15">669</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2018_To_9_30_2018_us-gaap_StatementBusinessSegmentsAxis_abt_DiagnosticProductsMember_us-gaap_SubsegmentsAxis_abt_RapidDiagnosticsMember_x8r1CxqLtEW9ljpb9_59AA" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_Xg-hDe3rqUeXhHZtZRgS6w_17_18">1,524</ix:nonfraction></p></td></tr><tr><td style="vertical-align:bottom;width:33.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">Total</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_abt_DiagnosticProductsMember_tuo4ZRxP5EyPHkkO5iEr3w" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_bkbUCGP_1kq6g_W6T5h2lw_18_3">2,121</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_abt_DiagnosticProductsMember_MoxoL5_2GES5O8ZAxasNxg" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_grvH18cIaUaE99QFQw89Tg_18_6">3,534</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_us-gaap_StatementBusinessSegmentsAxis_abt_DiagnosticProductsMember_99hhFMIAyki-Cl9qbcjYEg" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_abDhx_kOQkS2ZrtLwgCJzg_18_9">5,655</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_abt_DiagnosticProductsMember_d2w5vkkpmEioOWl8FtTS-Q" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_U1vfVY6A7ESf6y67UxsZNg_18_12">2,018</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_abt_DiagnosticProductsMember_uZdDKX3HLkqBln3Nxdz5zw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_lSkzEeua8kCpd2_ko0Af2A_18_15">3,516</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2018_To_9_30_2018_us-gaap_StatementBusinessSegmentsAxis_abt_DiagnosticProductsMember_xkFfRuL34kKosrhzdwxSRQ" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_P-YgGic9oEi9r8NDY3NB3w_18_18">5,534</ix:nonfraction></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:33.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:33.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">Cardiovascular and Neuromodulation&nbsp;—</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;">&nbsp;&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;">&nbsp;&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;">&nbsp;&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;">&nbsp;&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;">&nbsp;&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;">&nbsp;&nbsp;</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:33.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 6pt;">Rhythm Management</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_abt_CardiovascularAndNeuromodulationProductsMember_us-gaap_SubsegmentsAxis_abt_RhythmManagementMember_RCLLI31oW0CxXcKrNaJwcA" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_QeSJ7b0AyUWssc0p5aB9dQ_21_3">790</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_abt_CardiovascularAndNeuromodulationProductsMember_us-gaap_SubsegmentsAxis_abt_RhythmManagementMember_MQyhUqd6QUGn-psLVLhD8w" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_fCZD9xYfvk-jmqueF4jbaw_21_6">810</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_us-gaap_StatementBusinessSegmentsAxis_abt_CardiovascularAndNeuromodulationProductsMember_us-gaap_SubsegmentsAxis_abt_RhythmManagementMember_npRdt3_XZkSzvy1yQIlP-g" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_XkV4msJi506815cO0Aeflg_21_9">1,600</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_abt_CardiovascularAndNeuromodulationProductsMember_us-gaap_SubsegmentsAxis_abt_RhythmManagementMember_-CcPBQOMHke9S9fOwnBNpQ" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_N7cXXFEQf0KLDKhubAScEQ_21_12">843</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_abt_CardiovascularAndNeuromodulationProductsMember_us-gaap_SubsegmentsAxis_abt_RhythmManagementMember_fiXAovA1wUakFhWTkQnN4g" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_eJtOcdZpW0q5iJw7G01yCQ_21_15">824</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2018_To_9_30_2018_us-gaap_StatementBusinessSegmentsAxis_abt_CardiovascularAndNeuromodulationProductsMember_us-gaap_SubsegmentsAxis_abt_RhythmManagementMember_nSpxl2P3lEiCflnYuHWuog" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_3EZT6Hm_PkKHsfFeUyKtRQ_21_18">1,667</ix:nonfraction></p></td></tr><tr><td style="vertical-align:bottom;width:33.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 6pt;">Electrophysiology</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_abt_CardiovascularAndNeuromodulationProductsMember_us-gaap_SubsegmentsAxis_abt_ElectrophysiologyMember_B-InUodp-0axFdMh4cyTEg" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_OZ_HjrYinke_-W9y2vxZeg_22_3">549</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_abt_CardiovascularAndNeuromodulationProductsMember_us-gaap_SubsegmentsAxis_abt_ElectrophysiologyMember_rQmpPZxJt0-Ul22Xmx7nlQ" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_pNSv-yNAj0iAGwQZnO_anQ_22_6">713</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_us-gaap_StatementBusinessSegmentsAxis_abt_CardiovascularAndNeuromodulationProductsMember_us-gaap_SubsegmentsAxis_abt_ElectrophysiologyMember_8iFB3YhAP06DEJg8lFoWjQ" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_MwbQJawBik2AAIbKM5DVBA_22_9">1,262</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_abt_CardiovascularAndNeuromodulationProductsMember_us-gaap_SubsegmentsAxis_abt_ElectrophysiologyMember_uH30gnf4Xk2idPxcoUpsKA" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_BPH1VLttB0S7IKVqnEAeXw_22_12">499</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_abt_CardiovascularAndNeuromodulationProductsMember_us-gaap_SubsegmentsAxis_abt_ElectrophysiologyMember_6l87SjJ4mU2Ern3wEGByig" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_rpGV8jTCik6JMRe9h6YHJw_22_15">645</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2018_To_9_30_2018_us-gaap_StatementBusinessSegmentsAxis_abt_CardiovascularAndNeuromodulationProductsMember_us-gaap_SubsegmentsAxis_abt_ElectrophysiologyMember_kRjVH9SREkKr8yW5iOTf2A" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_EKy-MddmLk69S2sHTS1KDQ_22_18">1,144</ix:nonfraction></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:33.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 6pt;">Heart Failure</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_abt_CardiovascularAndNeuromodulationProductsMember_us-gaap_SubsegmentsAxis_abt_HeartFailureMember_W9069aCB3U2lmwHkJyVLJA" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_60Q2-c2aHE-zUh1sjPlaFQ_23_3">428</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_abt_CardiovascularAndNeuromodulationProductsMember_us-gaap_SubsegmentsAxis_abt_HeartFailureMember_DEf0YxIGZEe_iDdnv_NBvA" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_H-gpimZbckeuuFfDVDllgg_23_6">143</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_us-gaap_StatementBusinessSegmentsAxis_abt_CardiovascularAndNeuromodulationProductsMember_us-gaap_SubsegmentsAxis_abt_HeartFailureMember_6l7Ga-hSeUSTo5mLgmQz-w" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_9B8ThWfp2UeJzg3QyFsg_A_23_9">571</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_abt_CardiovascularAndNeuromodulationProductsMember_us-gaap_SubsegmentsAxis_abt_HeartFailureMember_-8orpn_WQEaZFY0qly7FoQ" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_a956BvAowUqH4gzWjC3RlA_23_12">342</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_abt_CardiovascularAndNeuromodulationProductsMember_us-gaap_SubsegmentsAxis_abt_HeartFailureMember_C7e69yvncEC_86ClR_66yw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_rLz0d4f_MEqaJQZ2DAxA4w_23_15">126</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2018_To_9_30_2018_us-gaap_StatementBusinessSegmentsAxis_abt_CardiovascularAndNeuromodulationProductsMember_us-gaap_SubsegmentsAxis_abt_HeartFailureMember_e8OON38b70qdpShAoZQzkw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_oIaBL6m_s0yo8tgXmoPdwA_23_18">468</ix:nonfraction></p></td></tr><tr><td style="vertical-align:bottom;width:33.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 6pt;">Vascular</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_abt_CardiovascularAndNeuromodulationProductsMember_us-gaap_SubsegmentsAxis_abt_VascularProductsMember_xzgQqLrW7kqCB5okIBohhA" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_Oze6KmOxHk2hD0E63rglPQ_24_3">787</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_abt_CardiovascularAndNeuromodulationProductsMember_us-gaap_SubsegmentsAxis_abt_VascularProductsMember_Hx0kTWTowk-3ycqtgcsqvA" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_1tHK5pBOJ0mdJGCo5vxM9g_24_6">1,349</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_us-gaap_StatementBusinessSegmentsAxis_abt_CardiovascularAndNeuromodulationProductsMember_us-gaap_SubsegmentsAxis_abt_VascularProductsMember_iDqKVkz9O063ZJZ4GwFtBQ" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_rSxrDhb_l0Socz60gDm0Pw_24_9">2,136</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_abt_CardiovascularAndNeuromodulationProductsMember_us-gaap_SubsegmentsAxis_abt_VascularProductsMember_GaNh01bgSES8ox3IgpmDcA" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_0ONLFgYX_Eq8kf4jNkzZQg_24_12">854</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_abt_CardiovascularAndNeuromodulationProductsMember_us-gaap_SubsegmentsAxis_abt_VascularProductsMember_HFbuFHW5ukWZ8eGGXRi8RQ" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_w483MijyNkqYKTJT3IqO-w_24_15">1,355</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2018_To_9_30_2018_us-gaap_StatementBusinessSegmentsAxis_abt_CardiovascularAndNeuromodulationProductsMember_us-gaap_SubsegmentsAxis_abt_VascularProductsMember_dRdpUmU-iU2CvlXiwo7kAg" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_xfuUvZKkr02FAw78ORSS7A_24_18">2,209</ix:nonfraction></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:33.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 6pt;">Structural Heart</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_abt_CardiovascularAndNeuromodulationProductsMember_us-gaap_SubsegmentsAxis_abt_StructuralHeartMember_6P1Vl7-fR0OsKxDX3kmXFg" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_MyZAWnN9Y0arcHO5xiz9wg_25_3">446</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_abt_CardiovascularAndNeuromodulationProductsMember_us-gaap_SubsegmentsAxis_abt_StructuralHeartMember_44n-r_eSQUOIEw9ippKdCQ" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_W5kjBEGs5EWVvQv3NZE52g_25_6">578</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_us-gaap_StatementBusinessSegmentsAxis_abt_CardiovascularAndNeuromodulationProductsMember_us-gaap_SubsegmentsAxis_abt_StructuralHeartMember_597US2EM4Ee2adQJtqyKZQ" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_Eacp5ylp8UCB-e2D6Cwtlw_25_9">1,024</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_abt_CardiovascularAndNeuromodulationProductsMember_us-gaap_SubsegmentsAxis_abt_StructuralHeartMember_RMMBYOluM0uAaJHVaqsj6A" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_6en5iMCZh0aY__ichXbWEQ_25_12">353</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_abt_CardiovascularAndNeuromodulationProductsMember_us-gaap_SubsegmentsAxis_abt_StructuralHeartMember_CMmYjisOuEKLSHbdQsNJCw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_mPcW9oUjCEyu8WbYGS6VnQ_25_15">560</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2018_To_9_30_2018_us-gaap_StatementBusinessSegmentsAxis_abt_CardiovascularAndNeuromodulationProductsMember_us-gaap_SubsegmentsAxis_abt_StructuralHeartMember_WI2emWZX0kCq01Hbzp5u9g" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_vbzRyhs69keBPx0okHLPDg_25_18">913</ix:nonfraction></p></td></tr><tr><td style="vertical-align:bottom;width:33.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 6pt;">Neuromodulation</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_abt_CardiovascularAndNeuromodulationProductsMember_us-gaap_SubsegmentsAxis_abt_NeuromodulationMember_BOwNApQZxEe9Prwwd4SWkA" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_Qk23cDAmekS_kJm4sK_yuA_26_3">485</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_abt_CardiovascularAndNeuromodulationProductsMember_us-gaap_SubsegmentsAxis_abt_NeuromodulationMember_n0ojBhLu4kyJCenM1lWQIQ" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_j6GwEGBfMUWVsyiUpixM1A_26_6">124</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_us-gaap_StatementBusinessSegmentsAxis_abt_CardiovascularAndNeuromodulationProductsMember_us-gaap_SubsegmentsAxis_abt_NeuromodulationMember_j5FIYrXLCEK_fuLEqsre0A" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc__jVh3yJ74ESFYWZnsfXOFw_26_9">609</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_abt_CardiovascularAndNeuromodulationProductsMember_us-gaap_SubsegmentsAxis_abt_NeuromodulationMember_qqxTMb7T_0uAViBwaew1Mw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_Jl4UTGkdU0-40uOAKE_uuA_26_12">513</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_abt_CardiovascularAndNeuromodulationProductsMember_us-gaap_SubsegmentsAxis_abt_NeuromodulationMember_T-CdJpKIk0iiTl4HRoAF9Q" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_YbujkmFRMUaLTjX8FqLL-w_26_15">133</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2018_To_9_30_2018_us-gaap_StatementBusinessSegmentsAxis_abt_CardiovascularAndNeuromodulationProductsMember_us-gaap_SubsegmentsAxis_abt_NeuromodulationMember_HRvHEXdV80e4RGEPZftXyA" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_HIhGAp74EkKgPmP5CnUWUA_26_18">646</ix:nonfraction></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:33.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">Total</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_abt_CardiovascularAndNeuromodulationProductsMember_iRzKEq3YyUW1ZBBgem-ErA" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_3MXCi9xcHEKXEBBeq8bfjQ_27_3">3,485</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_abt_CardiovascularAndNeuromodulationProductsMember_ReihajC5y0603BDLWr_Clg" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_Jx9CbCVGak-mggM_zXtzig_27_6">3,717</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_us-gaap_StatementBusinessSegmentsAxis_abt_CardiovascularAndNeuromodulationProductsMember_6GcC8cvXM0CCyPebis87CQ" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_Q2iNFkaucku9TJUowEGgwQ_27_9">7,202</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_abt_CardiovascularAndNeuromodulationProductsMember_xrTvDfYJU0OdWlo07U8VFA" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_hc0Eoe6z7kiwy1P1ewZzeg_27_12">3,404</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_abt_CardiovascularAndNeuromodulationProductsMember_DIzJJ0DKaUmVhq6Hnzp8pA" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_NYPIPxLzQEu69-k6fbtPgg_27_15">3,643</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2018_To_9_30_2018_us-gaap_StatementBusinessSegmentsAxis_abt_CardiovascularAndNeuromodulationProductsMember_uiw4JYwlAEudlK8OtDkuGA" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_e_yvnXm25k67skb8WT1YTQ_27_18">7,047</ix:nonfraction></p></td></tr><tr><td style="vertical-align:bottom;width:33.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:33.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">Other</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_us-gaap_AllOtherSegmentsMember_0AWmrCZiBkKVFCjCSGMKVw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_Loqs6Z2nTkutbpHmeqN1jQ_29_3">511</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_us-gaap_AllOtherSegmentsMember_BzVUo3WeWEm2wCCm9H5Z8A" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_fnJnvAKPcEClp77lkJirng_29_6">1,369</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_us-gaap_StatementBusinessSegmentsAxis_us-gaap_AllOtherSegmentsMember_bEC5ujKIG064i9f7edUrGg" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_amwvKSC9U02JRVRQpfGh9w_29_9">1,880</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_country_US_us-gaap_StatementBusinessSegmentsAxis_us-gaap_AllOtherSegmentsMember_yanEVFf890u2tgjT9wNV8w" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_C02AtmxZj0-upSH99WtV3Q_29_12">349</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_us-gaap_NonUsMember_us-gaap_StatementBusinessSegmentsAxis_us-gaap_AllOtherSegmentsMember_HlN_IlGwYkGhZzjQ6w-Lmw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_990Oj2-TmUiFdAfXnPpt1Q_29_15">1,099</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2018_To_9_30_2018_us-gaap_StatementBusinessSegmentsAxis_us-gaap_AllOtherSegmentsMember_ZR9EI4Kh7UeN1hu1pcbUqQ" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_QWR411EPI0CSEt-9PbkkVw_29_18">1,448</ix:nonfraction></p></td></tr><tr><td style="vertical-align:bottom;width:33.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">Total</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_srt_StatementGeographicalAxis_country_US_GDkXKrZ42Ea8pLWCW9oidg" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc__xXyZinbD0uVfigGifgQ4Q_30_3">8,438</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_srt_StatementGeographicalAxis_us-gaap_NonUsMember_BDZKwUhqvE6BItkVxM0xJw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_VSanMFsU2Ua1IcXForqTkA_30_6">15,152</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.86%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_O4ushO81Z0mAnTH_cLUPFw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_lX4NsVDH60qXvdwEQP1ebQ_30_9">23,590</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_country_US_ukRLAyTp0kmpYTxoa2DqxQ" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_gF2q6au9TUOM0BmvVJyLKg_30_12">8,084</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.84%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_us-gaap_NonUsMember_7ac9eNGy-0Gsc4xouGtflg" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_tNYI5TfZWk27gO8BaW-a4w_30_15">14,729</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.86%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:9pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2018_To_9_30_2018_3n65uNcjAUKkwLDxHE9Yow" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_eGCIaRhrQUOr4QO-OJ8nXg_30_18">22,813</ix:nonfraction></p></td></tr></tbody></table><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:10pt;text-align:justify;margin:0pt;">Note: Insertable Cardiac Monitor (ICM) sales, which had previously been reported in Electrophysiology, are now included in Rhythm Management. Historic periods have been adjusted to reflect this change. </p></ix:nonnumeric><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></ix:continuation></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">10</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><a href="#TOC"><span style="font-family:'Times New Roman';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Table of Contents</span></a></p><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:10pt;text-align:center;margin:0pt;">Abbott Laboratories and Subsidiaries</p><p style="font-family:'Times New Roman';font-size:10pt;text-align:center;margin:0pt;">Notes to the Condensed Consolidated Financial Statements</p><p style="font-family:'Times New Roman';font-size:10pt;text-align:center;margin:0pt;">September 30, 2019</p><p style="font-family:'Times New Roman';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;">(Unaudited)</p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_57e2d0e6_1d16_4d4c_8358_07a390ecd931"></a><a id="Tc_4ls2f-TEJE2yKImSN_fWTw_1_0"></a><a id="Tc_IMHzcpTquk6mSaZZPBCLrg_2_0"></a><a id="Tc_zUZgWTkjIEqAWzTqMgccFw_3_0"></a><a id="Tc_9lu0wLL-CUyxOQyAvOM9Zw_3_2"></a><a id="Tc_3mfNr6r8QU2LPJmzgIvKJA_4_0"></a><a id="Tc_s3B-19SxKUO7wMnTD-7SEQ_5_0"></a><a id="Tc_K00Q1xBk40qRjupX-Ctpyw_6_0"></a><a id="Tc_Tbe_JwsSKE203q8dH3m2yg_6_2"></a><ix:continuation id="Tb_nHylNyAPqEWRP1ke_nPG7w_cont2"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;"><i style="font-style:italic;">Remaining Performance Obligations</i></p><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:10pt;text-align:justify;margin:0pt;">As of September 30, 2019, the estimated revenue expected to be recognized in the future related to performance obligations that are unsatisfied (or partially unsatisfied) was approximately $<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_9_30_2019_us-gaap_StatementBusinessSegmentsAxis_abt_DiagnosticProductsMember_ri__PwPJn06gNt3sCbH5ag" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:RevenueRemainingPerformanceObligation" scale="9" id="Narr_2lg7_wj6l0GXKZbiADot-g">3.2</ix:nonfraction> billion in the Diagnostics segment and approximately $<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_9_30_2019_us-gaap_StatementBusinessSegmentsAxis_abt_CardiovascularAndNeuromodulationProductsMember_mLmh_6-3VkiqgiDyhwOAjA" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueRemainingPerformanceObligation" scale="6" id="Narr_0QJfNqv67Umb1Gm_CeRnBw">350</ix:nonfraction> million in the Cardiovascular and Neuromodulation segment. &nbsp;Abbott expects to recognize revenue on approximately <ix:nonfraction unitref="Unit_Standard_pure_0hvT7e8qLkipZ3XmLkD-nQ" contextref="Duration_1_1_2019_To_9_30_2019_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_abt_cnst_2019-10-01_T8BFLnHyn0u8l7-D6g-oYw" decimals="2" format="ixt:numdotdecimal" name="abt:RevenueremainingperformanceObligationExpectedTimingPercentage" scale="-2" id="Narr_ai0iDUcpiEGURdDZQju--w">60</ix:nonfraction> percent of these remaining performance obligations over the next <ix:nonnumeric contextref="As_Of_9_30_2019_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_abt_cnst_2019-10-01_vdsdJvVVQEifrRMWIGhX8w" format="ixt-sec:durwordsen" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" id="Narr__dEpN7BAE0CbJVBeQJEr2g">24 months</ix:nonnumeric>, approximately <ix:nonfraction unitref="Unit_Standard_pure_0hvT7e8qLkipZ3XmLkD-nQ" contextref="Duration_1_1_2019_To_9_30_2019_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_abt_cnst_2021-10-01_h_f9OLOKA0-A7E_9UlfP_A" decimals="2" format="ixt:numdotdecimal" name="abt:RevenueremainingperformanceObligationExpectedTimingPercentage" scale="-2" id="Narr_EDMWxWWVfECAxqVIWAOHEg">16</ix:nonfraction> percent over the subsequent <ix:nonnumeric contextref="As_Of_9_30_2019_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_abt_cnst_2021-10-01_Ya3YxLZ1-063gJOi7Pwe0g" format="ixt-sec:durwordsen" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" id="Narr_Xa9Zyrcez0uXQwHj__HsnQ">12 months</ix:nonnumeric> and the remainder thereafter. &nbsp;</p><p style="font-family:'Times New Roman';font-size:12pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:10pt;text-align:justify;margin:0pt;">These performance obligations primarily reflect the future sale of reagents/consumables in contracts with minimum purchase obligations, extended warranty or service obligations related to previously sold equipment, and remote monitoring services related to previously implanted devices. &nbsp;Abbott has applied the practical expedient described in Accounting Standards Codification (ASC) 606-10-50-14 and has not included remaining performance obligations related to contracts with original expected durations of one year or less in the amounts above.</p><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;"><i style="font-style:italic;">Other Contract Assets and Liabilities</i></p><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:10pt;text-align:justify;margin:0pt;">Abbott discloses Trade receivables separately in the Condensed Consolidated Balance Sheet at their net realizable value. &nbsp;Contract assets primarily relate to Abbott’s conditional right to consideration for work completed but not billed at the reporting date. Contract assets at the beginning and end of the period, as well as the changes in the balance, were not significant.</p><p style="font-family:'Times New Roman';font-size:12pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:10pt;text-align:justify;margin:0pt;">Contract liabilities primarily relate to payments received from customers in advance of performance under the contract. Abbott’s contract liabilities arise primarily in the Cardiovascular and Neuromodulation reportable segment when payment is received upfront for various multi-period extended service arrangements. &nbsp;</p><p style="font-family:'Times New Roman';font-size:12pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:10pt;text-align:justify;margin:0pt;"><span style="text-decoration:underline;text-decoration-color:#000000;">Changes in the contract liabilities during the period are as follows:</span></p><ix:nonnumeric contextref="Duration_1_1_2019_To_9_30_2019_O4ushO81Z0mAnTH_cLUPFw" name="us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock" id="Tb_KRA5OGUDvkm8hGD16CqPQg" escape="true"><p style="font-family:'Times New Roman';font-size:12pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tbody><tr style="height:1pt;"><td style="vertical-align:bottom;width:84.97%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.62%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="background-color:auto;vertical-align:bottom;width:84.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0pt;">(in millions)</p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:2.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&nbsp;&nbsp;&nbsp;&nbsp;</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:10.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:84.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">Contract Liabilities:</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:center;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:84.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Balance at December 31, 2018</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_12_31_2018_INezHDkjn0-L7OMGoLMjhA" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiability" scale="6" id="Tc_grCNsOvq8UyEEaAx0Sre-g_3_3">259</ix:nonfraction></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:84.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt 0pt 0pt 12pt;">Unearned revenue from cash received during the period</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_O4ushO81Z0mAnTH_cLUPFw" decimals="-6" format="ixt:numdotdecimal" name="abt:ContractWithCustomerLiabilityChangeInUnearnedRevenueFromCashReceivedRecognized" scale="6" id="Tc_m7-UvbYxT0ic1TRBr8_fpg_4_3">285</ix:nonfraction></p></td></tr><tr><td style="vertical-align:bottom;width:84.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt 0pt 0pt 12pt;">Revenue recognized that was included in contract liability balance at beginning of period</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.62%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_O4ushO81Z0mAnTH_cLUPFw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" sign="-" scale="6" id="Tc_tUXowwe8Jk2uU3JEf9WlhQ_5_3">249</ix:nonfraction>)</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:84.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Balance at September&nbsp;30,&nbsp;2019</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.7%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.62%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_9_30_2019_Q77aJBXiP0qCmJ4Yd2DnHw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiability" scale="6" id="Tc_nQLgnocUJ0iR60Zvpmxr0g_6_3">295</ix:nonfraction></p></td></tr></tbody></table></ix:nonnumeric><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:1pt;font-weight:bold;visibility:hidden;">​</span></p></ix:continuation><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><a id="_5fadaf95_a93e_41ff_a931_0ff5ae2de8b1"></a><a id="Tc_9gFN7jcMHUyYNWeg-wWBfQ_1_2"></a><a id="Tc_91uV2sSuAkas-0iy9IoXAQ_1_5"></a><a id="Tc_QeLEmaBnJ0O_xmdamrfuFQ_2_0"></a><a id="Tc_ok2pTbHlv0yAHCys_1PWsA_2_2"></a><a id="Tc_mQsK9ckE90qTWUh9KADPVQ_2_5"></a><a id="Tc_FfeT7w_CtkyudB7-iNx9Bg_3_0"></a><a id="Tc_0eV_uQGb8kaL8V5VocywGQ_4_0"></a><a id="Tc_PAMsqBmc3UuH8qgBUm0Fug_4_2"></a><a id="Tc_7j-4AylciUqYIi52scgYiA_4_5"></a><a id="Tc_BuN1SWGrq0eJ_JbRByE5Yw_5_0"></a><a id="Tc_SKF6Sf30yUW2txOGKr_4Nw_6_0"></a><a id="Tc_-9KShm-AOUGHaEWnRSY6bA_6_2"></a><a id="Tc_RZQQv7Clik2SUJ2qUqtotQ_6_5"></a><ix:nonnumeric contextref="Duration_1_1_2019_To_9_30_2019_O4ushO81Z0mAnTH_cLUPFw" name="us-gaap:AdditionalFinancialInformationDisclosureTextBlock" id="Tb_DRybtItIh06GTZhYWyhwSA" continuedat="Tb_DRybtItIh06GTZhYWyhwSA_cont1" escape="true"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">Note 4 — Supplemental Financial Information</p><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:10pt;text-align:justify;margin:0pt;">Shares of unvested restricted stock that contain non-forfeitable rights to dividends are treated as participating securities and are included in the computation of earnings per share under the two-class method. &nbsp;Under the two-class method, net earnings are allocated between common shares and participating securities. Earnings from Continuing Operations allocated to common shares for the three months ended September 30, 2019 and 2018 were $<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2019_To_9_30_2019_5CXepWtEPEKQA-bPz0Tp7A" decimals="-6" format="ixt:numdotdecimal" name="abt:IncomeLossFromContinuingOperationsAllocatedToCommonShares" scale="6" id="Narr_TY7ORL4eZkWuI7xYAe78Zg">954</ix:nonfraction> million and $<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2018_To_9_30_2018_lS4NEZw67ECck2zY72MWgg" decimals="-6" format="ixt:numdotdecimal" name="abt:IncomeLossFromContinuingOperationsAllocatedToCommonShares" scale="6" id="Narr_bXgBUQ1gOUqgL5kaFq1t0A">548</ix:nonfraction> million, respectively, and for the nine months ended September 30, 2019 and 2018 were $<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_O4ushO81Z0mAnTH_cLUPFw" decimals="-6" format="ixt:numdotdecimal" name="abt:IncomeLossFromContinuingOperationsAllocatedToCommonShares" scale="9" id="Narr_ocIU-qBVqEidHPiiEwtz7A">2.622</ix:nonfraction> billion and $<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2018_To_9_30_2018_3n65uNcjAUKkwLDxHE9Yow" decimals="-6" format="ixt:numdotdecimal" name="abt:IncomeLossFromContinuingOperationsAllocatedToCommonShares" scale="9" id="Narr_F9pDBwgTAEquX_eT9NPepg">1.669</ix:nonfraction> billion, respectively. Net earnings allocated to common shares for the three months ended September 30, 2019 and 2018 were $<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2019_To_9_30_2019_5CXepWtEPEKQA-bPz0Tp7A" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="6" id="Narr_M-eNyGYw80exxb84WxEkBA">954</ix:nonfraction> million and $<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2018_To_9_30_2018_lS4NEZw67ECck2zY72MWgg" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="6" id="Narr_5OY-pOBTOEiaEj9k4856rQ">560</ix:nonfraction> million,&nbsp;respectively, and for the nine months ended September 30, 2019 and 2018 were $<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_O4ushO81Z0mAnTH_cLUPFw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="9" id="Narr_ZDbJCj5gP0G2Q_8E05gOZA">2.622</ix:nonfraction> billion and $<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2018_To_9_30_2018_3n65uNcjAUKkwLDxHE9Yow" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="9" id="Narr_V4yZmw3kJECTwSOMSxYmkA">1.704</ix:nonfraction> billion, respectively.</p><p style="font-family:'Times New Roman';font-size:12pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:10pt;text-align:justify;margin:0pt;">Other, net in Net cash from operating activities in the Condensed Consolidated Statement of Cash Flows for the first nine months of 2019 includes $<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember_lB8RTt7VykWlXZnoI4XA6w" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" scale="6" id="Narr_jj8_UHAIPEGwPVKzMI9hrA">337</ix:nonfraction> million of pension contributions and the payment of cash taxes of approximately $<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_O4ushO81Z0mAnTH_cLUPFw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PaymentsForOtherTaxes" scale="6" id="Narr_-y4LAkxsakumhtkVw1poUw">775</ix:nonfraction> million. &nbsp;The first nine months of 2018 includes the favorable impact of improvements in working capital management, as well as the effect of non-cash charges related to the impairment of certain assets and the accrual of certain debt extinguishment costs.</p><p style="font-family:'Times New Roman';font-size:12pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:10pt;text-align:justify;margin:0pt;">The components of long-term investments as of September 30, 2019 and December 31, 2018 are as follows:</p><ix:nonnumeric contextref="Duration_1_1_2019_To_9_30_2019_O4ushO81Z0mAnTH_cLUPFw" name="abt:ScheduleOfLongTermInvestmentsTableTextBlock" id="Tb_NrCSLyRugk2ssAqEolROhA" escape="true"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:79.99%;"><tbody><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:73.2%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;width:1.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.16%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;width:1.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.56%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.69%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="background-color:auto;vertical-align:bottom;width:73.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="background-color:auto;vertical-align:bottom;width:11.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">September&nbsp;30,&nbsp;</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:11.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&nbsp;31,&nbsp;</b></p></td></tr><tr><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:73.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">(in millions)</p></td><td style="background-color:auto;vertical-align:bottom;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&nbsp;&nbsp;&nbsp;&nbsp;</b></p></td><td colspan="2" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:11.8%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2019</b></p></td><td style="background-color:auto;vertical-align:bottom;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&nbsp;&nbsp;&nbsp;&nbsp;</b></p></td><td colspan="2" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:11.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2018</b></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:73.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">Long-term&nbsp;Investments:</p></td><td style="background-color:#cceeff;vertical-align:bottom;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:73.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">Equity securities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_9_30_2019_us-gaap_InvestmentTypeAxis_us-gaap_EquitySecuritiesMember_3nNMizmWaEa6tPmsSbXC9Q" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermInvestments" scale="6" id="Tc_WGsHp86xjUGpgBrLipG5xg_4_3">830</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_12_31_2018_us-gaap_InvestmentTypeAxis_us-gaap_EquitySecuritiesMember_1rLGYajW7ECYIIg9ayCVvA" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermInvestments" scale="6" id="Tc_k5-z0aiJ6UKE26A41jiXWA_4_6">856</ix:nonfraction></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:73.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">Other</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.16%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_9_30_2019_us-gaap_InvestmentTypeAxis_us-gaap_OtherInvestmentsMember_RqEewlvYWUOOc7tV6AAOvA" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermInvestments" scale="6" id="Tc_to7FlInzJ0aSqVGWvlIzeA_5_3">44</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.69%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_12_31_2018_us-gaap_InvestmentTypeAxis_us-gaap_OtherInvestmentsMember_CxtEgQasPkCsxRBKjx4EJg" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermInvestments" scale="6" id="Tc_-_X5ZaV33026z1wCspFs5Q_5_6">41</ix:nonfraction></p></td></tr><tr><td style="vertical-align:bottom;width:73.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">Total </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.16%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_9_30_2019_Q77aJBXiP0qCmJ4Yd2DnHw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermInvestments" scale="6" id="Tc_a-ecS3kYG0uGukVSh0S-sw_6_3">874</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.56%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.69%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_12_31_2018_INezHDkjn0-L7OMGoLMjhA" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermInvestments" scale="6" id="Tc_GwxMR97wskqAcS8UgOOITA_6_6">897</ix:nonfraction></p></td></tr></tbody></table></ix:nonnumeric><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></ix:nonnumeric></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">11</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><a href="#TOC"><span style="font-family:'Times New Roman';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Table of Contents</span></a></p><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:10pt;text-align:center;margin:0pt;">Abbott Laboratories and Subsidiaries</p><p style="font-family:'Times New Roman';font-size:10pt;text-align:center;margin:0pt;">Notes to the Condensed Consolidated Financial Statements</p><p style="font-family:'Times New Roman';font-size:10pt;text-align:center;margin:0pt;">September 30, 2019</p><p style="font-family:'Times New Roman';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;">(Unaudited)</p></div><div style="clear:both;max-width:100%;position:relative;"><ix:continuation id="Tb_DRybtItIh06GTZhYWyhwSA_cont1"><p style="font-family:'Times New Roman';font-size:10pt;text-align:justify;margin:0pt;">Abbott's equity securities as of September 30, 2019, include approximately $<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_9_30_2019_us-gaap_BusinessAcquisitionAxis_abt_StJudeMedicalInc.Member_us-gaap_InvestmentTypeAxis_us-gaap_EquitySecuritiesMember_8vo-99w8KkiVW35UmBSvVQ" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesHeldInEmployeeTrust" scale="6" id="Narr_RJBw1biInEGRFTJyZCvqSg">330</ix:nonfraction> million of investments in mutual funds that are held in a rabbi trust and were acquired as part of the St. Jude Medical, Inc. (St. Jude Medical) business acquisition. These investments, which are specifically designated as available for the purpose of paying benefits under a deferred compensation plan, are not available for general corporate purposes and are subject to creditor claims in the event of insolvency.</p><p style="font-family:'Times New Roman';font-size:12pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:10pt;text-align:justify;margin:0pt;">Abbott also holds certain investments as of September 30, 2019 with a carrying value of approximately $<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_9_30_2019_Q77aJBXiP0qCmJ4Yd2DnHw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:EquityMethodInvestments" scale="6" id="Narr_oiHPcdzFhk6qxXTRJzDk8g">335</ix:nonfraction> million that are accounted for under the equity method of accounting and other equity investments with a carrying value of approximately $<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_9_30_2019_Q77aJBXiP0qCmJ4Yd2DnHw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" scale="6" id="Narr_mmsGRE-RgEKKmxYaAp_-Nw">155</ix:nonfraction> million that do not have a readily determinable fair value. The $<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_9_30_2019_Q77aJBXiP0qCmJ4Yd2DnHw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" scale="6" id="Narr_qu9lyWCeiECLphraJe2Pag">155</ix:nonfraction> million carrying value includes cumulative unrealized gains of approximately $<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_9_30_2019_Q77aJBXiP0qCmJ4Yd2DnHw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount" scale="6" id="Narr_iOBvAMq6GUCd5bgsH3856Q">50</ix:nonfraction> million.</p><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:10pt;text-align:justify;margin:0pt;">In the first quarter of 2019, in conjunction with the acquisition of Cephea Valve Technologies, Inc., Abbott acquired a research &amp; development (R&amp;D) asset valued at $<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_3_31_2019_us-gaap_BusinessAcquisitionAxis_abt_CepheaValveTechnologiesInc.Member_QiXyi0x5aky0u96TQUbx9g" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" scale="6" id="Narr_PsTXlQT1SUCHJDwzKYBZFQ">102</ix:nonfraction> million, which was immediately expensed. The $<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_3_31_2019_us-gaap_BusinessAcquisitionAxis_abt_CepheaValveTechnologiesInc.Member_Ke1rNcqUMkOQeqAPYEGSMQ" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ResearchAndDevelopmentInProcess" scale="6" id="Narr_w7xrtCE_aEi_37UYM7gsgw">102</ix:nonfraction> million of expense was recorded in the R&amp;D line of Abbott's Condensed Consolidated Statement of Earnings.</p></ix:continuation><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><a id="_c7dfecad_b293_4f6b_9d86_f50fd9fe75bd"></a><a id="Tc_wBDCw9uLUUOGjioYUsblig_1_2"></a><a id="Tc_Um5-4-CpvkuK1zSxfWc6yQ_2_20"></a><a id="Tc_5HgDY_Te1EWmpxnok3pEMw_3_14"></a><a id="Tc_ZHnOPbgawE-Lx2X9AOT6Jg_3_20"></a><a id="Tc_g1MbW_YHl0mMdbAAp3r0rQ_4_8"></a><a id="Tc_1puWzavbSkWcVEZiOjCjsw_4_14"></a><a id="Tc_v7e5p5194kWMRXHpfno4GA_4_20"></a><a id="Tc_Rt-OK47TbU6OVoopr3Rs8Q_5_2"></a><a id="Tc_ZvD1utru20eJDt2luNGEDQ_5_8"></a><a id="Tc_RvyWr3oiEESm2zgel-H7Ag_5_14"></a><a id="Tc_F6cxtjYgQUWOKD20IkH5yw_5_20"></a><a id="Tc_1ppWeGhCmUCBLkX28G7sOg_6_2"></a><a id="Tc_cxLcIl6xWEiK4XyVoQS5Yg_6_8"></a><a id="Tc_auRiwOGkKkSTpn5b3cA8oA_6_14"></a><a id="Tc_OB5Cj8vhzUaf3k2pAckpNA_6_20"></a><a id="Tc_vNsk4u7d5kOlsnEmPAoZug_7_0"></a><a id="Tc_3MCoZcDcskm3LFaR8AAfoQ_7_2"></a><a id="Tc_0uDtVm2xSkGwi_lIBZBWrw_7_8"></a><a id="Tc_vkM6uw-5iUOGoodoNUudCA_7_14"></a><a id="Tc_NeI2okDRKkm8er9DBlggqg_7_20"></a><a id="Tc_JuJ-5icEpE6EQjJgB2neNQ_8_2"></a><a id="Tc_k2N001vS8kK1gKhnDEfWOw_8_5"></a><a id="Tc_X7g2UsQwrk-Dn-nfP8tNLQ_8_8"></a><a id="Tc_VtWQqaOXH0SigEbaK2DCZA_8_11"></a><a id="Tc_UKzqV1gn5k-RsztamQbhcQ_8_14"></a><a id="Tc_4s9WcKzLNUaGYGiclt2-Gw_8_17"></a><a id="Tc_-yDjbd1x8kW9Q-YLRRzZ8g_8_20"></a><a id="Tc_icjr0JLaOke1WJ4LsrR0Hg_8_23"></a><a id="Tc_A1TlB8lqREaiUGzDlRgJFw_9_0"></a><a id="Tc_tGUF3Ug-R02sNCF9Fvxv3Q_9_2"></a><a id="Tc_h7MW9FsLwE2j_FLoyJIS3w_9_5"></a><a id="Tc_ogTTUlKFRUSFKY_RU1La7w_9_8"></a><a id="Tc_hp_ZW5rWe0eGh-gi98m1sw_9_11"></a><a id="Tc_W97vL_co5Ui4V7ih4bfTuQ_9_14"></a><a id="Tc_u-Sfgf3sUE6Eg5Og6rAuuA_9_15"></a><a id="Tc_07SSiTb7xEqJYOZIW85Apw_9_17"></a><a id="Tc_ZdqFXECYSU6rzX2zZi5A-g_9_18"></a><a id="Tc_4-d9f31U60SD43LRDrP0XQ_9_20"></a><a id="Tc_-LbPsIeOYEqymFsYDEdBfA_9_23"></a><a id="Tc_BZzE-slEHEid8h8fdYpQ7w_10_0"></a><a id="Tc_DDOx78BOS0qFD3xqybIfqw_10_12"></a><a id="Tc_l7MjqQ7jIUyWbU6rx7D2tw_10_15"></a><a id="Tc_WnYZAuf0HkaFfkH6NUV6KA_10_18"></a><a id="Tc_5ak3fhwWUkCGhEMgursd2A_11_0"></a><a id="Tc_hgohuD7gsk-9NYwT3hDEZA_11_3"></a><a id="Tc_R9tKR3cZLEe10eQXIPMa3w_11_6"></a><a id="Tc_AG83rO3ibUKGEUfnBMrU4A_11_15"></a><a id="Tc_SIIDW11UNU2Cyw6dYEZvxA_11_18"></a><a id="Tc_MuCEHA2SIU29odhf5z5SaA_12_0"></a><a id="Tc_2Ual0SQVKUOAPLOnb5IqEA_12_15"></a><a id="Tc_XB9rqb6eMUSmy_V8RRk2Mw_12_18"></a><a id="Tc_2pcGYtZOz0yoWBTCl37eFQ_13_0"></a><a id="Tc_dkFXgCnHSkSBpC9niFM0Qw_13_2"></a><a id="Tc_LzK1FqPABUuv-NyVbc8kgQ_13_5"></a><a id="Tc_eQxeYBD8RUSuSCf_srZ2zg_13_8"></a><a id="Tc_UURsVUBA00yNHjqvdSqBiQ_13_11"></a><a id="Tc_n2A3KCdl9kq2kmup4Pd3PA_13_14"></a><a id="Tc_4h521cwBX0uMllb-9P0TsA_13_15"></a><a id="Tc_LnCHD7ElhU67qB7ScrAOqg_13_17"></a><a id="Tc_l5YK_vw0pkKIz_YkU-wC-g_13_18"></a><a id="Tc_cIwDgYrsdkK5Q7KXMjp-NA_13_20"></a><a id="Tc_lvFrPUlMvUC7xUfO1_18JA_13_23"></a><a id="_816769ad_09bd_4094_8db5_02f854540212"></a><a id="Tc_j-0C4Fnsc0q1z3VRs_BEwA_1_2"></a><a id="Tc_5wgf253I-kCCCtk36JxEgw_2_20"></a><a id="Tc_JK8-KJzY5EeO6mEua-hPmQ_3_14"></a><a id="Tc_h2Phw6-lF0qeVf_kKVjw4g_3_20"></a><a id="Tc_HAZug4W280uCgKiymbVGwA_4_8"></a><a id="Tc_8ckpyRyj3UmM4qNJtz34Zw_4_14"></a><a id="Tc_Vr8O7h4AKk6kZDN1XspBRQ_4_20"></a><a id="Tc_-S-oeHisPUyVoJT_TQXkxw_5_2"></a><a id="Tc_QSwkkDHbhE-uvc2SK_wd9A_5_8"></a><a id="Tc_xOkXkj-IHUCtV8s6TEM8ZQ_5_14"></a><a id="Tc_LWC8AiNW10GbMc1GgAAS6g_5_20"></a><a id="Tc_dJnTxLVE_UeFVZzCxNVhQA_6_2"></a><a id="Tc_K1lY3vmU9Ue9dICV_RJuVQ_6_8"></a><a id="Tc_eG7CBMVMt0-ms7meor1yXA_6_14"></a><a id="Tc_Ijz0tkjBU0Km0kTgeed7mg_6_20"></a><a id="Tc_mW9uaKtUDkaBW9YPhMFZeg_7_0"></a><a id="Tc_4NRfMtLFKkK7K-CEcAIe3w_7_2"></a><a id="Tc_6e3SGrA9AkyfxJ6o5j_nPA_7_8"></a><a id="Tc_OJGvtVlc0UuiON45wro14w_7_14"></a><a id="Tc_WlTKqwTsKkqtKmGMvNdVJA_7_20"></a><a id="Tc_x1ly1RJ4Xk27fg9581SFzg_8_2"></a><a id="Tc_M19DYeGuyk-eUZTOn6TZpA_8_5"></a><a id="Tc_FBccaU0Q106eDiCixqtlmQ_8_8"></a><a id="Tc_r_DEbnnp-Uu5qo58PU-keA_8_11"></a><a id="Tc_kiSQuZw6fEuIo-tlL9E9ZA_8_14"></a><a id="Tc_JdtHBCdjcUqGL3p9zQl5Zw_8_17"></a><a id="Tc_dvTtWj623UmTnH3CNbp7Yw_8_20"></a><a id="Tc_9n7kZFl6KkeRjPrSpo7QKg_8_23"></a><a id="Tc_UA-4LhcWCUeWVQlqj8XLHQ_9_0"></a><a id="Tc_Gln0-OtoK0qiWupOkktr1g_9_2"></a><a id="Tc_clL2lmUGK0GTlmuVnf2Z9Q_9_5"></a><a id="Tc__EL_itS-9kObnc8wNvXYJA_9_8"></a><a id="Tc_oHlSmVwGr0-rr0WfyOrV1Q_9_11"></a><a id="Tc_vTyAnSem_Ea140YRmAjltA_9_14"></a><a id="Tc_BYJS771Y0EGx5IywZtqSQg_9_15"></a><a id="Tc_Y9Be3KC3wkK79oFfCb7-SA_9_17"></a><a id="Tc_K718OMIyHkKdOzK9FewA7w_9_20"></a><a id="Tc_OytrjAeEAkC8S9Mr7iRHiA_9_23"></a><a id="Tc_MptA1Wv5YEq4BAVRGOY5Kw_10_0"></a><a id="Tc_X7sC1FGbRUyr7PAP1EYjHA_10_3"></a><a id="Tc_zqHsf6wcZE-FqOFodU7oOw_10_6"></a><a id="Tc_tJ4hIb6f3kmb8gcmBORKZQ_10_9"></a><a id="Tc_bNG5MqDNAEy3xkyZDB-kLg_10_12"></a><a id="Tc_zYCVEhQFKEaiujGZTfY8RA_10_15"></a><a id="Tc_-cQaMSh9qU2EiphQntmG9Q_10_21"></a><a id="Tc_Rx9HiQDJ00mRh4w0ui0tRA_10_24"></a><a id="Tc_SWDrgiw1m0SqTECqSVGN7A_11_0"></a><a id="Tc_L_6NJN07NkyN7piNJhmK1A_11_12"></a><a id="Tc_pDdaFhs69kyWlHVfFHmbFg_11_15"></a><a id="Tc_H3JuPcy1gU2JWYXnR7iFlg_11_18"></a><a id="Tc_KBStJz3eMU-VFqNl-HIwjA_12_0"></a><a id="Tc_GyEsSaaOzEOOBQiQ_-BlVA_12_3"></a><a id="Tc__3fDhkoqlkmFG59gOFNmYg_12_6"></a><a id="Tc_WmMSWbfbp0WS9xKWywndmQ_12_15"></a><a id="Tc_1vP8Pi8AU0SO--46ZXFSfQ_12_18"></a><a id="Tc_pVe2ExVtR0SdYJYadWk8VQ_13_0"></a><a id="Tc_Hrs9Vr2nt0u9PjNoPUP80w_13_15"></a><a id="Tc_O4Mb6tMfCUW5_p9CouY3Zg_13_18"></a><a id="Tc_4RMXBE7OMEOzpWJZ2ekmJg_14_0"></a><a id="Tc_03SOBOErsEOkDwa0HpmYnw_14_2"></a><a id="Tc_C3QPKNFdC0GdboNnNUVQRQ_14_5"></a><a id="Tc_hofSjkDOLkS_wdkd0Yz3EA_14_8"></a><a id="Tc_pF9R0iH2i0WMbU8OEDoCDA_14_11"></a><a id="Tc_MQijcUr060WFvPlZL-cU3g_14_14"></a><a id="Tc_Vdypg7dfa0uku1SYDp6MIg_14_15"></a><a id="Tc_xqV44yMnLE2QJlGCuwl57w_14_17"></a><a id="Tc_nYwcvM8u30GTb3z1m8LgFQ_14_18"></a><a id="Tc__BGeLQbTX0CRhhdSpe5_aw_14_20"></a><a id="Tc_maT4y15ruE2w1chU_2yA-w_14_23"></a><ix:nonnumeric contextref="Duration_1_1_2019_To_9_30_2019_O4ushO81Z0mAnTH_cLUPFw" name="us-gaap:ComprehensiveIncomeNoteTextBlock" id="Tb_7wxMrQbKnEK0lO1OGu8lJQ" escape="true"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">Note 5 — Changes in Accumulated Other Comprehensive Income (Loss) </p><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">The changes in accumulated other comprehensive income (loss), net of income taxes, are as follows:</p><ix:nonnumeric contextref="Duration_1_1_2019_To_9_30_2019_O4ushO81Z0mAnTH_cLUPFw" name="us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="Tb_d7-2i382T0-uSaM3xAfzAg" escape="true"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;padding-left:0pt;padding-right:0pt;width:100.05%;"><tbody><tr style="height:1pt;"><td style="vertical-align:bottom;width:26.92%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.14%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:5.8%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:5.8%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:5.8%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:5.8%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:5.8%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:5.8%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:5.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="background-color:auto;vertical-align:bottom;width:26.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;text-decoration:underline;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="23" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:71.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Three Months Ended September&nbsp;30</b></p></td></tr><tr><td style="background-color:auto;vertical-align:bottom;width:26.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:6.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:5.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:5.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:5.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:5.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:5.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="5" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:15.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Cumulative&nbsp;Gains</b></p></td></tr><tr><td style="background-color:auto;vertical-align:bottom;width:26.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:6.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:5.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:5.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:5.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="5" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:16.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Cumulative</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="5" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:15.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">(Losses)&nbsp;on</b></p></td></tr><tr><td style="background-color:auto;vertical-align:bottom;width:26.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:6.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:5.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="5" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:16.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Net&nbsp;Actuarial</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="5" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:16.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Unrealized&nbsp;Gains</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="5" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:15.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Derivative</b></p></td></tr><tr><td style="background-color:auto;vertical-align:bottom;width:26.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="5" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:16.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Cumulative</b><b style="font-family:'Calibri';font-weight:bold;">&nbsp;</b><b style="font-weight:bold;">Foreign</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="5" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:16.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">(Losses)&nbsp;and&nbsp;Prior</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="5" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:16.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">(Losses)&nbsp;on</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="5" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:15.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Instruments</b></p></td></tr><tr><td style="background-color:auto;vertical-align:bottom;width:26.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="5" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:16.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Currency&nbsp;Translation</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="5" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:16.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Service&nbsp;(Costs)</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="5" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:16.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Marketable&nbsp;Equity</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="5" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:15.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Designated&nbsp;as </b></p></td></tr><tr><td style="background-color:auto;vertical-align:bottom;width:26.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">(in millions)</p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="5" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:16.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Adjustments</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="5" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:16.23%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">and&nbsp;Credits</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="5" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:16.23%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Securities</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="5" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:15.85%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Cash&nbsp;Flow&nbsp;Hedges</b></p></td></tr><tr><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:26.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&nbsp;&nbsp;&nbsp;&nbsp;</b></p></td><td colspan="2" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:7.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2019</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&nbsp;&nbsp;&nbsp;&nbsp;</b></p></td><td colspan="2" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:7.1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2018</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&nbsp;&nbsp;&nbsp;&nbsp;</b></p></td><td colspan="2" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:7.09%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2019</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&nbsp;&nbsp;&nbsp;&nbsp;</b></p></td><td colspan="2" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:7.09%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2018</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&nbsp;&nbsp;&nbsp;&nbsp;</b></p></td><td colspan="2" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:7.09%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2019</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&nbsp;&nbsp;&nbsp;&nbsp;</b></p></td><td colspan="2" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:7.09%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2018</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&nbsp;&nbsp;&nbsp;&nbsp;</b></p></td><td colspan="2" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:7.09%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2019</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&nbsp;&nbsp;&nbsp;&nbsp;</b></p></td><td colspan="2" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:6.71%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2018</b></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:26.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">Balance at June 30</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:6.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"> (<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_6_30_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedTranslationAdjustmentMember_UTnN-uuZ1EyfcmdFnkKpFA" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" sign="-" scale="6" id="Tc_C_rvmGATik-_VUG-1NJoEA_9_3">4,699</ix:nonfraction>)</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.8%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"> (<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_6_30_2018_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedTranslationAdjustmentMember_l6OKU6ZMHESNVFXRA2PSyQ" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" sign="-" scale="6" id="Tc_REYW1YUDxkKOxORdJltamA_9_6">4,478</ix:nonfraction>)</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.29%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.8%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"> (<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_6_30_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_X_wXuipbAEW5xQez5JZxWw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" sign="-" scale="6" id="Tc_9ylXXKztq0aASyZl0wneLQ_9_9">2,677</ix:nonfraction>)</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.29%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.8%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"> (<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_6_30_2018_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_vJlPb8hcm0iSnnnsNQoY0g" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" sign="-" scale="6" id="Tc_zY4ikZzSsE6MzYEXcHEdMw_9_12">2,437</ix:nonfraction>)</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.29%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.8%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> —</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.29%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.8%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> —</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.29%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.8%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_6_30_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_xWVS2_dlmUWYlJ8-3gDO_Q" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="6" id="Tc_KOkDqLi0vUa6KIrViilffw_9_21">11</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.29%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.42%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_6_30_2018_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_cMMLNks1_USBkW1x4s71Qw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="6" id="Tc_O9hb0vU1rE6RTxzZrVagkQ_9_24">2</ix:nonfraction></p></td></tr><tr><td style="vertical-align:bottom;width:26.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">Other comprehensive income (loss) before reclassifications</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"> (<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2019_To_9_30_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedTranslationAdjustmentMember_QTmknphONka7wd6TxuDRwA" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" sign="-" scale="6" id="Tc_M83_NzuFGka3d-iLoyWu9Q_10_3">478</ix:nonfraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"> (<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2018_To_9_30_2018_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedTranslationAdjustmentMember_-leGWOkeKEawi-QLq6LVGw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" sign="-" scale="6" id="Tc_k7qsKITcoU--kyPwR0SUcw_10_6">153</ix:nonfraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2019_To_9_30_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_v7pihJwn_EmhBMZynyJ6qQ" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="Tc_yqfWf1wVkUCuJwIOzhXrww_10_9">7</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2019_To_9_30_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_0kVXboVkfEqGj4zXmlxZ1Q" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="Tc_cmdmCkJC60eyQ7KuNx8L_Q_10_21">67</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2018_To_9_30_2018_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_FcH8pG6M70SGkwFo_nAkaA" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="Tc_Rfs1Z_duQE2_g7Fehcwb7w_10_24">10</ix:nonfraction></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:26.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">Amounts reclassified from accumulated other comprehensive income</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:6.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> —</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.8%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> —</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.29%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.8%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2019_To_9_30_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_v7pihJwn_EmhBMZynyJ6qQ" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" sign="-" scale="6" id="Tc_WFUqwpzzKEq54XGPaESUgw_11_9">24</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.29%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.8%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2018_To_9_30_2018_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_HRtfunmfOUeJPnNKwhj38w" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" sign="-" scale="6" id="Tc_eiUcbVugu0Sf2iqN-ENcUw_11_12">22</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.29%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.8%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> —</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.29%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.8%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> —</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.29%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.8%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"> (<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2019_To_9_30_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_0kVXboVkfEqGj4zXmlxZ1Q" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="Tc_Eu8Vzhd-mkSmEFVU2Rct0w_11_21">18</ix:nonfraction>)</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.29%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.42%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2018_To_9_30_2018_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_FcH8pG6M70SGkwFo_nAkaA" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" sign="-" scale="6" id="Tc_8R-0QB12Jki3e5Jl6epAzA_11_24">25</ix:nonfraction></p></td></tr><tr><td style="vertical-align:bottom;width:26.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">Net current period comprehensive income (loss)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"> (<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2019_To_9_30_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedTranslationAdjustmentMember_QTmknphONka7wd6TxuDRwA" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" sign="-" scale="6" id="Tc_8f3aobgaL0CdWNtbo0lDwA_12_3">478</ix:nonfraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.8%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"> (<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2018_To_9_30_2018_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedTranslationAdjustmentMember_-leGWOkeKEawi-QLq6LVGw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" sign="-" scale="6" id="Tc_iPEp1uf74ESPBDLUdKZJmA_12_6">153</ix:nonfraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.8%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2019_To_9_30_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_v7pihJwn_EmhBMZynyJ6qQ" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="Tc_s3K3kra_6EuCfCDQlbTCWQ_12_9">31</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.8%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2018_To_9_30_2018_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_HRtfunmfOUeJPnNKwhj38w" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="Tc_ia3YJ_Fh8EuujP-VRAuVPA_12_12">22</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.8%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.8%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.8%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2019_To_9_30_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_0kVXboVkfEqGj4zXmlxZ1Q" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="Tc_Tnwb0Dryy06YkblyJ-XUWA_12_21">49</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.42%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2018_To_9_30_2018_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_FcH8pG6M70SGkwFo_nAkaA" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="Tc_EzgoBeYskUG5ybvDJ14Ymg_12_24">35</ix:nonfraction></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:26.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">Balance at September&nbsp;30</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.3%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:6.14%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"> (<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_9_30_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedTranslationAdjustmentMember_QperScMcXkef0ElUQzi7oQ" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" sign="-" scale="6" id="Tc_aWwm4xikykCYaZCuJy9iAQ_13_3">5,177</ix:nonfraction>)</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.3%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.8%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"> (<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_9_30_2018_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedTranslationAdjustmentMember_2cysz9O7IEursrDHfLQHWA" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" sign="-" scale="6" id="Tc_LxUzbbVzEEKUZ-NUCt5iXQ_13_6">4,631</ix:nonfraction>)</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.29%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.8%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"> (<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_9_30_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_kY8gy1aksESiVApQoJqTYA" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" sign="-" scale="6" id="Tc_2MWpTmaM80G-BnHsS2jZaQ_13_9">2,646</ix:nonfraction>)</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.29%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.8%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"> (<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_9_30_2018_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_q2xiHapVJUO_5rhTSwvlNA" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" sign="-" scale="6" id="Tc_ixm38BZTd0mCkVsbfQFNGw_13_12">2,415</ix:nonfraction>)</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.29%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.8%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> —</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.29%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.8%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> —</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.29%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.8%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_9_30_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_z5hAWCvHIUKcOkDryiupIA" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="6" id="Tc_fxXnwelWBEGAYPgoyfoq_w_13_21">60</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.29%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.42%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_9_30_2018_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_CWADNgfhz0q-L3-mkZGWzA" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="6" id="Tc_vE0nK7GFV0OLA_p2eRLxBg_13_24">37</ix:nonfraction></p></td></tr></tbody></table><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tbody><tr style="height:1pt;"><td style="vertical-align:bottom;width:26.88%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;width:2.04%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.16%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.16%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:5.79%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:5.79%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:5.79%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:5.79%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:5.79%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:5.08%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="background-color:auto;vertical-align:bottom;width:26.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="23" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:71.06%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Nine Months Ended September&nbsp;30</b></p></td></tr><tr><td style="background-color:auto;vertical-align:bottom;width:26.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="5" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:16.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="5" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:16.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="5" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:16.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="5" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:15.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Cumulative&nbsp;Gains</b></p></td></tr><tr><td style="background-color:auto;vertical-align:bottom;width:26.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="5" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:16.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="5" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:16.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="5" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:16.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Cumulative</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="5" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:15.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">(Losses)&nbsp;on</b></p></td></tr><tr><td style="background-color:auto;vertical-align:bottom;width:26.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="5" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:16.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="5" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:16.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Net&nbsp;Actuarial</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="5" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:16.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Unrealized&nbsp;Gains</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="5" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:15.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Derivative</b></p></td></tr><tr><td style="background-color:auto;vertical-align:bottom;width:26.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="5" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:16.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Cumulative</b><b style="font-family:'Calibri';font-weight:bold;">&nbsp;</b><b style="font-weight:bold;">Foreign</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="5" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:16.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">(Losses)&nbsp;and&nbsp;Prior</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="5" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:16.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">(Losses)&nbsp;on</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="5" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:15.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Instruments</b></p></td></tr><tr><td style="background-color:auto;vertical-align:bottom;width:26.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="5" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:16.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Currency&nbsp;Translation</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="5" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:16.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Service&nbsp;(Costs)</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="5" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:16.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Marketable&nbsp;Equity</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="5" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:15.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Designated&nbsp;as</b></p></td></tr><tr><td style="background-color:auto;vertical-align:bottom;width:26.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">(in millions)</p></td><td style="background-color:auto;vertical-align:bottom;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-style:italic;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="5" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:16.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Adjustments</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&nbsp;</b></p></td><td colspan="5" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:16.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">and&nbsp;Credits</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&nbsp;</b></p></td><td colspan="5" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:16.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Securities</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&nbsp;</b></p></td><td colspan="5" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:15.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Cash&nbsp;Flow&nbsp;Hedges</b></p></td></tr><tr><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:26.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri';font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;&nbsp;&nbsp;&nbsp;</p></td><td colspan="2" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:7.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2019</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&nbsp;&nbsp;&nbsp;&nbsp;</b></p></td><td colspan="2" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:7.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2018</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&nbsp;&nbsp;&nbsp;&nbsp;</b></p></td><td colspan="2" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:7.09%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2019</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&nbsp;&nbsp;&nbsp;&nbsp;</b></p></td><td colspan="2" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:7.09%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2018</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&nbsp;&nbsp;&nbsp;&nbsp;</b></p></td><td colspan="2" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:7.09%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2019</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&nbsp;&nbsp;&nbsp;&nbsp;</b></p></td><td colspan="2" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:7.09%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2018</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&nbsp;&nbsp;&nbsp;&nbsp;</b></p></td><td colspan="2" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:7.09%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2019</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&nbsp;&nbsp;&nbsp;&nbsp;</b></p></td><td colspan="2" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:6.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2018</b></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:26.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">Balance at December 31 , 2018 and 2017</p></td><td style="background-color:#cceeff;vertical-align:bottom;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:6.16%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"> (<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_12_31_2018_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedTranslationAdjustmentMember_65cF7pl2qUK4LywWRC10VA" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" sign="-" scale="6" id="Tc_GFTyvqfzQ0GiHMbJPfpJWQ_9_3">4,912</ix:nonfraction>)</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:6.16%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"> (<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_12_31_2017_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedTranslationAdjustmentMember_l7H_pAXqA0qtmOxmUxk1fw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" sign="-" scale="6" id="Tc_As6jcjZSrUaoXloqM1qG0A_9_6">3,452</ix:nonfraction>)</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.29%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"> (<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_12_31_2018_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember__fKYEvXnyk6FTU0nZfVV_Q" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" sign="-" scale="6" id="Tc_wFL1sH2kYUeN3Y81iX_11A_9_9">2,726</ix:nonfraction>)</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.29%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"> (<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_12_31_2017_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_ofh3Gnzk3UyE3R25lCHDaA" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" sign="-" scale="6" id="Tc_Pr8IhUMfzkOEkKfpbtnCEQ_9_12">2,521</ix:nonfraction>)</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.29%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> —</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.29%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"> (<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_12_31_2017_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_O20waITMiUGO-GV5b-rNfg" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" sign="-" scale="6" id="Tc_JzZYVG01Mk6KCO6okcaHdQ_9_18">5</ix:nonfraction>)</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.29%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_12_31_2018_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_Lgy2EE8hhUyJM-gEBs_YWw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="6" id="Tc_xtnLzlxcJE-l6nwVq4JTkw_9_21">52</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.29%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.08%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"> (<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_12_31_2017_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_tI1ocRnn8UuJHonG3ajMpw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" sign="-" scale="6" id="Tc_KKSIq8S6KkKWimABG4KG0g_9_24">84</ix:nonfraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:26.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">Impact of adoption of new accounting standard</p></td><td style="vertical-align:bottom;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.16%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.16%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_1_1_2018_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_dImliaxYGkubUQ6JT8eo1A" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption" scale="6" id="Tc_U3hMH0rc7E-lXlRKMPs1dg_10_18">5</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.08%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> —</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:26.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">Other comprehensive income (loss) before reclassifications</p></td><td style="background-color:#cceeff;vertical-align:bottom;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:6.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"> (<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedTranslationAdjustmentMember_ahRQcVKo5Ee9ibEOt4b1vg" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" sign="-" scale="6" id="Tc_5n-zbz3y2EiW8lu1JqA3nw_11_3">265</ix:nonfraction>)</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:6.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"> (<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2018_To_9_30_2018_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedTranslationAdjustmentMember_BTp83-aWHUWu-2eP47pxBg" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" sign="-" scale="6" id="Tc_64r4ozpGfUmBr1HA0bts7Q_11_6">1,179</ix:nonfraction>)</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_MmI0pTMZD0KzxQcfC1yCPA" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="Tc_HGObq2FjtEafT44WSN9Iyw_11_9">9</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> —</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> —</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> —</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_F4mEkPCE_E-rP4hjc0l1ww" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="Tc_ed1RWVhPeEux17cTDisUKQ_11_21">48</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2018_To_9_30_2018_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_RV18NRdLfUSZpzm0ZOAU_A" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="Tc_huyLIemfhk-aGnmjpfOs0Q_11_24">38</ix:nonfraction></p></td></tr><tr><td style="vertical-align:bottom;width:26.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">Amounts reclassified from accumulated other comprehensive income </p></td><td style="vertical-align:bottom;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.16%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.16%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_MmI0pTMZD0KzxQcfC1yCPA" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" sign="-" scale="6" id="Tc_humSjXeii0yUPIUuW5dVnA_12_9">71</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2018_To_9_30_2018_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_HuQINilLHkCUG87EDKyxJA" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" sign="-" scale="6" id="Tc_FfaxEBRHF0i0Ujm_KWNqvA_12_12">106</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;"> <span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"> (<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_F4mEkPCE_E-rP4hjc0l1ww" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="Tc_wVoEog2D506FwjnItf4rwQ_12_21">40</ix:nonfraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.08%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2018_To_9_30_2018_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_RV18NRdLfUSZpzm0ZOAU_A" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" sign="-" scale="6" id="Tc_oyiHumWsAUq_Efys-yO37g_12_24">83</ix:nonfraction></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:26.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">Net current period comprehensive income (loss)</p></td><td style="background-color:#cceeff;vertical-align:bottom;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:6.16%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"> (<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedTranslationAdjustmentMember_ahRQcVKo5Ee9ibEOt4b1vg" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" sign="-" scale="6" id="Tc_oN1V6MK03kymrOQ6DH8NPg_13_3">265</ix:nonfraction>)</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:6.16%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"> (<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2018_To_9_30_2018_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedTranslationAdjustmentMember_BTp83-aWHUWu-2eP47pxBg" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" sign="-" scale="6" id="Tc_75I4VOQQdEanmVATTlkR0A_13_6">1,179</ix:nonfraction>)</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.29%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_MmI0pTMZD0KzxQcfC1yCPA" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="Tc_wqhYTtK1yE-SHTCoiVWj_Q_13_9">80</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.29%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2018_To_9_30_2018_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_HuQINilLHkCUG87EDKyxJA" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="Tc_sr52dp2Na0e9Q_3CRnEUbQ_13_12">106</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.29%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> —</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.29%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> —</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.29%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_F4mEkPCE_E-rP4hjc0l1ww" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="Tc_QXRqxZy2pU24uWAYU2Geew_13_21">8</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.29%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.08%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2018_To_9_30_2018_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_RV18NRdLfUSZpzm0ZOAU_A" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="Tc_AkjwEXU1gkSHQ6tgHkhaBw_13_24">121</ix:nonfraction></p></td></tr><tr><td style="vertical-align:bottom;width:26.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">Balance at September&nbsp;30</p></td><td style="vertical-align:bottom;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.16%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"> (<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_9_30_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedTranslationAdjustmentMember_QperScMcXkef0ElUQzi7oQ" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" sign="-" scale="6" id="Tc_pYf5hSqCaEmafLEjhRoVIA_14_3">5,177</ix:nonfraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.3%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.16%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"> (<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_9_30_2018_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedTranslationAdjustmentMember_2cysz9O7IEursrDHfLQHWA" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" sign="-" scale="6" id="Tc_y9HyPtn35EyjMsL_CGdWlg_14_6">4,631</ix:nonfraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.79%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"> (<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_9_30_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_kY8gy1aksESiVApQoJqTYA" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" sign="-" scale="6" id="Tc_9uQHGOVC_UGjSEze24-pqQ_14_9">2,646</ix:nonfraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.79%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"> (<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_9_30_2018_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_q2xiHapVJUO_5rhTSwvlNA" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" sign="-" scale="6" id="Tc_-DVTce3vgEWUGfqVB8H7wg_14_12">2,415</ix:nonfraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.79%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.79%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.79%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_9_30_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_z5hAWCvHIUKcOkDryiupIA" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="6" id="Tc_dTvU_vgs3Um6uYuU5Q3Alg_14_21">60</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.08%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_9_30_2018_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_CWADNgfhz0q-L3-mkZGWzA" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="6" id="Tc_4ebTaOYnvUWNoah3Hi8jbQ_14_24">37</ix:nonfraction></p></td></tr></tbody></table></ix:nonnumeric><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:10pt;text-align:justify;margin:0pt;">Reclassified amounts for foreign currency translation are recorded in the Condensed Consolidated Statement of Earnings as Net foreign exchange (gain) loss and cash flow hedges as Cost of products sold. &nbsp;Net actuarial losses and prior service cost are included as a component of net periodic benefit costs; see Note 13 for additional details.</p></ix:nonnumeric><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">12</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><a href="#TOC"><span style="font-family:'Times New Roman';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Table of Contents</span></a></p><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:10pt;text-align:center;margin:0pt;">Abbott Laboratories and Subsidiaries</p><p style="font-family:'Times New Roman';font-size:10pt;text-align:center;margin:0pt;">Notes to the Condensed Consolidated Financial Statements</p><p style="font-family:'Times New Roman';font-size:10pt;text-align:center;margin:0pt;">September 30, 2019</p><p style="font-family:'Times New Roman';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;">(Unaudited)</p></div><div style="clear:both;max-width:100%;position:relative;"><ix:nonnumeric contextref="Duration_1_1_2019_To_9_30_2019_O4ushO81Z0mAnTH_cLUPFw" name="us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock" id="Tb__MYz7jol7kWzRjuEb3904g" escape="true"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">Note&nbsp;6&nbsp;— Goodwill and Intangible Assets</p><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:10pt;text-align:justify;margin:0pt;">The total amount of goodwill reported was $<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_9_30_2019_Q77aJBXiP0qCmJ4Yd2DnHw" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="9" id="Narr_YPuNKht5j0WuiMiIEx1x4A">23.0</ix:nonfraction> billion at September 30, 2019 and $<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_12_31_2018_INezHDkjn0-L7OMGoLMjhA" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="9" id="Narr_Ma7tbFu_RUG5pIlWvSFJmQ">23.3</ix:nonfraction> billion at December 31, 2018. Foreign currency translation adjustments decreased goodwill by approximately $<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_O4ushO81Z0mAnTH_cLUPFw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" sign="-" scale="6" id="Narr_V2rM07eA8U22LIAUc236Ig">252</ix:nonfraction> million during the first nine months of 2019. The amount of goodwill related to reportable segments at September 30, 2019 was $<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_9_30_2019_us-gaap_StatementBusinessSegmentsAxis_abt_EstablishedPharmaceuticalProductsMember_UnYrsB57Nkagfm2uHBTc5w" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="9" id="Narr_4Ocueq-wSUuYTeL6xUgmDA">3.0</ix:nonfraction> billion for the Established Pharmaceutical Products segment, $<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_9_30_2019_us-gaap_StatementBusinessSegmentsAxis_abt_NutritionalProductsMember_YoPRByOmokqwB0d5qJ5VbQ" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="Narr_c2LYgJhF4k2qZvFrHCv5gg">286</ix:nonfraction> million for the Nutritional Products segment, $<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_9_30_2019_us-gaap_StatementBusinessSegmentsAxis_abt_DiagnosticProductsMember_ri__PwPJn06gNt3sCbH5ag" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="9" id="Narr_COP95QZ17E2n-NQazAvQMw">3.7</ix:nonfraction> billion for the Diagnostic Products segment, and $<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_9_30_2019_us-gaap_StatementBusinessSegmentsAxis_abt_CardiovascularAndNeuromodulationProductsMember_mLmh_6-3VkiqgiDyhwOAjA" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="9" id="Narr_m6VTyVNrjUqDJatp86DZSw">15.2</ix:nonfraction> billion for the Cardiovascular and Neuromodulation Products segment. &nbsp;There was <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_O4ushO81Z0mAnTH_cLUPFw" decimals="-8" format="ixt-sec:numwordsen" name="us-gaap:GoodwillImpairmentLoss" scale="9" id="Narr_sjqgtvY53kudwimaSJEGfQ">no</ix:nonfraction> reduction of goodwill relating to impairments in the first nine months of 2019. </p><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:10pt;text-align:justify;margin:0pt;">The gross amount of amortizable intangible assets, primarily product rights and technology was $<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_9_30_2019_Q77aJBXiP0qCmJ4Yd2DnHw" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="9" id="Narr_8Rgvt8dOfEaAngYsy9IO1g">25.1</ix:nonfraction> billion as of September 30, 2019 and $<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_12_31_2018_INezHDkjn0-L7OMGoLMjhA" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="9" id="Narr_5KGEP8vGkUSwCxfScSeSHQ">25.7</ix:nonfraction> billion as of December 31, 2018, and accumulated amortization was $<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_9_30_2019_Q77aJBXiP0qCmJ4Yd2DnHw" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="9" id="Narr_9Z5Ngx4ZI0m1iAK-dT3sEg">11.2</ix:nonfraction> billion as of September 30, 2019 and $<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_12_31_2018_INezHDkjn0-L7OMGoLMjhA" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="9" id="Narr_L9wdvJgLEUibg55agXQN-Q">10.4</ix:nonfraction> billion as of December 31, 2018. Foreign currency translation adjustments decreased intangible assets by approximately $<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_O4ushO81Z0mAnTH_cLUPFw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss" scale="6" id="Narr_hGSow3lcL0CVbJG7Ty36Ug">110</ix:nonfraction> million during the first nine months of 2019. Abbott’s estimated annual amortization expense for intangible assets is approximately $<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_9_30_2019_Q77aJBXiP0qCmJ4Yd2DnHw" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" scale="9" id="Narr_Zuj2wt6mQ0uyb6RhPuj-LQ">1.9</ix:nonfraction> billion in 2019, $<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_9_30_2019_Q77aJBXiP0qCmJ4Yd2DnHw" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" scale="9" id="Narr_L-Cjsj74K0mJxrEI4qOk6g">2.1</ix:nonfraction> billion in 2020, $<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_9_30_2019_Q77aJBXiP0qCmJ4Yd2DnHw" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" scale="9" id="Narr_RSIqPCT3oESr-H0ea47dfw">2.0</ix:nonfraction> billion in 2021, $<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_9_30_2019_Q77aJBXiP0qCmJ4Yd2DnHw" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" scale="9" id="Narr_zhTvrY8z10qBq8IDD8vzWg">2.0</ix:nonfraction> billion in 2022 and $<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_9_30_2019_Q77aJBXiP0qCmJ4Yd2DnHw" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" scale="9" id="Narr_AWdAiG-lw0-QiLlsdqesdw">2.0</ix:nonfraction> billion in 2023. </p><p style="font-family:'Times New Roman';font-size:12pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:10pt;text-align:justify;margin:0pt;">Indefinite-lived intangible assets, which relate to in-process research and development acquired in a business combination, were approximately $<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_9_30_2019_Q77aJBXiP0qCmJ4Yd2DnHw" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="9" id="Narr_PXaSWv48BUim38Yr6umBYg"><ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_12_31_2018_INezHDkjn0-L7OMGoLMjhA" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="9" id="Narr_4SvUsxFGQkitON9UsK8Cwg">3.6</ix:nonfraction></ix:nonfraction> billion as of September 30, 2019 and December 31, 2018<span style="background-color:#ffffff;">.</span></p></ix:nonnumeric><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><a id="_285f1d1e_ba84_424f_a3fb_45b1a2beed1f"></a><a id="Tc_FyU-nGaMykWUlKrASRc4xw_1_0"></a><a id="Tc_fEcyhIRgJUSlUeWMS40Zpg_2_0"></a><a id="Tc_amyxYdmqFEeMIePTGlMKNQ_2_2"></a><a id="Tc_uCGC7hEFTku_qs_EAZrIGQ_3_0"></a><a id="Tc_tz2Y0Tue-0yIRL9MsfOQUg_4_0"></a><a id="Tc_3UektY5tBk-zQvZFxjqH-w_5_0"></a><a id="Tc__pDGqGoAD06Er9bCsjKFmg_5_2"></a><a id="_4aa1d8b8_15e7_4177_9e0c_29df846eeea6"></a><a id="Tc_JujTYTPMiUalNIF2Rg87LA_1_0"></a><a id="Tc_y3A04I9OJUGM00GbyXFvQQ_2_0"></a><a id="Tc_pEelvJeqH0CXAH5Wvfaxew_2_2"></a><a id="Tc_7-PIR3bsWkOpYx6uRcFFtQ_3_0"></a><a id="Tc_sl3PM1XwkUSqKM3JNxpo6w_4_0"></a><a id="Tc_VjraLnt4w0ilv6O1I-u9Eg_5_0"></a><a id="Tc_Qypn29S54UaXyBCeMTEMgw_5_2"></a><ix:nonnumeric contextref="Duration_1_1_2019_To_9_30_2019_O4ushO81Z0mAnTH_cLUPFw" name="us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock" id="Tb_jr-QyQN5-064hdxLVaCogQ" escape="true"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">Note 7 — Restructuring Plans</p><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:10pt;text-align:justify;margin:0pt;">From 2017 to 2019, Abbott management approved restructuring plans as part of the integration of the acquisitions of St. Jude Medical into the Cardiovascular and Neuromodulation segment, and Alere Inc. (Alere) into the Diagnostics segment, in order to leverage economies of scale and reduce costs. In the first nine months of 2019, charges of $<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_us-gaap_RestructuringCostAndReserveAxis_abt_RestructuringPlan2017To2019StjudeAndAlereMember_lJdOhY467UKrCdJ7FcN3_Q" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RestructuringCharges" scale="6" id="Narr_NPvK2oYd-kWd6ex6Xdaq3g">66</ix:nonfraction> million were recognized, of which $<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember_us-gaap_RestructuringCostAndReserveAxis_abt_RestructuringPlan2017To2019StjudeAndAlereMember_JP-ZjJPCSEK7ootjdi_kaw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RestructuringCharges" scale="6" id="Narr_gbOtGU8ebkqwLOnsiFmIbw">18</ix:nonfraction> million is recorded in Cost of products sold, $<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_us-gaap_IncomeStatementLocationAxis_us-gaap_ResearchAndDevelopmentExpenseMember_us-gaap_RestructuringCostAndReserveAxis_abt_RestructuringPlan2017To2019StjudeAndAlereMember_8TVhyOFuH0KUpdd182ROmw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RestructuringCharges" scale="6" id="Narr_OJvHoQbyuE-ReMH-FViFNg">4</ix:nonfraction> million is recorded in Research and development and $<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_us-gaap_IncomeStatementLocationAxis_us-gaap_SellingGeneralAndAdministrativeExpensesMember_us-gaap_RestructuringCostAndReserveAxis_abt_RestructuringPlan2017To2019StjudeAndAlereMember_IZFYhFP0dEuk_E4iS5hi9A" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RestructuringCharges" scale="6" id="Narr_XdwKqhoF6ECjud2309-pDw">44</ix:nonfraction> million as Selling, general and administrative expense. &nbsp;The following summarizes the activity for the first nine months of 2019 related to these actions and the status of the related accrual as of September 30, 2019:</p><ix:nonnumeric contextref="Duration_1_1_2019_To_9_30_2019_us-gaap_RestructuringCostAndReserveAxis_abt_RestructuringPlan2017To2019StjudeAndAlereMember_lJdOhY467UKrCdJ7FcN3_Q" name="us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock" id="Tb_aD6LsY2Um0CUFscnS5-eqw" escape="true"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p><table style="border-collapse:collapse;font-size:16pt;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tbody><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:86.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.74%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.81%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:86.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">(in millions)</p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:2.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;&nbsp;&nbsp;&nbsp;</p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:8.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:86.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">Accrued balance at December&nbsp;31,&nbsp;2018</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_12_31_2018_us-gaap_RestructuringCostAndReserveAxis_abt_RestructuringPlan2017To2019StjudeAndAlereMember_Fb8XUZ5dakWllMJpk3jgdQ" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RestructuringReserve" scale="6" id="Tc_ag9sXK-EMkyiVTkwCq2kZg_2_3">41</ix:nonfraction></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:86.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">Restructuring charges recorded in 2019</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_us-gaap_RestructuringCostAndReserveAxis_abt_RestructuringPlan2017To2019StjudeAndAlereMember_lJdOhY467UKrCdJ7FcN3_Q" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RestructuringCharges" scale="6" id="Tc_m40sSLbRL0yEt-yhYADR9A_3_3">66</ix:nonfraction></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:86.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">Payments and other adjustments</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.73%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.81%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"> (<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_us-gaap_RestructuringCostAndReserveAxis_abt_RestructuringPlan2017To2019StjudeAndAlereMember_lJdOhY467UKrCdJ7FcN3_Q" decimals="-6" format="ixt:numdotdecimal" name="abt:RestructuringReservePeriodCashSettledAndOtherAdjustments" scale="6" id="Tc_IdS58JimAU-go9gWLvoBbg_4_3">45</ix:nonfraction>)</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:86.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">Accrued balance at September&nbsp;30,&nbsp;2019</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.81%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_9_30_2019_us-gaap_RestructuringCostAndReserveAxis_abt_RestructuringPlan2017To2019StjudeAndAlereMember_q0pnQ18-YEuHt43XHzsrkA" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RestructuringReserve" scale="6" id="Tc_TmNrpAW9x0em3EqnauLsuQ_5_3">62</ix:nonfraction></p></td></tr></tbody></table><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></ix:nonnumeric><p style="font-family:'Times New Roman';font-size:10pt;text-align:justify;margin:0pt;">From 2016 to 2019, Abbott management approved plans to streamline operations in order to reduce costs and improve efficiencies in various Abbott businesses, including the nutritional, established pharmaceuticals and vascular businesses. In the first nine months of 2019, charges of $<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_us-gaap_RestructuringCostAndReserveAxis_abt_RestructuringPlanFrom2016To2019Member_NzEXx0HK5kKauLcx72p8kA" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RestructuringCharges" scale="6" id="Narr_cNie8UEVpUSAtKyI24_kZw">35</ix:nonfraction> million were recognized, of which $<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember_us-gaap_RestructuringCostAndReserveAxis_abt_RestructuringPlanFrom2016To2019Member_jjdDvedzc0mSQzR7w5ZX2g" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RestructuringCharges" scale="6" id="Narr_zYqOkg42M0qr-oMqGgCmlQ">10</ix:nonfraction> million is recorded in Cost of products sold, $<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_us-gaap_IncomeStatementLocationAxis_us-gaap_ResearchAndDevelopmentExpenseMember_us-gaap_RestructuringCostAndReserveAxis_abt_RestructuringPlanFrom2016To2019Member_Z97JbKaNV0ackA_Pb1ZDmg" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RestructuringCharges" scale="6" id="Narr_qLtmTtA4VEaxAJ3T8Xt9xg">8</ix:nonfraction> million is recorded in Research and development and $<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_us-gaap_IncomeStatementLocationAxis_us-gaap_SellingGeneralAndAdministrativeExpensesMember_us-gaap_RestructuringCostAndReserveAxis_abt_RestructuringPlanFrom2016To2019Member_hXefKCu4AEauZ3mXVC2eKQ" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RestructuringCharges" scale="6" id="Narr_KTUm1AHcJ0-Yvopj0uBMFg">17</ix:nonfraction> million as Selling, general and administrative expense. The following summarizes the activity for the first nine months of 2019 related to these restructuring actions and the status of the related accrual as of September 30, 2019:</p><ix:nonnumeric contextref="Duration_1_1_2019_To_9_30_2019_us-gaap_RestructuringCostAndReserveAxis_abt_RestructuringPlanFrom2016To2019Member_NzEXx0HK5kKauLcx72p8kA" name="us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock" id="Tb_AuK8BGLxnUagRav8lWEQPw" escape="true"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p><table style="border-collapse:collapse;font-size:16pt;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tbody><tr style="height:1pt;"><td style="vertical-align:bottom;width:86.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;width:2.74%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;width:1.73%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.81%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="background-color:auto;vertical-align:bottom;width:86.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0pt;">(in millions)</p></td><td style="background-color:auto;vertical-align:bottom;width:2.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&nbsp;&nbsp;&nbsp;&nbsp;</b></p></td><td style="background-color:auto;vertical-align:bottom;width:1.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:8.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:86.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">Accrued balance at December&nbsp;31,&nbsp;2018</p></td><td style="background-color:#cceeff;vertical-align:bottom;width:2.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;width:1.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_12_31_2018_us-gaap_RestructuringCostAndReserveAxis_abt_RestructuringPlanFrom2016To2019Member_7eMMCbXeYk-atM_ubYsnUA" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RestructuringReserve" scale="6" id="Tc_VS_1h9hgxECHqcXWhPHorg_2_3">70</ix:nonfraction></p></td></tr><tr><td style="vertical-align:bottom;width:86.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">Restructuring charges recorded in 2019</p></td><td style="vertical-align:bottom;width:2.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:1.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_us-gaap_RestructuringCostAndReserveAxis_abt_RestructuringPlanFrom2016To2019Member_NzEXx0HK5kKauLcx72p8kA" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RestructuringCharges" scale="6" id="Tc_sQsLksYWqky1UcAgwEVXPA_3_3">35</ix:nonfraction></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:86.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">Payments and other adjustments</p></td><td style="background-color:#cceeff;vertical-align:bottom;width:2.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;width:1.73%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.81%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0pt;"> (<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_us-gaap_RestructuringCostAndReserveAxis_abt_RestructuringPlanFrom2016To2019Member_NzEXx0HK5kKauLcx72p8kA" decimals="-6" format="ixt:numdotdecimal" name="abt:RestructuringReservePeriodCashSettledAndOtherAdjustments" scale="6" id="Tc_BrX8cBx2LkWSU7DhE1qgkQ_4_3">29</ix:nonfraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:86.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">Accrued balance at September&nbsp;30,&nbsp;2019</p></td><td style="vertical-align:bottom;width:2.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:1.73%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.81%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_9_30_2019_us-gaap_RestructuringCostAndReserveAxis_abt_RestructuringPlanFrom2016To2019Member_E-pYV7ivokmSZFV8XbRIPA" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RestructuringReserve" scale="6" id="Tc_2y_8E_PcW0uwCa4eU7edqA_5_3">76</ix:nonfraction></p></td></tr></tbody></table></ix:nonnumeric><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></ix:nonnumeric><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><a id="_a2d74916_c6d7_4ffa_bff0_f8f526a5426a"></a><a id="Tc_ifA3aZ2P90yKU8p5GT4Msw_1_2"></a><a id="Tc_I75kWeJYikmxnbMMmG21uA_1_5"></a><a id="Tc_9PqTMm-6f02u6sMqmQ2JgQ_2_0"></a><a id="Tc_9qVTGpjHw0amhuzSAWGlXA_3_0"></a><a id="Tc_o5VEunHweUWXXtps1TM9pw_4_0"></a><a id="Tc_PwFjt_pACkOHdXrGvc8AwA_4_2"></a><a id="Tc_GrLq3Kykz0mYqY367k88RQ_4_5"></a><a id="Tc_Pdr344a7OU-g2mPmirBe3A_5_0"></a><a id="Tc_UXvaMJEAv0CkOZvF1MiNlQ_5_2"></a><a id="Tc_rA5ekii5E0u-lkl-AGebFg_5_5"></a><ix:nonnumeric contextref="Duration_1_1_2019_To_9_30_2019_O4ushO81Z0mAnTH_cLUPFw" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="Tb_ul4vzzE1y0aOlkEdGNgsKQ" continuedat="Tb_ul4vzzE1y0aOlkEdGNgsKQ_cont1" escape="true"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">Note 8 — Incentive Stock Programs</p><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:10pt;text-align:justify;margin:0pt;">In the first nine months of 2019, Abbott granted <ix:nonfraction unitref="Unit_Standard_shares__pDT34XXdk2QZR7p6i5hkA" contextref="Duration_1_1_2019_To_9_30_2019_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_oFOh67Kt6E6KfotbtDbBzA" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" scale="0" id="Narr_kcLKKr97TEeSUjrnzbhvdg">4,579,283</ix:nonfraction> stock options, <ix:nonfraction unitref="Unit_Standard_shares__pDT34XXdk2QZR7p6i5hkA" contextref="Duration_1_1_2019_To_9_30_2019_us-gaap_AwardTypeAxis_abt_RestrictedStockAwardsMember_KfhBgacjXkqVbU7PBnxC7A" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="0" id="Narr_CVpnsuVpR0eJ_QkQzl2tJA">736,100</ix:nonfraction> restricted stock awards and <ix:nonfraction unitref="Unit_Standard_shares__pDT34XXdk2QZR7p6i5hkA" contextref="Duration_1_1_2019_To_9_30_2019_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember_E8NWHWr5YkKQuxb7kFQkyg" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" scale="0" id="Narr_bBMWlo0_jkCGlCL6daogIg">6,568,376</ix:nonfraction> restricted stock units under its incentive stock programs. At September 30, 2019, approximately <ix:nonfraction unitref="Unit_Standard_shares__pDT34XXdk2QZR7p6i5hkA" contextref="As_Of_9_30_2019_Q77aJBXiP0qCmJ4Yd2DnHw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" scale="6" id="Narr_5FSOhb7OX0SLbNsym3SVkg">126</ix:nonfraction> million shares were reserved for future grants. Information regarding the number of options outstanding and exercisable at September 30, 2019 is as follows:</p><ix:nonnumeric contextref="Duration_1_1_2019_To_9_30_2019_O4ushO81Z0mAnTH_cLUPFw" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" id="Tb_gsGOyesvFUuhUeREBIxbOQ" escape="true"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tbody><tr style="height:1pt;"><td style="vertical-align:bottom;width:70.59%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.68%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.68%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="background-color:auto;vertical-align:bottom;width:70.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&nbsp;&nbsp;&nbsp;&nbsp;</b></p></td><td colspan="2" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:12.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Outstanding</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&nbsp;&nbsp;&nbsp;&nbsp;</b></p></td><td colspan="2" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:12.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Exercisable</b></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:70.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">Number of shares </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_shares__pDT34XXdk2QZR7p6i5hkA" contextref="As_Of_9_30_2019_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_AJoUbmQxD0ixUlxv_IKhUg" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="0" id="Tc_dNIt8dfivU6eYEPD87VAwg_2_3">30,219,778</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_shares__pDT34XXdk2QZR7p6i5hkA" contextref="As_Of_9_30_2019_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_AJoUbmQxD0ixUlxv_IKhUg" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" scale="0" id="Tc_DiucTKwSqUG7FuMA3RxN4g_2_6">20,793,077</ix:nonfraction></p></td></tr><tr><td style="vertical-align:bottom;width:70.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">Weighted&nbsp;average&nbsp;remaining&nbsp;life&nbsp;(<i style="font-style:italic;">years</i>)<i style="font-style:italic;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"><ix:nonnumeric contextref="Duration_1_1_2019_To_9_30_2019_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_oFOh67Kt6E6KfotbtDbBzA" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" id="Tc_uelNYwa7u0K0aW65hqj3CQ_3_3"> 6.5</ix:nonnumeric></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"><ix:nonnumeric contextref="Duration_1_1_2019_To_9_30_2019_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_oFOh67Kt6E6KfotbtDbBzA" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" id="Tc_r-1iZ7eakUOLIcbdH_Gt1Q_3_6"> 5.5</ix:nonnumeric></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:70.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">Weighted&nbsp;average&nbsp;exercise&nbsp;price </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Divide_USD_shares_xJ2idvgWWEuE1nW1pOVAfA" contextref="As_Of_9_30_2019_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_AJoUbmQxD0ixUlxv_IKhUg" decimals="2" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="Tc_gNifWuu7p06F_NvZuY-SNA_4_3">48.65</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Divide_USD_shares_xJ2idvgWWEuE1nW1pOVAfA" contextref="As_Of_9_30_2019_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_AJoUbmQxD0ixUlxv_IKhUg" decimals="2" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" scale="0" id="Tc_dsQb-gAoZESnPXOhmcsiig_4_6">41.13</ix:nonfraction></p></td></tr><tr><td style="vertical-align:bottom;width:70.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">Aggregate&nbsp;intrinsic&nbsp;value&nbsp;(<i style="font-style:italic;">in&nbsp;millions</i>) </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_9_30_2019_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_AJoUbmQxD0ixUlxv_IKhUg" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" scale="6" id="Tc_Qc6YqC_zHkG6NxXpk9FYeA_5_3">1,058</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_9_30_2019_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_AJoUbmQxD0ixUlxv_IKhUg" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" scale="6" id="Tc_yCOTSIS09USr4Fk3D0B8EA_5_6">885</ix:nonfraction></p></td></tr></tbody></table></ix:nonnumeric><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></ix:nonnumeric></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">13</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><a href="#TOC"><span style="font-family:'Times New Roman';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Table of Contents</span></a></p><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:10pt;text-align:center;margin:0pt;">Abbott Laboratories and Subsidiaries</p><p style="font-family:'Times New Roman';font-size:10pt;text-align:center;margin:0pt;">Notes to the Condensed Consolidated Financial Statements</p><p style="font-family:'Times New Roman';font-size:10pt;text-align:center;margin:0pt;">September 30, 2019</p><p style="font-family:'Times New Roman';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;">(Unaudited)</p></div><div style="clear:both;max-width:100%;position:relative;min-height:11.5pt;"><ix:continuation id="Tb_ul4vzzE1y0aOlkEdGNgsKQ_cont1"><p style="font-family:'Times New Roman';font-size:10pt;text-align:justify;margin:0pt;">The total unrecognized share-based compensation cost at September 30, 2019 amounted to approximately $<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_9_30_2019_Q77aJBXiP0qCmJ4Yd2DnHw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" scale="6" id="Narr_ngM6UgaDi0mSHa7WY4Vsiw">501</ix:nonfraction> million which is expected to be recognized over the next <ix:nonnumeric contextref="Duration_1_1_2019_To_9_30_2019_O4ushO81Z0mAnTH_cLUPFw" format="ixt-sec:durwordsen" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" id="Narr_4QkUf247PkqRizHqf75ZLA">three years</ix:nonnumeric>.</p></ix:continuation><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><ix:nonnumeric contextref="Duration_1_1_2019_To_9_30_2019_O4ushO81Z0mAnTH_cLUPFw" name="us-gaap:DebtDisclosureTextBlock" id="Tb_yGJCZb3TG0qCQTUycGwHBg" escape="true"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">Note 9 — Debt and Lines of Credit</p><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:10pt;text-align:justify;margin:0pt;">On February 24, 2019, Abbott redeemed the $<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_2_24_2019_To_2_24_2019_us-gaap_DebtInstrumentAxis_abt_LongTermNotesDueIn2020At2.80PercentMember_OvmFiM0KakOZD1aXcBSa-w" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfDebt" scale="6" id="Narr_TLVD6vN2PUGxDs6RMpVbzA">500</ix:nonfraction> million outstanding principal amount of its <ix:nonfraction unitref="Unit_Standard_pure_0hvT7e8qLkipZ3XmLkD-nQ" contextref="As_Of_2_24_2019_us-gaap_DebtInstrumentAxis_abt_LongTermNotesDueIn2020At2.80PercentMember_RRQASgqPwUa9r9QrzxbkyQ" decimals="4" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="Narr_rIZuHKMpVk6W5wTVo7gW9w">2.80</ix:nonfraction>% Notes due 2020. </p><p style="font-family:'Times New Roman';font-size:12pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:10pt;text-align:justify;margin:0pt;">In September 2019, the board of directors authorized the early redemption of up to $<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_abt_DebtInstrumentRedemptionAuthorizationAxis_abt_DebtRedemptionSeptember2019Member_8fm8KC_d9kyDDuTmLvZr5w" decimals="-9" format="ixt:numdotdecimal" name="abt:AuthorizeRedemptionOfDebt" scale="9" id="Narr_c7H8c-l5pU-PXXA20LSYOw">5</ix:nonfraction><span style="font-size:12pt;"> </span>billion of outstanding long-term notes. This bond redemption authorization supersedes the board's previous authorization under which $<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_9_30_2019_abt_DebtInstrumentRedemptionAuthorizationAxis_abt_DebtRedemptionFebruary2018Member_rwgB-m8Hbka3hsTA8ibAFQ" decimals="-6" format="ixt:numdotdecimal" name="abt:BondRedemptionAuthorizationNotYetRedeemed" scale="6" id="Narr_f6WWgFr9EEKjQ0O093NT3Q">700</ix:nonfraction> million had not yet been redeemed.</p></ix:nonnumeric><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><a id="_9fbe5972_f6f5_44d5_9207_dab1dbd8ac6b"></a><a id="_6e86e595_404e_4f3e_9d40_7aa0d630dc88"></a><a id="_c920d801_da0e_4c02_958e_9a5add4e31be"></a><a id="_d71ea280_867c_4c27_aaab_fe162a422a3d"></a><a id="Tc_S4PnaGtLwE-mJrBgoKQHxg_1_2"></a><a id="Tc_A0977p0vAUy5pcyhP2TnrA_1_5"></a><a id="Tc_xHu561_Df0OhRpXGi2O4Dw_2_0"></a><a id="Tc_1uiMAgTY3EOrrGfDkcOPng_2_2"></a><a id="Tc_bGwSLa0PNEeP6RNbcRS3_g_2_5"></a><a id="Tc_lxigE_niqUibgNb1dwBfkw_3_0"></a><a id="Tc_8GXmtTOWgkmM2WDX65UsNA_3_2"></a><a id="Tc_Q7Fgmjl4-EivlBCSbzw3pg_3_5"></a><a id="Tc_e1fIorDb3E6Z0eVnGCZkAQ_4_0"></a><a id="Tc_csWMKFO-nEWPtrYpIkdfRg_4_2"></a><a id="Tc_0MdLe6WN7EaDuVtqbxkNrQ_4_5"></a><a id="Tc_6I3HktZn2UyYdp1LUxb1cA_5_0"></a><a id="Tc_bMYDFL_eS0W4SaRT-VHY7A_5_2"></a><a id="Tc_T_ND9c3qp0C5O2EZ5gfcPw_5_5"></a><a id="_312cc67f_f287_4882_8994_13e4991d4b00"></a><a id="_9091b557_d30c_4819_88f8_c00cefb2bf78"></a><a id="Tc_7FIpdoSjX06UlNhIM9js5g_1_0"></a><a id="Tc_vwFvwxMNxUuaY04-L5z8GA_2_0"></a><a id="Tc_YJa1DcMic0ijxxquR4D5sQ_2_2"></a><a id="Tc_uuz0eOL_90O6XSEDT28EoA_3_0"></a><a id="Tc_bAn7v-z200ipwmwjSOf66A_4_0"></a><a id="Tc_Rox4L2xxOESQ2f1FRpwfog_5_0"></a><a id="Tc_PRFfaOWzD0-mTMatdXjbMg_6_0"></a><a id="Tc_Y6LwA7FdVkmKZmKGVBH0Gg_7_0"></a><a id="Tc_YzthjEu4KUSEhEP3p1Cm-w_8_0"></a><a id="Tc_vXDi_TDY_0uUpeDeEgmUlA_9_0"></a><a id="Tc_stujzmxeOEmmSAkW3i8r6w_10_0"></a><a id="Tc_-2d06xJpHEeo2GCqKw-Ktw_10_2"></a><ix:nonnumeric contextref="Duration_1_1_2019_To_9_30_2019_O4ushO81Z0mAnTH_cLUPFw" name="abt:LeaseDisclosureTextBlock" id="Tb_zbHHxovebUKX6dvAzDovWw" continuedat="Tb_zbHHxovebUKX6dvAzDovWw_cont1" escape="true"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">Note 10 — Leases</p><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;"><i style="font-style:italic;">Leases where Abbott is the Lessee</i></p><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:10pt;text-align:justify;margin:0pt;">Abbott has entered into operating leases as the lessee for office space, manufacturing facilities, R&amp;D laboratories, warehouses, vehicles and equipment. &nbsp;Finance leases are not significant. &nbsp;Abbott’s operating leases generally have remaining lease terms of 1 to <ix:nonnumeric contextref="As_Of_9_30_2019_srt_RangeAxis_srt_MaximumMember_TIf3O5zuGEK_gbVC_qJfFA" format="ixt-sec:durwordsen" name="us-gaap:LesseeOperatingLeaseTermOfContract" id="Narr_Meh6HPUYoUic6UT1TjGtjw">10 years</ix:nonnumeric>. Some leases include options to extend beyond the original lease term, generally up to <ix:nonnumeric contextref="As_Of_9_30_2019_Q77aJBXiP0qCmJ4Yd2DnHw" format="ixt-sec:durwordsen" name="us-gaap:LesseeOperatingLeaseRenewalTerm" id="Narr_kLn0_DZbBkCX0IULnoO6hQ">10 years</ix:nonnumeric> and some include options to terminate early. These options have been included in the determination of the lease liability when it is reasonably certain that the option will be exercised.</p><p style="font-family:'Times New Roman';font-size:12pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:10pt;text-align:justify;margin:0pt;">For all of its asset classes, Abbott elected the practical expedient allowed under FASB ASC No. 842, “Leases” to account for each lease component (e.g., the right to use office space) and the associated non-lease components (e.g., maintenance services) as a single lease component. Abbott also elected the short-term lease accounting policy for all asset classes; therefore, Abbott is not recognizing a lease liability or ROU asset for any lease that, at the commencement date, has a lease term of 12 months or less and does not include an option to purchase the underlying asset that Abbott is reasonably certain to exercise.</p><p style="font-family:'Times New Roman';font-size:12pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:10pt;text-align:justify;margin:0pt;">As Abbott’s leases typically do not provide an implicit rate, the interest rate used to determine the present value of the payments under each lease typically reflects Abbott’s incremental borrowing rate based on information available at the lease commencement date. Abbott’s incremental borrowing rates at January 1, 2019 were used for operating leases that commenced prior to January 1, 2019.</p><p style="font-family:'Times New Roman';font-size:12pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:10pt;text-align:justify;margin:0pt;">The following table provides information related to Abbott’s operating leases:</p><ix:nonnumeric contextref="Duration_1_1_2019_To_9_30_2019_O4ushO81Z0mAnTH_cLUPFw" name="us-gaap:LeaseCostTableTextBlock" id="Tb_RDUxaNYf3ECe5QWTxXthvg" escape="true"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tbody><tr style="height:1pt;"><td style="vertical-align:top;width:68.01%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="background-color:auto;vertical-align:bottom;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&nbsp;&nbsp;&nbsp;&nbsp;</b></p></td><td colspan="2" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:13.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Three Months Ended </b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&nbsp;&nbsp;&nbsp;&nbsp;</b></p></td><td colspan="2" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:13.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Nine Months Ended</b></p></td></tr><tr><td style="background-color:auto;vertical-align:bottom;width:68.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">(in millions)</p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:13.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">September&nbsp;30,&nbsp;2019</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:13.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">September&nbsp;30,&nbsp;2019</b></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:top;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">Operating lease cost (a) </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2019_To_9_30_2019_5CXepWtEPEKQA-bPz0Tp7A" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseCost" scale="6" id="Tc__LxTDVJeOE-_Gi6H46GQBw_3_3">79</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_O4ushO81Z0mAnTH_cLUPFw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseCost" scale="6" id="Tc_c2Ns7j_BeEOpcS0aibYzaQ_3_6">233</ix:nonfraction></p></td></tr><tr><td style="vertical-align:top;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">Cash paid for amounts included in the measurement of operating lease liabilities </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2019_To_9_30_2019_5CXepWtEPEKQA-bPz0Tp7A" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingLeasePayments" scale="6" id="Tc_9tZLRhF3BUi4MBx8Hu5T2A_4_3">64</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_O4ushO81Z0mAnTH_cLUPFw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingLeasePayments" scale="6" id="Tc_uSNz-hQrPkypVetwXZx92g_4_6">190</ix:nonfraction></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:top;width:68.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">ROU assets arising from entering into new operating lease obligations</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2019_To_9_30_2019_5CXepWtEPEKQA-bPz0Tp7A" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" scale="6" id="Tc_2-xtQnFDU0e1q9Zh6JI3lA_5_3">104</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_O4ushO81Z0mAnTH_cLUPFw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" scale="6" id="Tc_gw3gvq7QfkONwr5c5Q8G3w_5_6">201</ix:nonfraction></p></td></tr></tbody></table><div style="font-family:'Times New Roman';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"></div></div><table style="border-collapse:collapse;font-family:'Times New Roman';font-size:12pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tbody><tr><td style="font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(a)</td><td style="padding:0pt;"><span style="color:#000000;font-family:'Times New Roman';font-size:10pt;font-style:normal;font-weight:normal;text-align:justify;">Includes short-term lease expense and variable lease costs, which were immaterial in the three and nine months ended September 30, 2019.</span></td></tr></tbody></table></ix:nonnumeric><p style="font-family:'Times New Roman';font-size:12pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:10pt;text-align:justify;margin:0pt;">The weighted average remaining lease term and discount rate for operating leases as of September 30, 2019 were <ix:nonnumeric contextref="As_Of_9_30_2019_Q77aJBXiP0qCmJ4Yd2DnHw" format="ixt-sec:durwordsen" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" id="Narr_CqqzbwFaMESHc-3yO_Fonw">8 years</ix:nonnumeric> and <ix:nonfraction unitref="Unit_Standard_pure_0hvT7e8qLkipZ3XmLkD-nQ" contextref="As_Of_9_30_2019_Q77aJBXiP0qCmJ4Yd2DnHw" decimals="3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="Narr_DPIewngXO0KbeJ5NhUZCoQ">4.1</ix:nonfraction>%, respectively.</p><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><ix:nonnumeric contextref="Duration_1_1_2019_To_9_30_2019_O4ushO81Z0mAnTH_cLUPFw" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" id="Tb_wk_isYI2j0-Vl4U3vVmlIA" escape="true"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">Future minimum lease payments under non-cancellable operating leases as of September 30, 2019 were as follows:</p><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tbody><tr style="height:1pt;"><td style="vertical-align:bottom;width:84.97%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.62%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="background-color:auto;vertical-align:bottom;width:84.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">(in millions)</p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:2.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&nbsp;&nbsp;&nbsp;&nbsp;</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:10.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:84.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">2019</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_9_30_2019_Q77aJBXiP0qCmJ4Yd2DnHw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" scale="6" id="Tc_aZERSjqL-0ik-pdUNiny-Q_2_3">61</ix:nonfraction></p></td></tr><tr><td style="vertical-align:top;width:84.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">2020</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_9_30_2019_Q77aJBXiP0qCmJ4Yd2DnHw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" scale="6" id="Tc_wT3lAQN0o0-2cCdfzgJ2Mg_3_3">225</ix:nonfraction></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:top;width:84.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">2021</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_9_30_2019_Q77aJBXiP0qCmJ4Yd2DnHw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" scale="6" id="Tc_Nu9rs0a52Ee_iwH21Elu-Q_4_3">177</ix:nonfraction></p></td></tr><tr><td style="vertical-align:top;width:84.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">2022</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_9_30_2019_Q77aJBXiP0qCmJ4Yd2DnHw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" scale="6" id="Tc_aoVT6XkZJUmxS5Pgbqsixg_5_3">137</ix:nonfraction></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:top;width:84.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">2023</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_9_30_2019_Q77aJBXiP0qCmJ4Yd2DnHw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive" scale="6" id="Tc_GpLI8sNizkSg3VaH9O0kSw_6_3">98</ix:nonfraction></p></td></tr><tr><td style="vertical-align:top;width:84.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">Thereafter</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.62%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_9_30_2019_Q77aJBXiP0qCmJ4Yd2DnHw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" scale="6" id="Tc_U4qiNQrA806ULCkR1dIBug_7_3">380</ix:nonfraction></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:top;width:84.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">Total future minimum lease payments – undiscounted</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_9_30_2019_Q77aJBXiP0qCmJ4Yd2DnHw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" scale="6" id="Tc_uHlqYJoJ_ka1siSEnTX1DQ_8_3">1,078</ix:nonfraction></p></td></tr><tr><td style="vertical-align:top;width:84.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 6pt;">Less: imputed interest</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.62%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"> (<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_9_30_2019_Q77aJBXiP0qCmJ4Yd2DnHw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" scale="6" id="Tc_2DZlc1Vmu06Aaz5DCwzS9w_9_3">174</ix:nonfraction>)</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:top;width:84.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">Present value of lease liabilities</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.7%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.62%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_9_30_2019_Q77aJBXiP0qCmJ4Yd2DnHw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiability" scale="6" id="Tc_sJnpVGtNdE2nK65C3Sj_fw_10_3">904</ix:nonfraction></p></td></tr></tbody></table></ix:nonnumeric><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></ix:nonnumeric></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">14</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><a href="#TOC"><span style="font-family:'Times New Roman';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Table of Contents</span></a></p><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:10pt;text-align:center;margin:0pt;">Abbott Laboratories and Subsidiaries</p><p style="font-family:'Times New Roman';font-size:10pt;text-align:center;margin:0pt;">Notes to the Condensed Consolidated Financial Statements</p><p style="font-family:'Times New Roman';font-size:10pt;text-align:center;margin:0pt;">September 30, 2019</p><p style="font-family:'Times New Roman';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;">(Unaudited)</p></div><div style="clear:both;max-width:100%;position:relative;"><a id="Tc_SXJ3Hud3K0eSGkndLeElHQ_1_0"></a><a id="Tc_mxO93gxuU0C-NTFDIualcw_1_2"></a><a id="Tc_nnqfMnYzOkCFQHXpq_CRTw_1_5"></a><a id="Tc_RyvMEINID0CnOcfWsfbSSA_3_0"></a><a id="Tc_qX-yMbYdr0Saiu4Oqdod7w_3_2"></a><a id="Tc_coml7E2WtU6oksU61qgjJw_3_5"></a><a id="Tc_7p8vH2JhOECmtNxJJRTCtw_5_0"></a><a id="Tc_Nd1QSDKkQ0ueZos2w5H-3A_7_0"></a><a id="Tc_8lPCuVGOe0qQZY53ZC-y7w_7_2"></a><a id="Tc_6FA2zEPv1kOhLCmQNzFdiw_7_5"></a><a id="Tc_gKuzV7XfBkKor-cMUfyFcA_8_0"></a><a id="Tc_JxlBujRB60uaMF_3L-wOTw_8_5"></a><a id="Tc_rFVRQ_TsNUyzxq6gJy32Cg_9_0"></a><a id="Tc_o1ayolvM0E-5ySpmuOeNXQ_9_2"></a><ix:continuation id="Tb_zbHHxovebUKX6dvAzDovWw_cont1"><p style="font-family:'Times New Roman';font-size:10pt;text-align:justify;margin:0pt;">The following table summarizes the amounts and location of operating lease ROU assets and lease liabilities as of September 30, 2019:</p><ix:nonnumeric contextref="Duration_1_1_2019_To_9_30_2019_O4ushO81Z0mAnTH_cLUPFw" name="abt:LeaseBalanceSheetDisclosureTableTextBlock" id="Tb_tzNAhirtYkuZ-UoQpAgWZw" escape="true"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tbody><tr style="height:1pt;"><td style="vertical-align:bottom;width:33.08%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.91%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:15.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.91%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:43.84%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="background-color:auto;vertical-align:bottom;width:33.08%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">(in millions)</p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:2.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&nbsp;&nbsp;&nbsp;&nbsp;</b></p></td><td colspan="2" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:17.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">September&nbsp;30,&nbsp;2019</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:2.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&nbsp;&nbsp;&nbsp;&nbsp;</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:43.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&nbsp;Balance&nbsp;Sheet&nbsp;Caption</b></p></td></tr><tr><td style="background-color:auto;vertical-align:bottom;width:33.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-style:italic;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:2.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:15.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:2.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:43.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:top;width:33.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">Operating Lease - ROU Asset</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.84%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:15.39%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_9_30_2019_Q77aJBXiP0qCmJ4Yd2DnHw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="Tc_RfmMIQ4XTUiQjLKIEZIx4Q_3_3">881</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;width:43.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">Deferred income taxes and other assets</p></td></tr><tr><td style="vertical-align:top;width:33.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:43.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:top;width:33.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">Operating Lease Liability:</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&nbsp;</b></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:15.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;">&nbsp;&nbsp;</b></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&nbsp;</b></p></td><td style="background-color:#cceeff;vertical-align:bottom;width:43.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&nbsp;&nbsp;</b></p></td></tr><tr><td style="vertical-align:top;width:33.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:43.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:top;width:33.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 6pt;">Current</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:15.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_9_30_2019_Q77aJBXiP0qCmJ4Yd2DnHw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="Tc_QnalaA2rfkCM_rHwUFyPTQ_7_3">202</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;width:43.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">Other accrued liabilities</p></td></tr><tr><td style="vertical-align:top;width:33.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 6pt;">Non-current</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:15.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_9_30_2019_Q77aJBXiP0qCmJ4Yd2DnHw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="Tc_sNQJvT8Y-U2OrIqkvefEjA_8_3">702</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;width:43.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">Post-employment obligations, deferred income taxes and other long-term liabilities</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:top;width:33.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">Total Liability</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.84%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:15.39%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_9_30_2019_Q77aJBXiP0qCmJ4Yd2DnHw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiability" scale="6" id="Tc_DA6hAcX2lkCle1LPk5b02w_9_3">904</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&nbsp;</b></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:43.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;">&nbsp;&nbsp;</b></p></td></tr></tbody></table></ix:nonnumeric><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;"><i style="font-style:italic;">Leases where Abbott is the Lessor</i></p><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:10pt;text-align:justify;margin:0pt;">Certain assets, primarily diagnostics instruments, are leased to customers under contractual arrangements that typically include an operating or sales-type lease as well as performance obligations for reagents and other consumables. Sales-type leases are not significant. Contract terms vary by customer and may include options to terminate the contract or options to extend the contract. Where instruments are provided under operating lease arrangements, some portion or the entire lease revenue may be variable and subject to subsequent non-lease component (e.g., reagent) sales. The allocation of revenue between the lease and non-lease components is based on stand-alone selling prices. Operating lease revenue represented less than <ix:nonfraction unitref="Unit_Standard_pure_0hvT7e8qLkipZ3XmLkD-nQ" contextref="Duration_1_1_2019_To_9_30_2019_srt_RangeAxis_srt_MaximumMember_oEw0uzOe0kevCxfIgw_0NA" decimals="2" format="ixt:numdotdecimal" name="abt:LeaseIncomePercentToNetRevenue" scale="-2" id="Narr_GcsmSFm7AUuU5lh8DP6cMw"><ix:nonfraction unitref="Unit_Standard_pure_0hvT7e8qLkipZ3XmLkD-nQ" contextref="Duration_7_1_2019_To_9_30_2019_srt_RangeAxis_srt_MaximumMember_55egElMjA0O-wU66kRvjAw" decimals="2" format="ixt:numdotdecimal" name="abt:LeaseIncomePercentToNetRevenue" scale="-2" id="Narr_TPDq_iHrn0exwFVODSWQLA">3</ix:nonfraction></ix:nonfraction> percent of Abbott’s total net sales in the three and nine months ended September 30, 2019. </p><p style="font-family:'Times New Roman';font-size:12pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:10pt;text-align:justify;margin:0pt;">Assets related to operating leases are reported within Net property and equipment on the Condensed Consolidated Balance Sheet. &nbsp;The original cost and the net book value of such assets were $<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_9_30_2019_Q77aJBXiP0qCmJ4Yd2DnHw" decimals="-8" format="ixt:numdotdecimal" name="abt:OperatingLeaseAssetOriginalCost" scale="9" id="Narr_mpTrjw6j1kGupkPA8fTuVQ">2.7</ix:nonfraction> billion and $<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_9_30_2019_Q77aJBXiP0qCmJ4Yd2DnHw" decimals="-8" format="ixt:numdotdecimal" name="abt:OperatingLeaseAssetNetBookValue" scale="9" id="Narr_cKKQMVYVbESZVKL1FORXuw">1.1</ix:nonfraction> billion, respectively, as of September 30, 2019.</p></ix:continuation><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><a id="_10b38471_5b24_47cb_a49b_4865f0d2df34"></a><ix:nonnumeric contextref="Duration_1_1_2019_To_9_30_2019_O4ushO81Z0mAnTH_cLUPFw" name="us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" id="Tb_uXm3xDzRP0qb1DNHtSLlHw" continuedat="Tb_uXm3xDzRP0qb1DNHtSLlHw_cont1" escape="true"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">Note 11 — Financial Instruments, Derivatives and Fair Value Measures</p><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:10pt;text-align:justify;margin:0pt;">Certain Abbott foreign subsidiaries enter into foreign currency forward exchange contracts to manage exposures to changes in foreign exchange rates<span style="font-size:12pt;"> </span>primarily for anticipated intercompany purchases by those subsidiaries whose functional currencies are not the U.S. dollar. &nbsp;These contracts, with gross notional amounts totaling $<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_9_30_2019_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember_iqx5P_Re402relQSOxoCQw" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="9" id="Narr_CrkvMPox1kquihMRlJDcDg">6.3</ix:nonfraction> billion at September 30, 2019 and $<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_12_31_2018_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember__kXMQQ6af0ClMJyFgxeKow" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="9" id="Narr_7SEHUXIGQUGNNmDWXrfe_Q">5.1</ix:nonfraction> billion at December 31, 2018 are designated as cash flow hedges of the variability of the cash flows due to changes in foreign exchange rates and are recorded at fair value.<span style="font-size:12pt;"> </span>Accumulated gains and losses as of September 30, 2019 on contracts related to intercompany purchases will be included in Cost of products sold at the time the products are sold, generally through the next twelve to <ix:nonnumeric contextref="Duration_1_1_2019_To_9_30_2019_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember_OXdQKT5IXk6AhArCbD7s4w" format="ixt-sec:durwordsen" name="us-gaap:MaximumLengthOfTimeHedgedInCashFlowHedge1" id="Narr_glA9P85XjEuzJ29h7XQx_Q">eighteen months</ix:nonnumeric>. </p><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:10pt;text-align:justify;margin:0pt;">Abbott enters into foreign currency forward exchange contracts to manage currency exposures for foreign currency denominated third-party trade payables and receivables, and for intercompany loans and trade accounts payable where the receivable or payable is denominated in a currency other than the functional currency of the entity. &nbsp;For intercompany loans, the contracts require Abbott to sell or buy foreign currencies, primarily European currencies, in exchange for primarily U.S. dollars and other European currencies. &nbsp;For intercompany and trade payables and receivables, the currency exposures are primarily the U.S. dollar and European currencies. &nbsp;At September 30, 2019 and December 31, 2018, Abbott held the gross notional amount of $<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_9_30_2019_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember_OWSwzCnJhEykAb_M6QaL6g" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="9" id="Narr_Zi7nkerTHkmvtxiHU5lfvA">10.4</ix:nonfraction> billion and $<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_12_31_2018_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember_xdx2l_dh2ES7V9IUsP-UMg" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="9" id="Narr_NXHPN6UKuU6HbQSKKPHpbQ">13.6</ix:nonfraction> billion, respectively, of such foreign currency forward exchange contracts.</p><p style="font-family:'Times New Roman';font-size:12pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:10pt;text-align:justify;margin:0pt;">Abbott is a party to interest rate hedge contracts totaling approximately $<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_9_30_2019_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_FairValueHedgingMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember_m_aY3BlibEu5mFrN4z-K3A" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="9" id="Narr_fbX4tBuw4U-8jZ8E4u0R2Q"><ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_12_31_2018_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_FairValueHedgingMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember_pzqC_GsZqkG9JSKompp5RA" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="9" id="Narr_wx06kLB_6Eyh-unesWTPWA">2.9</ix:nonfraction></ix:nonfraction> billion at September 30, 2019 and December 31, 2018 to manage its exposure to changes in the fair value of fixed-rate debt. These contracts are designated as fair value hedges of the variability of the fair value of fixed-rate debt due to changes in the long-term benchmark interest rates. &nbsp;The effect of the hedge is to change a fixed-rate interest obligation to a variable rate for that portion of the debt. Abbott records the contracts at fair value and adjusts the carrying amount of the fixed-rate debt by an offsetting amount. </p><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></ix:nonnumeric></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">15</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><a href="#TOC"><span style="font-family:'Times New Roman';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Table of Contents</span></a></p><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:10pt;text-align:center;margin:0pt;">Abbott Laboratories and Subsidiaries</p><p style="font-family:'Times New Roman';font-size:10pt;text-align:center;margin:0pt;">Notes to the Condensed Consolidated Financial Statements</p><p style="font-family:'Times New Roman';font-size:10pt;text-align:center;margin:0pt;">September 30, 2019</p><p style="font-family:'Times New Roman';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;">(Unaudited)</p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_d68a4736_6251_4a68_8ce3_1e9d6fd668a5"></a><a id="Tc_egzLVlw3rkOScI0cFV9ipA_1_2"></a><a id="Tc_2mn6OCafnUeKIDz_cNhAuA_1_10"></a><a id="Tc_DoZwk94kWUSUH3HX2a0mCg_2_2"></a><a id="Tc_OSOMV-nAE0KnyqbMQRJkGw_2_5"></a><a id="Tc_szhEGp9w_k62W8R4lBsHVA_2_10"></a><a id="Tc_yL7cDyp8WEiJW-2hVitlGg_2_13"></a><a id="Tc_kQOEBIcT2kerwQCSvhYxGw_3_0"></a><a id="Tc_jQ6KQFV6dkCHS6WpLyAZYg_3_2"></a><a id="Tc_HYhJD8rv40OmHTtfZASkLg_3_5"></a><a id="Tc_Muj3FfQK10OtZ6BXRqkGrw_3_8"></a><a id="Tc_VFNS_L2FiUKodrsfL_OUOw_3_10"></a><a id="Tc_YtvV3GjWmEqOmGcYLmZnBg_3_13"></a><a id="Tc_1Ppbn4_aG06_nSW0kIhezw_3_16"></a><a id="Tc_cK1RBtbSK0ixZ8MRku5vIw_5_0"></a><a id="Tc_YDTnNle570WeFp3L4Gekxg_5_2"></a><a id="Tc_3Fm3qD5uUEWDnAPT6p3Qxw_5_5"></a><a id="Tc_p346PfAiikuS6E0FWUIDmw_5_6"></a><a id="Tc_TF1T-N22CEaAz2s67P5pXw_5_8"></a><a id="Tc_F14X1RTI0EyiPVm82SrSNQ_5_10"></a><a id="Tc_3RSW6A-3vkG3v2YUUz4-1A_5_11"></a><a id="Tc_Ra7ZicqZ4kWnrNDwIh9_xg_5_13"></a><a id="Tc_RQVLpElN_Uug3BzPFiqSRA_5_16"></a><a id="Tc_wXIaByZgAEakTjNDk9yDMQ_7_0"></a><a id="Tc_zXQw2C0ZbE-paY1iYf-8dQ_8_0"></a><a id="Tc_unqbSCtx0kKxlP9x8NXDOw_8_8"></a><a id="Tc_rcSh20TbukqS9J096lOEsg_8_16"></a><a id="Tc_N1v7LSQ7IUGXGSkBksbRcA_9_0"></a><a id="Tc_sDWTydBSwECoIaRU0RRcPA_9_8"></a><a id="Tc_5qDICM-BxkeDu947TEFKHg_9_16"></a><a id="Tc_5mG0Tj-nq0Oe3Ahom09MEA_11_2"></a><a id="Tc_W1otnskXMUuNnLuG0o63dw_11_5"></a><a id="Tc_5zyVZQ0iI0uvmK2xNhIBrA_11_10"></a><a id="Tc_Ga-W_hk7MUeUgO5ReNZZ4w_11_13"></a><a id="_e0f4779b_54fc_47ba_8325_e30b2dd99122"></a><a id="Tc_veevvSTUokSaqq5nYhy3vg_1_2"></a><a id="Tc_vCWIvmlb7EyZAI-MOHkcoA_1_14"></a><a id="Tc_IG3hPjMXo0qvu3oC9aklUg_2_2"></a><a id="Tc_3GE-XET9pECfs4Y-r2v9OQ_2_14"></a><a id="Tc_5-aqJ-b8pUyws2INJaylOA_3_2"></a><a id="Tc_CAyS_-_qvkyT6epv5Vf_-g_3_8"></a><a id="Tc_VJJjrrD6o0G1OW36U86V5w_3_14"></a><a id="Tc_ZEH3WfCCxEK8RA-N8uAZZw_3_20"></a><a id="Tc_SV39D9JgMUWtBAKpwt9U7g_4_2"></a><a id="Tc_292KAUNaQ0CtkqSAGpWIxw_4_8"></a><a id="Tc_VZlQa5c39UWf6U7zj7RXMA_4_14"></a><a id="Tc_ffHkHalY4U-FJCZIf2aqFA_4_20"></a><a id="Tc_Xrxi88pN8k6dAB4UfQpoEg_4_26"></a><a id="Tc_QvTtuGIPckyK-wFuG-IWww_5_0"></a><a id="Tc_cn_xr6vn3EiAgINn5-DaJQ_5_2"></a><a id="Tc_JaglKWYP0Eqvdc6C6BLzLQ_5_5"></a><a id="Tc_scHhsHqUIUmXF8ntJ3UQ2A_5_8"></a><a id="Tc_dX0EkDueEkO5ufkI_xo3mg_5_11"></a><a id="Tc_-_CVUKaQpEauJifdYWEEAw_5_14"></a><a id="Tc_7vOlAFrAfke10BX08D4wJw_5_17"></a><a id="Tc_HjApXXaSAkii_S0nH54DoA_5_20"></a><a id="Tc_tIJi4aoMSUanqeYT7QHXYQ_5_23"></a><a id="Tc_ME1pNMRlhES4uKNH3MVHNg_5_26"></a><a id="Tc_m-nhrE2dsEGauwksSc00tg_7_0"></a><a id="Tc_tCUU56soLUiHECN9-yrhaQ_7_2"></a><a id="Tc_aV0U1uCnhEO9c7ysvK6NQA_7_5"></a><a id="Tc_XupcZAMpH0Woq16CHKbC8w_7_8"></a><a id="Tc_l-sRLd89CUSuNK5wPmFq-w_7_11"></a><a id="Tc_K-ewFpWkuUawiuGEcWPUnA_7_14"></a><a id="Tc_9qbX67YQ8UmcIilzh6w9Jg_7_17"></a><a id="Tc_BeK3TFSmbkS-CruM21WBmQ_7_20"></a><a id="Tc_O3tVkjN9vECJKFZ9aeYY5w_7_23"></a><a id="Tc_y513vYtcuEWe79NOmoASpQ_7_26"></a><a id="Tc_c9w3rghdKUay8iHv0Vkwag_9_0"></a><a id="Tc_U0SG-3t2H0GTDXVuXRpUcQ_9_3"></a><a id="Tc_LBEFhcA7hUW7RODUY-csuw_9_6"></a><a id="Tc_kc42KX5sJkGvCZhM9YPDsA_9_9"></a><a id="Tc_lcLN757PIEmDI36IJ3aXtA_9_12"></a><a id="Tc__J8PF12SFkaazwteqv6S5Q_9_26"></a><ix:continuation id="Tb_uXm3xDzRP0qb1DNHtSLlHw_cont1" continuedat="Tb_uXm3xDzRP0qb1DNHtSLlHw_cont2"><p style="font-family:'Times New Roman';font-size:10pt;text-align:justify;margin:0pt;">The following table summarizes the amounts and location of certain derivative financial instruments as of September 30, 2019 and December 31, 2018:</p><ix:nonnumeric contextref="Duration_1_1_2019_To_9_30_2019_O4ushO81Z0mAnTH_cLUPFw" name="us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" id="Tb_kYHnYvbtNk6bXbIumBcBIQ" escape="true"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tbody><tr style="height:1pt;"><td style="vertical-align:top;width:26.19%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:5.6%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:5.6%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;width:19.79%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:5.6%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.1%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:5.6%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;width:16.75%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="background-color:auto;vertical-align:bottom;width:26.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="7" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:36.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Fair&nbsp;Value&nbsp;-&nbsp;Assets</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="7" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:33.64%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Fair&nbsp;Value&nbsp;-&nbsp;Liabilities</b></p></td></tr><tr><td style="background-color:auto;vertical-align:bottom;width:26.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:6.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Sept. 30,</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:6.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Dec.&nbsp;31,</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;width:19.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:6.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Sept. 30,</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:6.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Dec.&nbsp;31,</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;width:16.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="background-color:auto;vertical-align:bottom;width:26.19%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">(in&nbsp;millions)</p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&nbsp;&nbsp;&nbsp;&nbsp;</b></p></td><td colspan="2" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:6.7%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2019</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&nbsp;&nbsp;&nbsp;&nbsp;</b></p></td><td colspan="2" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:6.7%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2018</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&nbsp;&nbsp;&nbsp;&nbsp;</b></p></td><td style="background-color:auto;vertical-align:bottom;width:19.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Balance&nbsp;Sheet&nbsp;Caption</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&nbsp;&nbsp;&nbsp;&nbsp;</b></p></td><td colspan="2" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:6.7%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2019</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&nbsp;&nbsp;&nbsp;&nbsp;</b></p></td><td colspan="2" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:6.7%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2018</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&nbsp;&nbsp;&nbsp;&nbsp;</b></p></td><td style="background-color:auto;vertical-align:bottom;width:16.75%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Balance&nbsp;Sheet&nbsp;Caption</b></p></td></tr><tr><td style="background-color:auto;vertical-align:top;width:26.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:5.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:5.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;width:19.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:5.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:5.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;width:16.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:top;width:26.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">Interest rate swaps designated as fair value hedges</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:1.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:5.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_9_30_2019_us-gaap_BalanceSheetLocationAxis_abt_DeferredIncomeTaxesAndOtherAssetsMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_FairValueHedgingMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember_a8_qiANHDkSJpz_fTHYXBQ" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="Tc_IBu8g9LCQ0ij--zBnp0unw_5_3">74</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:1.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:5.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> —</p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:top;width:19.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">Deferred income taxes and other assets</p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:1.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:5.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> —</p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:1.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:5.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_12_31_2018_us-gaap_BalanceSheetLocationAxis_abt_PostemploymentObligationsDeferredIncomeTaxesAndOtherLongTermLiabilitiesMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_FairValueHedgingMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember_gsmrr18YxkKh2iRP6H_wgA" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="Tc_iGYZe6dxB0eIw7VpjSvv8Q_5_14">100</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:top;width:16.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">Post-employment obligations, deferred income taxes and other long-term liabilities</p></td></tr><tr><td style="vertical-align:top;width:26.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:5.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:5.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;width:19.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:5.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:5.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;width:16.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:top;width:26.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">Foreign currency forward exchange contracts: </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:1.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:5.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:1.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:5.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:top;width:19.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:1.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:5.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:1.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:5.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:top;width:16.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:top;width:26.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 6pt;">Hedging instruments</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:top;white-space:nowrap;width:5.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_9_30_2019_us-gaap_BalanceSheetLocationAxis_abt_PrepaidExpensesAndOtherReceivablesMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember_D9fu9Wl98Eu8Dzr0qJyDdA" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="Tc_VUdrq7WTn0u716HZYHBx-w_8_3">244</ix:nonfraction></p></td><td style="vertical-align:top;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:top;white-space:nowrap;width:5.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_12_31_2018_us-gaap_BalanceSheetLocationAxis_abt_PrepaidExpensesAndOtherReceivablesMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember_z1WuvwgbbkWpw_g8_D6jYQ" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="Tc_0wN2NAQ3W06Dg5m84y3oGA_8_6">81</ix:nonfraction></p></td><td style="vertical-align:top;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:top;width:19.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">Prepaid expenses and other receivables</p></td><td style="vertical-align:top;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:top;white-space:nowrap;width:5.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_9_30_2019_us-gaap_BalanceSheetLocationAxis_us-gaap_AccruedLiabilitiesMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember_8AkAOFGOA0yntAAIwKSYPw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="Tc__Mgi8QhnT0iC6pexfvdl2w_8_11">33</ix:nonfraction></p></td><td style="vertical-align:top;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:top;white-space:nowrap;width:5.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_12_31_2018_us-gaap_BalanceSheetLocationAxis_us-gaap_AccruedLiabilitiesMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember_VzE3asdseku4XPLX0uzykg" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="Tc_LTBIBDCOWE-r5zMOnmNs4Q_8_14">44</ix:nonfraction></p></td><td style="vertical-align:top;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:top;width:16.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">Other accrued liabilities</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:top;width:26.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 6pt;">Others not designated as hedges</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:1.1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:5.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_9_30_2019_us-gaap_BalanceSheetLocationAxis_abt_PrepaidExpensesAndOtherReceivablesMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember_ovW4USmZ0k29DzOuU2JY5w" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="Tc_KNK6FCvGL0GnJ-L6ceNccg_9_3">54</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:1.1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:5.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_12_31_2018_us-gaap_BalanceSheetLocationAxis_abt_PrepaidExpensesAndOtherReceivablesMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember_QGA5BKfpPECDcDSYOgK6rg" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="Tc_C3ucnbRzL0CDxUbW75nfQA_9_6">33</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:top;width:19.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">Prepaid expenses and other receivables</p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:1.1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:5.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_9_30_2019_us-gaap_BalanceSheetLocationAxis_us-gaap_AccruedLiabilitiesMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember_OnxvvpO_8E2IGaj-4RWbjQ" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="Tc_yfpEIazCj0ep4tSm4VRqjQ_9_11">62</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:1.1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:5.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_12_31_2018_us-gaap_BalanceSheetLocationAxis_us-gaap_AccruedLiabilitiesMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember_4SJ2lgc4MU6nf-Fk4-J1_Q" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="Tc_u0IVf7th20aG5g3wekSO_A_9_14">51</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:top;width:16.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">Other accrued liabilities</p></td></tr><tr><td style="vertical-align:top;width:26.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:5.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:5.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;width:19.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:5.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:5.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;width:16.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:top;width:26.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:1.1%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:5.6%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_9_30_2019_Q77aJBXiP0qCmJ4Yd2DnHw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="Tc_zAURB8GPt0S8QWUhnSUsUQ_11_3">372</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:1.1%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:5.6%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_12_31_2018_INezHDkjn0-L7OMGoLMjhA" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="Tc_h3orkXZhJ0eJJGg7-us5qA_11_6">114</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:top;width:19.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:1.1%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:5.6%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_9_30_2019_Q77aJBXiP0qCmJ4Yd2DnHw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="Tc_jkbUxbcZzkO1HSq839rrBg_11_11">95</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:1.1%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:5.6%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_12_31_2018_INezHDkjn0-L7OMGoLMjhA" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="Tc_1yXF0-fbwECQgTYmF1qopw_11_14">195</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:top;width:16.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td></tr></tbody></table><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></ix:nonnumeric><p style="font-family:'Times New Roman';font-size:10pt;text-align:justify;margin:0pt;">The following table summarizes the activity for foreign currency forward exchange contracts designated as cash flow hedges and certain other derivative financial instruments, as well as the amounts and location of income (expense) and gain (loss) reclassified into income for the three and nine months ended September 30, 2019 and 2018. </p><ix:nonnumeric contextref="Duration_1_1_2019_To_9_30_2019_O4ushO81Z0mAnTH_cLUPFw" name="us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" id="Tb_D1faZHNGYUO0uCZkBT5WSQ" escape="true"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tbody><tr style="height:1pt;"><td style="vertical-align:bottom;width:27.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;width:1.62%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.01%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:5.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.01%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:5.23%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:4.02%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:4.02%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:5.23%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:5.23%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:4.02%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:4.02%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:top;white-space:nowrap;width:12.63%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="background-color:auto;vertical-align:bottom;width:27.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="11" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:27.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Gain (loss) Recognized in Other </b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="11" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:27.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Income (expense) and Gain (loss)</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:12.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="background-color:auto;vertical-align:bottom;width:27.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="11" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:27.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Comprehensive Income (loss)</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="11" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:27.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Reclassified into Income</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:12.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="background-color:auto;vertical-align:bottom;width:27.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="5" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:14.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Three Months</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="5" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:11.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Nine&nbsp;Months</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="5" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:14.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Three Months</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="5" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:11.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Nine&nbsp;Months</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:12.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="background-color:auto;vertical-align:bottom;width:27.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="5" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:14.11%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Ended Sept. 30</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="5" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:11.73%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Ended Sept. 30</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="5" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:14.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Ended Sept. 30</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="5" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:11.73%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Ended Sept. 30</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:12.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Income&nbsp;Statement</b></p></td></tr><tr><td style="background-color:auto;vertical-align:bottom;width:27.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">(in&nbsp;millions)</p></td><td style="background-color:auto;vertical-align:bottom;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&nbsp;&nbsp;&nbsp;&nbsp;</b></p></td><td colspan="2" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:6.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2019</b></p></td><td style="background-color:auto;vertical-align:bottom;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&nbsp;&nbsp;&nbsp;&nbsp;</b></p></td><td colspan="2" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:6.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2018</b></p></td><td style="background-color:auto;vertical-align:bottom;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&nbsp;&nbsp;&nbsp;&nbsp;</b></p></td><td colspan="2" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:5.05%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2019</b></p></td><td style="background-color:auto;vertical-align:bottom;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&nbsp;&nbsp;&nbsp;&nbsp;</b></p></td><td colspan="2" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:5.05%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2018</b></p></td><td style="background-color:auto;vertical-align:bottom;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&nbsp;&nbsp;&nbsp;&nbsp;</b></p></td><td colspan="2" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:6.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2019</b></p></td><td style="background-color:auto;vertical-align:bottom;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&nbsp;&nbsp;&nbsp;&nbsp;</b></p></td><td colspan="2" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:6.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2018</b></p></td><td style="background-color:auto;vertical-align:bottom;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&nbsp;&nbsp;&nbsp;&nbsp;</b></p></td><td colspan="2" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:5.05%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2019</b></p></td><td style="background-color:auto;vertical-align:bottom;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&nbsp;&nbsp;&nbsp;&nbsp;</b></p></td><td colspan="2" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:5.05%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2018</b></p></td><td style="background-color:auto;vertical-align:bottom;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&nbsp;&nbsp;&nbsp;&nbsp;</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:12.63%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Caption</b></p></td></tr><tr><td style="background-color:auto;vertical-align:bottom;width:27.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:5.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:5.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:4.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:4.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:5.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:5.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:4.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:4.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:top;white-space:nowrap;width:12.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:top;width:27.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">Foreign currency forward exchange contracts designated as cash flow hedges</p></td><td style="background-color:#cceeff;vertical-align:bottom;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:1.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:5.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2019_To_9_30_2019_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember_q3XZa8hMBEWuiq7vj3A2nw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="Tc_8_p4evf4qUWLpr__AXAykw_7_3">99</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:1.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:5.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2018_To_9_30_2018_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember_SHhbDIAoWU2fbpNhC66XDA" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="Tc_PmbXv36ZR0GDTguRZMbEKg_7_6">18</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:4.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember_v24RB4FtHkOllQj-3c5MOA" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="Tc_pTfRXb7Y7UyQAA8EHtHVsw_7_9">78</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:4.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2018_To_9_30_2018_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember_JvrolFTPeUmRoiE1y7qEUw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="Tc_-KWG4pqlfkysRYXugrFWLA_7_12">45</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:5.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2019_To_9_30_2019_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember_q3XZa8hMBEWuiq7vj3A2nw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" scale="6" id="Tc_TYUs8KRoL0aUl3iUOvUcTg_7_15">26</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:5.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"> (<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2018_To_9_30_2018_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember_SHhbDIAoWU2fbpNhC66XDA" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" sign="-" scale="6" id="Tc_6QhLwDADVEKMkMRWJGxQ4w_7_18">37</ix:nonfraction>)</p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:4.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember_v24RB4FtHkOllQj-3c5MOA" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" scale="6" id="Tc_5u5l2Nl9rky0VvjWlGvDRw_7_21">58</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:4.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"> (<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2018_To_9_30_2018_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember_JvrolFTPeUmRoiE1y7qEUw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" sign="-" scale="6" id="Tc_gRXGrulltkuYCQYRCeyd8g_7_24">120</ix:nonfraction>)</p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:12.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">Cost of products sold</p></td></tr><tr><td style="vertical-align:top;width:27.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:5.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:5.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:4.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:4.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:5.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:5.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:4.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:4.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:12.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:top;width:27.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">Interest rate swaps designated as fair value hedges</p></td><td style="background-color:#cceeff;vertical-align:bottom;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:1.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;">n/a</p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:1.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;">n/a</p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:4.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;">n/a</p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:4.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;">n/a</p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:5.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2019_To_9_30_2019_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_FairValueHedgingMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember_-cEhq1VeyUW5kwGWV_fCww" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" scale="6" id="Tc_8yaWqGYXf0-0H18DIITDDg_9_15">35</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:5.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"> (<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2018_To_9_30_2018_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_FairValueHedgingMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember_TOgEmx4ZnUyLlxWakY7ATQ" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" sign="-" scale="6" id="Tc__-Iit4Rp3ECY4u399Dweqg_9_18">42</ix:nonfraction>)</p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:4.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_FairValueHedgingMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember_f9-khleCD0ie4NuOzNmLoQ" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" scale="6" id="Tc_l3MIvsDCqUuUrmy_p2B2cA_9_21">174</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:4.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"> (<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2018_To_9_30_2018_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_FairValueHedgingMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember_us-gaap_IncomeStatementLocationAxis_us-gaap_InterestExpenseMember_KVlOnIcop0W0p5XoJA3m9w" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" sign="-" scale="6" id="Tc_odadoV8_N0e-i8lF_LI-6w_9_24">179</ix:nonfraction>)</p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:12.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">Interest expense</p></td></tr></tbody></table><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></ix:nonnumeric><p style="font-family:'Times New Roman';font-size:10pt;text-align:justify;margin:0pt;">Gains of $<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2019_To_9_30_2019_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember_OaDghxREG0uobIbjFOFDdQ" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" scale="6" id="Narr_sdUU-hRzCkyP5wsRztKmAQ">49</ix:nonfraction> million and losses of $<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2018_To_9_30_2018_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember_tMykbeJAIUGQ7YdHOvPtvA" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" sign="-" scale="6" id="Narr_ZK9NE8QgoUCgVl2WtrKkUg">10</ix:nonfraction> million were recognized in the three months ended September 30, 2019 and 2018, respectively, related to foreign currency forward exchange contracts not designated as a hedge. Gains of $<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember_f92R9C_oiUWyvriT6Shvgg" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" scale="6" id="Narr_-uXiSeAKZE-FjObr68xpYA">124</ix:nonfraction> million and losses of $<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2018_To_9_30_2018_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember_rkBIsOpOKkibOdH_cYMofQ" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" sign="-" scale="6" id="Narr_BYi5LxLJUUONA9Sq4MLKpQ">60</ix:nonfraction> million were recognized in the nine months ended September 30, 2019 and 2018, respectively, related to foreign currency forward exchange contracts not designated as a hedge. &nbsp;These amounts are reported in the Condensed Consolidated Statement of Earnings on the Net foreign exchange (gain) loss line. </p><p style="font-family:'Times New Roman';font-size:12pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:10pt;text-align:justify;margin:0pt;">The interest rate swaps are designated as fair value hedges of the variability of the fair value of fixed-rate debt due to changes in the long-term benchmark interest rates. &nbsp;The hedged debt is marked to market, offsetting the effect of marking the interest rate swaps to market.</p><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></ix:continuation></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">16</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><a href="#TOC"><span style="font-family:'Times New Roman';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Table of Contents</span></a></p><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:10pt;text-align:center;margin:0pt;">Abbott Laboratories and Subsidiaries</p><p style="font-family:'Times New Roman';font-size:10pt;text-align:center;margin:0pt;">Notes to the Condensed Consolidated Financial Statements</p><p style="font-family:'Times New Roman';font-size:10pt;text-align:center;margin:0pt;">September 30, 2019</p><p style="font-family:'Times New Roman';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;">(Unaudited)</p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_056e6427_f447_4cb6_a2b2_05925215cd02"></a><a id="Tc__bTA_VpW906pT2ut9PgJlA_1_2"></a><a id="Tc_pVLBLpHDyEGWAT1-IQ039Q_1_8"></a><a id="Tc_jI1uTSF0BEev4rvCXU5JMg_2_2"></a><a id="Tc_-e_rglwFv0aqN8AYvf2XNg_2_5"></a><a id="Tc_2GpXxmTSQEOyG_o6-eSazg_2_8"></a><a id="Tc_VOQMtMpsJkiCAVxp8gl1_A_2_11"></a><a id="Tc_9my62WHj1EyowXWRN0GJ6A_3_0"></a><a id="Tc_RfNgjD1dz0-yBsXhdEUYOg_3_2"></a><a id="Tc_f4RK93HbUkywtA_Ajr4WyQ_3_5"></a><a id="Tc_tqny4HaMk028Cy--O5QRRA_3_8"></a><a id="Tc_uYvMsXAD9UKNDFF_WTGkzg_3_11"></a><a id="Tc_SdhpX_r12UqMGRd1RGOWzA_5_0"></a><a id="Tc__pPx5Ygqak2CRar2JK9UTA_6_0"></a><a id="Tc_pBUfq1cADUOUjupwlTdfBA_6_2"></a><a id="Tc_RmWNEXRbg0yGF94LQwzJxw_6_5"></a><a id="Tc_9vSyjGSglkSXJCdJwV-gUA_6_8"></a><a id="Tc_UzY7m2Gwfk2gES4yM5xYiQ_6_11"></a><a id="Tc_fCas5_SYh0O3-myzjTFyrA_7_0"></a><a id="Tc_szY530f-L0KoErNlIyqVJA_8_0"></a><a id="Tc_r5k-qPNePEyJ69QA9dOFqQ_9_0"></a><a id="Tc_yoEaa0XuSki7NqNQ7h7VjQ_10_0"></a><a id="Tc_4ygCtnJ6u06aCvmpSPFT5A_11_0"></a><a id="Tc_pO2k6q-l0U-zvF02ZRuCNg_12_0"></a><a id="Tc_fk9_0AYtD0qQrn17dMorCA_13_0"></a><a id="Tc_XgAgyNpgd06Dut_MMMQEMQ_13_9"></a><a id="Tc__nZfcY4YuEGzq5YDRbY_oQ_13_12"></a><a id="Tc_-Lk3_4KFikuEqX3xZJ-GNA_14_0"></a><a id="Tc_o58OKKRt-E2i76Hsxp1EUQ_14_3"></a><a id="Tc_jo5V7YOUsUaXDop6BapX9g_14_6"></a><a id="_79ba42be_f593_4420_b4e1_c0c89b6cf986"></a><a id="Tc_BIU4YVQ-yUWrzN1ig638zg_1_5"></a><a id="Tc_1z2Zp84CVUi-A-KCRa0aLQ_2_5"></a><a id="Tc_ZlvqJIQZ8E2cZ_BveCOBDA_2_8"></a><a id="Tc_7RxfhkiHT0K0Rt8yfpL1Yg_3_5"></a><a id="Tc_q0l8SM6WnEGpGtbVYn0FpQ_3_8"></a><a id="Tc_7rctOFxME0mVNiJe0LzWFQ_3_11"></a><a id="Tc_44WK6Ixf006R5EvD_IC3jA_4_2"></a><a id="Tc_jsPX5A4dLUer_aH4LG6oXw_4_5"></a><a id="Tc_UQ2IQpeTlUK4qdtHAucchA_4_8"></a><a id="Tc_2x6LiUsTAECWidV282lZ3Q_4_11"></a><a id="Tc_mO16buPb8kGG3CmmzMmIwQ_5_0"></a><a id="Tc_lU6rGS8rPESQ7RmI3-p94A_5_2"></a><a id="Tc_Cq_dSkXz6UiREKDGKc1I5w_5_5"></a><a id="Tc_OMB99JB9SEyaNymNUSSZGA_5_8"></a><a id="Tc_RqQ03bWT_E-ed5S_lHR-oA_5_11"></a><a id="Tc_pB4h5dYalEiaSvdHShsLVA_6_0"></a><a id="Tc_tptEzEq-U0Se4br3Mzyo3Q_7_0"></a><a id="Tc_meTdcG5p3Ea-kiChjQXhcA_7_2"></a><a id="Tc_p-H1bwt47k6x6E08SjfP5A_7_5"></a><a id="Tc_RSPKsQz5CEyQO0VA29W4pg_7_8"></a><a id="Tc_4xu-aNmv-ECaw0iAER2H4A_7_9"></a><a id="Tc_LVyjYumVYkeByqrDM7sq0Q_7_11"></a><a id="Tc_sUVl6OP_2kOEz6MOl9__vA_7_12"></a><a id="Tc_j3vWG_-uQEOKL52cg4IpgQ_8_0"></a><a id="Tc_i4xNVSIcXk2aPtFft8ImIw_8_6"></a><a id="Tc_LQ5b13qi_06o_UvB9mi-9Q_8_12"></a><a id="Tc_8mYW2SmX-kiIeFZyvyjbOA_9_0"></a><a id="Tc_6Jq3HyqRN0aVTQkxmaHjFg_9_6"></a><a id="Tc_V_AHEVkJi0uzIWCIV5UXCQ_9_12"></a><a id="Tc_34krwUdPTEu0xVGR7yLv2Q_10_0"></a><a id="Tc_BKHxUINeZkqUgze_hGqOiQ_10_2"></a><a id="Tc_rgqpzCyNO0WUDtM-APacrQ_10_5"></a><a id="Tc_XVhcFuOqmkKXq5yB5ptK0g_10_8"></a><a id="Tc_jz5X07TLwEimhWmV9ywfTQ_10_11"></a><a id="Tc_GIXEHMs8REWZ7gs4pY_NQA_10_12"></a><a id="Tc_HkOT_wq_okiZG73D_2OLmw_12_0"></a><a id="Tc_d8dlkHNBe02jJkNyD4NUQg_12_2"></a><a id="Tc_maYNA7To7ECsHRvDjA_4eQ_12_5"></a><a id="Tc_6_2fch8rQ0auAF-sacuq_w_12_6"></a><a id="Tc_6EOurv0qJEydF94pj3YMCQ_12_8"></a><a id="Tc_6oQAay45pkKAKNKrbwYtGw_12_11"></a><a id="Tc_udqZV9qBMEmmdfI-7eR89g_12_12"></a><a id="Tc_OO6E3gvdtkGqpXcUoI82Lg_13_0"></a><a id="Tc_4BK0U9Rq2EOhB9dH2oCf6A_13_6"></a><a id="Tc_IyY0dvadkkCr5bINhdBvOg_13_12"></a><a id="Tc_m0SO1YYvLUSrYf6OBamyUw_14_0"></a><a id="Tc_NKy0WD7hMkKP_ohVPa0Epg_14_6"></a><a id="Tc_KnngqFPdZkisn0938EhRfQ_14_9"></a><a id="Tc_qY8dPRZUlk-dLLzFsvgOWQ_15_0"></a><a id="Tc_8m2ThtrnqEeeMHEr69B1sQ_15_2"></a><a id="Tc_FrOKfOrDvEmLoqPweC3JCw_15_5"></a><a id="Tc_FEW-ELc_uEWEzQ3UUfG-Fg_15_6"></a><a id="Tc_OH7x0pIEyE6AcKuWThKj8A_15_8"></a><a id="Tc_O9Drf-3TiEqPmAvjkO5etQ_15_11"></a><a id="Tc_x8uTmpwRF0mezepHUNXxlw_17_0"></a><a id="Tc_BdwvfhwbzkaWbvmcWDihYQ_18_0"></a><a id="Tc_pSpkQ8zBrUOT_0krE7K9Bw_18_2"></a><a id="Tc_ymlLQ-JEHUmyDDLajjc-lQ_18_5"></a><a id="Tc_gPy_GSYWAUCro7EaFAlCcg_18_8"></a><a id="Tc__p3Tdr7Wkk2fK97K_cDPCw_18_9"></a><a id="Tc_zJEoh_XnCEazaDryXsvDqA_18_11"></a><a id="Tc_7dSoU9ytx0yn972ITLZrGg_18_12"></a><a id="Tc_OO8kA-sGoUeFHNqP-Jejkg_19_0"></a><a id="Tc_Eoskm8IQ6Ea-K5pylIOIbg_19_6"></a><a id="Tc_OHWXnF6hrEueKoYYqqmIlA_19_12"></a><a id="Tc_jSfEcQHF-kWDIqyEieX43w_20_0"></a><a id="Tc_FlrKcOqphEil_bpgOwB6rw_20_2"></a><a id="Tc_l5S6DqKur0K_v7GVRSlCmw_20_5"></a><a id="Tc_-oTklhFrTEGDgd2GUYRJsA_20_8"></a><a id="Tc_1dtGpQ3KvE6k90kvqS2PVQ_20_11"></a><a id="Tc_-_ZVYSVpuEuD1Ct9QipCIg_20_12"></a><a id="Tc_tMpYrI1AqkC2xK_XeUb_gA_22_0"></a><a id="Tc_yie1_7R9eUWbKv8yg2bWHw_22_2"></a><a id="Tc_slTq2FrBMUC8nBsfxoY_kQ_22_5"></a><a id="Tc_zwjkCbWqA0qUaWyxceN8ng_22_6"></a><a id="Tc_y7U8gwqh4U-XkhEj_XToRw_22_8"></a><a id="Tc_kDFB_lDZt0KVrh6iO6lcPA_22_11"></a><a id="Tc_syQ6X9uzv0GjmaXXXNizmQ_22_12"></a><a id="Tc_JOdRvyYk1km6OBHvGI4oHw_23_0"></a><a id="Tc_OOry41qJ8keuNJAAR0lztQ_23_6"></a><a id="Tc_5_xnKhbPOEuxEqwITace3A_23_12"></a><a id="Tc_xrDqNXWkQ0edhJAdlyN6wA_24_0"></a><a id="Tc_fTJITDMoKESDDs6c0_weOQ_24_6"></a><a id="Tc_xHMBBwSXREefbbe1kfd1yg_24_12"></a><a id="Tc_4VbfqZ3fmk-QsyLfXd8eaA_25_0"></a><a id="Tc_t_4v5dEqIEuJClg3Qddj8A_25_6"></a><a id="Tc__akayvFphkGUF75Npb-LZA_25_9"></a><a id="Tc_bXtwjK1Fm0a-8r0cnvWF8A_26_0"></a><a id="Tc_PGJUA0lhW0y26vkod8wOyA_26_2"></a><a id="Tc_CNRM6xYcH0eBqOjEwkx-Ig_26_5"></a><a id="Tc_b8t_xRsAZkmeTk_-8Oq9wg_26_6"></a><a id="Tc_Ew70mmEJzkG2EC9g-jvgTA_26_8"></a><a id="Tc_Pn83vFyH20uRbCXJT7azKQ_26_11"></a><ix:continuation id="Tb_uXm3xDzRP0qb1DNHtSLlHw_cont2"><p style="font-family:'Times New Roman';font-size:10pt;text-align:justify;margin:0pt;">The carrying values and fair values of certain financial instruments as of September 30, 2019 and December 31, 2018 are shown in the following table. &nbsp;The carrying values of all other financial instruments approximate their estimated fair values. &nbsp;The counterparties to financial instruments consist of select major international financial institutions. &nbsp;Abbott does not expect any losses from nonperformance by these counterparties.</p><ix:nonnumeric contextref="Duration_1_1_2019_To_9_30_2019_O4ushO81Z0mAnTH_cLUPFw" name="us-gaap:FairValueByBalanceSheetGroupingTextBlock" id="Tb_455AOYzIA0yS1CT5SLcwSA" escape="true"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80.01%;"><tbody><tr style="height:1pt;"><td style="vertical-align:bottom;width:51.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.3%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.3%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.3%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="background-color:auto;vertical-align:bottom;width:51.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="5" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:22.06%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">September&nbsp;30,&nbsp;2019</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:2.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="5" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:22.06%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December&nbsp;31,&nbsp;2018</b></p></td></tr><tr><td style="background-color:auto;vertical-align:bottom;width:51.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:9.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Carrying</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:2.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:9.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Fair</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:2.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:9.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Carrying</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:2.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:9.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Fair</b></p></td></tr><tr><td style="background-color:auto;vertical-align:bottom;width:51.27%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">(in&nbsp;millions)</p></td><td style="background-color:auto;vertical-align:bottom;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&nbsp;&nbsp;&nbsp;&nbsp;</b></p></td><td colspan="2" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:9.88%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Value</b></p></td><td style="background-color:auto;vertical-align:bottom;width:2.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&nbsp;&nbsp;&nbsp;&nbsp;</b></p></td><td colspan="2" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:9.88%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Value</b></p></td><td style="background-color:auto;vertical-align:bottom;width:2.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&nbsp;&nbsp;&nbsp;&nbsp;</b></p></td><td colspan="2" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:9.88%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Value</b></p></td><td style="background-color:auto;vertical-align:bottom;width:2.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&nbsp;&nbsp;&nbsp;&nbsp;</b></p></td><td colspan="2" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:9.88%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Value</b></p></td></tr><tr><td style="background-color:auto;vertical-align:bottom;width:51.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:8.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:2.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:8.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:2.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:8.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:2.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:8.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:51.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">Investment Securities:</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:51.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 12pt;">Equity securities </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_9_30_2019_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_CarryingReportedAmountFairValueDisclosureMember_us-gaap_InvestmentTypeAxis_us-gaap_EquitySecuritiesMember_5I6guGkvEEeOvzmRp9OCOA" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermInvestments" scale="6" id="Tc_YsUCXY0SZUaa0cnH-kj1bg_6_3">830</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_9_30_2019_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_EstimateOfFairValueFairValueDisclosureMember_us-gaap_InvestmentTypeAxis_us-gaap_EquitySecuritiesMember_g7gwhwY-LUeXkEPOZVCoFQ" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermInvestments" scale="6" id="Tc_o8CHMbBj6EW8rXSYiZTOKw_6_6">830</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_12_31_2018_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_CarryingReportedAmountFairValueDisclosureMember_us-gaap_InvestmentTypeAxis_us-gaap_EquitySecuritiesMember_KKskyI4iaUyJWLlAlXrwxw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermInvestments" scale="6" id="Tc_ffCb1g0E40-eay5hcPuttg_6_9">856</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_12_31_2018_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_EstimateOfFairValueFairValueDisclosureMember_us-gaap_InvestmentTypeAxis_us-gaap_EquitySecuritiesMember_P7Ou1KW7Hk6AJ-5yBe7BgQ" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermInvestments" scale="6" id="Tc_mZrrdlKuaEWz4ncTLruW3Q_6_12">856</ix:nonfraction></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:51.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 12pt;"><span style="white-space:pre-wrap;">Other  </span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_9_30_2019_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_CarryingReportedAmountFairValueDisclosureMember_us-gaap_InvestmentTypeAxis_us-gaap_OtherAggregatedInvestmentsMember_rQcPakxmUkut_lJbDmRdmw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermInvestments" scale="6" id="Tc_5_5661PEw0mVZDb7g-NFBA_7_3">44</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_9_30_2019_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_EstimateOfFairValueFairValueDisclosureMember_us-gaap_InvestmentTypeAxis_us-gaap_OtherAggregatedInvestmentsMember_P7JTdZ1jJUOn-y7zA6RR2w" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermInvestments" scale="6" id="Tc_FMBMP0Jn_U2hex--CGh_dw_7_6">44</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_12_31_2018_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_CarryingReportedAmountFairValueDisclosureMember_us-gaap_InvestmentTypeAxis_us-gaap_OtherAggregatedInvestmentsMember_RAAT8gNePEOGPotd79zykg" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermInvestments" scale="6" id="Tc_34J4FuMlCUK8Ms28Meu2Rg_7_9">41</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_12_31_2018_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_EstimateOfFairValueFairValueDisclosureMember_us-gaap_InvestmentTypeAxis_us-gaap_OtherAggregatedInvestmentsMember_NNh-icx5SkaSUKVwiFXgEw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermInvestments" scale="6" id="Tc_b0YYCXPZJ06G9vPSXUZ4rg_7_12">41</ix:nonfraction></p></td></tr><tr><td style="vertical-align:bottom;width:51.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">Total Long-term Debt </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"> (<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_9_30_2019_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_CarryingReportedAmountFairValueDisclosureMember_aSz4hVbPbkajcgZye1Napw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtFairValue" scale="6" id="Tc_4B1SLtcpRUegwAjLZogprQ_8_3">18,893</ix:nonfraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"> (<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_9_30_2019_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_EstimateOfFairValueFairValueDisclosureMember_-Q-LIZ0OPkSZIwT0yHkPXA" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtFairValue" scale="6" id="Tc_qVNQ1VoByEudn8ci8Sj6mw_8_6">21,525</ix:nonfraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"> (<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_12_31_2018_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_CarryingReportedAmountFairValueDisclosureMember_313ViIP4YEWf51iTcGQTlw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtFairValue" scale="6" id="Tc_gwR-CMeU0UuNE-HzgR6EbQ_8_9">19,366</ix:nonfraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"> (<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_12_31_2018_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_EstimateOfFairValueFairValueDisclosureMember_T9iW39RvE0KqQjvg5INJMg" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtFairValue" scale="6" id="Tc_AmpO0MrHOkK-G6g_5tIhdQ_8_12">19,871</ix:nonfraction>)</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:51.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">Foreign Currency Forward Exchange Contracts:</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:51.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 12pt;">Receivable position </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_9_30_2019_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_CarryingReportedAmountFairValueDisclosureMember_aSz4hVbPbkajcgZye1Napw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ForeignCurrencyCashFlowHedgeAssetAtFairValue" scale="6" id="Tc_Wz7hQ4sDAEGFyAoIxue6kw_10_3">298</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_9_30_2019_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_EstimateOfFairValueFairValueDisclosureMember_-Q-LIZ0OPkSZIwT0yHkPXA" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ForeignCurrencyCashFlowHedgeAssetAtFairValue" scale="6" id="Tc_uyoF0DpKEES9XtMjrJj1Jg_10_6">298</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_12_31_2018_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_CarryingReportedAmountFairValueDisclosureMember_313ViIP4YEWf51iTcGQTlw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ForeignCurrencyCashFlowHedgeAssetAtFairValue" scale="6" id="Tc_aJs6ki7Ok0uEm6ur2xmjKA_10_9">114</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_12_31_2018_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_EstimateOfFairValueFairValueDisclosureMember_T9iW39RvE0KqQjvg5INJMg" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ForeignCurrencyCashFlowHedgeAssetAtFairValue" scale="6" id="Tc_UpGLTgYgSU29p2t6ZgLY1A_10_12">114</ix:nonfraction></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:51.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 12pt;">(Payable) position </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"> (<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_9_30_2019_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_CarryingReportedAmountFairValueDisclosureMember_aSz4hVbPbkajcgZye1Napw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ForeignCurrencyCashFlowHedgeLiabilityAtFairValue" scale="6" id="Tc_D9o8EPhwREyzejRSZBDScg_11_3">95</ix:nonfraction>)</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"> (<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_9_30_2019_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_EstimateOfFairValueFairValueDisclosureMember_-Q-LIZ0OPkSZIwT0yHkPXA" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ForeignCurrencyCashFlowHedgeLiabilityAtFairValue" scale="6" id="Tc_5pW2MkC4CkuX3T3YR7WsbA_11_6">95</ix:nonfraction>)</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"> (<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_12_31_2018_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_CarryingReportedAmountFairValueDisclosureMember_313ViIP4YEWf51iTcGQTlw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ForeignCurrencyCashFlowHedgeLiabilityAtFairValue" scale="6" id="Tc_yqIj_HrwUUqk1hlcxq2eFg_11_9">95</ix:nonfraction>)</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"> (<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_12_31_2018_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_EstimateOfFairValueFairValueDisclosureMember_T9iW39RvE0KqQjvg5INJMg" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ForeignCurrencyCashFlowHedgeLiabilityAtFairValue" scale="6" id="Tc_tEKqYpaJgEWSg-H6umvp3g_11_12">95</ix:nonfraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:51.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">Interest Rate Hedge Contracts:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:51.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 12pt;">Receivable position</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_9_30_2019_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_CarryingReportedAmountFairValueDisclosureMember_aSz4hVbPbkajcgZye1Napw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:InterestRateFairValueHedgeAssetAtFairValue" scale="6" id="Tc_A6BwlaNdYUiFQOa9I1I38w_13_3">74</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_9_30_2019_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_EstimateOfFairValueFairValueDisclosureMember_-Q-LIZ0OPkSZIwT0yHkPXA" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:InterestRateFairValueHedgeAssetAtFairValue" scale="6" id="Tc_mMImXHYbukWsLI193g16Wg_13_6">74</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> —</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:51.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 12pt;">(Payable) position</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"> (<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_12_31_2018_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_CarryingReportedAmountFairValueDisclosureMember_313ViIP4YEWf51iTcGQTlw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:InterestRateFairValueHedgeLiabilityAtFairValue" scale="6" id="Tc_7p0sNkGBdUCcPuDyp0ENqA_14_9">100</ix:nonfraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"> (<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_12_31_2018_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_EstimateOfFairValueFairValueDisclosureMember_T9iW39RvE0KqQjvg5INJMg" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:InterestRateFairValueHedgeLiabilityAtFairValue" scale="6" id="Tc_wtGkOJbJWU66gt-LLI7m7A_14_12">100</ix:nonfraction>)</p></td></tr></tbody></table></ix:nonnumeric><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:10pt;text-align:justify;margin:0pt;">The fair value of the debt was determined based on significant other observable inputs, including current interest rates.</p><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:10pt;text-align:justify;margin:0pt;">The following table summarizes the bases used to measure certain assets and liabilities at fair value on a recurring basis in the balance sheet:</p><ix:nonnumeric contextref="Duration_1_1_2019_To_9_30_2019_O4ushO81Z0mAnTH_cLUPFw" name="us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" id="Tb_j0UspuDQbESpheYqz68eeQ" escape="true"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tbody><tr style="height:1pt;"><td style="vertical-align:bottom;width:43.02%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.55%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.08%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.55%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.08%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.55%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.08%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.55%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.01%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="background-color:auto;vertical-align:bottom;width:43.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:2.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:10.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:2.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="8" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:40.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Basis&nbsp;of&nbsp;Fair&nbsp;Value&nbsp;Measurement</b></p></td></tr><tr><td style="background-color:auto;vertical-align:bottom;width:43.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:2.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:10.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:2.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:11.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Quoted</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:2.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:11.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Significant</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:2.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:10.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="background-color:auto;vertical-align:bottom;width:43.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:2.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:10.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:2.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:11.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Prices&nbsp;in</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:2.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:11.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Other</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:2.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:11.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Significant</b></p></td></tr><tr><td style="background-color:auto;vertical-align:bottom;width:43.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:2.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:11.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Outstanding</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:2.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:11.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Active</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:2.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:11.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Observable</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:2.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:11.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Unobservable</b></p></td></tr><tr><td style="background-color:auto;vertical-align:bottom;width:43.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">(in&nbsp;millions)</p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:2.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&nbsp;&nbsp;&nbsp;&nbsp;</b></p></td><td colspan="2" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:11.7%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Balances</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:2.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&nbsp;&nbsp;&nbsp;&nbsp;</b></p></td><td colspan="2" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:11.7%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Markets</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:2.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&nbsp;&nbsp;&nbsp;&nbsp;</b></p></td><td colspan="2" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:11.7%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Inputs</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:2.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&nbsp;&nbsp;&nbsp;&nbsp;</b></p></td><td colspan="2" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:11.63%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Inputs</b></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:43.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">September&nbsp;30,&nbsp;2019:</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:43.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">Equity securities </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_9_30_2019_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_kkmtQBxmAUeEg6e6Pmxiuw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecurities" scale="6" id="Tc_HprtrhBK206fSbgTslr5qg_7_3">341</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_9_30_2019_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_QB0ZMuPwIEKXfWRHKPnjMg" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecurities" scale="6" id="Tc_bHVJOk0AekqXmAmAHwU3Ug_7_6">341</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> —</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:43.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">Interest rate swap derivative financial instruments</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_9_30_2019_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_kkmtQBxmAUeEg6e6Pmxiuw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:InterestRateDerivativeAssetsAtFairValue" scale="6" id="Tc_AeM3bICrskG9RPGwFdrUZg_8_3">74</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> —</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_9_30_2019_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_ul-yLL0ZFEuq6vE5Os0W9w" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:InterestRateDerivativeAssetsAtFairValue" scale="6" id="Tc_XKt3rZFJb0296oFuya8VKg_8_9">74</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&nbsp;</b></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:43.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">Foreign currency forward exchange contracts </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.08%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_9_30_2019_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_kkmtQBxmAUeEg6e6Pmxiuw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ForeignCurrencyCashFlowHedgeAssetAtFairValue" scale="6" id="Tc_0H33ov34hEiH29vca0I77Q_9_3">298</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.08%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.08%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_9_30_2019_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_ul-yLL0ZFEuq6vE5Os0W9w" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ForeignCurrencyCashFlowHedgeAssetAtFairValue" scale="6" id="Tc_ZPCNvcOFfUGoxGxOMambMQ_9_9">298</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&nbsp;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> —</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:43.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 12pt;">Total Assets </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.62%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.08%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_9_30_2019_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_kkmtQBxmAUeEg6e6Pmxiuw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="Tc_1xORG14mOkixhmub0P9jjQ_10_3">713</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.62%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.08%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_9_30_2019_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_QB0ZMuPwIEKXfWRHKPnjMg" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="Tc_nuQ57k5hhEyqgISK2MFLuw_10_6">341</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.62%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.08%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_9_30_2019_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_ul-yLL0ZFEuq6vE5Os0W9w" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="Tc_mimyTMmg3EOtM6xTuaqmoA_10_9">372</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&nbsp;</b></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.62%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.01%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:43.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:43.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">Fair value of hedged long-term debt </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_9_30_2019_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_kkmtQBxmAUeEg6e6Pmxiuw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:HedgedLiabilityFairValueHedge" scale="6" id="Tc_I7sYjkr1gE6MNPRq5WeIRQ_12_3">2,927</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> —</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_9_30_2019_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_ul-yLL0ZFEuq6vE5Os0W9w" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:HedgedLiabilityFairValueHedge" scale="6" id="Tc_LP3KearmZEqNYjeRGLcqZw_12_9">2,927</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:43.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">Foreign currency forward exchange contracts</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_9_30_2019_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_kkmtQBxmAUeEg6e6Pmxiuw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ForeignCurrencyCashFlowHedgeLiabilityAtFairValue" scale="6" id="Tc_LMzI2aAn8k6KNxf-Z-hzhw_13_3">95</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_9_30_2019_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_ul-yLL0ZFEuq6vE5Os0W9w" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ForeignCurrencyCashFlowHedgeLiabilityAtFairValue" scale="6" id="Tc_3vPataYO_k-UKAsoU7by2Q_13_9">95</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> —</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:43.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">Contingent consideration related to business combinations </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.62%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.08%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_9_30_2019_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_kkmtQBxmAUeEg6e6Pmxiuw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="Tc_Dh4QdZVT_0az46tFzCyIeg_14_3">68</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.62%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.08%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> —</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.62%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.08%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> —</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.62%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_9_30_2019_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_5s1_qJcZbkOGM8oz400wTQ" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="Tc_t-iMbXCYnU2BfcfSSOKdyg_14_12">68</ix:nonfraction></p></td></tr><tr><td style="vertical-align:bottom;width:43.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 12pt;">Total Liabilities </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.08%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_9_30_2019_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_kkmtQBxmAUeEg6e6Pmxiuw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="Tc_6A9JCA17GUujMA30gZT6HA_15_3">3,090</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.08%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.08%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_9_30_2019_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_ul-yLL0ZFEuq6vE5Os0W9w" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="Tc_8ULUEsJ8lEWTQpga-sZhXg_15_9">3,022</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.01%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_9_30_2019_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_5s1_qJcZbkOGM8oz400wTQ" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="Tc_YFDeCpexWkm1nGolTeJWJg_15_12">68</ix:nonfraction></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:43.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:43.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">December&nbsp;31,&nbsp;2018:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:43.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">Equity securities </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_12_31_2018_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember__3b9oiVbFkuHXAmmv2aTGQ" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecurities" scale="6" id="Tc_5sXR2fWQv0KGdnsJ4NkplA_18_3">320</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_12_31_2018_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_nRdEWmxCjE6Tsq35dV79tA" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecurities" scale="6" id="Tc_zFTo5-DR20OSFRvUqjEoUQ_18_6">320</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> —</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:43.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">Foreign currency forward exchange contracts </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.08%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_12_31_2018_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember__3b9oiVbFkuHXAmmv2aTGQ" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ForeignCurrencyCashFlowHedgeAssetAtFairValue" scale="6" id="Tc_4Fb4ciqUX0yC1zJJ4wdEIw_19_3">114</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.08%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.08%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_12_31_2018_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_RyqZHLXBfUKcYRtWgHbEBA" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ForeignCurrencyCashFlowHedgeAssetAtFairValue" scale="6" id="Tc_yW1589k3dkumZbqlCCZ40w_19_9">114</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> —</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:43.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 12pt;">Total Assets </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.62%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.08%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_12_31_2018_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember__3b9oiVbFkuHXAmmv2aTGQ" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="Tc_mv_y2RKTQ0-3nak6VdREYw_20_3">434</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.62%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.08%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_12_31_2018_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_nRdEWmxCjE6Tsq35dV79tA" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="Tc_yKk4RhouXkCw62fz6psLiA_20_6">320</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.62%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.08%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_12_31_2018_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_RyqZHLXBfUKcYRtWgHbEBA" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="Tc_p7KJmmel0kujIgrE0OhgCw_20_9">114</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.62%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.01%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:43.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:43.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">Fair value of hedged long-term debt </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_12_31_2018_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember__3b9oiVbFkuHXAmmv2aTGQ" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:HedgedLiabilityFairValueHedge" scale="6" id="Tc_zqDPHN1-n0e45j49BhoegA_22_3">2,743</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> —</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_12_31_2018_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_RyqZHLXBfUKcYRtWgHbEBA" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:HedgedLiabilityFairValueHedge" scale="6" id="Tc_5AaKGlyWS0y54XpxnuS3kA_22_9">2,743</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:43.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">Interest rate swap derivative financial instruments</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_12_31_2018_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember__3b9oiVbFkuHXAmmv2aTGQ" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:InterestRateFairValueHedgeLiabilityAtFairValue" scale="6" id="Tc_VwRv_2lsEkuLjquEQW3QOg_23_3">100</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_12_31_2018_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_RyqZHLXBfUKcYRtWgHbEBA" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:InterestRateFairValueHedgeLiabilityAtFairValue" scale="6" id="Tc_-bwuCO-MOUmVNqNRF5015Q_23_9">100</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> —</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:43.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">Foreign currency forward exchange contracts </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_12_31_2018_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember__3b9oiVbFkuHXAmmv2aTGQ" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ForeignCurrencyCashFlowHedgeLiabilityAtFairValue" scale="6" id="Tc_9nRZO9wpfUuHxMTAfybpWA_24_3">95</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> —</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_12_31_2018_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_RyqZHLXBfUKcYRtWgHbEBA" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ForeignCurrencyCashFlowHedgeLiabilityAtFairValue" scale="6" id="Tc_XcJ2YPIjHEOHFCNRT4hHJQ_24_9">95</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:43.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">Contingent consideration related to business combinations </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.08%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_12_31_2018_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember__3b9oiVbFkuHXAmmv2aTGQ" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="Tc_4TSuILWTd0Wm3WHXbZAKUQ_25_3">71</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.08%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.08%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.62%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_12_31_2018_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_CO3UAdKD2kCSe3FNpfmZcQ" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="Tc_j8qey8FED0ez3nKIaED-4Q_25_12">71</ix:nonfraction></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:43.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 12pt;">Total Liabilities </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.62%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.08%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_12_31_2018_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember__3b9oiVbFkuHXAmmv2aTGQ" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="Tc_UoXhTesoMUORZVjOpB-o4Q_26_3">3,009</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.62%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.08%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> —</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.62%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.08%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_12_31_2018_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_RyqZHLXBfUKcYRtWgHbEBA" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="Tc_pkwNJApiwkGQNeTTFkn13A_26_9">2,938</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.62%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.01%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_12_31_2018_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_CO3UAdKD2kCSe3FNpfmZcQ" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="Tc_y-GQ7pXPXUCGcSRr3gKa-w_26_12">71</ix:nonfraction></p></td></tr></tbody></table><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></ix:nonnumeric><p style="font-family:'Times New Roman';font-size:10pt;text-align:justify;margin:0pt;">The fair value of debt was determined based on the face value of the debt adjusted for the fair value of the interest rate swaps, which is based on a discounted cash flow analysis. &nbsp;The fair value of foreign currency forward exchange contracts is determined using a market approach, which utilizes values for comparable derivative instruments. &nbsp;The fair value of the contingent consideration was determined based on an independent appraisal adjusted for the time value of money and other changes in fair value.</p></ix:continuation><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">17</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><a href="#TOC"><span style="font-family:'Times New Roman';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Table of Contents</span></a></p><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:10pt;text-align:center;margin:0pt;">Abbott Laboratories and Subsidiaries</p><p style="font-family:'Times New Roman';font-size:10pt;text-align:center;margin:0pt;">Notes to the Condensed Consolidated Financial Statements</p><p style="font-family:'Times New Roman';font-size:10pt;text-align:center;margin:0pt;">September 30, 2019</p><p style="font-family:'Times New Roman';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;">(Unaudited)</p></div><div style="clear:both;max-width:100%;position:relative;"><ix:nonnumeric contextref="Duration_1_1_2019_To_9_30_2019_O4ushO81Z0mAnTH_cLUPFw" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="Tb_EytM1NRSwECwRxgE4PWp2w" escape="true"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">Note 12 — Litigation and Environmental Matters</p><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:10pt;text-align:justify;margin:0pt;">Abbott has been identified as a potentially responsible party for investigation and cleanup costs at a number of locations in the United States and Puerto Rico under federal and state remediation laws and is investigating potential contamination at a number of company-owned locations. Abbott has recorded an estimated cleanup cost for each site for which management believes Abbott has a probable loss exposure. No individual site cleanup exposure is expected to exceed $<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_9_30_2019_Q77aJBXiP0qCmJ4Yd2DnHw" decimals="-6" format="ixt:numdotdecimal" name="abt:LossContingencyRangeOfPossibleLossMaximumIndividualSite" scale="6" id="Narr_FW4qR5QXp0m8J4AIIq5SEQ">4</ix:nonfraction>&nbsp;million, and the aggregate cleanup exposure is not expected to exceed $<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_9_30_2019_Q77aJBXiP0qCmJ4Yd2DnHw" decimals="-6" format="ixt:numdotdecimal" name="abt:LossContingencyRangeOfPossibleLossMaximumAggregateSites" scale="6" id="Narr_-RYu4Ush6k2DukINYSWc7A">10</ix:nonfraction>&nbsp;million.</p><p style="font-family:'Times New Roman';font-size:12pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:10pt;text-align:justify;margin:0pt;">Abbott is involved in various claims and legal proceedings, and Abbott estimates the range of possible loss for its legal proceedings and environmental exposures to be from approximately $<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_9_30_2019_srt_RangeAxis_srt_MinimumMember_us-gaap_LossContingenciesByNatureOfContingencyAxis_abt_LegalProceedingsAndEnvironmentalExposuresMember_I5vPWeZRqk-P4NsBXTp0oA" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LossContingencyEstimateOfPossibleLoss" scale="6" id="Narr_jBylSTmoNU61fk7pqAgefQ">110</ix:nonfraction>&nbsp;million to $<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_9_30_2019_srt_RangeAxis_srt_MaximumMember_us-gaap_LossContingenciesByNatureOfContingencyAxis_abt_LegalProceedingsAndEnvironmentalExposuresMember_TuM9GVdwQEKD34JXMhYUwA" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LossContingencyEstimateOfPossibleLoss" scale="6" id="Narr_qsiHJI4x_E6MQTcdka_4GA">140</ix:nonfraction>&nbsp;million. The recorded accrual balance at September 30, 2019 for these proceedings and exposures was approximately $<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_9_30_2019_us-gaap_LossContingenciesByNatureOfContingencyAxis_abt_LegalProceedingsAndEnvironmentalExposuresMember_6vWgLBy-skicYXf8KTe4vw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LossContingencyAccrualAtCarryingValue" scale="6" id="Narr_nM2YkUQwM0ezxZU_Usk2HA">125</ix:nonfraction>&nbsp;million. This accrual represents management’s best estimate of probable loss, as defined by FASB ASC No.&nbsp;450, “Contingencies.” Within the next year, legal proceedings may occur that may result in a change in the estimated loss accrued by Abbott. While it is not feasible to predict the outcome of all such proceedings and exposures with certainty, management believes that their ultimate disposition should not have a material adverse effect on Abbott’s financial position, cash flows, or results of operations.</p><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></ix:nonnumeric><a id="_c33d75b3_db85_48cf_a3bc_a468547fcdc7"></a><a id="Tc_8fWX2uf3T0qthRXGicMGvg_1_2"></a><a id="Tc_iC6IGpF8ZU2fmqvJZbj_2A_1_14"></a><a id="Tc_jKb9zWzUhEaNhYXcybhcUQ_2_2"></a><a id="Tc_JbVo3qmOikiSgac_4havZw_2_8"></a><a id="Tc_wDyyqK9t7kGtan9bMlcbIw_2_14"></a><a id="Tc_aeyuRfXF8E6aIcGC_HtxXg_2_20"></a><a id="Tc_WZCCqN3UbUaze-6tRXgP_A_3_0"></a><a id="Tc_TFdi8XEcokWKdyzxysKd-w_3_2"></a><a id="Tc_fXlqY6T5J0CLwOgNA0Djlg_3_8"></a><a id="Tc_hRA3nKRdR0KgXxpdXqXy1g_3_14"></a><a id="Tc_yWZDrq1NXEWXodVOG4nmVA_3_20"></a><a id="Tc_jc6zz-s_hUCfUEY8IUpxjQ_4_2"></a><a id="Tc_aC6IUJSPhkqQ_fB-rz1RIA_4_5"></a><a id="Tc_fIk09MfS10iTYTWFOEp37g_4_8"></a><a id="Tc_4F1iacnahka2lw5Ecl0oFA_4_11"></a><a id="Tc_COmMLV2BL0-wHRyQKb_7lA_4_14"></a><a id="Tc_Q5xpdRU1zEC8Cehi777YcA_4_17"></a><a id="Tc_Iyd4Swdab0mtc2N04YxWVg_4_20"></a><a id="Tc_mXDYd0Zrz0ySjJYIV2h8_w_4_23"></a><a id="Tc_m_gKjS3ElU-bXPafnZp-Vw_5_0"></a><a id="Tc_7vHq3NyYB0yBfzq4MftQQQ_5_2"></a><a id="Tc_MSDl8rk1PkSYEbbqGMuMoA_5_5"></a><a id="Tc_C3Ke8IxWbkuImz6wZ-a7UA_5_8"></a><a id="Tc_eOrRRw_B4EC-sYfUy4apKA_5_11"></a><a id="Tc_CrIjfVVZQEi8Oh6FHUZWxQ_5_14"></a><a id="Tc_PKVeuCz8xUWISkV7aKsfEA_5_17"></a><a id="Tc_k1K668rhaEiUWPtRBYNAJg_5_20"></a><a id="Tc_8h5DONDIT06qsp2hEakqSQ_5_23"></a><a id="Tc_WhZqCU3k_0CqcL7huIbiLA_6_0"></a><a id="Tc_4qap6Tund0uNzrfAsflLAQ_7_0"></a><a id="Tc_WIJGt8DV0E6z1cQgTr41Pw_8_0"></a><a id="Tc_Fj7wQdRgYUiZcQRgMnTQ5A_9_0"></a><a id="Tc_GiEZLVtmmEyNa_tXQfW21A_10_0"></a><a id="Tc_I-NqqmPuGEqNjAzC9gjaEQ_10_3"></a><a id="Tc_0GBad0q5jE2iA14JH4Kh9Q_10_6"></a><a id="Tc_7ZwlfAI7NkeH8NdZLdLmlg_11_0"></a><a id="Tc_6U62kAmiT0SDq0EB6qeIkg_11_2"></a><a id="Tc_HWdIfr2XY0u6F81VmegAMw_11_5"></a><a id="Tc_o-XHIjnHTkq6nEjpHTI-pA_11_8"></a><a id="Tc_gf1_jGzfakKTCEddDfGxdg_11_11"></a><a id="Tc_5m8scua4wkepyLAY3-QEcg_11_14"></a><a id="Tc_riCyYC52VEazwWSVdeup8w_11_17"></a><a id="Tc_mIed65pmdECmH3-H0p1uhA_11_20"></a><a id="Tc_AvoLurOHZUy7ZjrNo7hrVA_11_23"></a><ix:nonnumeric contextref="Duration_1_1_2019_To_9_30_2019_O4ushO81Z0mAnTH_cLUPFw" name="us-gaap:PostemploymentBenefitsDisclosureTextBlock" id="Tb_f63qqFLIu0aTkFjxnluDUA" escape="true"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">Note 13 — Post-Employment Benefits</p><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:10pt;text-align:justify;margin:0pt;">Retirement plans consist of defined benefit, defined contribution, and medical and dental plans. Net periodic benefit costs, other than service costs, are recognized in the Other (income) expense, net line of the Condensed Consolidated Statement of Earnings. Net cost recognized in continuing operations for the three and nine months ended September 30 for Abbott’s major defined benefit plans and post-employment medical and dental benefit plans is as follows:</p><ix:nonnumeric contextref="Duration_1_1_2019_To_9_30_2019_O4ushO81Z0mAnTH_cLUPFw" name="us-gaap:ScheduleOfNetBenefitCostsTableTextBlock" id="Tb_10pBTr867Uuw0ptg7jLWsw" escape="true"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p><table style="border-collapse:collapse;font-size:16pt;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tbody><tr style="height:1pt;"><td style="vertical-align:bottom;width:36.38%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:5.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:5.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:4.52%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:4.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.07%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:5.65%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.07%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:5.65%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:4.52%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:4.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:36.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="11" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:30.05%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Defined&nbsp;Benefit&nbsp;Plans</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="11" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:30.1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Medical&nbsp;and&nbsp;Dental&nbsp;Plans</b></p></td></tr><tr><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:36.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="5" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:15.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Three&nbsp;Months</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="5" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:13.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Nine&nbsp;Months</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="5" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:15.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Three&nbsp;Months</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="5" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:13.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Nine&nbsp;Months</b></p></td></tr><tr><td style="background-color:auto;vertical-align:bottom;width:36.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">(in millions)</p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="5" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:15.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Ended September&nbsp;30</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="5" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:13.17%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Ended September&nbsp;30</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="5" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:15.19%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Ended September&nbsp;30</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="5" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:13.17%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Ended September&nbsp;30</b></p></td></tr><tr><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:36.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;&nbsp;&nbsp;&nbsp;</p></td><td colspan="2" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:6.71%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2019</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&nbsp;&nbsp;&nbsp;&nbsp;</b></p></td><td colspan="2" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:6.71%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2018</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&nbsp;&nbsp;&nbsp;&nbsp;</b></p></td><td colspan="2" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:5.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2019</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&nbsp;&nbsp;&nbsp;&nbsp;</b></p></td><td colspan="2" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:5.66%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2018</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&nbsp;&nbsp;&nbsp;&nbsp;</b></p></td><td colspan="2" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:6.73%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2019</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&nbsp;&nbsp;&nbsp;&nbsp;</b></p></td><td colspan="2" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:6.73%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2018</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&nbsp;&nbsp;&nbsp;&nbsp;</b></p></td><td colspan="2" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:5.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2019</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&nbsp;&nbsp;&nbsp;&nbsp;</b></p></td><td colspan="2" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:5.66%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2018</b></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:36.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">Service cost - benefits earned during the period </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2019_To_9_30_2019_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember_lK6ibUzmhUyQKDST8N8Wcw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="Tc_Km70YyIT4EWh2BDQsTHryg_5_3">63</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2018_To_9_30_2018_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember_UQ4wAcf7eka8fnkFZEvV-A" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="Tc_oys-Y77C2UeOUnl6ctk2SA_5_6">76</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:4.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember_lB8RTt7VykWlXZnoI4XA6w" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="Tc_6mDqt8goakKzDTez2M5zHA_5_9">188</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:4.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2018_To_9_30_2018_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember_n53CHi7vukugJ6IfhgDWmQ" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="Tc_PdJtdDUtxkCsPpW2Su9Y1A_5_12">221</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2019_To_9_30_2019_us-gaap_RetirementPlanTypeAxis_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_peLAPtPdO0i7sEgvdxD48g" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="Tc_pRQluagiKkiBwEBjiJFzhg_5_15">5</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2018_To_9_30_2018_us-gaap_RetirementPlanTypeAxis_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_hjSt1qqsSUyf4oneowhAAQ" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="Tc_8ccxeATb3UipcmD_kRGViQ_5_18">7</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:4.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_us-gaap_RetirementPlanTypeAxis_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_zZGCXN2-QUiC_W6F9cgj6A" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="Tc_oC1cp9NGFEy7lPWc-HtclA_5_21">17</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:4.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2018_To_9_30_2018_us-gaap_RetirementPlanTypeAxis_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_Y_TwTX3MfUCiGOSbOE4-kA" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="Tc_fjtQpcpLqUOWVO2C-mEAIQ_5_24">20</ix:nonfraction></p></td></tr><tr><td style="vertical-align:bottom;width:36.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">Interest cost on projected benefit obligations </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;"> <span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2019_To_9_30_2019_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember_lK6ibUzmhUyQKDST8N8Wcw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="Tc_Y7l6JnbYkke_65Q4WvpBJQ_6_3">84</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2018_To_9_30_2018_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember_UQ4wAcf7eka8fnkFZEvV-A" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="Tc_KqOC-VmeVUKL07i8ph_2ag_6_6">77</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember_lB8RTt7VykWlXZnoI4XA6w" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="Tc_0QAxh3tH8Eq7aXTbTHZq0A_6_9">253</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2018_To_9_30_2018_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember_n53CHi7vukugJ6IfhgDWmQ" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="Tc_aT_WCK4zXkGVW-lfcDuUfA_6_12">232</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;"> <span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2019_To_9_30_2019_us-gaap_RetirementPlanTypeAxis_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_peLAPtPdO0i7sEgvdxD48g" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="Tc_NRsilKJdmUCmy7LXSwxJ4w_6_15">13</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2018_To_9_30_2018_us-gaap_RetirementPlanTypeAxis_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_hjSt1qqsSUyf4oneowhAAQ" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="Tc_SHlJpCXL30WgDRALKXXojA_6_18">12</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_us-gaap_RetirementPlanTypeAxis_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_zZGCXN2-QUiC_W6F9cgj6A" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="Tc_HLswM75Ho067yN2QXIbE9Q_6_21">39</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2018_To_9_30_2018_us-gaap_RetirementPlanTypeAxis_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_Y_TwTX3MfUCiGOSbOE4-kA" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="Tc_Xon1Ka7OIUakVMT9-KY2vQ_6_24">36</ix:nonfraction></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:36.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="white-space:pre-wrap;">Expected return on plan assets  </span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"> (<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2019_To_9_30_2019_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember_lK6ibUzmhUyQKDST8N8Wcw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="Tc_jErkoZQi4kufoNOCOV_NHQ_7_3">177</ix:nonfraction>)</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"> (<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2018_To_9_30_2018_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember_UQ4wAcf7eka8fnkFZEvV-A" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="Tc_5F-Dytj8HUymiC3H4QelGA_7_6">169</ix:nonfraction>)</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:4.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"> (<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember_lB8RTt7VykWlXZnoI4XA6w" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="Tc_wauQ24hwvUyfPFAo_uVtgA_7_9">533</ix:nonfraction>)</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:4.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"> (<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2018_To_9_30_2018_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember_n53CHi7vukugJ6IfhgDWmQ" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="Tc_OtGrn9BQvUuqr9acbL2p9A_7_12">511</ix:nonfraction>)</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"> (<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2019_To_9_30_2019_us-gaap_RetirementPlanTypeAxis_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_peLAPtPdO0i7sEgvdxD48g" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="Tc_53CNvmyvFEul_JLl6EKgRA_7_15">6</ix:nonfraction>)</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"> (<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2018_To_9_30_2018_us-gaap_RetirementPlanTypeAxis_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_hjSt1qqsSUyf4oneowhAAQ" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="Tc_Fa_OZHE150OncC5AINtGKw_7_18">9</ix:nonfraction>)</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:4.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"> (<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_us-gaap_RetirementPlanTypeAxis_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_zZGCXN2-QUiC_W6F9cgj6A" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="Tc_6r5V48BGrE-l2sJu8HML1w_7_21">20</ix:nonfraction>)</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:4.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"> (<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2018_To_9_30_2018_us-gaap_RetirementPlanTypeAxis_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_Y_TwTX3MfUCiGOSbOE4-kA" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="Tc_z6C2e93mZ0esW3XDJXcqeQ_7_24">25</ix:nonfraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:36.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">Net amortization of:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:36.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 6pt;">Actuarial loss, net </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2019_To_9_30_2019_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember_lK6ibUzmhUyQKDST8N8Wcw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" sign="-" scale="6" id="Tc_92lx3mpgy0SKUtkezr_Jjw_9_3">33</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2018_To_9_30_2018_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember_UQ4wAcf7eka8fnkFZEvV-A" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" sign="-" scale="6" id="Tc_UOu5vp_LHUWzFJPmUtBmMw_9_6">51</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:4.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember_lB8RTt7VykWlXZnoI4XA6w" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" sign="-" scale="6" id="Tc_j6RtuPZ8gkukSgI3Z3CePA_9_9">99</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:4.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2018_To_9_30_2018_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember_n53CHi7vukugJ6IfhgDWmQ" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" sign="-" scale="6" id="Tc_-chJ7uHv102i47egUuqwYA_9_12">154</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2019_To_9_30_2019_us-gaap_RetirementPlanTypeAxis_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_peLAPtPdO0i7sEgvdxD48g" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" sign="-" scale="6" id="Tc_d6DUNv2TAEy4GwzjmfCbXQ_9_15">6</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2018_To_9_30_2018_us-gaap_RetirementPlanTypeAxis_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_hjSt1qqsSUyf4oneowhAAQ" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" sign="-" scale="6" id="Tc_J6Z2-K5qvEqp9VTIC0L2Dg_9_18">8</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:4.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_us-gaap_RetirementPlanTypeAxis_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_zZGCXN2-QUiC_W6F9cgj6A" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" sign="-" scale="6" id="Tc_vzrPW4U34UyxPTZRlJ3Png_9_21">17</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:4.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2018_To_9_30_2018_us-gaap_RetirementPlanTypeAxis_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_Y_TwTX3MfUCiGOSbOE4-kA" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" sign="-" scale="6" id="Tc_OKsFGoNX3Eez2V1balvxPg_9_24">25</ix:nonfraction></p></td></tr><tr><td style="vertical-align:bottom;width:36.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 6pt;"><span style="white-space:pre-wrap;">Prior service cost (credit)  </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.06%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.64%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.06%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.64%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.52%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember_lB8RTt7VykWlXZnoI4XA6w" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" scale="6" id="Tc_EGVkv-LEe0a52n0H4QLp-w_10_9">1</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2018_To_9_30_2018_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember_n53CHi7vukugJ6IfhgDWmQ" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" scale="6" id="Tc_oFJz2rhdqUG4u-jGVfDm2A_10_12">1</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.07%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"> (<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2019_To_9_30_2019_us-gaap_RetirementPlanTypeAxis_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_peLAPtPdO0i7sEgvdxD48g" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" sign="-" scale="6" id="Tc_tCE31wrg5ESAG-EZJWRtYQ_10_15">8</ix:nonfraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.07%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"> (<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2018_To_9_30_2018_us-gaap_RetirementPlanTypeAxis_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_hjSt1qqsSUyf4oneowhAAQ" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" sign="-" scale="6" id="Tc_8I_lJHb-Gka0B_LfAD8Jkg_10_18">11</ix:nonfraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.52%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"> (<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_us-gaap_RetirementPlanTypeAxis_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_zZGCXN2-QUiC_W6F9cgj6A" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" sign="-" scale="6" id="Tc_y3ZSiA0ZZUGbgrHClqSllw_10_21">24</ix:nonfraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"> (<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2018_To_9_30_2018_us-gaap_RetirementPlanTypeAxis_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_Y_TwTX3MfUCiGOSbOE4-kA" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" sign="-" scale="6" id="Tc_PuU80M_Cp0KE9VQlNv8ssA_10_24">34</ix:nonfraction>)</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:36.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">Net cost - continuing operations</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.06%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.64%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2019_To_9_30_2019_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember_lK6ibUzmhUyQKDST8N8Wcw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="Tc_mvCtplt8eEmPcbUEP46AoA_11_3">3</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.06%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.64%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2018_To_9_30_2018_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember_UQ4wAcf7eka8fnkFZEvV-A" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="Tc__YdddvLkvESs0hOLrV59_g_11_6">35</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:4.52%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember_lB8RTt7VykWlXZnoI4XA6w" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="Tc_UK3YZCepCki0w9sODsSgDw_11_9">8</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.14%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:4.51%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2018_To_9_30_2018_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember_n53CHi7vukugJ6IfhgDWmQ" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="Tc_FwMs_8xBUEKYq1AO1gS3Jg_11_12">97</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.07%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.65%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2019_To_9_30_2019_us-gaap_RetirementPlanTypeAxis_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_peLAPtPdO0i7sEgvdxD48g" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="Tc_nCK0ZlZDeEOgWMoq2h2vsw_11_15">10</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.07%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.65%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2018_To_9_30_2018_us-gaap_RetirementPlanTypeAxis_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_hjSt1qqsSUyf4oneowhAAQ" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="Tc_w0XwjCZShkWfwmYqmvBidg_11_18">7</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:4.52%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_us-gaap_RetirementPlanTypeAxis_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_zZGCXN2-QUiC_W6F9cgj6A" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="Tc_pzyHRuuJv0WC4eoKAmtdIw_11_21">29</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.14%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:4.51%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2018_To_9_30_2018_us-gaap_RetirementPlanTypeAxis_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_Y_TwTX3MfUCiGOSbOE4-kA" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="Tc_RerTosr4oUuwXCmqI_0FKg_11_24">22</ix:nonfraction></p></td></tr></tbody></table><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></ix:nonnumeric><p style="font-family:'Times New Roman';font-size:10pt;text-align:justify;margin:0pt;">Abbott funds its domestic defined benefit plans according to IRS funding limitations. &nbsp;International pension plans are funded according to similar regulations. &nbsp;In the first nine months of 2019 and 2018, $<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember_lB8RTt7VykWlXZnoI4XA6w" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" scale="6" id="Narr_fpG3shETGU2kJ86skqy_6Q">337</ix:nonfraction> million and $<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2018_To_9_30_2018_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember_n53CHi7vukugJ6IfhgDWmQ" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" scale="6" id="Narr_EQmG6PENPUqkUiJOX3KfvQ">71</ix:nonfraction> million, respectively, were contributed to defined benefit plans and $<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2018_To_9_30_2018_us-gaap_RetirementPlanTypeAxis_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_Y_TwTX3MfUCiGOSbOE4-kA" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" scale="6" id="Narr_kUnze4nMQEKHLl4BIY9QgA"><ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_us-gaap_RetirementPlanTypeAxis_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_zZGCXN2-QUiC_W6F9cgj6A" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" scale="6" id="Narr_Mus1I0XrGEiCznX9pS21Zw">11</ix:nonfraction></ix:nonfraction> million was contributed to the post-employment medical and dental benefit plans in each year.</p></ix:nonnumeric><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><ix:nonnumeric contextref="Duration_1_1_2019_To_9_30_2019_O4ushO81Z0mAnTH_cLUPFw" name="us-gaap:IncomeTaxDisclosureTextBlock" id="Tb_y7WsK22F0kKo4B1tb2-emA" continuedat="Tb_y7WsK22F0kKo4B1tb2-emA_cont1" escape="true"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">Note 14 — Taxes on Earnings</p><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:10pt;text-align:justify;margin:0pt;">Taxes on earnings from continuing operations reflect the estimated annual effective rates and include charges for interest and penalties. In the first nine months of 2019, taxes on earnings from continuing operations include a $<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_O4ushO81Z0mAnTH_cLUPFw" decimals="-6" format="ixt:numdotdecimal" name="abt:TaxCutsAndJobsActOf2017TransitionTaxIncomeTaxExpenseBenefit" sign="-" scale="6" id="Narr_cVRVwR0gbEWsTnvb2nXhhg">78</ix:nonfraction> million reduction to the transition tax related to the Tax Cut and Jobs Act (TCJA) and approximately $<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_O4ushO81Z0mAnTH_cLUPFw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" scale="6" id="Narr_jBFbJM3_j0Gc_7DtA2b7Gg">95</ix:nonfraction> million in excess tax benefits associated with share-based compensation. &nbsp;The $<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_O4ushO81Z0mAnTH_cLUPFw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:TaxCutsAndJobsActOf2017ChangeInTaxRateIncomeTaxExpenseBenefit" sign="-" scale="6" id="Narr_uBZ7xLIO_EGtXIYuo6UiuA">78</ix:nonfraction> million reduction to the transition tax liability was the result of the issuance of final transition tax regulations by the U.S. Department of Treasury in the first quarter. &nbsp;This adjustment decreased the cumulative net tax expense related to the TCJA to $<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_9_30_2019_Q77aJBXiP0qCmJ4Yd2DnHw" decimals="-7" format="ixt:numdotdecimal" name="abt:TaxCutsAndJobsActOf2017IncomeTaxExpenseBenefitCumulative" scale="9" id="Narr_ntsPrHTO7Em0P_9VMbUFxg">1.51</ix:nonfraction> billion. &nbsp;In the first nine months of 2018, taxes on earnings from continuing operations include approximately $<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2018_To_9_30_2018_3n65uNcjAUKkwLDxHE9Yow" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" scale="6" id="Narr_cgT-wMRcxUavWRw8MDnVkA">80</ix:nonfraction> million in excess tax benefits associated with share-based compensation and a $<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2018_To_9_30_2018_3n65uNcjAUKkwLDxHE9Yow" decimals="-6" format="ixt:numdotdecimal" name="abt:TaxCutsAndJobsActOf2017TransitionTaxIncomeTaxExpenseBenefit" scale="6" id="Narr_YB-16fedQEuLmO4Dgaa_3w">53</ix:nonfraction> million adjustment to the transition tax liability for associated effects related to state tax. Earnings from discontinued operations, net of tax, in the first nine months of 2018 reflect the recognition of $<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2018_To_9_30_2018_us-gaap_StatementOperatingActivitiesSegmentAxis_us-gaap_SegmentDiscontinuedOperationsMember_qVc5axf-dk2sztcbRDmn3Q" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxReconciliationPriorYearIncomeTaxes" sign="-" scale="6" id="Narr_VSrmtO3DoE2UOuAfYbEjWg">40</ix:nonfraction> million of net tax benefits primarily as a result of the resolution of various tax positions related to prior years which decreased the gross amount of unrecognized tax benefits by $<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2018_To_9_30_2018_us-gaap_StatementOperatingActivitiesSegmentAxis_us-gaap_SegmentDiscontinuedOperationsMember_qVc5axf-dk2sztcbRDmn3Q" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:UnrecognizedTaxBenefitsPeriodIncreaseDecrease" sign="-" scale="6" id="Narr_Lyva-OKrRkuzjYxqgB5mDA">47</ix:nonfraction> million. </p><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></ix:nonnumeric></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">18</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><a href="#TOC"><span style="font-family:'Times New Roman';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Table of Contents</span></a></p><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:10pt;text-align:center;margin:0pt;">Abbott Laboratories and Subsidiaries</p><p style="font-family:'Times New Roman';font-size:10pt;text-align:center;margin:0pt;">Notes to the Condensed Consolidated Financial Statements</p><p style="font-family:'Times New Roman';font-size:10pt;text-align:center;margin:0pt;">September 30, 2019</p><p style="font-family:'Times New Roman';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;">(Unaudited)</p></div><div style="clear:both;max-width:100%;position:relative;"><ix:continuation id="Tb_y7WsK22F0kKo4B1tb2-emA_cont1"><p style="font-family:'Times New Roman';font-size:10pt;text-align:justify;margin:0pt;">Tax authorities in various jurisdictions regularly review Abbott’s income tax filings. &nbsp;Abbott believes that it is reasonably possible that the recorded amount of gross unrecognized tax benefits may decrease between $<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_9_30_2019_srt_RangeAxis_srt_MinimumMember_CX2tJ3HgS06yfIVVN84Uaw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" scale="6" id="Narr_4WTSvjX5HkeqBH1k-fSTCA">185</ix:nonfraction> million and $<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="As_Of_9_30_2019_srt_RangeAxis_srt_MaximumMember_TIf3O5zuGEK_gbVC_qJfFA" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" scale="6" id="Narr_LMnO042X1kyZvpKoZWRDqQ">430</ix:nonfraction> million, including cash adjustments, within the next twelve months as a result of concluding various domestic and international tax matters. In the U.S., Abbott’s federal income tax returns through 2016 are settled except for the federal income tax returns of the former Alere consolidated group which are settled through 2014 and the former St. Jude Medical consolidated group which are settled through 2013.</p></ix:continuation><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><ix:nonnumeric contextref="Duration_1_1_2019_To_9_30_2019_O4ushO81Z0mAnTH_cLUPFw" name="us-gaap:SegmentReportingDisclosureTextBlock" id="Tb_kwg2bZCZNUO1tqcqLItnjA" continuedat="Tb_kwg2bZCZNUO1tqcqLItnjA_cont1" escape="true"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">Note 15 — Segment Information</p><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:10pt;text-align:justify;margin:0pt;">Abbott’s principal business is the discovery, development, manufacture and sale of a broad line of health care products. &nbsp;Abbott’s products are generally sold directly to retailers, wholesalers, hospitals, health care facilities, laboratories, physicians’ offices and government agencies throughout the world.<span style="font-size:12pt;"> </span></p><p style="font-family:'Times New Roman';font-size:12pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:10pt;text-align:justify;margin:0pt;">Abbott’s reportable segments are as follows:</p><p style="font-family:'Times New Roman';font-size:12pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:10pt;text-align:justify;margin:0pt;"><i style="font-style:italic;">Established Pharmaceutical Products</i> — International sales of a broad line of branded generic pharmaceutical products.</p><p style="font-family:'Times New Roman';font-size:12pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:10pt;text-align:justify;margin:0pt;"><i style="font-style:italic;">Nutritional Products</i> — Worldwide sales of a broad line of adult and pediatric nutritional products.</p><p style="font-family:'Times New Roman';font-size:12pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:10pt;text-align:justify;margin:0pt;"><i style="font-style:italic;">Diagnostic Products</i> — Worldwide sales of diagnostic systems and tests for blood banks, hospitals, commercial laboratories, physician offices and alternate-care testing sites. For segment reporting purposes, the Core Laboratory Diagnostics, Rapid Diagnostics, Molecular Diagnostics and Point of Care Diagnostics divisions are aggregated and reported as the Diagnostic Products segment.</p><p style="font-family:'Times New Roman';font-size:12pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:10pt;text-align:justify;margin:0pt;"><i style="font-style:italic;">Cardiovascular and Neuromodulation Products</i> — Worldwide sales of cardiac rhythm management, electrophysiology, heart failure, vascular, structural heart and neuromodulation products. For segment reporting purposes, the Cardiac Arrhythmias &amp; Heart Failure, Vascular, Neuromodulation and Structural Heart divisions are aggregated and reported as the Cardiovascular and Neuromodulation segment.</p><p style="font-family:'Times New Roman';font-size:12pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:10pt;text-align:justify;margin:0pt;">Non-reportable segments include Diabetes Care.</p><p style="font-family:'Times New Roman';font-size:12pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:10pt;text-align:justify;margin:0pt;">Abbott’s underlying accounting records are maintained on a legal entity basis for government and public reporting requirements. &nbsp;Segment disclosures are on a performance basis consistent with internal management reporting. &nbsp;Intersegment transfers of inventory are recorded at standard cost and are not a measure of segment operating earnings. &nbsp;The cost of some corporate functions and the cost of certain employee benefits are charged to segments at predetermined rates that approximate cost. &nbsp;Remaining costs, if any, are not allocated to segments. &nbsp;In addition, intangible asset amortization is not allocated to operating segments, and intangible assets and goodwill are not included in the measure of each segment’s assets. </p><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:10pt;text-align:justify;margin:0pt;">The following segment information has been prepared in accordance with the internal accounting policies of Abbott, as described above, and is not presented in accordance with generally accepted accounting principles applied to the consolidated financial statements.</p><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></ix:nonnumeric></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">19</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><a href="#TOC"><span style="font-family:'Times New Roman';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Table of Contents</span></a></p><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:10pt;text-align:center;margin:0pt;">Abbott Laboratories and Subsidiaries</p><p style="font-family:'Times New Roman';font-size:10pt;text-align:center;margin:0pt;">Notes to the Condensed Consolidated Financial Statements</p><p style="font-family:'Times New Roman';font-size:10pt;text-align:center;margin:0pt;">September 30, 2019</p><p style="font-family:'Times New Roman';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;">(Unaudited)</p></div><div style="clear:both;max-width:100%;position:relative;min-height:11.5pt;"><a id="_7257e7a9_47d3_40c4_9f02_15c112bded18"></a><a id="Tc_A33LdxknH0CkcHG5OaAawg_1_2"></a><a id="Tc_FWXv774LgkOXvm6Tzq9AWQ_1_14"></a><a id="Tc_EfW6GJpnC0uQrn7-wyDCSA_2_2"></a><a id="Tc_WXGNmUygTEeZKUQ1skI3lg_2_8"></a><a id="Tc_7V9nBJs3IEGOmHLJ11D1mA_2_14"></a><a id="Tc_nLJKVwl0LEuNgz64NHYtiA_2_20"></a><a id="Tc_NuX4QEjA8EOi_ozKQjlAhQ_3_2"></a><a id="Tc_NPEuh5fTG0qQT-cDZUjlRQ_3_8"></a><a id="Tc_whCjU9oy-0668kl2yYomqw_3_14"></a><a id="Tc_hy1qZKJaDUmVZbBeWVG92A_3_20"></a><a id="Tc_xJ6xj5gw00Sgfp_BTndJyg_4_0"></a><a id="Tc_zOQBV02OUEycODr23X02FQ_4_2"></a><a id="Tc_ewyfhQh_q0mqQ7Ufreg3GQ_4_5"></a><a id="Tc_so7n5KBjAEyj3qoBnuimVA_4_8"></a><a id="Tc_gElmUeRn30qekMyyA-qF6Q_4_11"></a><a id="Tc_ueqpcdR4HE-xSXO-q4NWkg_4_14"></a><a id="Tc_b7lLiHp74EiPztrQ-cjDxQ_4_17"></a><a id="Tc_KF3H3t0bREeS0t4FLj1fMw_4_20"></a><a id="Tc_JSc8BTPOp0C2DDmqlFyhyQ_4_23"></a><a id="Tc_DA7psj13uk2tL-8QC0TZYA_5_0"></a><a id="Tc_UsW7lETEjEKpo6z7yetPAA_5_2"></a><a id="Tc_TZTGWy22Zkm-uujvrRDR5w_5_5"></a><a id="Tc_pbr-XuD0Z0ehwFMieaUWOA_5_8"></a><a id="Tc_xmQqosx25keb9ZsMc6ID1w_5_11"></a><a id="Tc_TaHWF089x0KQzc8u0UYLag_5_14"></a><a id="Tc_114i5T1juEObdYpGjiGLLQ_5_17"></a><a id="Tc_39g7xxT1_ESP-fxQvCwPCg_5_20"></a><a id="Tc_blpCpuHDNkqZJW3eGsCx5Q_5_23"></a><a id="Tc_2-jMFk27CUCVF_h3hkGu1Q_6_0"></a><a id="Tc_kA2Vw9BOlUmOoxOtTGTXZQ_7_0"></a><a id="Tc_hkL9eiWWWU2paWrI0XMlsQ_8_0"></a><a id="Tc_E1UN5q3WtUumQYmsYh6mvA_9_0"></a><a id="Tc_Ks0mvuq_ZkKJiix_sYgQ3A_10_0"></a><a id="Tc_0_qXpuAXRUaN6UkwLBbwcA_11_0"></a><a id="Tc_yORPMx2jzkSszkiw8j8HlQ_11_2"></a><a id="Tc_Ncz1X8ZjyESRenWaCGYEBQ_11_5"></a><a id="Tc_8fXTgpNaTUq5GkSwAWY1jg_11_8"></a><a id="Tc_GsGtsVVYIUOLIe2OKzfVsA_11_11"></a><a id="Tc_RbAmP5M8wkKok5adTrOFdQ_12_0"></a><a id="Tc_4D-PZDPJzE23NFwbPjb1Pg_13_0"></a><a id="Tc_cUChjmGLOkij6YdqGDX9SQ_14_0"></a><a id="Tc_ZHm0IjBny0a_TsvvMl9Iiw_15_0"></a><a id="Tc_MXHDE_L5Wkus_G8XEz664w_16_0"></a><a id="Tc_7XZx4uTCWU6_etJ1EgJMag_17_0"></a><a id="Tc_rPgOGaoM8USH62VD-qwDqw_18_0"></a><a id="Tc_PdLH9RahykyMpkzKVR4ifw_18_14"></a><a id="Tc_QnFcL1VVtEWSl9Y4Fsbpmw_18_17"></a><a id="Tc_2RkZPDcdwkCifaCouDUagQ_18_20"></a><a id="Tc_ixh0absyuUSWhCIvqwLt5Q_18_23"></a><ix:continuation id="Tb_kwg2bZCZNUO1tqcqLItnjA_cont1"><ix:nonnumeric contextref="Duration_1_1_2019_To_9_30_2019_O4ushO81Z0mAnTH_cLUPFw" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock" id="Tb_Dcd9oM4IPkCGxu27yLQlUQ" escape="true"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tbody><tr style="height:1pt;"><td style="vertical-align:bottom;width:35.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:5.19%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:5.19%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.11%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.11%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:5.19%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:5.19%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:5.87%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:5.87%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="background-color:auto;vertical-align:bottom;width:35.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-style:italic;font-weight:bold;"> </span><span style="font-style:italic;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="11" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:30.75%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Net Sales to External Customers</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="11" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:30.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Operating Earnings</b></p></td></tr><tr><td style="background-color:auto;vertical-align:bottom;width:35.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="5" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:13.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Three Months</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="5" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:15.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Nine&nbsp;Months</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="5" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:13.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Three Months</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="5" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:15.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Nine&nbsp;Months</b></p></td></tr><tr><td style="background-color:auto;vertical-align:bottom;width:35.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="5" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:13.72%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Ended September&nbsp;30</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="5" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:15.55%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Ended September&nbsp;30</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="5" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:13.72%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Ended September&nbsp;30</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="5" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:15.08%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Ended September&nbsp;30</b></p></td></tr><tr><td style="background-color:auto;vertical-align:bottom;width:35.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">(in millions)</p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&nbsp;&nbsp;&nbsp;&nbsp;</b></p></td><td colspan="2" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:6.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2019</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&nbsp;&nbsp;&nbsp;&nbsp;</b></p></td><td colspan="2" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:6.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2018</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&nbsp;&nbsp;&nbsp;&nbsp;</b></p></td><td colspan="2" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:7.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2019</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&nbsp;&nbsp;&nbsp;&nbsp;</b></p></td><td colspan="2" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:7.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2018</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&nbsp;&nbsp;&nbsp;&nbsp;</b></p></td><td colspan="2" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:6.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2019</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&nbsp;&nbsp;&nbsp;&nbsp;</b></p></td><td colspan="2" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:6.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2018</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&nbsp;&nbsp;&nbsp;&nbsp;</b></p></td><td colspan="2" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:6.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2019</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&nbsp;&nbsp;&nbsp;&nbsp;</b></p></td><td colspan="2" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:6.8%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2018</b></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:35.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">Established Pharmaceutical Products</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2019_To_9_30_2019_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_abt_EstablishedPharmaceuticalProductsMember_keh92wNn8kaKtQ9J5JbgwA" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_nJPFyprL00alPe4rdLI-nA_5_3">1,212</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2018_To_9_30_2018_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_abt_EstablishedPharmaceuticalProductsMember_oXOcmR6rpECCikSKHRh5dQ" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_dUaoXIXRNEC0SICiAE82Pg_5_6">1,159</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:6.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_abt_EstablishedPharmaceuticalProductsMember_rJA5x0gXxkGHub8Kg-iK0w" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_NhQcgQqXakyyvNnx6Ke4BA_5_9">3,312</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:6.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2018_To_9_30_2018_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_abt_EstablishedPharmaceuticalProductsMember_4X5ZASo2QUypfnofJHcSZQ" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_pUXfaF1W_kqXwteMCw2fsg_5_12">3,332</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2019_To_9_30_2019_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_abt_EstablishedPharmaceuticalProductsMember_keh92wNn8kaKtQ9J5JbgwA" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="Tc_dTCBdtsNQUaVtHD1sIaY5g_5_15">281</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2018_To_9_30_2018_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_abt_EstablishedPharmaceuticalProductsMember_oXOcmR6rpECCikSKHRh5dQ" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="Tc_kq_saiSMDESTMtqWfcNtDQ_5_18">289</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_abt_EstablishedPharmaceuticalProductsMember_rJA5x0gXxkGHub8Kg-iK0w" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="Tc_cHYkgake4kiWaPFhz7LMXw_5_21">654</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2018_To_9_30_2018_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_abt_EstablishedPharmaceuticalProductsMember_4X5ZASo2QUypfnofJHcSZQ" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="Tc_kwGooV5LL0myts75Y5QK5Q_5_24">664</ix:nonfraction></p></td></tr><tr><td style="vertical-align:bottom;width:35.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">Nutritional Products</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2019_To_9_30_2019_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_abt_NutritionalProductsMember_nni-LDY7YkiSXaaKiZziQw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_F3e5Z3uFv06nplLS2PfZ7Q_6_3">1,874</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2018_To_9_30_2018_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_abt_NutritionalProductsMember_m1Tmoie0pUagbwg4aIQj5Q" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_X0p0hcy62Ey4OYGj7LCy6g_6_6">1,838</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_abt_NutritionalProductsMember_ogKwSHLFqUC88g-lA6iueA" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_6wb87aM9_k2Ypcln6k15kQ_6_9">5,541</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2018_To_9_30_2018_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_abt_NutritionalProductsMember_On0QXDSsaUuuRKag9KNMtg" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_TENQcvXGgU2DN7X1GiNkBA_6_12">5,452</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2019_To_9_30_2019_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_abt_NutritionalProductsMember_nni-LDY7YkiSXaaKiZziQw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="Tc_G8BEuX1aPEKIwRlUm0PXZg_6_15">414</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2018_To_9_30_2018_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_abt_NutritionalProductsMember_m1Tmoie0pUagbwg4aIQj5Q" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="Tc_6OqpnTtQQEurH2Ih3CKJXw_6_18">435</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_abt_NutritionalProductsMember_ogKwSHLFqUC88g-lA6iueA" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="Tc_ryz_bg6m5k20iNciT7juyg_6_21">1,241</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2018_To_9_30_2018_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_abt_NutritionalProductsMember_On0QXDSsaUuuRKag9KNMtg" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="Tc_2PMxN0g-1kyJOwd9-Hh4pg_6_24">1,224</ix:nonfraction></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:35.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">Diagnostic Products</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2019_To_9_30_2019_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_abt_DiagnosticProductsMember_FnP06bxi60-w30Oo_2zs4g" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_v7OKZh34IUSf2dM8ReS3Rg_7_3">1,909</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2018_To_9_30_2018_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_abt_DiagnosticProductsMember_8muEd-xSoUCoq2Pl8AzzUw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_eOMv5hrOg0WELVl6ph91Qg_7_6">1,824</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:6.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_abt_DiagnosticProductsMember_RTLOqDB56EK401Q7B97VVg" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_VxbHHJsK_0SglMetHqd7Vg_7_9">5,655</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:6.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2018_To_9_30_2018_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_abt_DiagnosticProductsMember_ImQQ9QI3kUGd0c3G4jsDMQ" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_uy4XYhWca0m12Khn0IodXQ_7_12">5,534</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2019_To_9_30_2019_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_abt_DiagnosticProductsMember_FnP06bxi60-w30Oo_2zs4g" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="Tc_pW0Jo6jtrUWRsYXXRnMhMQ_7_15">456</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2018_To_9_30_2018_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_abt_DiagnosticProductsMember_8muEd-xSoUCoq2Pl8AzzUw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="Tc_b8dxYbXZJEO4kPcTntH7AQ_7_18">443</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_abt_DiagnosticProductsMember_RTLOqDB56EK401Q7B97VVg" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="Tc_AP12XyqzOUKNw5SVdwYTYQ_7_21">1,356</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2018_To_9_30_2018_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_abt_DiagnosticProductsMember_ImQQ9QI3kUGd0c3G4jsDMQ" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="Tc_b6VN_YCDqU6Xf2NdlSTW5g_7_24">1,375</ix:nonfraction></p></td></tr><tr><td style="vertical-align:bottom;width:35.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">Cardiovascular and Neuromodulation Products </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.19%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2019_To_9_30_2019_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_abt_CardiovascularAndNeuromodulationProductsMember_rH7Zs0lLdUCD9w4VvAC-lw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_YBbKySXb8USlTVc_JDx2vg_8_3">2,400</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.19%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2018_To_9_30_2018_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_abt_CardiovascularAndNeuromodulationProductsMember_JvEaRnkAC0WA20wSIW-m6Q" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_gx63WMwEtUmpa_Z1zU30Yw_8_6">2,303</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.11%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_abt_CardiovascularAndNeuromodulationProductsMember_DqQTOcfsnkKBI-L6UijMkA" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_A8Ops0M2vUmgIoSKoVxu4A_8_9">7,202</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.11%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2018_To_9_30_2018_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_abt_CardiovascularAndNeuromodulationProductsMember_9rCo2bjOCUC_2432Z5UMFw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_2dBLxkYBQEeFSTX9lTWSqg_8_12">7,047</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.19%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2019_To_9_30_2019_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_abt_CardiovascularAndNeuromodulationProductsMember_rH7Zs0lLdUCD9w4VvAC-lw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="Tc_Opwlkb3gdUSHgXxOk_Laew_8_15">741</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.19%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2018_To_9_30_2018_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_abt_CardiovascularAndNeuromodulationProductsMember_JvEaRnkAC0WA20wSIW-m6Q" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="Tc_Z5gtNTjUR0agM-MK3U7P7Q_8_18">730</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_abt_CardiovascularAndNeuromodulationProductsMember_DqQTOcfsnkKBI-L6UijMkA" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="Tc_YeaJHb1OtUmN71Ymw06RpQ_8_21">2,179</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2018_To_9_30_2018_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_abt_CardiovascularAndNeuromodulationProductsMember_9rCo2bjOCUC_2432Z5UMFw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="Tc_hj6QRl55zkqQHjsI3CcheA_8_24">2,215</ix:nonfraction></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:35.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">Total Reportable Segments</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2019_To_9_30_2019_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_jRxvW21N206hpcGBDrYIEw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_dGomaLAHWkSGodzZch65Hw_9_3">7,395</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2018_To_9_30_2018_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_RwywU8gxUEGoaKIjGkIOSA" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_j043Z24B2k-yUMjXLeGvTA_9_6">7,124</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:6.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_RpOultrMfkWf8eSh9ZHUJg" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_UxEoj6inVEKYjirFYB6khw_9_9">21,710</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:6.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2018_To_9_30_2018_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_IukYM-KoVUWSdFGyAxl5_A" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_-sbxRbLfhkOJ_HULrg_kZA_9_12">21,365</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2019_To_9_30_2019_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_jRxvW21N206hpcGBDrYIEw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="Tc_fpgOrVPKF06gn1lZL-KWVg_9_15">1,892</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2018_To_9_30_2018_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_RwywU8gxUEGoaKIjGkIOSA" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="Tc_Ime8LOWMrE2gloIosoBYig_9_18">1,897</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_RpOultrMfkWf8eSh9ZHUJg" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="Tc_7Wjbd0RPC0G9ZPSFNiwSCA_9_21">5,430</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2018_To_9_30_2018_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_IukYM-KoVUWSdFGyAxl5_A" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="Tc__PUekG0gekOHpaRZWxmMEQ_9_24">5,478</ix:nonfraction></p></td></tr><tr><td style="vertical-align:bottom;width:35.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">Other </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.19%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2019_To_9_30_2019_us-gaap_StatementBusinessSegmentsAxis_us-gaap_AllOtherSegmentsMember_6xuLziuqYUu7G9wnH5DWIQ" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_uO8n0GF820eDXbfroUHR2w_10_3">681</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.19%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2018_To_9_30_2018_us-gaap_StatementBusinessSegmentsAxis_us-gaap_AllOtherSegmentsMember_m4XzPpMweEeW0W5huKZbPA" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_jeKkNx62_EC8AkvkUeIuVw_10_6">532</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.11%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_us-gaap_StatementBusinessSegmentsAxis_us-gaap_AllOtherSegmentsMember_bEC5ujKIG064i9f7edUrGg" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_uXU_LR-I3k6Rf3FisEA5tQ_10_9">1,880</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.11%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2018_To_9_30_2018_us-gaap_StatementBusinessSegmentsAxis_us-gaap_AllOtherSegmentsMember_ZR9EI4Kh7UeN1hu1pcbUqQ" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_pCbPl9rj3E6mZKv6hWxgDA_10_12">1,448</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:35.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">Net sales</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.92%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.19%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2019_To_9_30_2019_5CXepWtEPEKQA-bPz0Tp7A" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_CD1BCr7lk0-tN32NSQUfZw_11_3">8,076</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.92%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.19%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2018_To_9_30_2018_lS4NEZw67ECck2zY72MWgg" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_XimcAWNN3Uy3PTLpgJoSGg_11_6">7,656</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.92%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:6.11%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_O4ushO81Z0mAnTH_cLUPFw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_QWKVrdYQlEmtnCgYJNCUow_11_9">23,590</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.92%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:6.11%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2018_To_9_30_2018_3n65uNcjAUKkwLDxHE9Yow" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="Tc_YqLkBm3zxUetJKWQ1xnsMA_11_12">22,813</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:35.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">Corporate functions and benefit plan costs</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri';font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"> (<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2019_To_9_30_2019_srt_ConsolidationItemsAxis_us-gaap_MaterialReconcilingItemsMember__wUjSJgFbEu6Pote3jc1PA" decimals="-6" format="ixt:numdotdecimal" name="abt:CorporateAndBenefitPlanCosts" scale="6" id="Tc_ZBExycuhpUW4IIh2Ed4gtQ_12_15">131</ix:nonfraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"> (<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2018_To_9_30_2018_srt_ConsolidationItemsAxis_us-gaap_MaterialReconcilingItemsMember_tjHvMEY3JkKkdQKEDCWrLg" decimals="-6" format="ixt:numdotdecimal" name="abt:CorporateAndBenefitPlanCosts" scale="6" id="Tc_r1kdkkmBE0eySLV-xNuPIw_12_18">143</ix:nonfraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"> (<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_srt_ConsolidationItemsAxis_us-gaap_MaterialReconcilingItemsMember_eeQRmzzg7UiQsV7K0trnSg" decimals="-6" format="ixt:numdotdecimal" name="abt:CorporateAndBenefitPlanCosts" scale="6" id="Tc_MA6GO6-SOkiluQ9wFN8SWA_12_21">332</ix:nonfraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"> (<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2018_To_9_30_2018_srt_ConsolidationItemsAxis_us-gaap_MaterialReconcilingItemsMember_sAEGWGP4ekuJbwi-Szm8Ww" decimals="-6" format="ixt:numdotdecimal" name="abt:CorporateAndBenefitPlanCosts" scale="6" id="Tc_ht7Zngm1hkq4AvLVOMIWiA_12_24">435</ix:nonfraction>)</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:35.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">Non-reportable segments</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:6.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:6.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri';font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2019_To_9_30_2019_srt_ConsolidationItemsAxis_us-gaap_MaterialReconcilingItemsMember__wUjSJgFbEu6Pote3jc1PA" decimals="-6" format="ixt:numdotdecimal" name="abt:NonReportableSegmentIncome" scale="6" id="Tc_rX14luAyCEyzDQq2xS1rPw_13_15">220</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2018_To_9_30_2018_srt_ConsolidationItemsAxis_us-gaap_MaterialReconcilingItemsMember_tjHvMEY3JkKkdQKEDCWrLg" decimals="-6" format="ixt:numdotdecimal" name="abt:NonReportableSegmentIncome" scale="6" id="Tc_MbhrhgJF-UCxgaI-adKn-g_13_18">148</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_srt_ConsolidationItemsAxis_us-gaap_MaterialReconcilingItemsMember_eeQRmzzg7UiQsV7K0trnSg" decimals="-6" format="ixt:numdotdecimal" name="abt:NonReportableSegmentIncome" scale="6" id="Tc_cegJEM_ucUq76ifXjNXEew_13_21">547</ix:nonfraction></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2018_To_9_30_2018_srt_ConsolidationItemsAxis_us-gaap_MaterialReconcilingItemsMember_sAEGWGP4ekuJbwi-Szm8Ww" decimals="-6" format="ixt:numdotdecimal" name="abt:NonReportableSegmentIncome" scale="6" id="Tc_4XRKPYyaVE6kBr0NhqH0Dw_13_24">365</ix:nonfraction></p></td></tr><tr><td style="vertical-align:bottom;width:35.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">Net interest expense </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri';font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"> (<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2019_To_9_30_2019_srt_ConsolidationItemsAxis_us-gaap_MaterialReconcilingItemsMember__wUjSJgFbEu6Pote3jc1PA" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:InterestIncomeExpenseNet" sign="-" scale="6" id="Tc_lLGMjQCe00SekX7n13VM6w_14_15">143</ix:nonfraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"> (<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2018_To_9_30_2018_srt_ConsolidationItemsAxis_us-gaap_MaterialReconcilingItemsMember_tjHvMEY3JkKkdQKEDCWrLg" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:InterestIncomeExpenseNet" sign="-" scale="6" id="Tc_ku-EKUG8skCQvGWX4AkUgw_14_18">181</ix:nonfraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"> (<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_srt_ConsolidationItemsAxis_us-gaap_MaterialReconcilingItemsMember_eeQRmzzg7UiQsV7K0trnSg" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:InterestIncomeExpenseNet" sign="-" scale="6" id="Tc_jJqKOvZuuUaJ2o8_GOBUHg_14_21">437</ix:nonfraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"> (<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2018_To_9_30_2018_srt_ConsolidationItemsAxis_us-gaap_MaterialReconcilingItemsMember_sAEGWGP4ekuJbwi-Szm8Ww" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:InterestIncomeExpenseNet" sign="-" scale="6" id="Tc_G72ngSJDC0yhhUc5dhjlbw_14_24">569</ix:nonfraction>)</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:35.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">Share-based compensation (a) </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:6.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:6.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri';font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"> (<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2019_To_9_30_2019_srt_ConsolidationItemsAxis_us-gaap_MaterialReconcilingItemsMember__wUjSJgFbEu6Pote3jc1PA" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="Tc_STUeabJmZk6GEEKTlTDVDA_15_15">94</ix:nonfraction>)</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"> (<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2018_To_9_30_2018_srt_ConsolidationItemsAxis_us-gaap_MaterialReconcilingItemsMember_tjHvMEY3JkKkdQKEDCWrLg" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="Tc_w4rCzf6jf0SRRtYQnb0eyQ_15_18">83</ix:nonfraction>)</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"> (<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_srt_ConsolidationItemsAxis_us-gaap_MaterialReconcilingItemsMember_eeQRmzzg7UiQsV7K0trnSg" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="Tc_HAGXRh81GUGHSeB4za-GVA_15_21">434</ix:nonfraction>)</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"> (<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2018_To_9_30_2018_srt_ConsolidationItemsAxis_us-gaap_MaterialReconcilingItemsMember_sAEGWGP4ekuJbwi-Szm8Ww" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="Tc_IT-kbh1d90KbZwUP8AL-vg_15_24">396</ix:nonfraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:35.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">Amortization of intangible assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri';font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"> (<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2019_To_9_30_2019_srt_ConsolidationItemsAxis_us-gaap_MaterialReconcilingItemsMember__wUjSJgFbEu6Pote3jc1PA" decimals="-6" format="ixt:numdotdecimal" name="abt:AmortizationOfIntangibleAssetsExcludingDiscontinuedOperations" scale="6" id="Tc_YbyyYQdDlUymPOg9obrH6A_16_15">484</ix:nonfraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"> (<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2018_To_9_30_2018_srt_ConsolidationItemsAxis_us-gaap_MaterialReconcilingItemsMember_tjHvMEY3JkKkdQKEDCWrLg" decimals="-6" format="ixt:numdotdecimal" name="abt:AmortizationOfIntangibleAssetsExcludingDiscontinuedOperations" scale="6" id="Tc_bOf63BIx9k-gftFkLvS08A_16_18">544</ix:nonfraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"> (<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_srt_ConsolidationItemsAxis_us-gaap_MaterialReconcilingItemsMember_eeQRmzzg7UiQsV7K0trnSg" decimals="-6" format="ixt:numdotdecimal" name="abt:AmortizationOfIntangibleAssetsExcludingDiscontinuedOperations" scale="6" id="Tc_lWsAbVa_2UKnqemuBiloeg_16_21">1,453</ix:nonfraction>)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"> (<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2018_To_9_30_2018_srt_ConsolidationItemsAxis_us-gaap_MaterialReconcilingItemsMember_sAEGWGP4ekuJbwi-Szm8Ww" decimals="-6" format="ixt:numdotdecimal" name="abt:AmortizationOfIntangibleAssetsExcludingDiscontinuedOperations" scale="6" id="Tc_tPKK41j2r0aR98z5gGTF8Q_16_24">1,690</ix:nonfraction>)</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:35.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">Other, net (b)</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:6.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:6.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.92%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri';font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.19%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"> (<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2019_To_9_30_2019_srt_ConsolidationItemsAxis_us-gaap_MaterialReconcilingItemsMember__wUjSJgFbEu6Pote3jc1PA" decimals="-6" format="ixt:numdotdecimal" name="abt:OtherCostAndExpenseOperatingAndNonoperating" scale="6" id="Tc_vftaHmoAnE6rWa7ACdbnzA_17_15">157</ix:nonfraction>)</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.92%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.19%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"> (<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2018_To_9_30_2018_srt_ConsolidationItemsAxis_us-gaap_MaterialReconcilingItemsMember_tjHvMEY3JkKkdQKEDCWrLg" decimals="-6" format="ixt:numdotdecimal" name="abt:OtherCostAndExpenseOperatingAndNonoperating" scale="6" id="Tc_2_R1FmpwmkeN2-e1ATrIvw_17_18">376</ix:nonfraction>)</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.92%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"> (<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_srt_ConsolidationItemsAxis_us-gaap_MaterialReconcilingItemsMember_eeQRmzzg7UiQsV7K0trnSg" decimals="-6" format="ixt:numdotdecimal" name="abt:OtherCostAndExpenseOperatingAndNonoperating" scale="6" id="Tc_SasHrvQXX0KHkMZ5mMSRSA_17_21">484</ix:nonfraction>)</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.92%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"> (<ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2018_To_9_30_2018_srt_ConsolidationItemsAxis_us-gaap_MaterialReconcilingItemsMember_sAEGWGP4ekuJbwi-Szm8Ww" decimals="-6" format="ixt:numdotdecimal" name="abt:OtherCostAndExpenseOperatingAndNonoperating" scale="6" id="Tc_30FPyeKmhkuy8VTczvJI0A_17_24">827</ix:nonfraction>)</p></td></tr><tr><td style="vertical-align:bottom;width:35.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">Earnings from continuing operations before taxes</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri';font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.19%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2019_To_9_30_2019_5CXepWtEPEKQA-bPz0Tp7A" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="Tc_KG78d8ibjkau9EahSh_0aQ_18_15">1,103</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.19%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_7_1_2018_To_9_30_2018_lS4NEZw67ECck2zY72MWgg" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="Tc_6fBBCho_4EqIXld5mX7wgA_18_18">718</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.87%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2019_To_9_30_2019_O4ushO81Z0mAnTH_cLUPFw" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="Tc_FbXPx7LLmEe1qTNTShFUEA_18_21">2,837</ix:nonfraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.87%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"> <ix:nonfraction unitref="Unit_Standard_USD_bs98OkMlRUmnlJ5h3csqRA" contextref="Duration_1_1_2018_To_9_30_2018_3n65uNcjAUKkwLDxHE9Yow" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="Tc_oY3SAjrdDkKBi5D2E03vsA_18_24">1,926</ix:nonfraction></p></td></tr></tbody></table><div style="font-family:'Times New Roman';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"></div></div><table style="border-collapse:collapse;font-family:'Times New Roman';font-size:12pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tbody><tr><td style="font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(a)</td><td style="padding:0pt;"><span style="color:#000000;font-family:'Times New Roman';font-size:10pt;font-style:normal;font-weight:normal;text-align:justify;">Approximately </span><span style="color:#000000;font-family:'Times New Roman';font-size:10pt;font-style:normal;font-weight:normal;text-align:justify;"><ix:nonfraction unitref="Unit_Standard_pure_0hvT7e8qLkipZ3XmLkD-nQ" contextref="Duration_1_1_2018_To_9_30_2018_3n65uNcjAUKkwLDxHE9Yow" decimals="2" format="ixt:numdotdecimal" name="abt:AnnualShareBasedAwardsRecognizedInFirstQuarterPercent" scale="-2" id="Narr_IDhXrmtI10Gu2vuPiUoAwQ"><ix:nonfraction unitref="Unit_Standard_pure_0hvT7e8qLkipZ3XmLkD-nQ" contextref="Duration_1_1_2019_To_9_30_2019_O4ushO81Z0mAnTH_cLUPFw" decimals="2" format="ixt:numdotdecimal" name="abt:AnnualShareBasedAwardsRecognizedInFirstQuarterPercent" scale="-2" id="Narr_A82hJiG4GEyQSUvlADb0Rw">50</ix:nonfraction></ix:nonfraction></span><span style="color:#000000;font-family:'Times New Roman';font-size:10pt;font-style:normal;font-weight:normal;text-align:justify;"> percent of the annual net cost of share-based awards will typically be recognized in the first quarter due to the timing of the granting of share-based awards.</span></td></tr></tbody></table><table style="border-collapse:collapse;font-family:'Times New Roman';font-size:12pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tbody><tr><td style="font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(b)</td><td style="padding:0pt;"><span style="color:#000000;font-family:'Times New Roman';font-size:10pt;font-style:normal;font-weight:normal;text-align:justify;">Other, net for the three and nine months ended September 30, 2019 and 2018 includes restructuring charges and integration costs associated with the acquisitions of St. Jude Medical and Alere. &nbsp;Other, net for the nine months ended September 30, 2019 includes charges associated with R&amp;D assets acquired and immediately expensed. Other, net for the nine months ended September 30, 2018 includes inventory step-up amortization.</span></td></tr></tbody></table></ix:nonnumeric></ix:continuation><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="display:none;font-size:12pt;line-height:0pt;margin:0pt;"><span style="font-family:'Times New Roman';font-size:0pt;visibility:hidden;">​</span></p><a id="_8aa1e1a5_7654_44d9_8f2c_9b437fc38941"></a></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">20</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><a href="#TOC"><span style="font-family:'Times New Roman';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="Item2ManagementsDiscussionandAnalysisofF"></a><p style="font-family:'Times New Roman';font-size:10pt;padding-left:18pt;text-indent:-18pt;margin:0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><span style="color:#000000;font-family:'Times New Roman';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Item&nbsp;2.</span></span>Management’s Discussion and Analysis of Financial Condition and Results of Operations</p><p style="font-family:'Times New Roman';font-size:12pt;padding-left:18pt;text-indent:-18pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">Financial Review&nbsp;- Results of Operations</p><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:10pt;text-align:justify;margin:0pt;">Abbott’s revenues are derived primarily from the sale of a broad line of health care products under short-term receivable arrangements. Patent protection and licenses, technological and performance features, and inclusion of Abbott’s products under a contract most impact which products are sold; price controls, competition and rebates most impact the net selling prices of products; and foreign currency translation impacts the measurement of net sales and costs. Abbott’s primary products are nutritional products, branded generic pharmaceuticals, diagnostic testing products and cardiovascular and neuromodulation products.</p><p style="font-family:'Times New Roman';font-size:12pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:10pt;text-align:justify;margin:0pt;">The following table details sales by reportable segment for the three&nbsp;months and nine months ended September&nbsp;30.&nbsp;Percent changes are versus the prior&nbsp;year and are based on unrounded numbers.</p><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;padding-left:0pt;padding-right:0pt;width:100%;"><tbody><tr style="height:1pt;"><td style="vertical-align:bottom;width:42.78%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.61%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.69%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.61%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.69%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.61%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.79%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.79%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.79%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="background-color:auto;vertical-align:bottom;width:42.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="11" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:54.05%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Net&nbsp;Sales&nbsp;to&nbsp;External&nbsp;Customers</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&nbsp;</b></p></td></tr><tr><td style="background-color:auto;vertical-align:bottom;width:42.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&nbsp;&nbsp;&nbsp;&nbsp;</b></p></td><td colspan="2" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:9.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Three&nbsp;Months</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&nbsp;&nbsp;&nbsp;&nbsp;</b></p></td><td colspan="2" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:9.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Three&nbsp;Months</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&nbsp;&nbsp;&nbsp;&nbsp;</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:8.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&nbsp;&nbsp;&nbsp;&nbsp;</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:8.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&nbsp;&nbsp;&nbsp;&nbsp;</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:8.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&nbsp;</b></p></td></tr><tr><td style="background-color:auto;vertical-align:bottom;width:42.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:9.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Ended</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:9.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Ended</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:8.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:8.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Impact&nbsp;of</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:8.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total&nbsp;Change</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&nbsp;</b></p></td></tr><tr><td style="background-color:auto;vertical-align:bottom;width:42.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:9.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">September&nbsp;30,&nbsp;</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:9.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">September&nbsp;30,&nbsp;</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:8.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:8.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Foreign</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:8.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Excl.&nbsp;Foreign</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&nbsp;</b></p></td></tr><tr><td style="background-color:auto;vertical-align:bottom;width:42.78%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">(in millions)</p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:9.75%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2019</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:9.75%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2018</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:8.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Change</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:8.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Exchange</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:8.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Exchange</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&nbsp;</b></p></td></tr><tr><td style="background-color:auto;vertical-align:bottom;width:42.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:8.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:8.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:8.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:8.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:8.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:42.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">Established Pharmaceutical Products</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 1,212</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 1,159</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 4.4</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">%&nbsp;&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> (3.5)</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">%&nbsp;&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 7.9</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:42.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">Nutritional Products</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 1,874</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 1,838</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 2.0</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> (1.3)</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 3.3</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:42.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">Diagnostic Products</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 1,909</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 1,824</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 4.7</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> (1.9)</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 6.6</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:42.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">Cardiovascular and Neuromodulation Products</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;width:8.69%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 2,400</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.69%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 2,303</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 4.2</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> (1.4)</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 5.6</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:42.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">Total Reportable Segments</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 7,395</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 7,124</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 3.8</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> (1.8)</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 5.6</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:42.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">Other</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.69%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 681</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.69%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 532</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 28.0</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> (3.5)</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 31.5</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:42.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">Net Sales</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.05%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.69%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 8,076</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.05%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.69%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 7,656</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 5.5</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> (1.9)</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 7.4</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:42.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:42.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">Total U.S.</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.05%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.69%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 2,834</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.05%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.69%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 2,707</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 4.7</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> —</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 4.7</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:42.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:42.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">Total International</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.05%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.69%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 5,242</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.05%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.69%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 4,949</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 5.9</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> (3.0)</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 8.9</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td></tr></tbody></table><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;padding-left:0pt;padding-right:0pt;width:100%;"><tbody><tr style="height:1pt;"><td style="vertical-align:bottom;width:42.83%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.76%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.77%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.84%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.84%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.84%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:42.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;&nbsp;&nbsp;&nbsp;</p></td><td colspan="11" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:53.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Net Sales to External Customers</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td></tr><tr><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:42.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:9.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Nine&nbsp;Months</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:9.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Nine&nbsp;Months</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:8.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:8.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:8.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td></tr><tr><td style="background-color:auto;vertical-align:bottom;width:42.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td colspan="2" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:9.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Ended&nbsp;</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td colspan="2" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:9.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Ended</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:8.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:8.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Impact&nbsp;of</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:8.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total&nbsp;Change</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td></tr><tr><td style="background-color:auto;vertical-align:bottom;width:42.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td colspan="2" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:9.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">September&nbsp;30,&nbsp;</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td colspan="2" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:9.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">September&nbsp;30,&nbsp;</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:8.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:8.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Foreign</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:8.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Excl.&nbsp;Foreign</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td></tr><tr><td style="background-color:auto;vertical-align:bottom;width:42.83%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">(in millions)</p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;&nbsp;&nbsp;&nbsp;</p></td><td colspan="2" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:9.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2019</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;&nbsp;&nbsp;&nbsp;</p></td><td colspan="2" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:9.83%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2018</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;&nbsp;&nbsp;&nbsp;</p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:8.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Change</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;&nbsp;&nbsp;&nbsp;</p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:8.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Exchange</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;&nbsp;&nbsp;&nbsp;</p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:8.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Exchange</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td></tr><tr><td style="background-color:auto;vertical-align:bottom;width:42.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:8.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:8.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:8.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:8.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:8.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;font-style:italic;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:42.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">Established Pharmaceutical Products</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 3,312</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 3,332</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> (0.6)</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">%&nbsp;&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> (7.1)</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">%&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 6.5</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:42.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">Nutritional Products </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 5,541</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 5,452</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 1.6</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> (2.8)</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 4.4</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:42.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">Diagnostic Products</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 5,655</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 5,534</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 2.2</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> (3.5)</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 5.7</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:42.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">Cardiovascular and Neuromodulation Products</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.76%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 7,202</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 7,047</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 2.2</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> (2.8)</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 5.0</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:42.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">Total Reportable Segments</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 21,710</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 21,365</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 1.6</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> (3.7)</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 5.3</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:42.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">Other</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.76%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 1,880</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 1,448</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 29.9</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> (5.7)</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 35.6</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:42.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">Net Sales</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.05%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.76%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 23,590</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.05%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.77%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 22,813</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 3.4</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> (3.8)</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 7.2</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:42.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:42.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">Total U.S. </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.05%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.76%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 8,438</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.05%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.77%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 8,084</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 4.4</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> —</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 4.4</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:42.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:42.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">Total International</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.05%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.76%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 15,152</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.05%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.77%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 14,729</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 2.9</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> (5.8)</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 8.7</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td></tr></tbody></table><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:10pt;text-align:justify;margin:0pt;">Note: In order to compute results excluding the impact of exchange rates, current&nbsp;year U.S. dollar sales are multiplied or divided, as appropriate, by the current&nbsp;year average foreign exchange rates and then those amounts are multiplied or divided, as appropriate, by the prior&nbsp;year average foreign exchange rates.</p><p style="font-family:'Times New Roman';font-size:12pt;text-align:justify;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:10pt;text-align:justify;margin:0pt;">Net sales growth in 2019, excluding the impact of foreign exchange, was driven by growth in all of Abbott’s reportable segments. The increase in the Other category reflects growth in Abbott’s Diabetes Care business where sales in the first nine &nbsp;months of 2019 increased 30.6&nbsp;percent in total and 36.5&nbsp;percent, excluding the effects of foreign exchange, to $1.833 billion. The Diabetes Care sales growth was led by FreeStyle Libre<sup style="font-size:7.5pt;vertical-align:top;">®</sup>, Abbott’s continuous glucose monitoring system with worldwide sales of $1.308 billion, which reflected an increase versus the prior year of 65.4 percent in total and 72.9 percent, excluding the effects of foreign exchange.</p><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">21</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><a href="#TOC"><span style="font-family:'Times New Roman';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;"><span style="white-space:pre-wrap;">Excluding the impact of foreign exchange, total net sales increased 7.4 percent in the third quarter of 2019 and 7.2 percent in the first nine months of 2019.  Abbott’s net sales were unfavorably impacted by changes in foreign exchange rates during the period compared to 2018.  The relatively stronger U.S. dollar decreased total international sales by 3.0 percent and total sales by 1.9 percent in the third quarter of 2019.  The relatively stronger U.S. dollar decreased total international sales by 5.8 percent and total sales by 3.8 percent in the first nine months of 2019.</span></p><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;"><span style="white-space:pre-wrap;">The table below provides detail by sales category for the nine months ended September 30.  Percent changes are versus the prior year and are based on unrounded numbers.</span></p><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tbody><tr style="height:1pt;"><td style="vertical-align:bottom;width:50.57%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.12%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.12%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:4.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.17%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.6%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="background-color:auto;vertical-align:bottom;width:50.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&nbsp;&nbsp;&nbsp;&nbsp;</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:8.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&nbsp;&nbsp;&nbsp;&nbsp;</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:8.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&nbsp;&nbsp;&nbsp;&nbsp;</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:4.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&nbsp;&nbsp;&nbsp;&nbsp;</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:6.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Impact&nbsp;of</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&nbsp;&nbsp;&nbsp;&nbsp;</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:8.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total&nbsp;Change</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&nbsp;</b></p></td></tr><tr><td style="background-color:auto;vertical-align:bottom;width:50.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:9.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">September&nbsp;30,&nbsp;</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:9.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">September&nbsp;30,&nbsp;</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:4.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:6.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Foreign</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:8.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Excl.&nbsp;Foreign</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&nbsp;</b></p></td></tr><tr><td style="background-color:auto;vertical-align:bottom;width:50.57%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;">(in millions)</p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:9.42%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2019</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:9.42%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2018</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:4.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Change</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:6.17%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Exchange</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:8.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Exchange</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&nbsp;</b></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:50.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">Established Pharmaceutical Products —</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;">&nbsp;&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;">&nbsp;&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:4.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;">&nbsp;&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:6.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;">&nbsp;&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;">&nbsp;&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:50.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 12pt;">Key Emerging Markets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 2,496</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 2,525</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;">(1.2)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">%&nbsp;&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> (8.6)</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">%&nbsp;&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 7.4</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">%</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:50.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 12pt;">Other Emerging Markets</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 816</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 807</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:4.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 1.0</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:6.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> (2.7)</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 3.7</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:50.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:50.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">Nutritionals —</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;">&nbsp;&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;">&nbsp;&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:4.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;">&nbsp;&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:6.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;">&nbsp;&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;">&nbsp;&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:50.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 12pt;">International Pediatric Nutritionals</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 1,718</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 1,708</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 0.6</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> (4.2)</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 4.8</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:50.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 12pt;">U.S. Pediatric Nutritionals</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 1,406</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 1,376</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:4.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 2.2</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:6.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> —</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 2.2</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:50.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 12pt;">International Adult Nutritionals</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 1,502</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 1,431</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 4.9</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> (5.7)</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 10.6</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:50.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 12pt;">U.S. Adult Nutritionals</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 915</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 937</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:4.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> (2.4)</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:6.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> —</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> (2.4)</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:50.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:50.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">Diagnostics —</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;">&nbsp;&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;">&nbsp;&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:4.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;">&nbsp;&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:6.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;">&nbsp;&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;">&nbsp;&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:50.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 12pt;">Core Laboratory</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 3,407</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 3,233</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 5.4</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> (4.6)</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 10.0</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:50.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 12pt;">Molecular</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 326</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 361</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:4.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> (9.5)</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:6.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> (2.5)</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> (7.0)</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:50.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 12pt;">Point of Care</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 424</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 416</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 2.1</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> (0.5)</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 2.6</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:50.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 12pt;">Rapid Diagnostics</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 1,498</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 1,524</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:4.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> (1.7)</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:6.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> (2.3)</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 0.6</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:50.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:50.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">Cardiovascular and Neuromodulation —</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;">&nbsp;&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;">&nbsp;&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:4.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;">&nbsp;&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:6.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;">&nbsp;&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;">&nbsp;&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:50.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 12pt;">Rhythm Management</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 1,600</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 1,667</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> (4.0)</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> (2.8)</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> (1.2)</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:50.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 12pt;">Electrophysiology</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 1,262</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 1,144</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:4.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 10.3</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:6.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> (2.8)</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 13.1</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:50.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 12pt;">Heart Failure</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 571</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 468</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 22.0</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> (1.5)</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 23.5</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:50.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 12pt;">Vascular (a)</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 2,136</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 2,209</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:4.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> (3.3)</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:6.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> (3.0)</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> (0.3)</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:50.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 12pt;">Structural Heart</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 1,024</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 913</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 12.1</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> (3.8)</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 15.9</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:50.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 12pt;">Neuromodulation</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 609</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 646</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:4.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> (5.7)</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:6.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> (1.4)</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> (4.3)</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:50.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 12pt;"><span style="font-size:10pt;margin-left:0pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:50.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 12pt;">(a) Vascular Product Lines: </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:4.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:6.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:50.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 24pt;">Coronary and Endovascular </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 2,049</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 2,085</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> (1.7)</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> (3.1)</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 1.4</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td></tr></tbody></table><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:10pt;text-align:justify;margin:0pt;">Note: Insertable Cardiac Monitor (ICM) sales, which had previously been reported in Electrophysiology, are now included in Rhythm Management. Historic periods have been adjusted to reflect this change.</p><p style="font-family:'Times New Roman';font-size:12pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:10pt;text-align:justify;margin:0pt;">Key Emerging Markets for the Established Pharmaceutical Products business include India, Russia, Brazil and China, along with several other markets that represent the most attractive long-term growth opportunities for Abbott’s branded generics product portfolio. Excluding the unfavorable effect of foreign exchange, sales in the Key Emerging Markets increased 7.4&nbsp;percent compared to the first nine months of 2018 due to growth across several geographies including India, Russia, China and Brazil. Excluding the unfavorable effect of foreign exchange, sales in Other Emerging Markets increased 3.7 percent compared to the first nine months of 2018. Sales growth in Other Emerging Markets was negatively impacted in the first nine months of 2019 by the discontinuation of a non-core, low-margin agreement under which Abbott supplied product to a third party.</p><p style="font-family:'Times New Roman';font-size:12pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:10pt;text-align:justify;margin:0pt;">The 4.8&nbsp;percent increase in International Pediatric Nutritional sales, excluding the effect of foreign exchange, was driven by growth in various countries in Asia and Latin America across Abbott’s portfolio, including PediaSure<sup style="font-size:7.5pt;vertical-align:top;">®</sup> and Pedialyte<sup style="font-size:7.5pt;vertical-align:top;">®</sup>. This growth was partially offset by challenging market dynamics in the Greater China infant category. In the U.S., the 2.2&nbsp;percent increase in Pediatric Nutritional sales reflects growth in Pedialyte and PediaSure. The 10.6&nbsp;percent increase in International Adult Nutritional sales, excluding the effect of foreign exchange, reflects continued growth of the Ensure<sup style="font-size:7.5pt;vertical-align:top;">®</sup> and Glucerna<sup style="font-size:7.5pt;vertical-align:top;">®</sup> brands in several countries. In the U.S. Adult Nutritional business, the decline reflects Abbott’s discontinuation of a non-core product line during the third quarter of 2018.</p><p style="font-family:'Times New Roman';font-size:12pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:10pt;text-align:justify;margin:0pt;">The 5.7 percent increase in Diagnostic Products sales, excluding the effect of foreign exchange, was driven by above-market growth in Core Laboratory in the U.S., and internationally where Abbott is achieving continued adoption of its Alinity<sup style="font-size:7.5pt;vertical-align:top;">®</sup> family of diagnostic instruments. &nbsp;In July 2019, Abbott received U.S. Food and Drug Administration (FDA) approval for its Alinity blood and plasma screening system. &nbsp;The 7.0 percent decrease in Molecular sales, excluding the effect of foreign exchange, reflects the negative impact of lower non-governmental organization purchases in Africa. &nbsp;In March 2019, Abbott announced that it obtained CE Mark for its Alinity molecular diagnostics system and several testing assays. &nbsp;In Rapid Diagnostics, sales growth in several areas, including cardio-metabolic testing, was mostly offset by lower than expected infectious disease testing sales in Africa.</p><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">22</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><a href="#TOC"><span style="font-family:'Times New Roman';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:justify;margin:0pt;">Excluding the effect of foreign exchange, total Cardiovascular and Neuromodulation Products sales grew 5.0&nbsp;percent; the increase was driven by double-digit growth in Electrophysiology, Heart Failure and Structural Heart. The growth in Electrophysiology reflects higher sales of cardiac diagnostic and ablation catheters in both the U.S. and internationally. In January&nbsp;2019, Abbott announced U.S. FDA approval of its TactiCath<sup style="font-size:7.5pt;vertical-align:top;">®</sup> contact force ablation catheter, Sensor Enabled™, which is designed to help physicians treat atrial fibrillation, a form of irregular heartbeat.</p><p style="font-family:'Times New Roman';font-size:12pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:10pt;text-align:justify;margin:0pt;">In Heart Failure, growth was driven by rapid market adoption in the U.S.of Abbott’s HeartMate 3<sup style="font-size:7.5pt;vertical-align:top;">®</sup> Left Ventricular Assist Device following FDA approval in October&nbsp;2018 as a destination (long-term use) therapy for people living with advanced heart failure. In March&nbsp;2019, Abbott announced new data from its MOMENTUM 3 clinical study, the largest randomized controlled trial to assess outcomes in patients receiving a heart pump to treat advanced heart failure, which demonstrated HeartMate 3 improved survival and clinical outcomes in this patient population.</p><p style="font-family:'Times New Roman';font-size:12pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:10pt;text-align:justify;margin:0pt;">Growth in Structural Heart was broad-based across several areas of the business, including MitraClip<sup style="font-size:7.5pt;vertical-align:top;">®</sup>, Abbott's market-leading device for the minimally invasive treatment of mitral regurgitation (MR), a leaky heart valve. During the first quarter of 2019, Abbott received U.S. FDA approval for a new, expanded indication for MitraClip to treat clinically significant secondary MR as a result of underlying heart failure. This new indication expands the number of people with MR that can be treated with the MitraClip device. &nbsp;In July 2019, Abbott received U.S. FDA approval of the next generation of its MitraClip device, which includes a new leaflet grasping enhancement, an expanded range of clip sizes and facilitation of procedure assessment in real time to offer doctors further options when treating mitral valve disease.</p><p style="font-family:'Times New Roman';font-size:12pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:10pt;text-align:justify;margin:0pt;">In Vascular, excluding the effect of foreign exchange, revenues were basically flat as the 1.4&nbsp;percent increase in coronary and endovascular product sales, which includes drug-eluting stents, balloon catheters, guidewires, vascular imaging/diagnostics products, vessel closure, carotid and other coronary and peripheral products, was offset primarily by a reduction in royalty revenue. In Rhythm Management, the 1.2&nbsp;percent decline in revenues, excluding the effect of foreign exchange, reflects a 6.3&nbsp;percent decrease in U.S. sales partially offset by a 4.0&nbsp;percent increase in international sales. The 4.3&nbsp;percent decline in Neuromodulation sales, excluding the effect of foreign exchange, reflects a 5.4 percent decline in U.S. sales.</p><p style="font-family:'Times New Roman';font-size:12pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:10pt;text-align:justify;margin:0pt;">The gross profit margin percentage was 52.4 percent for the third quarter of 2019 compared to 51.5 percent for the third quarter of 2018. &nbsp;The gross profit margin percentage was 52.3 percent for the first nine months of 2019 compared to 50.9 percent for the first nine months of 2018. &nbsp;The increase in the first nine months of 2019 primarily reflects the favorable comparison versus the prior year from lower intangible amortization expense, and integration and restructuring costs in 2019.</p><p style="font-family:'Times New Roman';font-size:12pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:10pt;text-align:justify;margin:0pt;">Research and development expenses increased by $22 million, or 3.7 percent, in the third quarter of 2019 and increased by $107 million, or 6.1 percent, in the first nine months of 2019 compared to the prior year. The increase in the third quarter of 2019 reflects higher R&amp;D spending in various businesses and the acquisition of an R&amp;D asset. &nbsp;The increase in R&amp;D spending in the first nine months of 2019 primarily reflects higher spending on the acquisition of R&amp;D assets. &nbsp;In the first quarter of 2019, in conjunction with the acquisition of Cephea Valve Technologies, Inc., Abbott acquired an R&amp;D asset valued at $102 million, which was immediately expensed. &nbsp;During the first nine months of 2018, Abbott acquired R&amp;D assets valued at $43 million, which were immediately expensed. The increase in R&amp;D expense during the first nine months of 2019 was also driven by higher R&amp;D spending in various businesses, including Cardiovascular and Neuromodulation, partially offset by the favorable effect of foreign exchange. &nbsp;For the nine months ended September 30, 2019, research and development expenditures totaled $811 million for the Cardiovascular and Neuromodulation Products segment, $419 million for the Diagnostic Products segment, $142 million for the Nutritional Products segment and $137 million for the Established Pharmaceutical Products segment.</p><p style="font-family:'Times New Roman';font-size:12pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:10pt;text-align:justify;margin:0pt;">Selling, general and administrative (SG&amp;A) expenses increased 2.7 percent in the third quarter and decreased 0.4 percent in first nine months of 2019. &nbsp;The increase in the quarter is primarily due to higher selling and marketing costs to drive continued growth across various businesses, partially offset by the favorable effect of foreign exchange and lower acquisition-related integration costs. &nbsp;The decrease in the first nine months of 2019 is due primarily to the favorable effect of foreign exchange and lower acquisition-related integration costs, partially offset by higher selling and marketing costs to drive continued growth across various businesses.</p><p style="font-family:'Times New Roman';font-size:12pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:10pt;text-align:justify;margin:0pt;"><span style="text-decoration:underline;text-decoration-color:#000000;">Restructuring Plans</span></p><p style="font-family:'Times New Roman';font-size:12pt;text-align:justify;margin:0pt;"><span style="font-size:10pt;text-decoration:underline;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:10pt;text-align:justify;margin:0pt;">The results for the first nine months of 2019 reflect charges under approved restructuring plans as part of the integration of the acquisitions of St. Jude Medical and Alere or as part of various cost reduction programs. &nbsp;Abbott recorded employee related severance and other charges of $101 million in the first nine months of 2019 related to these initiatives, of which $28 million is recognized in Cost of products sold, $12 million is recognized in Research and development and $61 million is recognized in SG&amp;A expense. &nbsp;See Note 7 to the financial statements, “Restructuring Plans,” for additional information regarding these charges.</p><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">23</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><a href="#TOC"><span style="font-family:'Times New Roman';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:justify;margin:0pt;"><span style="text-decoration:underline;text-decoration-color:#000000;">Other (Income) Expense, net</span></p><p style="font-family:'Times New Roman';font-size:12pt;text-align:justify;margin:0pt;"><span style="font-size:10pt;text-decoration:underline;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:10pt;text-align:justify;margin:0pt;">Other (income) expense, net totaled $55 million of income in the third quarter of 2019 compared to $18 million of expense in 2018 and $140 million of income in the first nine months of 2019 compared to $93 million of income in 2018. The change in Other (income) expense, net in the third quarter of 2019 as compared to 2018 was primarily due to the recording of an impairment of an investment in 2018. The increase in Other (income) expense, net in the first nine months of 2019 compared to 2018 was due to higher 2019 income related to the non-service cost component of the net periodic benefit associated with Abbott’s pension and post-retirement benefit plans and the 2018 investment impairment, partially offset by an unrealized gain on an investment in 2018 that resulted from an observable price change for a similar investment of the same issuer.</p><p style="font-family:'Times New Roman';font-size:12pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:10pt;text-align:justify;margin:0pt;"><span style="text-decoration:underline;text-decoration-color:#000000;">Interest Expense, net</span></p><p style="font-family:'Times New Roman';font-size:12pt;text-align:justify;margin:0pt;"><span style="font-size:10pt;text-decoration:underline;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:10pt;text-align:justify;margin:0pt;">Interest expense, net decreased $38 million in the third quarter of 2019 and $132 million in the first nine months of 2019 due to a reduction in interest expense resulting from the favorable impact of the euro debt refinancing in September 2018, as well as the repayment of debt in 2018 and the first quarter of 2019.</p><p style="font-family:'Times New Roman';font-size:12pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:10pt;text-align:justify;margin:0pt;"><span style="text-decoration:underline;text-decoration-color:#000000;">Taxes on Earnings from Continuing Operations</span></p><p style="font-family:'Times New Roman';font-size:12pt;text-align:justify;margin:0pt;"><span style="font-size:10pt;text-decoration:underline;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:10pt;text-align:justify;margin:0pt;">Taxes on earnings from continuing operations reflect the estimated annual effective rates and include charges for interest and penalties. In the first nine months of 2019, taxes on earnings from continuing operations include a $78 million reduction to the transition tax related to the Tax Cut and Jobs Act (TCJA) and approximately $95 million in excess tax benefits associated with share-based compensation. The $78 million reduction to the transition tax liability was the result of the issuance of final transition tax regulations by the U.S. Department of Treasury in the first quarter. This adjustment decreased the cumulative net tax expense related to the TCJA to $1.51 billion. In the first nine months of 2018, taxes on earnings from continuing operations include approximately $80 million in excess tax benefits associated with share-based compensation and a $53 million adjustment to the transition tax liability for associated effects related to state tax. Earnings from discontinued operations, net of tax, in the first nine months of 2018 reflect the recognition of $40 million of net tax benefits primarily as a result of the resolution of various tax positions related to prior&nbsp;years which decreased the gross amount of unrecognized tax benefits by $47 million.</p><p style="font-family:'Times New Roman';font-size:12pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:10pt;text-align:justify;margin:0pt;">Tax authorities in various jurisdictions regularly review Abbott’s income tax filings. Abbott believes that it is reasonably possible that the recorded amount of gross unrecognized tax benefits may decrease between $185 million and $430 million, including cash adjustments, within the next twelve&nbsp;months as a result of concluding various domestic and international tax matters. In the U.S., Abbott’s federal income tax returns through 2016 are settled except for the federal income tax returns of the former Alere consolidated group which are settled through 2014 and the former St.&nbsp;Jude Medical consolidated group which are settled through 2013.</p><p style="font-family:'Times New Roman';font-size:12pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:10pt;text-align:justify;margin:0pt;"><span style="text-decoration:underline;text-decoration-color:#000000;">Liquidity and Capital Resources September 30, 2019 Compared with December&nbsp;31, 2018</span></p><p style="font-family:'Times New Roman';font-size:12pt;text-align:justify;margin:0pt;"><span style="font-size:10pt;text-decoration:underline;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:10pt;text-align:justify;margin:0pt;">The $247 million increase in cash and cash equivalents from $3.8 billion at December 31, 2018 to $4.1 billion at September 30, 2019 primarily reflects the favorable impact of cash generated by operating activities, partially offset by the payment of dividends, capital expenditures and the repayment of approximately $500 million of debt in the first nine months of 2019. &nbsp;Working capital was $5.6 billion at September 30, 2019 and December 31, 2018. &nbsp;In 2019, increases in inventory, accounts receivable and cash and cash equivalents were offset by an increase in the current portion of long-term debt related to debt that will mature in September 2020.</p><p style="font-family:'Times New Roman';font-size:12pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:10pt;text-align:justify;margin:0pt;">In the Condensed Consolidated Statement of Cash Flows, Net cash from operating activities for the first nine months of 2019 totaled $3.7 billion, a decrease of $815 million over the prior year due primarily to an increased investment in working capital, higher cash taxes paid and the timing of pension contributions in 2019 relative to 2017 and 2018, partially offset by higher operating earnings. &nbsp;Other, net in Net cash from operating activities for the first nine months of 2019 was a use of $523 million and includes the impact of the payment of cash taxes of approximately $775 million and $337 million of pension contributions, partially offset by payment timing for various accrued expenses. &nbsp;Other, net in Net cash from operating activities for the first nine months of 2018 of $608 million includes the favorable impact of improvements in working capital management, as well as the effect of non-cash charges related to the impairment of certain assets and the accrual of certain debt extinguishment costs. &nbsp;Other, net in Net cash from operating activities for the first nine months of 2018 also includes $71 million of pension contributions as a pension contribution of $270 million was made in December 2017. &nbsp;Abbott expects to fund cash dividends, capital expenditures and its other investments in its businesses with cash flow from operating activities, cash on hand, short-term investments and borrowings.</p><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">24</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><a href="#TOC"><span style="font-family:'Times New Roman';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:justify;margin:0pt;">In September 2019, the board of directors authorized the early redemption of up to $5 billion of outstanding long-term notes. &nbsp;This bond redemption authorization supersedes the board’s previous authorization under which $700 million had not yet been redeemed.</p><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:10pt;text-align:justify;margin:0pt;">At September 30, 2019, Abbott’s long-term debt rating was BBB+ by Standard &amp; Poor’s Corporation and A3 by Moody’s Investors Service. &nbsp;Abbott expects to maintain an investment grade rating. &nbsp;Abbott has readily available financial resources, including lines of credit of $5.0 billion which expire in 2023.</p><p style="font-family:'Times New Roman';font-size:12pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:10pt;text-align:justify;margin:0pt;">In October 2019, the board of directors authorized the repurchase of up to $3 billion of Abbott’s common shares from time to time. The new authorization is in addition to the $795 million unused portion of the previous share repurchase program that was authorized in September 2014.</p><p style="font-family:'Times New Roman';font-size:12pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:10pt;text-align:justify;margin:0pt;">On April&nbsp;27, 2016, the board of directors authorized the issuance and sale of up to $3 billion of common shares for general corporate purposes. No shares have been issued under this authorization.</p><p style="font-family:'Times New Roman';font-size:12pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:10pt;text-align:justify;margin:0pt;">In each of the first three quarters of 2019, Abbott declared a quarterly dividend of $0.32 per share on its common shares, which represents an increase of approximately 14&nbsp;percent over the $0.28 per share quarterly dividend declared in each of the first three quarters of 2018.</p><p style="font-family:'Times New Roman';font-size:12pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:10pt;text-align:justify;margin:0pt;"><span style="text-decoration:underline;text-decoration-color:#000000;">Recently Issued Accounting Standards Not Yet Adopted</span></p><p style="font-family:'Times New Roman';font-size:12pt;text-align:justify;margin:0pt;"><span style="font-size:10pt;text-decoration:underline;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:10pt;text-align:justify;margin:0pt;">In June&nbsp;2016, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) 2016-13, <i style="font-style:italic;">Financial Instruments&nbsp;– Credit Losses </i>which changes the methodology to be used to measure credit losses for certain financial instruments and financial assets, including trade receivables. The new methodology requires the recognition of an allowance that reflects the current estimate of credit losses expected to be incurred over the life of the financial asset. The new standard will be effective for Abbott at the beginning of 2020, with early adoption permitted. Abbott is currently assessing the impact of this new standard on its consolidated financial statements.</p><p style="font-family:'Times New Roman';font-size:12pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:10pt;text-align:justify;margin:0pt;"><span style="text-decoration:underline;text-decoration-color:#000000;">Lease Accounting Standard</span></p><p style="font-family:'Times New Roman';font-size:12pt;text-align:justify;margin:0pt;"><span style="font-size:10pt;text-decoration:underline;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:10pt;text-align:justify;margin:0pt;">In February&nbsp;2016, the FASB issued ASU 2016-02, <i style="font-style:italic;">Leases</i>, which requires lessees to measure and recognize a lease asset and liability on the balance sheet for most leases, including operating leases. Abbott adopted the new standard as of January&nbsp;1, 2019 using the modified retrospective approach and applied the standard’s transition provisions as of January&nbsp;1, 2019. As a result, no changes were made to the December&nbsp;31, 2018 Consolidated Balance Sheet. Abbott elected to apply the package of practical expedients related to transition. These practical expedients allowed Abbott to carry forward its historical assessments of whether any existing contracts are or contain leases, the lease classification for each lease existing at January&nbsp;1, 2019, and whether any initial direct costs for such leases qualified for capitalization.</p><p style="font-family:'Times New Roman';font-size:12pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:10pt;text-align:justify;margin:0pt;">The new lease accounting standard does not have a material impact on the amounts reported in the Condensed Consolidated Statement of Earnings but does have a material impact on the amounts reported in the Condensed Consolidated Balance Sheet. Adoption of the new standard resulted in the recording of approximately $850 million of new right of use (ROU) assets and additional liabilities for operating leases on the Condensed Consolidated Balance Sheet as of January&nbsp;1, 2019.</p><p style="font-family:'Times New Roman';font-size:12pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:10pt;text-align:justify;margin:0pt;"><span style="text-decoration:underline;text-decoration-color:#000000;">Legislative Issues</span></p><p style="font-family:'Times New Roman';font-size:12pt;text-align:justify;margin:0pt;"><span style="font-size:10pt;text-decoration:underline;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:10pt;text-align:justify;margin:0pt;">Abbott’s primary markets are highly competitive and subject to substantial government regulations throughout the world. Abbott expects debate to continue over the availability, method of delivery, and payment for health care products and services. It is not possible to predict the extent to which Abbott or the health care industry in general might be adversely affected by these factors in the future. A more complete discussion of these factors is contained in Item&nbsp;1, Business, and Item&nbsp;1A, Risk Factors, in the 2018 Annual Report on Form&nbsp;10-K.</p><p style="font-family:'Times New Roman';font-size:12pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:10pt;text-align:justify;margin:0pt;"><span style="text-decoration:underline;text-decoration-color:#000000;">Private Securities Litigation Reform Act of 1995&nbsp;— A Caution Concerning Forward-Looking Statements</span></p><p style="font-family:'Times New Roman';font-size:12pt;text-align:justify;margin:0pt;"><span style="font-size:10pt;text-decoration:underline;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:10pt;text-align:justify;margin:0pt;">Under the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, Abbott cautions investors that any forward-looking statements or projections made by Abbott, including those made in this document, are subject to risks and uncertainties that may cause actual results to differ materially from those projected. Economic, competitive, governmental, technological and other factors that may affect Abbott’s operations are discussed in Item&nbsp;1A, Risk Factors, in the 2018 Annual Report on Form&nbsp;10-K.</p><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><a id="_88eba1b2_4f9f_476c_bd38_43e50dc7cd9c"></a></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">25</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><a href="#TOC"><span style="font-family:'Times New Roman';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="PARTIFINANCIALINFORMATION_894041"></a><p style="font-family:'Times New Roman';font-size:10pt;padding-left:18pt;text-indent:-18pt;margin:0pt;">PART&nbsp;I.&nbsp;FINANCIAL INFORMATION</p><p style="font-family:'Times New Roman';font-size:12pt;padding-left:18pt;text-indent:-18pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p><a id="Item4ControlsandProcedures_983028"></a><p style="font-family:'Times New Roman';font-size:10pt;padding-left:18pt;text-indent:-18pt;margin:0pt;"><span style="text-decoration:underline;text-decoration-color:#000000;">Item&nbsp;4.</span>&nbsp;&nbsp;&nbsp;<span style="text-decoration:underline;text-decoration-color:#000000;">Controls and Procedures</span></p><p style="font-family:'Times New Roman';font-size:12pt;padding-left:18pt;text-indent:-18pt;margin:0pt;"><span style="font-size:10pt;text-decoration:underline;visibility:hidden;">​</span></p><div style="font-family:'Times New Roman';font-size:12pt;line-height:1.37;margin-bottom:0pt;margin-left:36pt;margin-top:0pt;padding-left:18pt;text-align:justify;text-indent:-18pt;"><span style="display:inline-block;min-width:18pt;text-indent:0pt;white-space:nowrap;">(a)</span><i style="font-size:10pt;font-style:italic;">Evaluation of disclosure controls and procedures. </i><span style="font-size:10pt;">The Chief Executive Officer, Miles D. White, and Chief Financial Officer, Brian B. Yoor, evaluated the effectiveness of Abbott Laboratories’ disclosure controls and procedures as of the end of the period covered by this report, and concluded that Abbott Laboratories’ disclosure controls and procedures were effective to ensure that information Abbott is required to disclose in the reports that it files or submits with the Securities and Exchange Commission (the “Commission”) under the Securities Exchange Act of 1934 (the “Exchange Act”) is recorded, processed, summarized and reported, within the time periods specified in the Commission’s rules&nbsp;and forms, and to ensure that information required to be disclosed by Abbott in the reports that it files or submits under the Exchange Act is accumulated and communicated to Abbott’s management, including its principal executive officer and principal financial officer, as appropriate to allow timely decisions regarding required disclosure.</span></div><p style="font-family:'Times New Roman';font-size:12pt;line-height:1.37;text-align:justify;margin:0pt 0pt 0pt 54pt;"><span style="font-size:10pt;margin-left:0pt;visibility:hidden;">​</span></p><div style="font-family:'Times New Roman';font-size:12pt;line-height:1.37;margin-bottom:0pt;margin-left:36pt;margin-top:0pt;padding-left:18pt;text-align:justify;text-indent:-18pt;"><span style="display:inline-block;min-width:18pt;text-indent:0pt;white-space:nowrap;">(b)</span><i style="font-size:10pt;font-style:italic;">Changes in internal control over financial reporting.</i><span style="font-size:10pt;">&nbsp;During the quarter ended September 30, 2019, there were no changes in Abbott’s internal control over financial reporting (as defined in Rule&nbsp;13a-15(f)&nbsp;under the Exchange Act) that have materially affected, or are reasonably likely to materially affect, Abbott’s internal control over financial reporting.</span></div><p style="font-family:'Times New Roman';font-size:12pt;line-height:1.37;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p><a id="_54d30a10_b264_4fc0_aa52_7854bee22cbe"></a><a id="PARTIIOTHERINFORMATION_986810"></a><p style="font-family:'Times New Roman';font-size:1pt;padding-left:18pt;text-indent:-18pt;margin:0pt;"><span style="font-size:10pt;">PART&nbsp;II.</span>&nbsp;<span style="font-size:10pt;">OTHER INFORMATION</span></p><p style="font-family:'Times New Roman';font-size:12pt;padding-left:18pt;text-indent:-18pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p><a id="Item1LegalProceedings_556418"></a><p style="font-family:'Times New Roman';font-size:1pt;padding-left:18pt;text-indent:-18pt;margin:0pt;"><span style="font-size:10pt;text-decoration:underline;text-decoration-color:#000000;">Item&nbsp;1.</span><span style="font-size:10pt;">&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="text-decoration:underline;text-decoration-color:#000000;">&nbsp;</span><span style="font-size:10pt;text-decoration:underline;text-decoration-color:#000000;">Legal Proceedings</span></p><p style="font-family:'Times New Roman';font-size:12pt;padding-left:18pt;text-indent:-18pt;margin:0pt;"><span style="font-size:10pt;text-decoration:underline;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:10pt;text-align:justify;margin:0pt;">Abbott is involved in various claims, legal proceedings and investigations, including those described in our Annual Report on Form&nbsp;10-K for the&nbsp;year ended December&nbsp;31, 2018.</p><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><a id="_ed9ab272_bcca_41c1_9dc7_cf35b24eeb15"></a></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">26</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><a href="#TOC"><span style="font-family:'Times New Roman';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;min-height:11.5pt;"><a id="Item2UnregisteredSalesofEquitySecurities"></a><p style="font-family:'Times New Roman';font-size:10pt;padding-left:18pt;text-indent:-18pt;margin:0pt;"><span style="text-decoration:underline;text-decoration-color:#000000;">Item&nbsp;2.</span>&nbsp;&nbsp;&nbsp;&nbsp;<span style="text-decoration:underline;text-decoration-color:#000000;">Unregistered Sales of Equity Securities and Use of Proceeds</span></p><p style="font-family:'Times New Roman';font-size:12pt;padding-left:18pt;text-indent:-18pt;margin:0pt;"><span style="font-size:9pt;text-decoration:underline;visibility:hidden;">​</span></p><div style="font-family:'Times New Roman';font-size:12pt;line-height:1.37;margin-bottom:0pt;margin-left:36pt;margin-top:0pt;padding-left:18pt;text-indent:-18pt;"><span style="display:inline-block;font-size:10pt;min-width:18pt;text-indent:0pt;white-space:nowrap;">(c)</span><i style="font-size:10pt;font-style:italic;">Issuer Purchases of Equity Securities</i></div><p style="font-family:'Times New Roman';font-size:12pt;line-height:1.37;margin:0pt 0pt 0pt 54pt;"><span style="font-size:9pt;font-style:italic;margin-left:0pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tbody><tr style="height:1pt;"><td style="vertical-align:bottom;width:54.45%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.87%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.8%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.07%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="background-color:auto;vertical-align:bottom;width:54.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&nbsp;&nbsp;&nbsp;&nbsp;</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:6.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&nbsp;&nbsp;&nbsp;&nbsp;</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:7.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&nbsp;&nbsp;&nbsp;&nbsp;</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:11.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&nbsp;&nbsp;&nbsp;&nbsp;</b></p></td><td colspan="2" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:11.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">(d)&nbsp;Maximum</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&nbsp;</b></p></td></tr><tr><td style="background-color:auto;vertical-align:bottom;width:54.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:6.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:7.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:11.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:11.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Number&nbsp;(or</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&nbsp;</b></p></td></tr><tr><td style="background-color:auto;vertical-align:bottom;width:54.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:6.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:7.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:11.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">(c)&nbsp;Total&nbsp;Number</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:11.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Approximate</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&nbsp;</b></p></td></tr><tr><td style="background-color:auto;vertical-align:bottom;width:54.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:6.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:7.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:11.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">of&nbsp;Shares&nbsp;(or</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:11.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Dollar&nbsp;Value)&nbsp;of</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&nbsp;</b></p></td></tr><tr><td style="background-color:auto;vertical-align:bottom;width:54.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:6.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">(a)&nbsp;Total</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:7.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:11.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Units)&nbsp;Purchased</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:11.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Shares&nbsp;(or&nbsp;Units)</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&nbsp;</b></p></td></tr><tr><td style="background-color:auto;vertical-align:bottom;width:54.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:6.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Number&nbsp;of</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:9.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">(b)&nbsp;Average</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:11.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">as&nbsp;Part&nbsp;of</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:11.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">that&nbsp;May&nbsp;Yet&nbsp;Be</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&nbsp;</b></p></td></tr><tr><td style="background-color:auto;vertical-align:bottom;width:54.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:6.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Shares&nbsp;(or</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:9.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Price&nbsp;Paid&nbsp;per</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:11.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Publicly</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:11.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Purchased&nbsp;Under</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&nbsp;</b></p></td></tr><tr><td style="background-color:auto;vertical-align:bottom;width:54.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:6.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Units)</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:9.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Share&nbsp;(or</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:11.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Announced&nbsp;Plans</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:11.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">the&nbsp;Plans&nbsp;or</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&nbsp;</b></p></td></tr><tr><td style="background-color:auto;vertical-align:bottom;width:54.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Period</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:6.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Purchased</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:9.05%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Unit)</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:11.07%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">or&nbsp;Programs</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:11.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Programs</b></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0.05pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&nbsp;</b></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:54.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">July 1, 2019 - July 31, 2019</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:6.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 294</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;"><sup style="font-size:7.5pt;vertical-align:top;">(1)</sup><span style="vertical-align:top;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 88.740</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 0</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 795,235,049</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;"><sup style="font-size:7.5pt;vertical-align:top;">(2)</sup><span style="vertical-align:top;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:54.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">August 1, 2019 - August 31, 2019</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 28,134</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;"><sup style="font-size:7.5pt;vertical-align:top;">(1)</sup><span style="vertical-align:top;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 85.134</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 0</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 795,235,049</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;"><sup style="font-size:7.5pt;vertical-align:top;">(2)</sup><span style="vertical-align:top;visibility:hidden;">​</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:54.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">September 1, 2019 - September 30, 2019</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:6.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 11,800</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;"><sup style="font-size:7.5pt;vertical-align:top;">(1)</sup><span style="vertical-align:top;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 83.354</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 0</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 795,235,049</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;"><sup style="font-size:7.5pt;vertical-align:top;">(2)</sup><span style="vertical-align:top;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:54.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">Total</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 40,228</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;"><sup style="font-size:7.5pt;vertical-align:top;">(1)</sup><span style="vertical-align:top;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 84.638</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">&nbsp;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 0</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 795,235,049</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 0pt;"><sup style="font-size:7.5pt;vertical-align:top;">(2)</sup><span style="vertical-align:top;visibility:hidden;">​</span></p></td></tr></tbody></table><div style="font-family:'Times New Roman';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1px;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"></div></div><table style="border-collapse:collapse;font-family:'Times New Roman';font-size:12pt;line-height:1.37;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tbody><tr><td style="font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">1.</td><td style="padding:0pt;"><span style="color:#000000;font-family:'Times New Roman';font-size:10pt;font-style:normal;font-weight:normal;line-height:1.37;text-align:left;">These shares include:</span></td></tr></tbody></table><p style="font-family:'Times New Roman';font-size:12pt;line-height:1.37;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-family:'Times New Roman';font-size:12pt;line-height:1.37;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tbody><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(i)</td><td style="padding:0pt;"><span style="color:#000000;font-family:'Times New Roman';font-size:10pt;font-style:normal;font-weight:normal;line-height:1.37;text-align:justify;">the shares deemed surrendered to Abbott to pay the exercise price in connection with the exercise of employee stock options – 294 in July, 16,334 in August, and 0 in September; and</span></td></tr></tbody></table><p style="font-family:'Times New Roman';font-size:12pt;line-height:1.37;text-align:justify;margin:0pt 0pt 0pt 54pt;"><span style="font-size:9pt;margin-left:0pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-family:'Times New Roman';font-size:12pt;line-height:1.37;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tbody><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(ii)</td><td style="padding:0pt;"><span style="color:#000000;font-family:'Times New Roman';font-size:10pt;font-style:normal;font-weight:normal;line-height:1.37;text-align:justify;">the shares purchased on the open market for the benefit of participants in the Abbott Laboratories, Limited Employee Stock Purchase Plan – 0 in July, 11,800 in August, and 11,800 in September.</span></td></tr></tbody></table><p style="font-family:'Times New Roman';font-size:12pt;line-height:1.37;text-align:justify;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:10pt;text-align:justify;margin:0pt 0pt 0pt 18pt;">These shares do not include the shares surrendered to Abbott to satisfy tax withholding obligations in connection with the vesting of restricted stock or restricted stock units.</p><p style="font-family:'Times New Roman';font-size:12pt;text-align:justify;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-family:'Times New Roman';font-size:12pt;line-height:1.37;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tbody><tr><td style="font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">2.</td><td style="padding:0pt;"><span style="color:#000000;font-family:'Times New Roman';font-size:10pt;font-style:normal;font-weight:normal;line-height:1.37;text-align:left;white-space:pre-wrap;">On September 11, 2014, the board of directors authorized the repurchase of up to $3 billion of Abbott common shares, from time to time (the “2014 Plan”).  On October 11, 2019, the board of directors authorized the repurchase of up to $3 billion of Abbott common shares, from time to time (the “2019 Plan”).  The 2019 Plan is in addition to the unused portion of the 2014 Plan.</span></td></tr></tbody></table><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><a id="_419e44f1_850b_43db_ae3f_41ae624a5165"></a></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">27</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><a href="#TOC"><span style="font-family:'Times New Roman';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="Item6Exhibits_559085"></a><p style="font-family:'Times New Roman';font-size:10pt;padding-left:18pt;text-indent:-18pt;margin:0pt;"><span style="text-decoration:underline;text-decoration-color:#000000;">Item&nbsp;6.</span>&nbsp;&nbsp;&nbsp;&nbsp;<span style="text-decoration:underline;text-decoration-color:#000000;">Exhibits</span></p><p style="font-family:'Times New Roman';font-size:12pt;padding-left:18pt;text-indent:-18pt;margin:0pt;"><span style="font-size:9pt;text-decoration:underline;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tbody><tr style="height:1pt;"><td style="vertical-align:bottom;width:9.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;width:2.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;width:88.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:9.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">Exhibit&nbsp;No.</b></p></td><td style="vertical-align:bottom;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&nbsp;&nbsp;&nbsp;&nbsp;</b></p></td><td style="vertical-align:bottom;width:88.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Exhibit</b></p></td></tr><tr><td style="vertical-align:top;width:9.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:88.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:top;width:9.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">3.1</p></td><td style="vertical-align:bottom;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:88.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><a href="http://www.sec.gov/Archives/edgar/data/1800/000141057819001152/tv529009_ex3-1.htm"><span style="font-family:'Times New Roman';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">By-Laws of Abbott Laboratories, as amended and restated effective September 9, 2019, filed as Exhibit 3.1 to the Abbott Laboratories Current Report on Form 8-K filed on September 10, 2019.</span></a></p></td></tr><tr><td style="vertical-align:top;width:9.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:88.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:top;width:9.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">31.1</p></td><td style="vertical-align:bottom;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="background-color:auto;vertical-align:bottom;width:88.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><a href="ex-31d1.htm"><span style="font-family:'Times New Roman';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Certification of Chief Executive Officer Required by Rule&nbsp;13a-14(a)&nbsp;(17 CFR 240.13a-14(a)).</span></a></p></td></tr><tr><td style="vertical-align:top;width:9.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:88.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:top;width:9.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">31.2</p></td><td style="vertical-align:bottom;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:88.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><a href="ex-31d2.htm"><span style="font-family:'Times New Roman';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Certification of Chief Financial Officer Required by Rule&nbsp;13a-14(a)&nbsp;(17 CFR 240.13a-14(a)).</span></a></p></td></tr><tr><td style="vertical-align:top;width:9.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:88.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td></tr><tr><td colspan="3" style="vertical-align:top;width:100%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">Exhibits 32.1 and 32.2 are furnished herewith and should not be deemed to be “filed” under the Securities Exchange Act of 1934.</p></td></tr><tr><td style="vertical-align:top;width:9.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:88.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:top;width:9.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">32.1</p></td><td style="vertical-align:bottom;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:88.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><a href="ex-32d1.htm"><span style="font-family:'Times New Roman';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Certification of Chief Executive Officer Pursuant to 18 U.S.C. Section&nbsp;1350, as Adopted Pursuant to Section&nbsp;906 of the Sarbanes-Oxley Act of 2002.</span></a></p></td></tr><tr><td style="vertical-align:top;width:9.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:88.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:top;width:9.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">32.2</p></td><td style="vertical-align:bottom;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:88.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><a href="ex-32d2.htm"><span style="font-family:'Times New Roman';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Certification of Chief Financial Officer Pursuant to 18 U.S.C. Section&nbsp;1350, as Adopted Pursuant to Section&nbsp;906 of the Sarbanes-Oxley Act of 2002.</span></a></p></td></tr><tr><td style="vertical-align:top;width:9.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:88.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:top;width:9.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">101</p></td><td style="vertical-align:bottom;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:88.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">The following financial statements and notes from the Abbott Laboratories Quarterly Report on Form&nbsp;10-Q for the quarter and nine months ended September 30, 2019, formatted in Inline XBRL: (i)&nbsp;Condensed Consolidated Statement of Earnings; (ii)&nbsp;Condensed Consolidated Statement of Comprehensive Income; (iii)&nbsp;Condensed Consolidated Balance Sheet; (iv)&nbsp;Condensed Consolidated Statement of Shareholders' Investment; (v) Condensed Consolidated Statement of Cash Flows; and (vi)&nbsp;Notes&nbsp;to the Condensed Consolidated Financial Statements. </p></td></tr><tr><td style="vertical-align:top;width:9.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:88.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:top;width:9.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">104</p></td><td style="vertical-align:bottom;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:88.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">Cover Page Interactive Data File (the cover page XBRL tags are embedded in the Inline XBRL document and included in Exhibit 101).</p></td></tr></tbody></table><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt 0pt 12pt 0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p><a id="_cdce3c87_ef31_4398_92d0_0e1e9efb3f83"></a></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">28</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><a href="#TOC"><span style="font-family:'Times New Roman';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Table of Contents</span></a></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="SIGNATURE_450348"></a><p style="font-family:'Times New Roman';font-size:10pt;text-align:center;margin:0pt;">SIGNATURE</p><p style="font-family:'Times New Roman';font-size:12pt;text-align:center;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:10pt;text-indent:36pt;margin:0pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</p><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tbody><tr style="height:1pt;"><td style="vertical-align:top;width:4.62%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td><td style="vertical-align:top;width:47.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td><td style="vertical-align:top;width:47.67%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td colspan="2" style="vertical-align:top;width:52.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">ABBOTT LABORATORIES</p></td><td style="vertical-align:top;width:47.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td colspan="2" style="vertical-align:top;width:52.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;width:47.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td></tr><tr><td colspan="2" style="vertical-align:top;width:52.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;width:47.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:top;width:4.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">By:</p></td><td style="vertical-align:top;width:47.7%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:justify;margin:0pt;">/s/ Brian B. Yoor</p></td><td style="vertical-align:top;width:47.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;text-align:justify;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:top;width:4.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;width:47.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">Brian B. Yoor</p></td><td style="vertical-align:top;width:47.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:top;width:4.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;width:47.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">Executive Vice President, Finance<br>and Chief Financial Officer</p></td><td style="vertical-align:top;width:47.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:top;width:4.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;width:47.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;width:47.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:top;width:4.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;width:47.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">Date: October 31, 2019</p></td><td style="vertical-align:top;width:47.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p></td></tr></tbody></table><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:12pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">29</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:avoid;width:88.24%;border:0;"></div>
</div>


	</div>

	<div id="form-information-modal" data-test="form-information-modal" class="reboot dialog-box fixed-dialog-box d-none bg-white">
		<div class="reboot dialog-header bg-sec text-white px-1 d-flex justify-content-between">
			<p id="form-information-modal-title" data-test="form-information-modal-title" class="reboot lead mb-0"></p>
			<div class="reboot dialog-header-actions">
				<i id="form-information-modal-drag" title="Click and drag to move this Dialog Box." class="reboot fas fa-arrows-alt m-1 drag-icon d-none d-sm-inline-block" tabindex="14"></i>

				<i id="dialog-box-copy-content" title="Click to Copy all Dialog Box Content." class="reboot fas fa-copy m-1 click" tabindex="14"></i>

				<i id="dialog-box-close" data-name="Form Information Modal" title="Click to Close this Dialog Box." class="reboot fas fa-times m-1 click" tabindex="14"></i>

			</div>
		</div>
		<div class="reboot dialog-content">
			<div id="form-information-copy-paste" class="reboot form-group d-none">
				<label class="reboot">Copy and Paste Below Content.</label>
				<a id="dialog-content-copy-content" class="reboot float-right click color-inherit" tabindex="14">
					<i class="reboot fas fa-times-circle mt-2"></i>
				</a>
				<textarea class="reboot form-control" rows="5" tabindex="14"></textarea>
			</div>
			<div id="form-information-modal-carousel" class="reboot carousel pointer-event" data-interval="false" data-ride="carousel">
				<div class="reboot carousel-inner">
					<div class="reboot carousel-item table-responsive active">
						<table class="reboot table table-striped table-sm">
							<tbody class="reboot" id="form-information-modal-carousel-page-1" tabindex="14">
								<!-- Below is populated dynamically VIA JS -->
								<tr class="reboot">
									<td class="reboot text-center">
										<i class="reboot fas fa-spinner fa-spin"></i>
									</td>
								</tr>
							</tbody>
						</table>
					</div>
					<div class="reboot carousel-item table-responsive">
						<table class="reboot table table-striped table-bordered table-sm">
							<tbody class="reboot" id="form-information-modal-carousel-page-2" tabindex="14">
								<!-- Below is populated dynamically VIA JS -->
								<tr class="reboot">
									<td class="reboot text-center">
										<i class="reboot fas fa-spinner fa-spin"></i>
									</td>
								</tr>
							</tbody>
						</table>
					</div>
					<div class="reboot carousel-item table-responsive">
						<table class="reboot table table-striped table-sm">
							<tbody class="reboot" id="form-information-modal-carousel-page-3" tabindex="14">
								<!-- Below is populated dynamically VIA JS -->
								<tr class="reboot">
									<td class="reboot text-center">
										<i class="reboot fas fa-spinner fa-spin"></i>
									</td>
								</tr>
							</tbody>
						</table>
					</div>
					<div class="reboot carousel-item table-responsive">
						<table class="reboot table table-striped table-sm">
							<tbody class="reboot" id="form-information-modal-carousel-page-4" tabindex="14">
								<!-- Below is populated dynamically VIA JS -->
								<tr class="reboot">
									<td class="reboot text-center">
										<i class="reboot fas fa-spinner fa-spin"></i>
									</td>
								</tr>
							</tbody>
						</table>
					</div>
				</div>
			</div>
		</div>
		<div class="reboot dialog-footer d-flex justify-content-around">
			<button id="form-information-prev" class="reboot btn btn-link text-dark" href="#form-information-modal-carousel" role="button" data-slide="prev" tabindex="14">
				<i class="reboot fas fa-chevron-left" title="Previous"></i>
				<span class="reboot sr-only">Previous</span>
			</button>
			<ol id="form-information-carousel-indicators" class="reboot carousel-indicators mx-0 my-3 p-initial">
			</ol>
			<button id="form-information-next" data-test="form-information-next" class="reboot btn btn-link text-dark" href="#form-information-modal-carousel" role="button" data-slide="next" tabindex="14">
				<i class="reboot fas fa-chevron-right" title="Next"></i>
				<span class="reboot sr-only">Next</span>
			</button>
		</div>
	</div>

	<div id="settings-modal" data-test="settings-modal" class="reboot dialog-box fixed-dialog-box d-none bg-white">
		<div class="reboot dialog-header bg-sec text-white px-1 d-flex justify-content-between">
			<p id="settings-modal-title" data-test="settings-modal-title" class="reboot lead mb-0">Settings</p>
			<div class="reboot dialog-header-actions">
				<i id="settings-modal-drag" title="Click and drag to move this Dialog Box." class="reboot fas fa-arrows-alt m-1 drag-icon d-none d-sm-inline-block" tabindex="15"></i>

				<i id="settings-modal-close" data-name="Settings Modal" title="Click to Close this Dialog Box." class="reboot fas fa-times m-1 click" tabindex="15"></i>
			</div>
		</div>
		<div class="reboot dialog-content">
			<form class="reboot">
				<div class="reboot form-group row">
					<label class="reboot col-sm-4 col-form-label" tabindex="15">Hover
						over Fact for quick information.</label>
					<select id="hover-option-select" class="reboot col-sm-8 form-control" tabindex="15">
						<option class="reboot" value="true">On</option>
						<option class="reboot" value="false">Off</option>
					</select>
				</div>
				<div class="reboot form-group row">
					<label class="reboot col-sm-4 col-form-label" tabindex="15">Auto
						Scrolling Position</label>
					<select id="scroll-position-select" class="reboot col-sm-8 form-control" tabindex="15">
						<option class="reboot" value="start">Top</option>
						<option class="reboot" value="center">Center</option>
					</select>
					<small class="reboot form-text text-muted col-sm-12" tabindex="15">Selecting
						a fact from the Sections Menu or the Fact Menu will automatically
						scroll that element to the (Top, or Middle) of the viewer window.
						This setting will have no use on IE 10, or Safari.</small>
				</div>
				<hr class="reboot">
				<div class="reboot form-group row">
					<label class="reboot col-sm-4 col-form-label" tabindex="15">
						<span class="reboot tagged-data-example-1">Tagged Data</span>
					</label>
					<div class="reboot col-sm-4">
						<div class="reboot" id="tagged-data-color-picker" tabindex="15"><div class="picker_wrapper layout_default no_alpha no_editor" tabindex="-1"><div class="picker_arrow"></div><div class="picker_hue picker_slider" style="color: rgb(255, 102, 0);"><div class="picker_selector" style="left: 6.66667%;"></div></div><div class="picker_sl" style="background-color: rgb(255, 102, 0); color: rgb(255, 102, 0);"><div class="picker_selector" style="left: 100%; top: 50%;"></div></div><div class="picker_alpha picker_slider" style="background-image: linear-gradient(rgb(255, 102, 0), rgba(255, 102, 0, 0)), url(&quot;data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='2' height='2'%3E%3Cpath d='M1,0H0V1H2V2H1' fill='lightgrey'/%3E%3C/svg%3E&quot;);"><div class="picker_selector" style="top: 0%;"></div></div><div class="picker_editor"><input aria-label="Type a color name or hex value"></div><div class="picker_sample" style="color: rgb(255, 102, 0);"></div><div class="picker_done"><button>Save</button></div><div class="picker_cancel"><button>Reset</button></div></div></div>
					</div>
				</div>
				<hr>
				<div class="reboot form-group row">
					<label class="reboot col-sm-4 col-form-label" tabindex="15">
						<span class="reboot search-results-example-1">Search
							Results</span>
					</label>
					<div class="reboot col-sm-4">
						<div class="reboot" id="search-results-color-picker" tabindex="15"><div class="picker_wrapper layout_default no_alpha no_editor" tabindex="-1"><div class="picker_arrow"></div><div class="picker_hue picker_slider" style="color: rgb(255, 215, 0);"><div class="picker_selector" style="left: 14.0523%;"></div></div><div class="picker_sl" style="background-color: rgb(255, 215, 0); color: rgb(255, 215, 0);"><div class="picker_selector" style="left: 100%; top: 50%;"></div></div><div class="picker_alpha picker_slider" style="background-image: linear-gradient(rgb(255, 215, 0), rgba(255, 215, 0, 0)), url(&quot;data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='2' height='2'%3E%3Cpath d='M1,0H0V1H2V2H1' fill='lightgrey'/%3E%3C/svg%3E&quot;);"><div class="picker_selector" style="top: 0%;"></div></div><div class="picker_editor"><input aria-label="Type a color name or hex value"></div><div class="picker_sample" style="color: rgb(255, 215, 0);"></div><div class="picker_done"><button>Save</button></div><div class="picker_cancel"><button>Reset</button></div></div></div>
					</div>
				</div>
				<hr>
				<div class="reboot form-group row">
					<label class="reboot col-sm-4 col-form-label" tabindex="15">
						<span class="reboot selected-fact-example-1">Selected Fact</span>
					</label>
					<div class="reboot col-sm-4">
						<div class="reboot" id="selected-fact-color-picker" tabindex="15"><div class="picker_wrapper layout_default no_alpha no_editor" tabindex="-1"><div class="picker_arrow"></div><div class="picker_hue picker_slider" style="color: rgb(0, 135, 255);"><div class="picker_selector" style="left: 57.8526%;"></div></div><div class="picker_sl" style="background-color: rgb(0, 135, 255); color: rgb(0, 55, 104);"><div class="picker_selector" style="left: 100%; top: 79.6078%;"></div></div><div class="picker_alpha picker_slider" style="background-image: linear-gradient(rgb(0, 55, 104), rgba(0, 55, 104, 0)), url(&quot;data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='2' height='2'%3E%3Cpath d='M1,0H0V1H2V2H1' fill='lightgrey'/%3E%3C/svg%3E&quot;);"><div class="picker_selector" style="top: 0%;"></div></div><div class="picker_editor"><input aria-label="Type a color name or hex value"></div><div class="picker_sample" style="color: rgb(0, 55, 104);"></div><div class="picker_done"><button>Save</button></div><div class="picker_cancel"><button>Reset</button></div></div></div>
					</div>
				</div>
				<hr>
				<div class="reboot form-group row">
					<label class="reboot col-sm-4 col-form-label" tabindex="15">
						<span class="reboot tag-shading-exmple-1">Tag Shading
							(hover)</span>
					</label>
					<div class="reboot col-sm-4">
						<div class="reboot" id="tag-shading-color-picker" tabindex="15"><div class="picker_wrapper layout_default no_editor" tabindex="-1"><div class="picker_arrow"></div><div class="picker_hue picker_slider" style="color: rgb(255, 0, 0);"><div class="picker_selector" style="left: 0%;"></div></div><div class="picker_sl" style="background-color: rgb(255, 0, 0); color: rgb(255, 0, 0);"><div class="picker_selector" style="left: 100%; top: 50%;"></div></div><div class="picker_alpha picker_slider" style="background-image: linear-gradient(rgb(255, 0, 0), rgba(255, 0, 0, 0)), url(&quot;data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='2' height='2'%3E%3Cpath d='M1,0H0V1H2V2H1' fill='lightgrey'/%3E%3C/svg%3E&quot;);"><div class="picker_selector" style="top: 70%;"></div></div><div class="picker_editor"><input aria-label="Type a color name or hex value"></div><div class="picker_sample" style="color: rgba(255, 0, 0, 0.3);"></div><div class="picker_done"><button>Save</button></div><div class="picker_cancel"><button>Reset</button></div></div></div>
					</div>
				</div>
				<hr>
				<div class="reboot form-group row">
					<label class="reboot col-sm-4 col-form-label" tabindex="15">
						<span class="reboot text-block-exmple-1">Text Block Indicators</span>
					</label>
					<div class="reboot col-sm-4">
						<div class="reboot" id="text-block-color-picker" tabindex="15"><div class="picker_wrapper layout_default no_alpha no_editor" tabindex="-1"><div class="picker_arrow"></div><div class="picker_hue picker_slider" style="color: rgb(0, 135, 255);"><div class="picker_selector" style="left: 57.8526%;"></div></div><div class="picker_sl" style="background-color: rgb(0, 135, 255); color: rgb(0, 55, 104);"><div class="picker_selector" style="left: 100%; top: 79.6078%;"></div></div><div class="picker_alpha picker_slider" style="background-image: linear-gradient(rgb(0, 55, 104), rgba(0, 55, 104, 0)), url(&quot;data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='2' height='2'%3E%3Cpath d='M1,0H0V1H2V2H1' fill='lightgrey'/%3E%3C/svg%3E&quot;);"><div class="picker_selector" style="top: 0%;"></div></div><div class="picker_editor"><input aria-label="Type a color name or hex value"></div><div class="picker_sample" style="color: rgb(0, 55, 104);"></div><div class="picker_done"><button>Save</button></div><div class="picker_cancel"><button>Reset</button></div></div></div>
					</div>
				</div>
			</form>
		</div>
		<div class="reboot dialog-footer d-flex justify-content-around"></div>
	</div>

	<div id="taxonomy-modal" class="reboot dialog-box fixed-dialog-box d-none bg-white">
		<div class="reboot dialog-header bg-sec text-white px-1 d-flex justify-content-between">
			<p id="taxonomy-modal-title" class="reboot lead mb-0"></p>
			<div class="reboot dialog-header-actions">

				<i id="taxonomy-modal-drag" title="Click and drag to move this Dialog Box." class="reboot fas fa-arrows-alt m-1 drag-icon d-none d-sm-inline-block" tabindex="16"></i>

				<i id="taxonomy-modal-jump" title="Click to see this in the Facts sidebar." class="reboot fas fa-directions m-1 click" tabindex="16"></i>
				<i id="taxonomy-modal-copy-content" class="reboot fas fa-copy m-1 click" tabindex="16"></i>

				<i id="taxonomy-modal-compress" class="reboot fas fa-compress m-1 click d-none" tabindex="16"></i>

				<i id="taxonomy-modal-expand" class="reboot fas fa-expand m-1 click d-none" tabindex="16"></i>

				<i id="taxonomy-modal-close" class="reboot fas fa-times m-1 click" tabindex="16"></i>
			</div>
		</div>
		<div class="reboot dialog-content">
			<p id="taxonomy-modal-subtitle" class="reboot text-center font-weight-bold"></p>
			<div id="taxonomy-copy-paste" class="reboot form-group d-none">
				<label>Copy and Paste Below Content.</label>
				<a id="taxonomy-copy-content" class="reboot float-right click color-inherit" tabindex="16">
					<i class="reboot fas fa-times-circle mt-2"></i>
				</a>
				<textarea class="reboot form-control" rows="5" tabindex="16"></textarea>
			</div>
			<div id="taxonomy-modal-carousel" class="reboot carousel" data-interval="false" data-keyboard="false">
				<div class="reboot carousel-inner">
					<div class="reboot carousel-item table-responsive active">
						<table class="reboot table table-striped table-sm" id="taxonomy-modal-carousel-page-1" tabindex="16">
							<!-- Below is populated dynamically VIA JS -->
							<tbody class="reboot">
								<tr class="reboot">
									<td class="reboot text-center">
										<i class="reboot fas fa-spinner fa-spin"></i>
									</td>
								</tr>
							</tbody>
						</table>
					</div>
					<div class="reboot carousel-item table-responsive">
						<table class="reboot table table-striped table-sm" id="taxonomy-modal-carousel-page-2" tabindex="16">
							<!-- Below is populated dynamically VIA JS -->
							<tbody class="reboot">
								<tr class="reboot">
									<td class="reboot text-center">
										<i class="reboot fas fa-spinner fa-spin"></i>
									</td>
								</tr>
							</tbody>
						</table>
					</div>
					<div class="reboot carousel-item table-responsive">
						<table class="reboot table table-striped table-sm" id="taxonomy-modal-carousel-page-3" tabindex="16">
							<!-- Below is populated dynamically VIA JS -->
							<tbody class="reboot">
								<tr class="reboot">
									<td class="reboot text-center">
										<i class="reboot fas fa-spinner fa-spin"></i>
									</td>
								</tr>
							</tbody>
						</table>
					</div>
					<div class="reboot carousel-item table-responsive">
						<table class="reboot table table-striped table-sm" id="taxonomy-modal-carousel-page-4" tabindex="16">
							<!-- Below is populated dynamically VIA JS -->
							<tbody class="reboot">
								<tr class="reboot">
									<td class="reboot text-center">
										<i class="reboot fas fa-spinner fa-spin"></i>
									</td>
								</tr>
							</tbody>
						</table>
					</div>
				</div>
			</div>
		</div>
		<div class="reboot dialog-footer d-flex justify-content-around">
			<button data-test="modal-taxonomy-prev" class="reboot btn btn-link text-dark" href="#taxonomy-modal-carousel" role="button" data-slide="prev" tabindex="16">
				<i class="reboot fas fa-chevron-left" title="Previous"></i>
				<span class="reboot sr-only">Previous</span>
			</button>
			<ol id="taxonomy-modal-carousel-indicators" class="reboot carousel-indicators mx-0 my-3 p-initial">
			</ol>
			<button data-test="modal-taxonomy-next" class="reboot btn btn-link text-dark" href="#taxonomy-modal-carousel" role="button" data-slide="next" tabindex="16">
				<i class="reboot fas fa-chevron-right" title="Next"></i>
				<span class="reboot sr-only">Next</span>
			</button>
		</div>
	</div>

	<div id="taxonomy-nested-modal" class="reboot dialog-box fixed-dialog-box d-none bg-white">
		<div class="reboot dialog-header bg-sec text-white px-1 d-flex justify-content-between">
			<p class="reboot lead mb-0">
				Nested Facts
				<span class="reboot" id="nested-page"></span>
				<span class="reboot">/</span>
				<span class="reboot" id="nested-count"></span>
			</p>
			<div class="reboot dialog-header-actions">
				<i id="taxonomy-nested-modal-drag" title="Click and drag to move this Dialog Box." class="reboot fas fa-arrows-alt m-1 drag-icon d-none d-sm-inline-block" tabindex="17"></i>

				<i id="nested-taxonomy-modal-jump" title="Click to see this in the Facts sidebar." class="reboot fas fa-directions m-1 click" tabindex="17"></i>

				<i id="taxonomy-nested-modal-copy-content" class="reboot fas fa-copy m-1 click" tabindex="17"></i>

				<i id="taxonomy-nested-modal-compress" class="reboot fas fa-compress m-1 click d-none" tabindex="17"></i>

				<i id="taxonomy-nested-modal-expand" class="reboot fas fa-expand m-1 click d-none" tabindex="17"></i>

				<i id="taxonomy-nested-modal-close" class="reboot fas fa-times m-1 click" tabindex="17"></i>
			</div>
		</div>
		<div class="reboot dialog-content pt-0">
			<div id="modal-nested-fact-labels" class="reboot carousel" data-interval="false" data-keyboard="false">
				<div class="reboot d-flex">
					<button data-test="modal-taxonomy-nested-prev" class="reboot btn btn-link text-dark" href="#modal-nested-fact-labels" role="button" data-slide="prev" tabindex="17">
						<i class="reboot fas fa-chevron-left" title="Previous"></i>
						<span class="reboot sr-only">Previous</span>
					</button>
					<div id="modal-taxonomy-nested-label-carousel" class="reboot carousel-inner">
						<!-- Below is populated dynamically VIA JS -->
					</div>
					<button data-test="modal-taxonomy-nested-next" class="reboot btn btn-link text-dark" href="#modal-nested-fact-labels" role="button" data-slide="next" tabindex="17">
						<i class="reboot fas fa-chevron-right" title="Next"></i>
						<span class="reboot sr-only">Next</span>
					</button>
				</div>
			</div>
			<div id="taxonomy-nested-copy-paste" class="reboot form-group d-none">
				<label class="reboot">Copy and Paste Below Content.</label>
				<a id="taxonomy-nested-copy-content" class="reboot float-right click color-inherit" tabindex="17">
					<i class="reboot fas fa-times-circle mt-2"></i>
				</a>
				<textarea class="reboot form-control" rows="5" tabindex="17"></textarea>
			</div>
			<div id="modal-taxonomy-nested-content-carousel" class="reboot carousel" data-interval="false" data-keyboard="false">
				<div class="reboot carousel-inner">
					<div class="reboot carousel-item table-responsive active">
						<table class="reboot table table-striped table-sm">
							<tbody class="reboot" id="modal-taxonomy-nested-content-carousel-page-1" tabindex="17">
								<!-- Below is populated dynamically VIA JS -->
								<tr class="reboot">
									<td class="reboot text-center">
										<i class="reboot fas fa-spinner fa-spin"></i>
									</td>
								</tr>
							</tbody>
						</table>
					</div>
					<div class="reboot carousel-item table-responsive">
						<table class="reboot table table-striped table-bordered table-sm">
							<tbody class="reboot" id="modal-taxonomy-nested-content-carousel-page-2" tabindex="17">
								<!-- Below is populated dynamically VIA JS -->
								<tr class="reboot">
									<td class="reboot text-center">
										<i class="reboot fas fa-spinner fa-spin"></i>
									</td>
								</tr>
							</tbody>
						</table>
					</div>
					<div class="reboot carousel-item table-responsive">
						<table class="reboot table table-striped table-sm">
							<tbody class="reboot" id="modal-taxonomy-nested-content-carousel-page-3" tabindex="17">
								<!-- Below is populated dynamically VIA JS -->
								<tr class="reboot">
									<td class="reboot text-center">
										<i class="reboot fas fa-spinner fa-spin"></i>
									</td>
								</tr>
							</tbody>
						</table>
					</div>
					<div class="reboot carousel-item table-responsive">
						<table class="reboot table table-striped table-sm">
							<tbody class="reboot" id="modal-taxonomy-nested-content-carousel-page-4" tabindex="17">
								<!-- Below is populated dynamically VIA JS -->
								<tr class="reboot">
									<td class="reboot text-center">
										<i class="reboot fas fa-spinner fa-spin"></i>
									</td>
								</tr>
							</tbody>
						</table>
					</div>
				</div>
			</div>
		</div>
		<div id="taxonomy-nested-nav-controls" class="reboot dialog-footer d-flex justify-content-around">
			<button data-test="modal-taxonomy-prev" class="reboot btn btn-link text-dark" href="#modal-taxonomy-nested-content-carousel" role="button" data-slide="prev" tabindex="17">
				<i class="reboot fas fa-chevron-left" title="Previous"></i>
				<span class="reboot sr-only">Previous</span>
			</button>
			<ol id="taxonomy-nested-modal-carousel-indicators" class="reboot carousel-indicators mx-0 my-3 p-initial">
				<!-- Below is populated dynamically VIA JS -->
			</ol>
			<button data-test="modal-taxonomy-next" class="reboot btn btn-link text-dark" href="#modal-taxonomy-nested-content-carousel" role="button" data-slide="next" tabindex="17">
				<i class="reboot fas fa-chevron-right" title="Next"></i>
				<span class="reboot sr-only">Next</span>
			</button>
		</div>
	</div>



</body></html>